%PDF-1.3
1 0 obj
<<
/Type /Pages
/Count 33
/Kids [ 3 0 R 4 0 R 5 0 R 6 0 R 7 0 R 8 0 R 9 0 R 10 0 R 11 0 R 12 0 R 13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R ]
>>
endobj
2 0 obj
<<
/Producer (PyPDF2)
>>
endobj
3 0 obj
<<
/Contents 37 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/Font <<
/C2_0 38 0 R
/C2_1 46 0 R
/F1 49 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
4 0 obj
<<
/Contents 50 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/Font <<
/C2_0 38 0 R
/T1_0 51 0 R
/F1 52 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
5 0 obj
<<
/Contents 53 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 63 0 R
/TT2 65 0 R
/F1 67 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
6 0 obj
<<
/Contents 68 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 63 0 R
/F1 69 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
7 0 obj
<<
/Contents 70 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 63 0 R
/F1 71 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
8 0 obj
<<
/Contents 72 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 63 0 R
/F1 73 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
9 0 obj
<<
/Contents 74 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/F1 75 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
10 0 obj
<<
/Contents 76 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 77 0 R
/F1 79 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
11 0 obj
<<
/Contents 80 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 81 0 R
/F1 84 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
12 0 obj
<<
/Contents 85 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 63 0 R
/F1 86 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
13 0 obj
<<
/Contents 87 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/F1 88 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
14 0 obj
<<
/Contents 89 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 90 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
15 0 obj
<<
/Contents 91 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 92 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
16 0 obj
<<
/Contents 93 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 94 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
17 0 obj
<<
/Contents 95 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/F1 96 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
18 0 obj
<<
/Contents 97 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 98 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
19 0 obj
<<
/Contents 99 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/TT2 63 0 R
/F1 100 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
20 0 obj
<<
/Contents 101 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/C2_1 102 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 108 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
21 0 obj
<<
/Contents 109 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 110 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
22 0 obj
<<
/Contents 111 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 112 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
23 0 obj
<<
/Contents 113 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/F1 114 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
24 0 obj
<<
/Contents 115 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 63 0 R
/TT2 65 0 R
/F1 116 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
25 0 obj
<<
/Contents 117 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 63 0 R
/F1 118 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
26 0 obj
<<
/Contents 119 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 63 0 R
/TT2 65 0 R
/F1 120 0 R
>>
/ColorSpace <<
/CS0 121 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
27 0 obj
<<
/Contents 123 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 124 0 R
>>
/ColorSpace <<
/CS0 121 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
28 0 obj
<<
/Contents 125 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 126 0 R
>>
/ColorSpace <<
/CS0 121 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
29 0 obj
<<
/Contents 127 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 128 0 R
>>
/ColorSpace <<
/CS0 121 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
30 0 obj
<<
/Contents 129 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 130 0 R
>>
/ColorSpace <<
/CS0 121 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
31 0 obj
<<
/Contents 131 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 132 0 R
>>
/ColorSpace <<
/CS0 121 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
32 0 obj
<<
/Contents 133 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/TT1 65 0 R
/F1 134 0 R
>>
/ColorSpace <<
/CS0 121 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
33 0 obj
<<
/Contents 135 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/F1 136 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
34 0 obj
<<
/Contents 137 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/C2_1 138 0 R
/TT0 61 0 R
/F1 144 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
35 0 obj
<<
/Contents 145 0 R
/CropBox [ 0 0 612 792 ]
/MediaBox [ 0 0 612 792 ]
/Parent 1 0 R
/Resources <<
/ExtGState <<
/GS0 54 0 R
>>
/Font <<
/C2_0 55 0 R
/TT0 61 0 R
/F1 146 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Rotate 0
/Type /Page
/Annots [ ]
>>
endobj
36 0 obj
<<
/Type /Catalog
/Pages 1 0 R
>>
endobj
37 0 obj
<<
/Length 8090
>>
stream
q
BT
/C2_0 12 Tf
217.83 710 Td
<00310025002800350003003a00320035002e002c0031002a0003003300240033002800350003003600280035002c00280036> Tj
-58.824 -100 Td
<00330035002c0026002c0031002a0003002c003100030037002b00280003003000240035002e0028003700030029003200350003002400310037002c0026002400310026002800350003002700350038002a0036> Tj
104.172 -28 Td
<002700440059004c00470003002b00110003002b0052005a004400550047> Tj
9.66 -14 Td
<003300480057004800550003002500110003002500440046004b> Tj
-4.338 -14 Td
<002800550051005600570003003500110003002500480055005100470057> Tj
1.998 -14 Td
<003500480051004400030030001100030026005200510057004c> Tj
-17.49 -28 Td
<003a00520055004e004c0051004a000300330044005300480055000300150013001b0019001a> Tj
-34.332 -14 Td
<004b005700570053001d00120012005a005a005a00110051004500480055001100520055004a00120053004400530048005500560012005a00150013001b0019001a> Tj
-45.336 -42 Td
<003100240037002c003200310024002f00030025003800350028002400380003003200290003002800260032003100320030002c002600030035002800360028002400350026002b> Tj
64.338 -14 Td
<00140013001800130003003000440056005600440046004b0058005600480057005700560003002400590048005100580048> Tj
12.492 -14 Td
<00260044005000450055004c0047004a0048000f00030030002400030013001500140016001b> Tj
23.67 -14 Td
<002d00440051005800440055005c00030015001300140018> Tj
95.5976 Tz
-201.84 -130 Td
<002700440059004c00470003002b00110003002b0052005a0044005500470003004b0044005600030055004800460048004c0059004800470003004a005500440051005700030049005800510047005600030049005500520050000300330049004c005d00480055000f0003002c0051004600110003004900520055000300440003005300550052004d00480046005700030058005100550048004f004400570048004700030057005200030057004b004c005600030056005700580047005c0011000300330048005700480055> Tj
97.3151 Tz
0 -14 TD
<002500110003002500440046004b0003004c005600030044000300460052005100560058004f005700440051005700030057005200030029005200580051004700440057004c005200510003003000480047004c0046004c0051004800030044005100470003004b0044005600030055004800460048004c00590048004700030056005300480044004e004c0051004a00030049004800480056000300490055005200500003002a0048005100480051005700480046004b000f00030057004b0048> Tj
97.9776 Tz
T*
<0025004c0052005700480046004b00510052004f0052004a005c0003002c005100470058005600570055005c000300320055004a00440051004c005d00440057004c005200510003000b0025002c0032000c000f00030030003300300003002600440053004c00570044004f000f0003002a0052004f00470050004400510003003600440046004b0056000f00030057004b00480003002500520056005700520051000300260052005100560058004f0057004c0051004a> Tj
100 Tz
T*
<002a00550052005800530003004400510047000300300046002e004c005100560048005c000300090003002600520050005300440051005c00110003002800550051005600570003003500110003002500480055005100470057000300560048005500590048005600030044005600030044005100030058005100530044004c0047000300500048005000450048005500030052004900030057004b00480003002400460044004700480050004c0046> Tj
95.7 Tz
T*
<002400470059004c005600520055005c> Tj
/C2_1 12 Tf
<0003> Tj
/C2_0 12 Tf
<0033004400510048004f00030057005200030057004b00480003002c003000360003002c005100560057004c005700580057004800030049005200550003002b00480044004f0057004b00460044005500480003002c0051004900520055005000440057004c0046005600110003003500480051004400030030001100030026005200510057004c00030055004800460048004c00590048004700030049005800510047004c0051004a00030049005500520050> Tj
96.4 Tz
T*
<00440003002e0013001a> Tj
/C2_1 12 Tf
<0003> Tj
/C2_0 12 Tf
<0026002400140016001b001c0013001900030044005a0044005500470003004900550052005000030057004b00480003003100440057004c005200510044004f00030026004400510046004800550003002c005100560057004c005700580057004800030057005200030057004b0048000300380051004c0059004800550056004c0057005c00030052004900030026004b004c00460044004a0052001100030037004b004c00560003004400550057004c0046004f0048> Tj
99.5 Tz
0 -14 Td
<004c005600030049005200550057004b004600520050004c0051004a> Tj
/C2_1 12 Tf
1 0 0 1 102.8403 214 Tm
39.14 -14 Td
<0003> Tj
/C2_0 12 Tf
<004c005100030057004b00480003003a004c00510057004800550003000b0029004800450055005800440055005c00030015001300140018000c0003004c005600560058004800030052004900030057004b00480003002d00520058005500510044004f0003005200490003002800460052005100520050004c0046000300330048005500560053004800460057004c005900480056000f00030058005600480047> Tj
98.6 Tz
-69.98 -14 Td
<005a004c0057004b00030053004800550050004c00560056004c005200510011> Tj
/C2_1 12 Tf
<0003> Tj
/C2_0 12 Tf
<0037004b004800030059004c0048005a005600030048005b00530055004800560056004800470003004b004800550048004c0051000300440055004800030057004b00520056004800030052004900030057004b00480003004400580057004b00520055005600030044005100470003004700520003005100520057000300510048004600480056005600440055004c004f005c0003005500480049004f004800460057> Tj
100 Tz
0 -14 Td
<0057004b004800030059004c0048005a005600030052004900030057004b0048> Tj
/C2_1 12 Tf
<0003> Tj
/C2_0 12 Tf
1 0 0 1 151.32 172 Tm
<003100440057004c005200510044004f00030025005800550048004400580003005200490003002800460052005100520050004c004600030035004800560048004400550046004b0011> Tj
95.7267 Tz
-79.32 -28 Td
<00310025002800350003005a00520055004e004c0051004a0003005300440053004800550056000300440055004800030046004c005500460058004f0044005700480047000300490052005500030047004c00560046005800560056004c00520051000300440051004700030046005200500050004800510057000300530058005500530052005600480056001100030037004b0048005c0003004b004400590048000300510052005700030045004800480051000300530048004800550010> Tj
99.6678 Tz
T*
<005500480059004c0048005a00480047000300520055000300450048004800510003005600580045004d00480046005700030057005200030057004b00480003005500480059004c0048005a00030045005c00030057004b00480003003100250028003500030025005200440055004700030052004900030027004c005500480046005700520055005600030057004b00440057000300440046004600520050005300440051004c004800560003005200490049004c0046004c0044004f> Tj
100 Tz
T*
<00310025002800350003005300580045004f004c004600440057004c0052005100560011> Tj
95.7572 Tz
0 -28 TD
<008b0003001500130014001800030045005c0003002700440059004c00470003002b00110003002b0052005a004400550047000f0003003300480057004800550003002500110003002500440046004b000f0003002800550051005600570003003500110003002500480055005100470057000f00030044005100470003003500480051004400030030001100030026005200510057004c001100030024004f004f00030055004c004a004b005700560003005500480056004800550059004800470011> Tj
92.6828 Tz
0 -14 TD
<0036004b00520055005700030056004800460057004c005200510056000300520049000300570048005b0057000f000300510052005700030057005200030048005b004600480048004700030057005a005200030053004400550044004a005500440053004b0056000f000300500044005c00030045004800030054005800520057004800470003005a004c0057004b00520058005700030048005b0053004f004c0046004c005700030053004800550050004c00560056004c0052005100030053005500520059004c004700480047> Tj
100 Tz
T*
<0057004b00440057000300490058004f004f00030046005500480047004c0057000f0003004c00510046004f00580047004c0051004a0003008b0003005100520057004c00460048000f0003004c00560003004a004c00590048005100030057005200030057004b004800030056005200580055004600480011> Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0.9 0.9 0.9 RG
n
217 710 176 8 re
S
0.9 0.9 0.9 RG
n
159 610 294 8 re
S
0.9 0.9 0.9 RG
n
263 582 86 8 re
S
0.9 0.9 0.9 RG
n
272 568 66 8 re
S
0.9 0.9 0.9 RG
n
268 554 75 8 re
S
0.9 0.9 0.9 RG
n
270 540 71 8 re
S
0.9 0.9 0.9 RG
n
253 512 106 8 re
S
0.9 0.9 0.9 RG
n
218 498 175 8 re
S
0.9 0.9 0.9 RG
n
173 456 265 8 re
S
0.9 0.9 0.9 RG
n
237 442 137 8 re
S
0.9 0.9 0.9 RG
n
250 428 112 8 re
S
0.9 0.9 0.9 RG
n
273 414 64 8 re
S
0.9 0.9 0.9 RG
n
71 284 468 8 re
S
0.9 0.9 0.9 RG
n
71 270 468 8 re
S
0.9 0.9 0.9 RG
n
71 256 468 8 re
S
0.9 0.9 0.9 RG
n
71 242 468 8 re
S
0.9 0.9 0.9 RG
n
71 228 468 8 re
S
0.9 0.9 0.9 RG
n
71 214 467 8 re
S
0.9 0.9 0.9 RG
n
71 200 467 8 re
S
0.9 0.9 0.9 RG
n
72 186 467 8 re
S
0.9 0.9 0.9 RG
n
72 172 273 8 re
S
0.9 0.9 0.9 RG
n
72 144 468 8 re
S
0.9 0.9 0.9 RG
n
72 130 468 8 re
S
0.9 0.9 0.9 RG
n
72 116 97 8 re
S
0.9 0.9 0.9 RG
n
72 88 468 8 re
S
0.9 0.9 0.9 RG
n
72 74 468 8 re
S
0.9 0.9 0.9 RG
n
72 60 275 8 re
S
Q

endstream
endobj
38 0 obj
<<
/BaseFont /RUYVXP+TimesNewRoman
/DescendantFonts 39 0 R
/Encoding /Identity-H
/Subtype /Type0
/ToUnicode 45 0 R
/Type /Font
>>
endobj
39 0 obj
[ 40 0 R ]
endobj
40 0 obj
<<
/BaseFont /RUYVXP+TimesNewRoman
/CIDSystemInfo 41 0 R
/CIDToGIDMap /Identity
/DW 1000
/FontDescriptor 42 0 R
/Subtype /CIDFontType2
/Type /Font
/W [ 0 [ 778 0 250 250 333 408 500 500 833 778 180 333 333 500 564 250 333 250 278 500 500 500 500 500 500 500 500 500 500 278 278 564 564 564 444 921 722 667 667 722 611 556 722 722 333 389 722 611 889 722 722 556 722 667 556 611 722 722 944 722 722 611 333 278 333 469 500 333 444 500 444 500 444 333 500 500 278 278 500 278 778 500 500 500 500 333 389 278 500 500 722 500 500 444 480 200 480 541 722 722 667 611 722 722 722 444 444 444 444 444 444 444 444 444 444 444 278 278 278 278 500 500 500 500 500 500 500 500 500 500 500 400 500 500 500 350 453 500 760 760 980 333 333 549 889 722 713 549 549 549 500 576 494 713 823 549 274 276 310 768 667 500 444 333 564 549 500 549 612 500 500 ] 172 [ 722 722 722 889 722 500 ] 179 [ 444 444 333 333 549 494 500 722 167 500 333 333 556 556 500 250 333 444 ] 198 [ 722 611 722 611 611 333 333 333 333 722 722 722 722 722 722 278 333 333 333 333 333 333 333 333 333 333 611 278 556 389 611 444 200 722 500 722 500 556 500 564 564 300 300 300 750 750 750 500 722 500 333 556 389 667 444 667 444 500 500 333 722 444 722 444 722 646 722 611 444 611 444 611 278 611 406 611 344 722 500 722 500 722 500 667 333 667 333 556 389 611 278 611 427 722 500 722 500 611 444 611 444 578 722 731 524 471 420 539 402 577 500 573 315 969 ] 313 [ 500 ] 315 [ 500 ] 317 [ 500 500 979 722 564 600 564 604 604 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 708 729 604 ] 376 [ 990 990 990 990 604 604 604 1021 1052 917 750 750 531 656 594 510 500 750 708 552 604 219 417 833 479 604 354 354 604 354 722 444 667 444 667 444 611 444 611 444 611 444 722 500 722 500 722 500 722 500 722 500 333 278 333 278 333 278 333 278 389 278 722 500 500 611 278 722 500 702 495 722 500 722 500 667 333 556 389 611 278 722 500 722 500 722 500 722 500 944 722 722 500 278 722 444 889 667 722 500 278 944 722 944 722 944 722 722 500 333 333 500 600 750 750 750 750 333 333 333 333 722 694 808 411 722 816 743 269 722 667 643 611 611 722 333 722 725 889 722 643 722 722 556 582 611 722 722 738 743 333 722 524 420 523 269 495 509 442 414 523 479 269 504 485 536 452 446 500 499 396 495 444 626 658 269 495 500 495 658 611 752 578 660 556 333 333 389 872 872 741 667 708 722 722 574 667 578 682 611 896 501 722 722 667 678 889 722 722 722 556 667 611 708 790 722 722 650 1009 1009 706 872 574 660 1028 667 444 509 472 410 509 444 691 395 535 535 486 499 633 535 500 535 500 444 437 500 648 500 535 503 770 770 517 672 456 429 747 460 444 483 410 429 389 278 278 278 727 723 500 486 500 535 450 351 ] 651 [ 954 505 0 0 0 0 0 0 0 0 0 0 0 0 0 356 0 291 0 0 278 481 455 335 419 471 279 286 477 476 267 452 433 432 507 485 274 305 475 454 454 440 482 460 474 469 610 500 557 545 533 209 372 776 279 452 452 432 432 454 610 610 610 610 481 481 481 455 335 419 471 279 309 476 267 452 433 432 485 305 475 454 440 460 474 469 610 500 279 455 433 440 502 0 0 0 0 319 319 356 413 207 0 0 0 0 0 0 0 0 526 526 526 526 526 526 526 526 526 526 526 319 526 750 750 282 750 526 526 526 750 750 750 750 750 0 750 750 750 750 750 750 750 750 638 750 750 750 713 713 244 244 750 750 750 750 563 526 530 530 489 489 812 933 394 515 812 933 394 515 638 588 375 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 0 0 0 0 0 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 500 ] 864 [ 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 319 319 750 616 413 207 229 207 229 432 432 207 229 638 588 244 244 207 229 713 713 244 244 282 375 713 713 244 244 713 713 244 244 563 526 530 530 563 526 530 530 563 526 530 530 337 337 337 337 489 489 489 489 821 821 531 531 821 821 531 531 1098 1098 846 846 1098 1098 846 846 582 582 582 582 582 582 582 582 544 450 526 394 544 450 526 394 789 789 268 263 582 582 268 263 601 601 394 394 506 506 207 207 338 338 394 394 526 526 244 244 282 375 450 394 432 432 638 588 638 588 244 244 544 601 544 601 544 601 544 601 750 750 0 0 750 750 750 0 0 750 750 0 0 750 750 750 0 0 0 0 0 0 750 0 0 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 319 319 319 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 750 125 ] 1129 [ 2000 722 529 776 542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 513 750 750 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 278 722 444 722 444 722 444 722 444 722 444 722 444 722 444 722 444 722 444 722 444 722 444 722 444 611 444 611 444 611 444 611 444 611 444 611 444 611 444 611 444 333 278 333 278 722 500 722 500 722 500 722 500 722 500 722 500 722 500 722 529 722 529 722 529 722 529 722 529 722 500 722 500 776 542 776 542 776 542 776 542 776 542 722 500 722 500 722 500 722 444 333 278 722 500 722 500 722 500 722 500 722 500 722 500 0 0 0 0 578 410 896 691 667 486 667 486 722 535 722 500 722 500 722 500 650 503 650 500 722 444 722 500 713 244 268 263 582 244 244 244 244 244 244 269 0 207 333 333 0 207 0 0 207 229 207 229 207 229 207 229 432 432 432 432 638 588 713 713 244 244 713 713 244 244 713 713 244 244 713 713 244 244 713 713 244 244 713 713 244 244 713 713 244 244 563 526 530 530 563 526 530 530 563 526 530 530 563 526 530 530 563 526 530 530 563 526 530 530 337 337 337 337 337 337 337 337 337 337 337 337 337 337 337 337 337 337 489 489 489 489 489 489 489 489 489 489 489 489 489 489 489 489 821 821 531 531 821 821 531 531 821 821 531 531 1098 1098 846 846 1098 1098 846 846 582 582 544 450 526 394 789 789 789 268 263 789 789 268 263 789 789 268 263 789 789 268 263 789 789 268 263 582 582 582 582 1155 1155 906 906 812 933 394 515 601 601 394 394 601 601 394 394 601 601 394 394 812 933 394 515 812 933 394 515 812 933 394 515 812 933 394 515 812 933 394 515 506 506 207 207 506 506 207 207 506 506 207 207 506 506 207 207 526 526 244 244 526 526 526 526 526 526 244 244 526 526 563 526 530 530 282 375 388 388 388 432 432 432 432 432 432 432 432 432 432 432 432 432 432 432 432 638 588 638 588 244 244 432 432 638 588 244 244 638 588 812 812 812 812 207 0 0 0 0 0 0 0 1123 1084 0 0 0 0 0 0 194 370 0 0 600 0 0 0 821 821 531 531 1098 1098 846 846 544 450 526 394 413 338 282 244 320 244 244 244 244 244 812 933 267 0 342 533 544 601 544 601 544 601 544 601 544 601 544 601 544 601 526 526 544 601 500 760 574 500 574 500 667 667 444 722 815 574 500 471 611 501 556 722 722 770 253 333 722 500 278 485 816 722 500 722 925 691 650 500 556 556 389 582 344 278 611 278 611 743 722 781 500 611 444 539 539 444 444 500 500 443 422 500 200 281 249 333 1333 1166 944 ] 1740 [ 889 556 1111 ] 1744 [ 778 444 722 444 0 722 444 889 667 722 500 722 500 722 500 722 500 722 500 539 444 278 1333 1166 944 722 500 950 560 722 500 722 444 722 444 611 444 611 444 333 278 333 278 722 500 722 500 667 333 667 333 722 500 722 500 556 389 611 278 563 395 722 500 650 604 500 611 444 722 444 611 444 722 500 0 722 500 722 500 722 500 722 500 444 523 523 500 444 444 500 500 444 627 420 420 588 443 333 500 500 453 500 444 500 500 500 278 269 278 278 278 278 578 778 778 778 500 500 497 500 630 658 553 333 333 333 333 333 333 333 488 488 389 333 333 436 333 278 278 500 549 470 500 722 500 493 444 496 444 444 444 444 444 444 722 472 443 453 535 278 500 430 500 444 444 802 845 853 565 460 649 788 566 560 514 481 321 321 155 217 217 217 293 428 297 219 365 333 333 333 333 333 248 248 564 564 564 564 333 333 333 333 333 333 333 278 278 333 333 333 333 333 333 333 382 293 166 212 289 248 383 383 383 383 383 333 333 333 333 444 542 542 542 542 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 542 383 542 542 542 542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 333 333 333 509 495 722 890 722 526 658 560 722 500 667 420 556 447 576 451 731 554 828 778 616 521 661 444 542 542 656 581 699 509 475 386 560 509 444 278 722 405 405 611 722 444 535 1172 633 671 543 968 677 722 590 1033 834 896 691 1208 935 501 395 738 626 722 500 813 589 813 589 1095 880 763 566 1213 792 0 1172 633 667 444 334 0 0 0 0 0 0 722 535 574 470 556 500 631 515 501 395 667 486 786 573 851 623 1032 789 667 444 667 444 611 437 797 603 650 503 878 546 878 546 333 896 691 667 515 678 499 722 535 722 535 650 503 889 633 535 722 444 722 444 889 667 611 444 722 444 896 691 501 395 501 444 722 535 722 535 722 500 722 500 660 429 708 500 708 500 708 500 650 503 872 672 574 500 804 771 802 706 574 453 907 752 950 788 722 453 696 602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 444 667 500 667 500 667 500 667 444 722 500 722 500 722 500 722 500 722 500 611 444 611 444 611 444 611 444 611 444 556 333 722 500 722 500 722 500 722 500 722 500 722 500 333 278 333 278 722 500 722 500 722 500 611 278 611 278 611 278 611 278 889 778 889 778 889 778 722 500 722 500 722 500 722 500 722 500 722 500 722 500 722 500 556 500 556 500 667 333 667 333 667 333 667 333 556 389 556 389 556 389 556 389 556 389 611 278 611 278 611 278 611 278 722 500 722 500 722 500 722 500 722 500 722 500 722 500 944 722 944 722 722 500 722 500 722 500 611 444 611 444 611 444 500 278 722 500 444 278 524 524 524 524 524 524 524 524 722 722 791 791 791 791 791 791 420 420 420 420 420 420 748 748 904 904 904 904 523 523 523 523 523 523 523 523 859 859 1016 1016 1016 1016 1016 1016 269 269 269 269 269 269 269 269 470 470 626 626 626 626 626 626 500 500 500 500 500 500 791 791 996 996 898 898 495 495 495 495 495 495 495 495 859 1021 1021 1021 658 658 658 658 658 658 658 658 812 812 998 998 929 929 929 929 524 524 420 420 523 523 269 269 500 500 495 495 658 658 524 524 524 524 524 524 524 524 722 722 791 791 791 791 791 791 523 523 523 523 523 523 523 523 859 859 1016 1016 1016 1016 1016 1016 658 658 658 658 658 658 658 658 812 812 998 998 929 929 929 929 524 524 524 524 524 524 524 722 722 722 722 722 333 333 333 333 333 523 523 523 523 523 748 759 860 871 722 333 333 333 269 269 269 269 269 269 333 333 471 481 333 333 333 495 495 495 495 499 499 495 495 722 722 879 900 693 333 333 333 658 658 658 658 658 850 773 861 774 743 333 333 617 667 667 778 722 1102 944 722 611 ] 2824 [ 500 594 0 0 0 0 278 278 500 556 500 278 500 317 625 616 333 333 333 333 333 333 333 333 333 278 333 333 333 333 397 397 333 0 0 0 0 0 0 0 0 0 0 0 556 500 502 645 667 465 478 524 524 444 395 278 296 540 445 633 535 500 478 542 538 542 722 437 500 500 456 460 460 437 537 505 655 504 500 722 444 395 397 539 410 500 535 456 528 499 422 538 387 387 430 370 370 433 440 200 247 458 371 540 462 441 418 336 332 410 362 453 554 273 273 314 390 310 311 256 256 242 242 301 164 315 489 282 288 256 288 288 311 191 328 306 489 294 319 282 265 271 334 282 164 229 328 294 282 265 296 334 282 741 1300 759 919 657 239 544 0 0 0 0 0 0 0 0 0 337 337 489 489 450 394 450 394 628 565 618 579 578 654 615 646 564 0 0 0 500 444 417 207 207 207 207 793 1221 500 ] 3024 [ 500 ] 3026 [ 333 250 167 500 250 200 83 0 667 889 633 761 774 772 722 667 500 611 611 389 444 534 0 0 0 0 0 499 667 667 667 578 410 0 0 0 305 0 263 289 0 0 0 0 0 0 0 713 713 244 244 713 713 244 244 713 713 244 244 713 713 244 244 713 713 244 244 713 713 244 244 713 713 244 244 563 526 530 530 563 526 530 530 337 337 337 337 489 489 821 821 531 531 544 450 526 394 544 450 526 394 544 450 526 394 789 789 268 263 789 789 268 263 812 933 394 515 812 933 394 515 812 933 394 515 338 338 394 394 338 338 394 394 526 526 244 244 526 526 244 244 526 526 244 244 506 506 207 207 489 489 489 489 821 821 531 531 500 500 333 778 500 500 333 333 389 278 444 500 323 471 766 278 269 500 537 549 500 500 333 597 500 278 778 500 500 333 389 424 500 500 444 444 523 500 444 420 420 444 278 444 439 500 444 314 256 256 288 242 208 208 266 321 164 182 165 165 193 164 164 271 448 489 328 328 322 288 321 212 215 191 328 317 325 291 294 274 274 304 266 270 0 0 0 0 278 273 256 288 290 256 722 722 556 667 333 524 524 524 524 524 524 524 524 269 269 269 269 269 269 269 269 495 495 495 495 495 495 495 495 269 269 269 269 495 495 495 495 544 601 397 667 722 725 611 444 389 278 702 500 667 333 722 500 444 444 444 278 578 410 722 500 722 500 501 395 678 499 0 0 0 0 0 0 0 0 0 882 417 444 611 278 611 556 667 444 278 722 500 722 500 611 444 472 659 504 577 0 0 0 0 0 0 278 702 722 702 0 0 0 0 0 0 0 0 0 0 0 722 500 944 722 713 0 723 597 998 824 278 369 180 180 500 500 333 333 333 333 611 500 500 500 ] ]
>>
endobj
41 0 obj
<<
/Ordering (Identity)
/Registry (Adobe)
/Supplement 0
>>
endobj
42 0 obj
<<
/Ascent 1007
/CIDSet 43 0 R
/CapHeight 662
/Descent -307
/Flags 6
/FontBBox [ -568 -307 2000 1007 ]
/FontFamily (Times\040New\040Roman)
/FontFile2 44 0 R
/FontName /RUYVXP+TimesNewRoman
/FontStretch /Normal
/FontWeight 400
/ItalicAngle 0
/StemV 80
/Type /FontDescriptor
/XHeight 448
>>
endobj
43 0 obj
<<
/Filter /FlateDecode
/Length 11
>>
stream
Hj 0   
endstream
endobj
44 0 obj
<<
/Filter /FlateDecode
/Length1 76640
/Length 42157
>>
stream
HdU{PTν{.}.bwa}@.( q!	oFVLX0615Z&&3LL;N'5mwbgXzd3~9w7  0஭6ljmڸmNcc?ew8_ОB|*_nomjyxQ>^loؽ8q{n/ -]ۚ4 =}j}PڿycOSw뭰};Z
ݖҥ $t  ]!bED	by@S>$	D[!,-0EKEP}fۤ0) Eo(յBF]+dtWu쩹j_qSynnWnןω//h~o_!>nD"?KYך#8JT&EfO 	ms2
]EgA	6g6
:Af/:IҥB|1x?(
&#h3x 2  .:.Nz>:W*ܿAz1QlpP,P(EBX~eJyc^/pQq.Of>=QzڕmFRG3x9͐npd%]*)rr:0
;U>*lv?/4ͮ`Yk,~ MkԬ*y6{Wt!߲\~ͨiӹPf~ifh`j*I\{I1ϙa%LEk-X]z6R<Py$1EOʦ)d2}Ivl}-;@ @ZE"1/Hx+,S+@R{~@:b\pExy8Dĕzi!,%%B-(OP=re>S0B}TimZy[-Zdel&Ma9eV	4X
{&{*FfʠGR$zĆM0P+2Q'+HcM@{o?` W b	f.Ɲy^y|M-fԓ^p;k_]wW*241SY5R[;RnWm:9mَ{n
+Uz6mtgg+}WC>̀ԷXU;&$I&Rћ֛-{1yQ(|cV	3}vwhYܨkj\q(ɝ*[	MGZ\SHQ+ǝ+F>vJ%_sR!R2RVrB5O,u%V**`C~L@"(O[Ur1w}%rܚn$Y3TUY)o]
eAɒ||ڂ{ )NMߑǍUȤiBbA--0:d|qYm
vk\,<؄_4ƺW+VgZ>ǹ5}aHdt:{ihlc/30dannUz/c8P'\+#>3eցB779X> b+N+Wd#
"qB	s$:[-]*WW7K#g (7A:Aq]|Ɣfo׺rcc㷾0zW8x|Fȑ"8	 $I	i7$=t@awRÀ(qѱ@MjZ~C=[wG'zbg-z^KJܧ)A pIˤdA3!5ॆd"K9~wR^RBf_i`
%O/VS
d֩aCQ&6Z%-}n,IC0:>E4n`X$4 fyXQn8U&?LlS=/yHbr(P~֪f	^iqZ`@VlwR&
)ilĤm6tuѪ2yNR=s
y[a-n-ɂ6lf̚dOTaiyVW646.6E	ZRSr2\0mBE9i9ʕP6ֿ䡜\έr'rS>k0YXxHhMҥ
',-A\$JϮy
Bp0 q,Ň|m>vޤ 9lZlHћ,O3U NRTbPYոO3\dĉ;wQ3Pf*͊-(Q|%[ՔǄ.tɑb
{ׯh?]\'sևkꢍU3"Eނ%Op߅n֙+Ǟ.AЃs"FKoC~n$'٢hAWCgGPைk/sP [#p>yNnW)iǃL/FWpsmL#3 $Eti4^F}7`X`
}*Y޻3;#Lc1흄.7p2Cc:6ok\[%}+#;>e;"\w?JK!kBY|!$l~[(v_4*~֋:,{srXlbT䰋jasM]v/ :{t]T.=30VFnz^jZ q=aGF[ͣ]c.dJZ'MH]c?xO;;]OXЕmE0I8'b"cDJԆ܇m`%G_}/Ӯ>'5Aes `'6t]zWɹ3\SMb?zNEY{lږEck[8&CUՌ*jO]KZ%;dBtJ͍ȍ_k5v>R.<:	./xw.ĒPfUٖ*xd[ZSM{sմkyRJr<S/Tզ@EuFZ4a!=ɑlH눧vA5UIFĈ13"\j6jrXrGȤ\m˒dRm(2u2ƛ[c/b֡1cfnYvߩ5{XbաH<'>Ғ2G["4"4//Y8#T~{'LXP]+qJ2)CND6^;#YJ$bxI[p}!([D"v;cX`ɲAw\2?4KvՐ)"@ҜߨtQ4nEkh6nt~F*DˢQBiq0߀0p|2B_=Km3|$,"Y^^~_H3323QI<ƽ/"CD@q=*Ϋ켜*n`u#P$?/Ӿ~]7A$Snz04o"e0\3`GE#4roEs!L֙+.m ň"]ft=.&4RߤNKMRph#Yշ6M8&h3_x:u!u9,ɐx3Ek<y1w+dc9ȇw,6m^[	T.\=xaɁ=ӟLԙ<Zϡg0;<`Fw1Q`ӖJQ"Z&rz,Ȏǘl_9WeFcKPhOC	>"K:jNTEysxܣQ@Ǩc3bM,i1ȏ	A*cxL !\eb8q32Ɏ(&4ȀR''Mp('0̙f"?;}ko\ݳoUUϼ/۽kK|s*n:!]I-[e#wJb\)`bnC*04M8IC؀eBt ڤhpLG%vdۧ{_:
aU)>'z͡GvTOn
d8 Lj̳ؓ	·&F
x$8E_qǮ+؄m)A8FHQ3Xc  9	E(&!y?/2<8v!8'H$vSλ]OL4: wpQ\)p$_HƉ=.'J&v<Gs"B  p'#+2=/8#<b]wO`0`:5?𜓞]V@
E
$zKR=UkA,Ű@h/`mVͳ1k[%#խV$ޠ^WtĈ]ʻbS`,r&!EL>h֐!9h .f@b\%@&izc	x?E,<HetR󀇼B N.غfe jj,/}+_53	ȓM;5-XOzOaGFćTmdkjzN۸jU$[Ćv78=5;jعemW6+ZmyqT	!LʹVUh%:.jd|SɾzU#P^"=@⬋ b| wS:b&NwB|z$=Gz0dP3jWJF^✷^sIOK1q7TRē_"'fJ}AZ
4gP*qYn±Xi6Qhf;)q}D	=AW$ %f0NOP2C5+ѡMѻ:9oe6߬66{gds{6=|1eaF|#1]U:?iNs~-=	]o	${L[g%!#J9tdBhdCa>%qM89iyBE3v8,Qk76X6Đ3/B_%j>m$!RuD+XF	z~
Á0[a̺P # 9	3n]
7-afX|Bp|DannC"tn1sflj,*#X{b39띄WGo}|yPśJ&(MbnM1_6Ǜo
JĜ2Ri%sj
"s**VᢒbL喸nKp@MqS
D~
!a&Ǡl41.~QU\.2GlR9SFK2iA cϼ}L"O:e;	L&v	`fjT5Q] (1zR//˃lY|K}3g~瞧~}dNŌw5K*#{D{>X52}_&J<$'~u R<CU%m/;EM]ǹMeuMcK|p r\,`BUCVt R3iIGCfaqF !EcDtK~?fj=OLWY\"-aL*l1XEd<G\A>4	ї-orN.^X
S2"ifg&^ʹUQ&}~U;N3ًco~<>d$t!6	XY"QJEoQLiUifffk8ULj
Za9Ʀak ܸ<)Ƶ:EI(K>$4zPr3ZB6vNYWhB5k0&`oKʤ6+(ug d~s:[*.E_RzZG .ywdY"`̆ᕢECv6qq~w;ۉ}ٗc;9ۀU%HQ-eZњ84t,V!Sxi	i0Rdbk=Lÿr<3G}ΔeU{חmJg"?bO z@lr%z.aq fF([?ؖjl;`U6FjN4A~t³XUMm#,LY*ݑkrݸTWG>(e)_C½}#R7UJ=uFAgiiR*6^2K]~1}l_n&e(M{ƌ҇{ʧJx#)|@4QEJ4NT&
@Ȍ+ev\u艎yyĂm6Bk)dV[TA{7iA˛'hftǃOԲ#=qshN"!kQTDWLALUgV.o]Sa
LYV103e
|f,]e^6/k!>̓TXI-4Pm5,$*Z*7(gKF-@ ڟ17x_Tg ˃f(#Kl,$>8	oSd-N~ⵣ7nOj0Za~Կз_Vyc?k=]œ'}on(WߑjHywoyX+6<z?󍕴mm?<0DBe,yG<G|=h;KujOMj_J&cKՔ-k
xd;EtMRhqʫ7A;5tMPY3 BEKz#&=B"CVy-++N?4=pcC9xǸ`yU#ɺd@exGQ gՂ})z֕V˨Ae3dh9]*&7(s'y}W?*>_{pΙ=Q/5H텚ӻkoL1>xԱOh%>}*S 8eb;slpNnB2gy}1bhgd@jvF?"5E@G;}hf	L7Oq}Ke܋s;
27eJV7nZ+Dp9Xi}lA<mhD91)x=(#{yW^NR418Ruf%l(( ޫW{#=wP[7zYq$V_>QQ-Zo=8	7P0?8T͝,{ ;bq2}PD>&%T%n%[tvRV"I(ǓH3zhZȖ	HEZ:D1j3v%	c;Y
5ivYTӺؒ? ծ@p*p*.**
**PZ_0&Lya4*Osp,iQ>ݎ<n>KGOnFXy%WNQ$o#-'f q/7TE͛RyFUnWkW8m7rsi/=`DYh;rfSMZm^o*^A_4LT"mA?ղH0g<gk%.}~t`<jeƀu:IV@Ie٘Pq3nK;OJ֜zFjHiIT)]Mh5MMt8È,d/Ybk!Imt'E2fcء5Cvpiӷ ![3x^Ba70@=#RAP&?KOstNԢtulne2rP]rdo{_:RR6jڕ55k	۠6yT6W:2h$dh[xxx%;\
3@5'"]OUZb.&|焥?8փ`(`4B=μ`%Y`p_ĳsGhLIkN6]IIIïIryriaݞ'` BeuEXMuLaJS/UU{ىs98]'4M3څδJX&_YDbSi0Sl&
tWF`TAi]EUBNti&&伻w}̱dZOR.^o;e`D,؎,Ix/
Y#O݄Kc& 6%,!f[.dPE[좒ha@ !k0"gWAW):ѻt}{2of׹Ck6=G- q?O뙉1M6:3/?8oYK+Pyv¤]DrAC"t~]ηiiQt`W3ļ˶ChTuɐ$jeJ28z`uB,@55idy6$MOKfNN:+zǪ>Rf鈖dFOD[Ѽ,Z4hbі@F[QZ%ɦjM*0mK4ƍIcpyUrމ^ދ{{bFK_zCV\{a <4,ȠOi)RmW
+<p϶h胏?d:
~HXY)Ѳ
Zתђ/( [EbP䮍̳~v;8;^fi7tNƄ
3:̮kQ@pc3hD+g0z"ZE˃@U	U]:WU3(JScV'm	iRrHN$:P8.lfE lM1`4C?4<ՂU'zdǠP|{kfBQSWʠDO1W9V̎*"QVa`bP=<69|c3IX-}WsuF$jd+vHU.럪ɒclG<ɽ$7qkrCY>r-*nǥ^TmGcYs*23f aROW\XxoKHúcaj _0&Gi?قǿiyOڊp'	-J _$d9dj>[)_y)vRB{Sc0.%BAU,56=<O7o逧T-piW}=/Ȋ"Ŀ'WU|{솏tJƇӾiKnδ63➕"~94jMZ-'>
C\BfgܾUfDcFC˺NhqmOi!AB(OګtȲ]um>LJkK%%zfmmTQnW~2.<®<Yfپ>#>˓ۍf@8ЂPbϻqNL/[*΂u*yS5\,*bwm!+PO&*'ɠ~M]抦ng?~AJþNʤS'-3?Qq5qTW/Hya!]҃KR'%O抖F12;iEl\\kHEƻ6&|\	6;s7h"g*`y]b%
2ܹ*
L]=attd$c6֒/]d~HQE/Fnol}< ;^;oDYTB6rUeR%	nɓl3wUcl 7ol5=̓8Yq}}Ŋ-Ls+2R 6UiZ].K}|m3U2Tl(1`:|2Q"@gHR.PhpZ%fo?*(*nkhV/u8nő@pՎڔmQ[}1ۭh}:^D/X#sY:M'Sה+:>T>bwO)~eee}ݺ@/Xw-?0zDbFR$Ee`n!"Rce,X&5	R
HBuT3i:gG)fcv
0'@`li%wNȹ91gs]4P0^)p`)P!X͔Cex33T. f	%XgW?cb.N%7x
&;l'wϾ|? WY`AkėQƚeЪ:u"+jZ7MF$ZiڵLbIV,#LrcVHĲ+
Lm$hٲZwo{?`ݧMq$-A)xC  κ[݇M<Yw<scWC*0qɄ;Slhr:{EZIvӹޢhKCŴ8\4`#ik6r_^6\mhU1lDro׵x͈/Ch1Pҳl|zQ@נ0*.,[hZF%ę0ߋ8C؜DP2-OlGuɗV9/y$\?m+\kl<)c5E0TOJ(KR`G){O,
y={,㘅}'9`ۊ0Z<yk	U ?h>m8eM,v1^arFD3!=C5jNkĊ}/3X.-Fӂޚa;Ap&l@ҝtH _<,ZͤYco߇&Lš]a8yJXGO?=ٯ};\mx_7>QT^0tr/$&,R_}S76	ߐG6y|C|Wj8UNTSF1&@0C0OK靶wwR古.dRi"	zc"
E3!W(ތ£ z`$`{H]Wk*!`H!	qØ6qaHV֮dLCj<ՈyUjc%MJ鶠/!'m<HA<$1f{7$ LG1Jdv
U:`X:,<42ZP gx0pu3o/6\g0o}lb6ҪW957ol~7Hry0OK>z\	3yUed/Ҧ+X"v"Eķ&xP$LO^NKަxFړ:,+ҩuVv:kQ+0/vtz\sƂAFg,Hs1Q	Ic`$b6~h?e,{,&)x^wvʡP;_,|zѕEQT1Ʊ\	HZ),,9XDY^Q^@HqÖϚ.N\z2(Mr3hZ#pTs
u Wu뭌s?|oَId\:dQy$JZ3H!xqP%R%niOYc5)o$F&2(PPd_0,7Կ]/0L.)4L#|$?|o;hգOv1@}˧{bΩd}S+[`]G4׎Mo2+t?b;8mrd6+0)X_+u`Z[_X#4f\6mmorlqG"#m)۸}ܱ9L&ob(*ĺ)Fl~>ǽ&ͯWW\l_-+DҠo?X9*J8-	iIkU'b徣ModTt|%a,. ~^<B!w
ÞXPZ2SjlM"'[`DcœHS \uمo :b\Sx|d2pd"GUR	ꋊ6`U5B&,DeX+e\N>MrNihԒLG#_~|@F*`Ғn9ikQIMV#ٖ<+)Pӑ$xB\żbШ4`Bs:zWu
ͩ@"|βIsӰ%%X7yick7+R2Y,TvKs	29a2ß<RO!?&g7|~Nw~%p㶮@(2~Kw6q{vgvc'ol͏k-4B!KД:4uPTMCilc*D7*uօ	1iX5:{ρjww~~ug|'OEpWTG&۷f96pPƕqk?vJ`c`OsRhUK&I.b\g9'44Uu}ԫCҖs4h
*:FʨoX#bh锑X3OE +^h7r͊PX@K7	Vˈ2[AlK8/V(->zCŞx)A+,lݜ!{~=\Zٝ{|۾VUhUoQ;՚ItŖ^v='u=nv&;͗L.eMԟ25m:DQt<)x%xS$hZ& ojhp2+Aޑ%yGi1bx"!0k+4|C4L$S#^A>]:|ͧk}翾G"#=B}Mf({OQqӐ'4[zsJj'.뭔%XҨܣe}g	k4~Kzҍ/tj@s(C15?]?]uwuyCZ?eP(׹qTE:Mk/
#ef]Ŷ6 F"OvY"WmY8!]IG<9o]WЮz<8FPtnr`wC̠pV`6gDK|V8Xfv9[Wص\2rgP6q4<2{ٽ^>t OӾgbG"/O*''9p^<>9=kp3;x+~u[ht(2[-zc[=63<nCW.<"%e(Lx9(]YRaĆ*^M/\)m.E/b=U)(/W|R,bbJqvqǌ"z&bBAw+HD<\JMD('βD`f}^ӲhyNX3,N!aDc<Nd˺e7f7ew?|7aߦ5*>uDGꓮJ.li,>}#$;D"7B-=U7~	~i4F?rr]GN.a`]Pa3߲**>hbAX9$	@#"B }	(t	|i>L]&x!՟^xBJs%$X !|)ZnȷЙhXՍ|rw\֧]a"Tv}-,JVc߿1#~<W)8pCpC2MѦ&rX\>v?i&NifKo`V>v`&	3}^~!v\P嘡)1jSA6&$6h950-tf& oqtd@Q	)0hp	8/Єܛ_L
e̈́c;	93g36Rs0Br8ZQLO151bWYUW`B(45R+;@S*X!8x5-RP5~A  "具"Lu넅c~^VxQ͵}+Dݱ=LyBņH&DQ4յxu*Nru*^튃3Өpm:/c:arq9K?[GDpqr\#kmiH[RT%G@/h%iv$9A2$we]*G1EmW*N`"N_]tZq#9ŊsE˛SgJre^w/۩u&zKNpq=.гbMk!a3)б
Qr[5y.
ERAFJc $4JTFuۃ.;6kn|{>;9?vKmc'!\sjR4DIhk5JRBD\y 4iҀPQ-d$h12""gmۙoMXĭ^o.4.2~Im)6服V{5-1etx'E6۱,]'m)c/Bƶ&o0X:|TW%m$SdH0JĄl8WD^(,4}PC948wEs`{]]vy\bAiWA59m.W0u[5Jeӊ/klc	r	j-}&YM [g R@ܴΛseN

\FUk2Wizz@)=	<TuW0;.aj;lFuoyNɄ:=fSӵpnæc]=_oX55M-Rc'D]G^ފ\zv`y<2P-~תe`qYi(ah3kflw56kZI;L?qôPUn*n:\9Oo:Em -)ake9aȈ2zq̰{<Ҵ /~l;fp	|R9%$9vw+)$V"[IY,jBZMӽqW*e+"V׽?ٿyT 1X-X'o/|osjWPQ%	*VS\鉘"jbEqZeREQ)T3{㐕n 3#"%lRC~?]
&q?ˇOtG#fc6~2녏.~PϾR//e꫿UU<:dߞvI!T*DSxMrָ%XH2<YQP Ԇйvehd.-p^b	ęjlN8{{Ͳ`7I#򈲉lbn
LezΡN<"x.3wG&C烓+p:~+p͛[8Ćñô_?ſ\C1EL[9`	-j[,I5e֜hy}wŰ»1J&HC7j/hQ+ʠGh
rr_0\UX]JQd=ā5߰/y+[XsP3},+*=ontuu.2ؠ	ga`Z4fΔ^< UB{
qAvC}/hk}>ܙ_:V޿^ؐH&»cC8yeD?</ɠP1,<D2ÐՠD8\%q!5`*egxaNCF
j.EYh,Kfeh0lxqMM"wL+&"'xOX*l9řh.*Dc*jp3$&XpkU`Plisxpʨ$[:%qsf6;۷ ܸ3$NK*|ZzZ>$$$I%ư3*69GYO0Mvz=cI?k<$#P:],@/H;<OЧ1tJ.Մ+XT:cY2Uj
kMM1Q!(3p(1fLaðg=Sߒbv>X.w&:Gߓʄ#섫"GK=)n0$fy<B~\JHxEБ;o
YxgU'-Jc-lzbuk^7(ʻ7Ox|c`<W8B(*~s.2ޔq,f B:\AqdRl?AD'a?Մ+#҅
\; *AUlqrx/GtH\!J;&ZaP2EDDr`|_zYDΡPd]`Ϣ&*+U
wf,:YH"rD`̴11v*OPc)"!V#-*½%mn]rPr@;D89'ߟ[` GrqMrշH ﳂf<Q'Ccڸ;|>l|9066e&Ⱡ$I`5Yi
]e2uGM:Ұ	ejWISשM*E)hJٙ:|>y,8N%viѻe*\1e޶¦0M;n	6měkp0Iɞqv8o9N_p Ā	={u/bz_p|9̺N.uXHRXؤPn	,*xUi`1vݞti\IBwO">RԙHy-`4%D6ȃ>@2d4a)*GUwkhYt-˙jke_]ZO̴KS![Z
OMM5nA=:T!9~Z^o^}({eaw3Ǟu,~Bȟ?#߽;cL٭j4aG1}	"K<8O혠>)Gx2&BXVﲝ֚ؒjtz](|UJ00UoaXI$W@oHkIAGxol ot|hٹA˰,wb` ie_2+E۪fySGڎ$X U0U9AVlV$1.9x$Ur2*2iKT7nV`}cf&Emoo5VwԒD0ďHsҚ)mL55]-]l|:}(0.AFPQ+:#+gQHTn5j@ʘj	I.?/O^z7pwH۾=e-sbPʷa?/ '|^ԿgwYp&ٓm'Lx>dg{NDeCx}O9gG~0XpXqW<Y+no}!gvdE/B&c\\F)&[FKh6759Jj;aɣ5ʩUrdbq}EyMpJ}0Eg@
:x:
:qqT7
 ,#2Pt vzɸwz`xHQ.ɻoo%p1\RI2,'W\҃`J$ӹnaL5BB㽊젍+8tiBHƠ9U\l-3$	W0wݎ#v"TLK"N7XRE!2$㤡X]sP?m8eAb課<w%qVz[Rªi26w>\|<N|}ѓH<ZUڦD鎜@;Vļ|Zy
۟"Di08JTn*ptHY=-<%L<[8xO3ȡ޽ᴿ!ƈ+{"c-:']?31$b3̸6g$&Bd3'OFSZz}0ܷUB:!}~D~?s0?u r_щf~m#iy
m!Ce{u;OS$ VPk]C<^AYNYdNE#j/MBx#gM|'A%cӳ~}v6I%rY8>wtoLVUw'O~yY4so:"9-d2pFs܁cx<jX+SNI5}z8r F(N5aull꘸h)0=X9:Ux	A#Q(}Rk(Ъ]A/4T(ǠqWRPiT
G(൦u3Mg`D-{.e]R*)'j_ц);d,Kڢ"_BHaYP<d{B
u+ԭܣW4xiZ$] #7l4 }zgVoKVY.eٵfKd<;C%!تUhaȅV%T9IhMG;Af@l6Yz%*Ή+M bR5F	wqmFڒƮjK[656s	ԡ 	%2\LwrTRh^EFfS3$-3Mx%1]u/۶uy)+4em63qmˊՊJMk$m`nk?3*n@3 u6`?"Êu![(D9RT=wɚC)B!&ZP1}Pٿԭ%c#~N4Gv|eogq![|uO}{EGlqr~6c=O{háGQ Y^&'9/8z	{"k ";(dr0X4oфb|0;pEϾ i8$RϡO@^R\PJI YBH gcHHYjϙ'lJ`f |	Ҫ$ME4|:	OP<``Sȹ b 1,o.P=Egɩ;-'l;sc`~rgf$Q{fzDۗt@X̊Nskux GY9xm8v\}p-89V7؜%nֿ3
|-H[L4^	~ XmN#}\s-\OMg4vLg0R8Qjdڇ tƞyemΒ Bc~	P;.6y>>QYx~ Aф<k>lp8ak0ާ-`X%[,A!^ |~[[yd+MXn%]4$˅sn}-Z+pq)0rsv%6񕤚tPGii94?;\]Om#Զj˪L٢j߲CK{@aY<swmRb}
J~eϗbSfʼYTIJuEA$drad7֪_ M@)4-,_nRxȦg	z^a԰|?w&"GyYO,!	 qBMiJ&6G2jaЅ-hF@$L<5ADu!NZ:C&E`4|Zm1=mnWq^0`rz4<	w7b6E]wcc2ݸ	EN:/!)~}%V)UTǫ⛱X,)cהqٲ'/.Z6֤].+oyqX$T"J=#|M@	?>n]^#֣]kY{]We-r&iICyzHL7cۚ0L	rb#&9MuIGF<x=8!YzfI$M_Sd&V:cz Ur}11ROĴ;ml&h&-ؖrS#V}Wx<&MӈG	.2%E3VAN>/x]s;=[,o7(W A]WV>D(2S咉E G)^Lzr!-l8w1ﳲ ,	2+&5 A(bةE9Aǡ{ڂ<Pfȍg;%)Ѩ3
:p}/oO}r}#Xc@`_w夝V>ygSm_z>Ouj#I9׳:=ۭ#<

Kd/UK,3q#`e67-	Qh!apȡ#RN@
B*kUCN#JQma$t$\zH!Fso<385'tsUXC>6r\eRH)&0'n8ɖ:gs-%^dK ˥O[fvS&-d<o6e/UO	fLYD	R8c3TmxVJG֪#-_3qi0Z5Z#~WTf+B@P*ޭWmj&Mե.mwp~

nw8+c[ Ҽ>
*Pɇjc$%{0q\j;Qcw=g|\jaivm{<RcF[X auwv_q=d6-ݥU	}=xGCcǬJW6J#0wi-TBW*m
lp9#Vm=w9{Ηo'@[ Ĵ)VH@@aDU֮[Q&NԩHPjmnVih&uTҊJ*mhyl^<}~qm"4E|kd2Y;>}sj,7@W |ՂfߺZJbAM-ՐʩX_jJ#KSc.M/3)ez|TS|$/]ݫius5961aֱ\o}D4922LaPrhn>H94kWRЋ
MU
]~+WfjYe4{ iH75wc6 ǯF~\: GSLS	g4x!'C`	f	ԴIk0o7%ipH9>1mXSDYww|R9:jlGv64iF~W0vˍᑂL87- NߝR٧-kTH"*zy4v8F`LBVzfg;0L$=mvROp"dq<yNx8qĒ8NJ$8Υ=SJ0L%*Ln#Z ?B#ଵYk"4MNfwhTN䰑2:߃(BAK3	!Q=4lrݻ" 2H!ƆmJ8Ocٗ'c|B#ٓ#N$OIdJ$T\&ar2L6g]hLf?&n,li)!?gTcX2:zYd"|juĊ9ISeF0]1MS1NSxXS`f_<Ό/Ɏ v.q!.s9[5Z1D6i좶5DpAk3ꐶIC<t$݁.&uXr;!MM#` -|xQ?-U%ޑ11vvrǁݞ"8\<\HW(H	ti)66^!8?cnB	Tv"-HIpYӉ2cӃ'YrOr1I53#-"\ஶNm<N7dKuDo, <dY(XX$aqA."_6}G??Ym~%ᓠ5b6dw9>}$fګqOׁ'@,Z}a%ZػNNPlQnzem3]޽\>vSy-|Իs}bEWp
2;Jf
KyN𡏐jP؝St2'-)U0U$`)(@sUf񂴁0oЖ)u>i9k?˟u?+q5(1m!U
B~QODOSF?fnI4zȩ~{#^~c^_;=:rܟ_c^cyJt5mĮZgnR<]hU"pzkwU,NvLfyx}I~fSą)r[#KRri++`Yضޤ
o`!X<ۇ`uD,xQ_Ak*\ma1 OMgDM\m-}$_r/ទr=ϸ9qybݳu憧9ӭ=U]/< W8Nj+ֻO@x%+/گ*YF͠VsQz1GWюV1Y$x|4k.Il9"Ëլa)g*4e;+Tw!]04HI}tD6RG0HN:?{s|/j`J m>ؓT.`Jz/|۸s$HrgC\_hy,>472;-S[,ZS:e9E2gAV	#$.<px)uK
@5lw<h57u^k-}()`[h0u`ʂL%ȭ^]elNEG2	єDf>%TR<ɇ2yyA.ɯ+EF[M=X{"yUEEJu8^SK:Jۊ'T$ceZBZDW8E*/>}mW>?|klWef2ek{8BvB.MF."1tkSҨqJm"T	G !$&XqA(uD	G(?(ER𝳻n#$,9g.{x}ވHFvX;NJ\>:Zn{&vcQwYX67M.1fc=Dm.3SºH%BP:Ê=ʛa/ x~7Cɳ?9Gsw?p0ˉ|@0*~K.$ "* *ht鱐ITtQeݗ|="I5
a>"N/DNF)Le1'L,?j$6R=CoxOxY/NpPh%kJP2Hz!LL\gȸ}0
6k_w@'U3ilϧ̝/e޺(1nLc.]%(1L3"&%4Ƌ?}k=MSfL!N!ߡqFܡu^s%:xس{6f3"R_|bZyd4A;;,sӮpѵo(Sg?  z9toeFR	
y 5'ʹ+?1Ar^p{L!Nx	UVND
R9CqmRc5gf=vM4r[[']W`Z0=R4%UliݙFt眬3WrLԗRl*'@VxֈZ6y4ŘL6uVo!C5d[fClIu<")z-b%buו33KY+t%_ry9p9ʶr\ͺḑ}⥆մ;nS)n:2Mǧ'NU]	?f<	.ѤZ[Yttʁ՞)>c=Y\&w#/zR"hvxJ559.Fx`Ι?0jiaCվGoH ҕIƅIaFdVtx9Isd_{V;KCs^E8D6hy.Vrԇ9-Á BR[
#޺nNؾ#W*7)Қ(uCz( WѓO8`gzd/}݂9
S~xP9vh3ge8J /㫙j[֙%*j[P`,nqFWE7o/F "|N;E(NrR\Rg.A[Hxn{ eBx =[
}xnJnL*:Y,uLF
*ɩL:#?mc߻ONGbt:v<i-$J~맿osXy`gS>w>Y̖?	AkX޿٭KLV5,%aI(ޯGdpt(S#hX O~#KgNzunu=:~Ć|d+z\&y8D0(E7'N9'uA'.]:Y)?|pF	9WI&\l.bCW5*l`eЬZzSu%#,R"pшj&?\Ze"^Mp_[eyVI6 8lae`dQ>//W.y<hJbCVBSl@d(#S*1"e%P(3	}s]V+wŊKk޽b᱉t=ǉ3VU%&wU5mOy@vu2R݄b4XjBMJ뤞ܤ^B)ۋA%⍠JZAoS^^7A[.itQ:=Iڙ2hdO1MxUjoSI)2ړ$3^؈˸C%"2q!0I0LMF~XbN#ǏǄg璞e>&CK"Ox>m29X`휤jYIzXilѕ.sZ5:BlZO%1	qVt M*01gfC6PN3	!ڻ}_G_-4\2g63vƮfY;mb;jZĭ\P\(nXhHAq(RdKVD/NP`Z&T[\@,[C99ggvSsoz_A"v~қ;/A
}Q5t95
X}'
-y
$8؀XyJ"òCe]<'ұVJsc;[WI_àqV!kelqeAMW%UVmiWjIn_,`~ʼfqy;YlEv[
ŭCyaxE*/6}=bx`` y@:E͢+S6䚒[]l|@/r9/HY%CUJs,xݫYdy,*cHKImb9.]BssUn[E9H{1-f;'H˧,oyǕDb\>XC78iʸ.ы1/=(	J4cB`jo=CF>_Co.rj>d_b\
qQ@CAF"fbz:SF"`hs1P麡ՀanP՚7KhX(9>bEcf`K_w-=eEHꗈR.1S+	NqD\٠tȞݓN0A/l2VGu꤆IplVku./&UV6	ҁN+o@)hjO؟ji	rJwXjmؠ,lG8}PxN<'ә8BBI`q<l-=~-V~!kxC0?jW͏vFX."mfjO㧅Qyt|	/JӕEmQ4z*D!XEAjUW(K)|IVj1Hs'iUZfֲLa,ðN\ӲUIJlY9D
^-!^ 3L@ĸTRU*DUC&6QǛljGKT/lQ/YKr^љ[2{z?:@kæ*MmaJr9u==AМ;ũz=3d?5ߢ0,ԳeaK<]k˺n֋qM\܅gf۰TZ[ +E!;zX{Y@Rc9`\?aߞ3R̒[#ZlC
UщAW|F  @9bpD'x,${sT	:D=HW~۔e_.*?ۃ'eT
kZXĕln>|L(!MKxz84HX_Aa<cB礦T̅`V@h̖.o!CKɥԒ/4oouNWǣ@揍EN;¸1H{2~(!>*զ'<e,6u%1/.	YpT;p߯q ucMP6ytm>4tȓM17O$`?hZ֛f򎀄|bpNRh/W+RUdͶ}2SZҚLՖmD0Fl؄049>N4?JM lGr	_Σ]BUUF2ny{r,l,oƨEol`jf2R5fawjLꙀ{.1R~aCkhd;HnN]+؟S0<XHቹ+W\a Ng]g NqnJuU%݁'9RB'qG"0!eT'ZnĊ Z&Ovow5'	
҄ȼ;
/ǧ]]%M5,oVe(&]/@&zicս	T!@[ɹcL5GM`.,Z -玒Wաr3gهYclbk8cmōdl8$$hʼ6AΆD>ҢB@ M kΌ7 *Ν;9*{˃9ybCJbfx/6`$%A&\NK8E6z|:[G$Ƕ]>.69*3|gSS~WcWҊT%%wxxZdN~X~(W>^ao`~f+b$1ޒ3at*Y8@1cˉE6
EVȒQ$#KIR^2!Ž-=*9EFjKsX"|wK g끫* W˦M? _rhZ]3/B#Sv>:Qh4*ڡvjD^72']Úacsk8tH=vt]BOkvӚ/:OZe>ID1j;>$ztFZ6؋A%pZu4ԾR { 8rzNKnhokAOZV{MYCjbbkTon»g܌!	#|T#Ł}KK.lumˋ⪝Bxř쓭A|X(J:L⒠dͤ^Yt䌵s͊rW$](>:e݇t@[^{&!caCQ"o5:v؉`Ưa׆}zGo#8zd.19;7fs\+A8`za;ke]`54*l,UM*QUUT_ɓ<Ov<G--I*ȫnS[c2[k@W R}O[<g9rx7
-\}iO(a%f=cgB,	
HԐ1LX3"	VЇuI`	__]Bzu/- XX4dRMs^-sR:("&iWe4lN|F>|aW4K0s[eysW9ADG''I<^y=Vdc?63X>Re,,lL:(>b뾐{~vذ;5^I$S7eEIR`kH`wȚ։DDDY-}lGl<v,v[z<vwnҦ;Ms͘L]xm<osqޥDOR4x@2.N<ǧjST[K2wq\e^@1%2<A*r-JԂVآXc:ԚL]Müzg]oC-AQ`ʓjΞ
$y8N"qf|^?Lc3d>W,dmu$|P<{U}ϐ,I/~qxcM`{f'ſ/í=ɦSP<sPt.Zgx%|iRy@gZ}򧄽xzJȟq8asZ@U4X0d,lj-/
qH᪺LVPO7~fYѲUʋp>o5٬9uzۿEZZ/״4IUSCM=f>@{O"KQy@Ӊ, ho 0|?`zlv 6{W3/ y@]8 o@ZHbf|ךS k_5
	8'VNzA@q|``'޿0`
¾L8R18D|G >S (
BP(
BP(
BP(
BP(
BP(
BP(0<,GR0gV$YkIsKukI:[N#?<[NI3`djJ *iuP)i-7H$PearxqC0JMM!QZJ;>ۃarc[Oa[fJzxPi5uC$7^!y|mb87疢;;sw'rɉɡX>:3MNvo+fGj:w=%j
",ߊF"FPQ&Qk	18!*C4jƷMD'Zo׶1L.=;/3}Y<y7ӜSmbPM\ʢ2 /gſr{Ww/CRդ(HB!&*Y	aPB)^Т'q2&qJ}ŻSX]FC$C$8O7YC]<\ڙe'Q7;^ZhgQ>g1ęwRm//y(qGa4H_o&-;!Gx$3ytP>Oc]20:P*5KS5RJQOUF_RϤNp&Fch:f;jkmaV}~k0RJrXZҭ6!bןĽdZm["A|"#FTZAtop#poӰ-5`[X.^K8rPOezp&q*7Lw֡2rE.BmN4h0_Qqqp<pA$J$U_-AI)&/|WacZn굈m,c!={W!Kۨ8	/;	/S<*^|s5iɃKR:;Q:i,z	^~:ˉ$'4`8,erqO;ﮮDIC" 
0Гg|)''{1h4Ϊʫ^:SX0:T*)B5̈́}%<ZJ/S%DM?t?!QgJ彼ĉbpt1M,jqR\䳲Tur<caZ2Tj3Aݻ~?~s>uԷηwYOԋa%;REw'
z+T|8;Q.dmrI<rOJ_r~Wlo6 >]	no(b!Q1H[c8`yb!2 >;IIDse|Oa$c1јfi㮊T5]թ}+{v=^`_j?nA1`_0WE"\
Alb%W/Tߔ&JY,g-2]ܑsxeJETMq[\6ByqP̑na+QǌP\]!(E-b,7UՉdE'jũsQ,(R1Zx9^7tM^8ģ19\*)wWL[em-KQ|\<Vr)rK|AKXr2j>"=i1M|۷괪Bm.dzZK@..rJh.BfAItR0.
w3&NV/Ն̔
i6ZvuƲWW*A76.XmbF_c*,<Ȃ^Cqγ0:=GFO<@z=q\WTYOd
]QPybJ0cG*vp8]7j7Ut>AG4"T.z7[l>DN%Pt$t=̻
SF[edۓ8	o7RLH6!Sп_>{%'=J#63:ʌI]wuԱCGi6$Mݦ)\gzi[F3##?wzЋ|K+23(
ɢL} /Ino!.4CiN'gb"͙gZ1QQX`z§+}JO~k
	v;')8,C90OJv0LX9X2-s=i]]uXn=!w@es[UMTжY蝒kIo_GMK.?ݹ*+=ŦZYYaZsIϯLj0s	]WlS>lbbjp~4VÁPZ&~*UPj6:EuJ%T&	4Ԗ(l"hy}~cXa">=s߹sh$}ޓuF%C"c}|cOPvo^^¾xS'zh=o~|R7i3
kϘ`;}.#9G*쑱=ͥڹD;cC⡚XSzco|vm-)q<%D'JJŜ (||EY>5al@>zmV#~?޾lXx{)T^M1ؚq+YikR1y|=h\U^_Pz_a7D|x,%G@Z Zb [",?=Pk7Pj1S^5jTK![S+3ki>	,%6YGGhg~V|iSd$?o?½q%5BW*5|X\c<F_DD$)<כ}9MW*-1==!eϊH?4EzUE-L.,*KYȌ<TE!Nդ@k2-Shmj<LLd!)?)j"9 +Z&x=|o\\pJ/6Ζ!KS*2ԟ;*yk],]~OrtQ#kC_{4 	ȗ_ 
"29sxb:Im4X]bm31cߛ-91)1o	}5l>f9a3h8{5?xXZt1^ a3_k1f,ƣ0nc;UA<kW9Eњ(W}=@-?	Uҷf`-jgrogi8lpRHSk@PkI|q~*[ܤt%א7T΄RK ="Tߣ{ȅiBڷS8@YBξq"3Q:)O9|Jp7^Y`3rd02aΣ#sfHmwI& s k{@>1
xsssC?I,fĆs̪O (Ic>Gk✱)ɼJ^*-ks+q3!"upZ!5aSOY#r8v|6c) 2zLIi+OA|\{"9@8K3sPو,.:UTtۼw[4ʀcHoij
w	ߕϦ@D9P+Ƀ	<Jmjd _˵;_}/tM_8G|K@/0x}M<̹sIR;_A654 *h~,k2h[soYwX;_Sy&[ii9v̼̤6,Is3iʾ.#y@ _&8oVǳfXjb?uz<=Yɻ,',MN -OgQpߐw,/!`9BCZ6=-^"K#GXh#ܥE2';(,)*JPðE&*MS=lHs@Y;4'uqVg"7P_J9wɽ=~qV,lM䜀62bռQlm)ߦJ|? UGU uȦ!d޿U~Y+0rcWKjޖ~rZ%sGMght1*ocgWCc}{߆6>w*巰{ʸo؟ȷDpw$g4 )lQů~@ͬS1"߁CZ-#hA>8=|)bsOo-eQyXݰ-b F I`1(?6u8*ѓo[oHA߼MBj^>oJ_dJ;4B.78~_Q$Zt^Pk3`'ƥ?Y<>vaSP!A!; ~m߹<<9Pn'TUj̓q=p\6O]{qϽKO_HcAZA<)}XQ.@[q	Jy!Wc)3~zV΃T>Bm!}f8NCwn^}Ђ7A	9Xx7XNu|c^xw_\z1WZq-}>digѿ/પ+{Ϲ&1
!@H	-bj)ӖQj tZjS<
u*89"e| =>$7'O7}c}^˱S#C~f{:ZƒDFy1/sń
mh!2!ڿt'/pjȫ|򼓺eXBMMz<`v;Ec}kO]ϊ{rGпf9}kQf5	ym)ƪ=X
`U`k?9^W==Lk{Fh!Zc|.~lxhu{i4{	-';tjJѪegՏuVmUƶ6OsjgկhWvT9] 'zBbkX_9\\=06-]nm9evL!_Wp.ϐ<=L+n%K-֖.	Q{,눜֢ww{}fˬјtY%S/ J˪Yokc+nZPn7momi?GsY3K?X~k{2s"zug'р-ځrlGXjA\~Z!_j2m*}e_1iO)smG.'y˴ο檪<_Fq3bY+/K#K|lEpG.uĝ"0\})%,/;s5>>\Rc4)JJDTIrƹ]*>{$+W5'_xڊ𝣚@_ OKHwpz.Ϥm!Zz?H`_UsCwY繺fm'frjٯYG}	bOkFmB{7=Fy~+Kf? G26|_umkK[QUc(⽤{
]+|lK;@,F}ˁJ.0|RA'-;Gi
(νuΕy^lۘ>W9|
>eVwDSMOEċ`}L[oTz{ktH\)kdw
RB0oKWH(5GHT`J>>(*X7?wA`ǀi?\1V|38msEuy'7ĨB_P8zP?	?2GQy4nQꋚoB'L#
=cR'E >}s/]Aw[K0/ym7?6yc]Ŀx4?ߴZ@7l0i;`>3[klv޽ߩhw:/S!	];|<0XԛN}\|9ercda`ݫLr]NZZH/ 'us~$~B\{Kr܅"P/Ji5bgPbگf|~HLfS&nj5q[!5Q.69xuK;A& /m%56Jd'J_MޔryN2!B"z|u>1ۤw+us[(] }59XU漈]z?hC}O)\XR'<)sebo{윪i7:$YْZYX Nh"Άckk5J&sc,3|4PoTV钨&ZwVs~Vz̗y4w|LKDӺkxPr6pF;٤v{y^.H3TVǹ&loFgFfLNÁl;гF:eZ{^X:ͨ_lYy눭M9w˝ΖoX]TT+OQdXttCM#n7HC!9!.jd]4^`m-b(	i̷o}YS0G	9˭	=\p]=xBwsÙ|ްҔߺ6Es/KGG*|b9hиo4)~΢HD \5xxgOH +a:^	bAw-YbxGYj󾪗?/wRib.q 1Nx{[jYe$%ۂe:N|K`Eu×&'$(tK: ;4>[.s*e,t\ӍWRl}ȝH`68FŻq'KS<:;:t3:}q),O8w5ṚXx
K=yC:ڠ唕+B؉ŎIk_lv-n͔D|[$nLkss}=gLMľLi7mR{QzǘOS~9Uf+ra/qgv8{wXrh GP\7gJUs. vꐪ]FBdء8 ljg/PцJTഴ_H[TTͭӤK{33o+v,V跑cw-Ž[ኰc쟿㿭k\&+\E&X|m^#2:g11iBđT DظZ˾p1/,e*tJ|On~0!kEZ
9i6Wqp%Qn?aR<]w!xX/c>_=	@;B#C7V7RE_P`/"kg>_7|&%0,wRSl:pѿ?&`Gj˴8etH$, b~g~Yi'}V?7ʏ!NT>F'QI*Ue8_!|A}[Z=
EU*-9;w\/s=C- tF#
VR47e⮉ĚyXL'(~XL8/jFdo󻮲9Y%׮<E_z>O@Zg]Y[X'q:;Cvr7<7)ߛT!.3$lܗGY-]
ziy;[`?|/_]'y1@=68@6?V kys{5L6q|T#CŎ07 b[Ŵs⃌	PdM/ 4@9gjkc,92Ec~V$7庽|SBr~5U\g 4q]`^q˄#sG2bŻF\aϪnWlsZZ0)Ί!2M1Q`t,N tE'0	VH#Dً~*t,)跒'?X!UWqp7Q'vd?>ޏ:kNEC{jˀU{	JPڇۇ%Mmp=Xv;R=XKߎkʵ36m6EڴMڴaUkp2  ފu' 0/Cv=T?:V`V\bm,NsXx.3sN?5Tڈ`~jIY7e<_"Lќ<V'6nՍ2Pb]Z%ϋ),Z;\z\1ր/8TtW7yZ<;=")D=IO,:DRTHpes#{"PrdQ;z]ƈ1jㆫĈIh2ZFcx.m􊀷&^t'br t:8}xHoPP (]Ώv~hedi j<Ld`AڎAS	CDDDQf, tc v-؛ CU	[j-wUd<aŒs!


ҡt8]՛C^=JS^=J^*T*eHe;/_.c?)&gŪRm n  @3kG R@pir/ұ[٨Dv3v﷗,JYupi~:_PA1O9{^BNpp557"nįG®Ȑh ]4Y/kk"4J6criSV W3I%_Wr	%K::Wu+uf
,)Lz-e,21#,[PI$SJFӃݠy'hGAsY5JzIJ)9/eif4-x;[dHksj021E<g-};?
+]4]zSZ#JoU$o<>nwQ!ԏSA櫔;o=lG~bv&{n;ii[xͬTYX;o*F^\kGW Wء20:iGa!5lR}ܯ&o""bvaLg}8urZ$g{RiH$;ƇXAY9,O7+~uw|<jèrWdt	YOd/KNKBߗ~<We,M%1Jq^HMemy1;u^5mQxf$[F Z0	2	^biRa5DBR=d6bzɡC\r(Ћޮj'K ޷ާ7t)f&22'3ƘaF`1NlY/W94tc]QSɆCu^!2{ژ֏(}H[,0(|&xT@H)*/m"W+KzrLr9tezq`x	L6|ٛPR(.[mmz0Nj_F8[P6 eA,:rύ8ODW(y'ԚG;MZS4`beI\R	$gJ(fJ J3qUJ"O/LPЈOi#t]m{kZ^߾a+bN}\i@nuqVt-ˍH[vlU[rՠ߫z}߫;XձW_c/$Wq/P9GqT}9;2YTxqN
;i[G㖣?`\+0SG!{01!MwCqv!+KjU/G8_ͽlOM=
WgW'|ࣘXڛO0Mq6< i'BQkiyXi@0B~;/߀4y )9`T9Ư.vTo:f28wrau-R7	۵	rnzoJv/`$UIUa2* 	tKP<@+ RA?{B8Bp+O 
endstream
endobj
45 0 obj
<<
/Filter /FlateDecode
/Length 540
>>
stream
H\͊@FyZv/$UV ?-ƙI$ĸ'ɑAP)w>Mݡ~sޗќnܚ.'Ϳt||܆x=46Y.Mc<ü_[_žn.jklT<їZ\Ikoj<x?]4v0e[[W/KLY~T˵ӹ]n|<l)@- !mޡ=)ϠCYYrrH!yAvIHڑ:_Cpwz&K2!%̒LHfI&$$Y	,ɄddB2K2!%̒L>DB;w)~#a9#bpPBg΄		ag03Aә03Oә0?ә33OgBgΔ<)y:S:ttL)~?/S~_O)~O9L"LOa`sWμ]3mk;3ޚ_ 1
endstream
endobj
46 0 obj
<<
/BaseFont /OWAUHL+TimesNewRoman
/DescendantFonts 47 0 R
/Encoding /Identity-H
/Subtype /Type0
/ToUnicode 48 0 R
/Type /Font
>>
endobj
47 0 obj
[ 40 0 R ]
endobj
48 0 obj
<<
/Filter /FlateDecode
/Length 227
>>
stream
H\j0~
C]C`trZ[Il琷&AO/-ua縰CqޕM6)-ps>xT9Kw-)}ㄔ@ӀAn']SEy=	\BUo=:dK#H5PJ5
wrq?ۘq=xr);(A# o
endstream
endobj
49 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
50 0 obj
<<
/Length 8979
>>
stream
q
BT
/C2_0 12 Tf
72 700 Td
<00330055004c0046004c0051004a0003004c005100030057004b00480003003000440055004e0048005700030049005200550003002400510057004c0046004400510046004800550003002700550058004a0056> Tj
0 -14 TD
<002700440059004c00470003002b00110003002b0052005a004400550047000f0003003300480057004800550003002500110003002500440046004b000f0003002800550051005600570003003500110003002500480055005100470057000f00030044005100470003003500480051004400030030001100030026005200510057004c> Tj
T*
<00310025002800350003003a00520055004e004c0051004a0003003300440053004800550003003100520011000300150013001b0019001a> Tj
T*
<002d00440051005800440055005c00030015001300140018> Tj
T*
<002d0028002f00030031005200110003002c0014> Tj
/T1_0 12 Tf
201.33 -28 Td
(ABSTRACT) Tj
/C2_0 12 Tf
95.2683 Tz
-201.33 -28 Td
<002700550058004a00560003004f004c004e0048000300450048005900440046004c005d00580050004400450003000b000700180013000f00130013001300030053004800550003005700550048004400570050004800510057000300480053004c0056005200470048000c00030044005100470003004c0053004c004f004c005000580050004400450003000b0007001400150013000f0013001300130003005300480055000300480053004c0056005200470048000c0003004b004400590048> Tj
99.7417 Tz
T*
<004900580048004f0048004700030057004b004800030053004800550046004800530057004c0052005100030057004b0044005700030057004b00480003004f0044005800510046004b000300530055004c0046004800560003005200490003004400510057004c0046004400510046004800550003004700550058004a005600030044005500480003004c005100460055004800440056004c0051004a0003005200590048005500030057004c005000480011000300380056004c0051004a000300440051> Tj
97.1841 Tz
T*
<00520055004c004a004c00510044004f0003004700440057004400560048005700030052004900030018001b0003004400510057004c0046004400510046004800550003004700550058004a00560003004400530053005500520059004800470003004500480057005a00480048005100030014001c001c0018000300440051004700030015001300140016000f0003005a004800030049004c0051004700030057004b004400570003004f0044005800510046004b000300530055004c004600480056000f> Tj
92.3842 Tz
T*
<00440047004d0058005600570048004700030049005200550003004c00510049004f00440057004c0052005100030044005100470003004700550058004a005600b600030056005800550059004c00590044004f000300450048005100480049004c00570056000f0003004c0051004600550048004400560048004700030045005c0003001400130008000f00030052005500030044004500520058005700030007001b000f001800130013000f00030053004800550003005c004800440055001100030024004f0057004b00520058004a004b> Tj
99.6652 Tz
T*
<0053004b005c0056004c0046004c0044005100560003004400550048000300510052005700030053004800510044004f004c005d0048004700030049005200550003005300550048005600460055004c0045004c0051004a00030046005200560057004f005c0003004700550058004a0056000f00030057004b0048005c000300500044005c000300450048000300550048004f0058004600570044005100570003005700520003005300550048005600460055004c004500480003004700550058004a0056> Tj
97.5244 Tz
T*
<005a004c0057004b000300530055004c00460048005600030057004b0044005700030048005b00460048004800470003005600580045004d004800460057004c005900480003005600570044005100470044005500470056000300520049000300490044004c00550051004800560056001100030030004400510058004900440046005700580055004800550056000300500044005c00030056004800570003004b004c004a004b004800550003004f0044005800510046004b000300530055004c004600480056> Tj
96.7142 Tz
T*
<005200590048005500030057004c0050004800030044005600030056005700440051004700440055004700560003004800590052004f005900480011000300330055004c0046004c0051004a0003005700550048005100470056000300500044005c00030044004f005600520003005500480049004f0048004600570003005000440051005800490044004600570058005500480055005600b600030055004800560053005200510056004800030057005200030048005b0053004400510056004c005200510056> Tj
94.8121 Tz
T*
<004c005100030057004b0048000300160017001300250003002700550058004a000300330055004c0046004c0051004a0003003300550052004a005500440050000f0003005a004b004c0046004b00030055004800540058004c0055004800560003005000440051005800490044004600570058005500480055005600030057005200030053005500520059004c0047004800030056005700480048005300030047004c005600460052005800510057005600030057005200030048004f004c004a004c0045004f0048> Tj
100 Tz
T*
<0053005500520059004c00470048005500560011> Tj
0 -42 TD
<002700440059004c00470003002b00110003002b0052005a004400550047> Tj
0 -14 TD
<00270048005300440055005700500048005100570003005200490003002b00480044004f0057004b000300330052004f004c0046005c000300440051004700030030004400510044004a00480050004800510057> Tj
T*
<0028005000520055005c000300380051004c0059004800550056004c0057005c> Tj
T*
<001400180014001b00030026004f004c004900570052005100030035005200440047000300310028> Tj
T*
<00240057004f0044005100570044000f0003002a0024000300160013001600150015> Tj
T*
<0047004b004b0052005a0044005500230048005000520055005c0011004800470058> Tj
0 -28 TD
<003300480057004800550003002500110003002500440046004b> Tj
0 -14 TD
<0027004800530044005500570050004800510057000300520049000300280053004c004700480050004c0052004f0052004a005c000300440051004700030025004c00520056005700440057004c00560057004c004600560003> Tj
T*
<00270048005300440055005700500048005100570003005200490003003000480047004c0046004c00510048> Tj
T*
<00300048005000520055004c0044004f00030036004f0052004400510003002e00480057005700480055004c0051004a00030026004400510046004800550003002600480051005700480055> Tj
T*
<00310048005a0003003c00520055004e000f00030031003c000300140013001300190018> Tj
T*
<004500440046004b0053002300500056004e00460046001100520055004a> Tj
234 168 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 434 Tm
<002800550051005600570003003500110003002500480055005100470057> Tj
-27 -14 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 420 Tm
<0030002c003700030036004f005200440051000300360046004b00520052004f00030052004900030030004400510044004a00480050004800510057> Tj
-27 -14 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 406 Tm
<001400130013000300300044004c00510003003600570055004800480057000f0003002800190015001000180014001b> Tj
-27 -14 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 392 Tm
<00260044005000450055004c0047004a0048000f000300300024000300130015001400170015> Tj
-27 -14 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 378 Tm
<00440051004700030031002500280035> Tj
-27 -14 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 364 Tm
<004800450048005500510047005700230050004c00570011004800470058> Tj
-27 -28 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 336 Tm
<003500480051004400030030001100030026005200510057004c> Tj
-27 -14 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 322 Tm
<00380051004c0059004800550056004c0057005c00030052004900030026004b004c004600460044004a0052> Tj
-27 -14 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 308 Tm
<00270048005300440055005700500048005100570003005200490003003300480047004c004400570055004c00460056> Tj
-27 -14 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 294 Tm
<0036004800460057004c005200510003005200490003002b00480044005000570052004f0052004a005c00120032005100460052004f0052004a005c> Tj
-27 -14 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 280 Tm
<0018001b0014001500030036001100030028004f004f004c00560003003600570055004800480057> Tj
-27 -14 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 266 Tm
<0026004b004c00460044004a0052000f0003002c002f00030019001300190016001a> Tj
-27 -14 Td
<000300030003000300030003000300030003> Tj
1 0 0 1 333 252 Tm
<00550046005200510057004c002300580046004b004c00460044004a00520011004800470058> Tj
ET
q
1 0 0 1 273.33 614.5 cm
0 0 0 RG
0 0 m
65.34 0 l
S
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0.9 0.9 0.9 RG
n
72 700 207 8 re
S
0.9 0.9 0.9 RG
n
72 686 336 8 re
S
0.9 0.9 0.9 RG
n
72 672 162 8 re
S
0.9 0.9 0.9 RG
n
72 658 64 8 re
S
0.9 0.9 0.9 RG
n
72 644 53 8 re
S
0.9 0.9 0.9 RG
n
273 616 65 8 re
S
0.9 0.9 0.9 RG
n
72 588 468 8 re
S
0.9 0.9 0.9 RG
n
72 574 468 8 re
S
0.9 0.9 0.9 RG
n
72 560 468 8 re
S
0.9 0.9 0.9 RG
n
72 546 468 8 re
S
0.9 0.9 0.9 RG
n
72 532 468 8 re
S
0.9 0.9 0.9 RG
n
72 518 468 8 re
S
0.9 0.9 0.9 RG
n
72 504 468 8 re
S
0.9 0.9 0.9 RG
n
72 490 468 8 re
S
0.9 0.9 0.9 RG
n
72 476 48 8 re
S
0.9 0.9 0.9 RG
n
72 434 86 8 re
S
0.9 0.9 0.9 RG
n
72 420 224 8 re
S
0.9 0.9 0.9 RG
n
72 406 86 8 re
S
0.9 0.9 0.9 RG
n
72 392 108 8 re
S
0.9 0.9 0.9 RG
n
72 378 92 8 re
S
0.9 0.9 0.9 RG
n
72 364 104 8 re
S
0.9 0.9 0.9 RG
n
72 336 66 8 re
S
0.9 0.9 0.9 RG
n
72 322 226 8 re
S
0.9 0.9 0.9 RG
n
72 308 118 8 re
S
0.9 0.9 0.9 RG
n
72 294 198 8 re
S
0.9 0.9 0.9 RG
n
72 280 107 8 re
S
0.9 0.9 0.9 RG
n
72 266 89 8 re
S
0.9 0.9 0.9 RG
n
306 434 102 8 re
S
0.9 0.9 0.9 RG
n
306 420 194 8 re
S
0.9 0.9 0.9 RG
n
306 406 152 8 re
S
0.9 0.9 0.9 RG
n
306 392 139 8 re
S
0.9 0.9 0.9 RG
n
306 378 79 8 re
S
0.9 0.9 0.9 RG
n
306 364 110 8 re
S
0.9 0.9 0.9 RG
n
306 336 98 8 re
S
0.9 0.9 0.9 RG
n
306 322 139 8 re
S
0.9 0.9 0.9 RG
n
306 308 147 8 re
S
0.9 0.9 0.9 RG
n
306 294 189 8 re
S
0.9 0.9 0.9 RG
n
306 280 120 8 re
S
0.9 0.9 0.9 RG
n
306 266 117 8 re
S
0.9 0.9 0.9 RG
n
306 252 130 8 re
S
Q

endstream
endobj
51 0 obj
<<
/BaseFont /Times-Bold
/Encoding <<
/BaseEncoding /WinAnsiEncoding
/Differences [ 0 /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /.notdef /space /exclam /quotedbl /numbersign /dollar /percent /ampersand /quotesingle /parenleft /parenright /asterisk /plus /comma /hyphen /period /slash /zero /one /two /three /four /five /six /seven /eight /nine /colon /semicolon /less /equal /greater /question /at /A /B /C /D /E /F /G /H /I /J /K /L /M /N /O /P /Q /R /S /T /U /V /W /X /Y /Z /bracketleft /backslash /bracketright /asciicircum /underscore /grave /a /b /c /d /e /f /g /h /i /j /k /l /m /n /o /p /q /r /s /t /u /v /w /x /y /z /braceleft /bar /braceright /asciitilde /bullet /Euro /bullet /quotesinglbase /florin /quotedblbase /ellipsis /dagger /daggerdbl /circumflex /perthousand /Scaron /guilsinglleft /OE /bullet /Zcaron /bullet /bullet /quoteleft /quoteright /quotedblleft /quotedblright /bullet /endash /emdash /tilde /trademark /scaron /guilsinglright /oe /bullet /zcaron /Ydieresis /space /exclamdown /cent /sterling /currency /yen /brokenbar /section /dieresis /copyright /ordfeminine /guillemotleft /logicalnot /hyphen /registered /macron /degree /plusminus /twosuperior /threesuperior /acute /mu /paragraph /periodcentered /cedilla /onesuperior /ordmasculine /guillemotright /onequarter /onehalf /threequarters /questiondown /Agrave /Aacute /Acircumflex /Atilde /Adieresis /Aring /AE /Ccedilla /Egrave /Eacute /Ecircumflex /Edieresis /Igrave /Iacute /Icircumflex /Idieresis /Eth /Ntilde /Ograve /Oacute /Ocircumflex /Otilde /Odieresis /multiply /Oslash /Ugrave /Uacute /Ucircumflex /Udieresis /Yacute /Thorn /germandbls /agrave /aacute /acircumflex /atilde /adieresis /aring /ae /ccedilla /egrave /eacute /ecircumflex /edieresis /igrave /iacute /icircumflex /idieresis /eth /ntilde /ograve /oacute /ocircumflex /otilde /odieresis /divide /oslash /ugrave /uacute /ucircumflex /udieresis /yacute /thorn /ydieresis ]
/Type /Encoding
>>
/FirstChar 32
/LastChar 255
/Subtype /Type1
/Type /Font
/Widths [ 250 333 555 500 500 1000 833 278 333 333 500 570 250 333 250 278 500 500 500 500 500 500 500 500 500 500 333 333 570 570 570 500 930 722 667 722 722 667 611 778 778 389 500 778 667 944 722 778 611 778 722 556 667 722 722 1000 722 722 667 333 278 333 581 500 333 500 556 444 556 444 333 500 556 278 333 556 278 833 556 500 556 556 444 389 333 556 500 722 500 500 444 394 220 394 520 350 500 350 333 500 500 1000 500 500 333 1000 556 333 1000 350 667 350 350 333 333 500 500 350 500 1000 333 1000 389 333 722 350 444 722 250 333 500 500 500 500 220 500 333 747 300 500 570 333 747 333 400 570 300 300 333 556 540 250 333 300 330 500 750 750 750 500 722 722 722 722 722 722 1000 722 667 667 667 667 389 389 389 389 722 722 778 778 778 778 778 570 778 722 722 722 722 722 611 556 500 500 500 500 500 500 722 444 444 444 444 444 278 278 278 278 500 556 500 500 500 500 500 570 500 556 556 556 556 500 556 500 ]
>>
endobj
52 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
53 0 obj
<<
/Length 8144
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 303.24 75.8401 Tm
(3\040) Tj
/C2_0 1 Tf
0 Tc
-21.06 -2.262 Td
<0003> Tj
/TT1 1 Tf
0.0006 Tc
12 0 0 12 72 708.84 Tm
[ (Introductio) 6 (n) 2 (\040) ] TJ
/TT0 1 Tf
0 Tc
0 -1.715 TD
(\040) Tj
0.0002 Tc
-0.0012 Tw
3 -1.725 Td
(In\0402004\054\040Genentech\040introduced\040the\040drug\040) Tj
0.0005 Tc
0.002 Tw
16.195 0 Td
[ (bevacizum) 8 (a) -1 (b\227brand\040nam) 8 (e) -1 (\040Avastin\227for\040) ] TJ
0.0006 Tc
-0.0031 Tw
-19.195 -1.725 Td
(patients\040with\040late\040stage\040colore) Tj
0.0002 Tc
-0.0002 Tw
11.89 0 Td
[ (ctal\040cancer\056\040The\040drug\040cost\040\04450\054000\040per\040treatm) 8 (e) -1 (nt\040episode\040and\040was\040) ] TJ
0.0007 Tc
-0.0017 Tw
-11.89 -1.725 Td
[ (associated\040w) 8 (ith\040an\040increm) 9 (ental\040increase\040in) ] TJ
-0.0022 Tw
16.86 0 Td
[ (\040life\040ex) 6 (pectancy\040of\040) ] TJ
0.0008 Tc
-0.0008 Tw
7.655 0 Td
[ (five\040m) 9 (onths\056\040Following\040) ] TJ
0.0002 Tc
-0.0014 Tw
-24.515 -1.725 Td
[ (Genentech\222s\040pricing\040announcem) 8 (ent\054\040newspapers\040ra) ] TJ
-0.0002 Tw
20.35 0 Td
[ (n\040stories\040w) 7 (ith\040titles\040like\040\223Cancer\040Weapons\054\040) ] TJ
0.0005 Tc
-0.0005 Tw
-20.35 -1.725 Td
(Out\040of\040Reach\224\040in\040the\040) Tj
/TT2 1 Tf
-0.0001 Tc
0.0001 Tw
8.525 0 Td
(Washington\040Post) Tj
/TT0 1 Tf
0.0006 Tc
-0.0006 Tw
[ (\040\050W) 9 (ittes\04020) 6 (04\051\040and\040\223Price\040of) 4 (\040Cancer) 4 (\040Drugs\040Calle) 4 (d\040\221Mind\055) ] TJ
0.0003 Tc
-0.0053 Tw
-8.525 -1.725 Td
(Boggling\222\224\040in\040) Tj
/TT2 1 Tf
0 Tc
0 Tw
5.775 0 Td
(USA\040Today) Tj
/TT0 1 Tf
0.0003 Tc
-0.0003 Tw
4.585 0 Td
[ (\040\050Szabo\0402004\051\056\040Som) 8 (e) -1 (\040Wall\040Street\040anal) ] TJ
-0.0019 Tw
15.08 0 Td
[ (ysts\040worried\040that\040bevacizum) 8 (a) -1 (b\222s\040) ] TJ
-0.0003 Tw
-25.44 -1.725 Td
[ (pricing\040would\040prom) 8 (pt\040Congress\040) ] TJ
0.0002 Tc
-0.0014 Tw
12.945 0 Td
(to\040regulate\040drug\040prices\040\050A) Tj
-0.0012 Tw
(nand\0402007\051\056\040By\0402011\054\040the\040backlash\040) Tj
0.0005 Tc
-0.0005 Tw
-12.945 -1.725 Td
[ (against\040bevacizum) 8 (a) -1 (b\040wa) -6 (s\040a\040distant\040m) 8 (e) -1 (m) 8 (o) 1 (ry\056\040Bris) ] TJ
0.0009 Tc
-0.0025 Tw
19.52 0 Td
[ (tol\055Mye) 5 (r) -1 (s\040Sq) 6 (uibb\040set\040th) ] TJ
0.0002 Tc
-0.0014 Tw
(e\040price\040of\040its\040newly\055) Tj
0.0008 Tc
-0.0008 Tw
-19.52 -1.725 Td
[ (approved\040melanom) 9 (a\040drug\040ipilim) 9 (um) 9 (a) -5 (b\227brand\040) ] TJ
0.0002 Tc
0.0006 Tw
18.61 0 Td
[ (nam) 8 (e) -1 (\040Yervoy\227at\040\044120\054000\040for\040a\040course\040of\040) ] TJ
0.0001 Tc
-0.0001 Tw
-18.61 -1.725 Td
(therapy\056\040The\040drug\040was\040associated\040with\040an\040incrementa) Tj
0.0004 Tc
-0.0016 Tw
21.22 0 Td
(l\040increase\040in\040life\040expect) Tj
0.0006 Tc
-0.0006 Tw
9.275 0 Td
[ (ancy\040of\040four\040m) 8 (onths\056\040) ] TJ
-27.495 -1.725 Td
[ (Drugs\040like\040bevacizum) 8 (a) -1 (b\040and\040ipilim) 8 (um) 8 (ab\040have\040fu) ] TJ
0.0008 Tc
-0.0024 Tw
19.495 0 Td
[ (eled\040th) 6 (e\040perception\040that\040the\040launch\040p) 6 (r) 4 (ices\040) ] TJ
0.0004 Tc
-0.001 Tw
-22.495 -1.725 Td
[ (of\040new\040anticancer\040d) 5 (r) -2 (ugs\040and\040other\040d) 5 (r) 3 (ugs\040in\040the\040) ] TJ
0.0006 Tc
-0.0018 Tw
[ (so) 6 (\055called\040\223sp) 6 (e) 4 (cialty\224\040pharm) 8 (aceutical\040m) 8 (a) -1 (rket\040have\040) ] TJ
-0.0014 Tw
0 -1.725 TD
[ (been\040increas) 5 (ing\040over\040time\040and\040that\040in) 6 (creas) 5 (es\040are\040) ] TJ
0.0001 Tc
-0.0009 Tw
[ (unrelated\040to\040the\040m) 8 (a) -1 (gnitude\040of\040the\040expected\040) ] TJ
-0.0011 Tw
T*
[ (benefits\040\050Experts\040in\040Chronic\040Myeloid\040Leukem) 8 (i) -2 (a\040) ] TJ
0.0002 Tc
-0.0002 Tw
19.44 0 Td
(2013\073\040Kantarjian\040et\040al\056\040) Tj
0.0001 Tc
-0.0017 Tw
9.195 0 Td
(2013\073\040Schrag\0402004\073\040Hall\040) Tj
-0.0001 Tc
0.0001 Tw
-28.635 -1.725 Td
(2013\051\056\040A\040commentary\040in\040) Tj
/TT2 1 Tf
0.0004 Tc
-0.0004 Tw
(The\040Lancet) Tj
/TT0 1 Tf
0.0006 Tc
-0.0006 Tw
14.555 0 Td
[ (\054) 6 (\040a\040lead) 6 (ing\040British\040m) 8 (e) -1 (dical\040jou) 6 (r) -1 (nal\054\040s) 5 (u) -4 (mm) 8 (arized\040the\040) ] TJ
0 Tc
0 Tw
-14.555 -1.725 Td
[ (conventional\040wisdom) 8 (\072\040\223\133T\135he\040cost\040of\040the\040new\040gene) ] TJ
0.0001 Tc
-0.0001 Tw
20.24 0 Td
(ration\040of\040drugs\040is\040getting\040out\040of\040all\040proportion\040) Tj
0 Tc
0 Tw
-20.24 -1.72 Td
[ (to\040the\040added\040benefit\224\040\050C) 7 (avalli\0402013\051\056\040The\040public\040) ] TJ
0.0003 Tc
-0.001 Tw
19.465 0 Td
(debate\040has\040focused\040on\040a\040handful\040of\040high\055profile\040) Tj
0 Tc
0 Tw
-19.465 -1.725 Td
[ (drugs\040like\040bevacizum) 8 (a) -1 (b\056\040It\040is\040unclear\040if\040these\040drug) ] TJ
0.0003 Tc
-0.0003 Tw
19.965 0 Td
(s\040are\040outliers\040or\040reflect\040) Tj
0.0007 Tc
-0.0023 Tw
9.245 0 Td
(broader\040trends\040in\040the\040) Tj
0.0002 Tc
0 Tw
-29.21 -1.725 Td
(industry\056\040) Tj
-0.0002 Tw
3 -1.725 Td
(In\040this\040paper\040we\040discuss\040the\040unique\040features\040) Tj
0 Tc
0 Tw
[ (of\040the\040m) 8 (a) -1 (rket\040for\040anticancer\040drugs\040and\040assess\040) ] TJ
0.0001 Tc
-0.0008 Tw
-3 -1.725 Td
(trends\040in\040the\040launch\040prices\040for\04058\040anticancer\040) Tj
-0.0001 Tc
0.0001 Tw
17.775 0 Td
(drugs\040approved\040between\0401995\040and\0402013\040in\040the\040US\056\040) Tj
0.0003 Tc
-0.001 Tw
-17.775 -1.725 Td
(Drugs\040used\040to\040treat\040other\040conditions\040have\040also\040) Tj
-0.0001 Tc
-0.0007 Tw
18.555 0 Td
(been\040closely\040scrutinized\040\226\040most\040recently\040the\040) Tj
0.0003 Tc
-0.0003 Tw
-18.555 -1.725 Td
[ (\04484\054000\040hepatitis\040C\040treatm) 8 (e) -1 (nt\040Sovaldi\040\226\040but\040we\040restri) ] TJ
0.0005 Tc
-0.0013 Tw
21.14 0 Td
[ (ct\040atten) 6 (t) -2 (ion\040to\040anticancer\040drugs\040b) 6 (ecause\040the\040) ] TJ
0.0006 Tc
-0.0006 Tw
-21.14 -1.725 Td
[ (use\040of\040survival\040tim) 8 (e) -1 (\040as\040a\040prim) 8 (ary\040outcom) 8 (e) ] TJ
0.0012 Tc
-0.0012 Tw
16.795 0 Td
[ (\040m) 9 (easure\040provides\040a\040co) ] TJ
0.0002 Tc
0.0014 Tw
9.17 0 Td
(mmon\054\040objective\040scale\040for\040) Tj
0.0008 Tc
-0.0033 Tw
-25.965 -1.725 Td
[ (quantifying\040the\040increm) 9 (ental\040) ] TJ
0 Tc
-0.0025 Tw
11.305 0 Td
(benefit\040of\040new\040products\056\040\040) Tj
0.0003 Tc
-0.0011 Tw
-8.305 -1.725 Td
[ (The\040m) 8 (a) -1 (rket\040for\040anticancer\040drugs\040is\040econom) 8 (i) ] TJ
0.0006 Tc
-0.0016 Tw
17.43 0 Td
[ (cally\040significant\056\040W) 9 (ithin\040the\040m) 8 (a) -1 (rket\040for\040) ] TJ
0.0009 Tc
-0.0025 Tw
-20.43 -1.725 Td
[ (pharm) 9 (aceuticals\054\040an) 6 (tican) 6 (cer\040drugs\040ra) ] TJ
0.0007 Tc
-0.0012 Tw
14.6 0 Td
[ (nk\040first\040in\040term) 9 (s\040of\040global\040spending\040b) 6 (y) 1 (\040therap) 6 (eutic\040class\072\040\04491\040) ] TJ
0.0004 Tc
0.0001 Tw
-14.6 -1.725 Td
[ (billion\040in\0402013\054\040up\040from) 8 (\040\04471\040billion\040in\0402008\040\050IMS) 7 (\040) ] TJ
0.0005 Tc
-0.0005 Tw
20.085 0 Td
[ (2014\051\056\040The\040US\040m) 8 (a) -1 (rket\040size\040was\040\04437\040billion\040in\040) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 68 8 re
S
0.9 0.9 0.9 RG
n
72 688 3 8 re
S
1 0 0 RG
n
108 667 395 8 re
S
0 1 1 RG
n
72 646 459 8 re
S
0 1 1 RG
n
72 626 409 8 re
S
0 1 1 RG
n
72 605 452 8 re
S
0 1 1 RG
n
72 584 459 8 re
S
0 1 1 RG
n
72 564 463 8 re
S
0 1 1 RG
n
72 543 448 8 re
S
0 1 1 RG
n
72 522 443 8 re
S
0 1 1 RG
n
72 501 432 8 re
S
0 1 1 RG
n
72 481 468 8 re
S
1 0 0 RG
n
108 460 433 8 re
S
0 1 1 RG
n
72 439 466 8 re
S
0 1 1 RG
n
72 419 440 8 re
S
0 1 1 RG
n
72 398 464 8 re
S
0 1 1 RG
n
72 377 423 8 re
S
0 1 1 RG
n
72 357 463 8 re
S
0 1 1 RG
n
72 336 463 8 re
S
0 1 1 RG
n
72 315 452 8 re
S
0 1 1 RG
n
72 295 45 8 re
S
1 0 0 RG
n
108 274 431 8 re
S
0 1 1 RG
n
72 253 459 8 re
S
0 1 1 RG
n
72 232 435 8 re
S
0 1 1 RG
n
72 212 463 8 re
S
0 1 1 RG
n
72 191 439 8 re
S
0 1 1 RG
n
72 170 257 8 re
S
1 0 0 RG
n
108 150 399 8 re
S
0 1 1 RG
n
72 129 469 8 re
S
0 1 1 RG
n
72 108 462 8 re
S
Q

endstream
endobj
54 0 obj
<<
/OP false
/OPM 1
/SA false
/SM 0.02
/Type /ExtGState
/op false
>>
endobj
55 0 obj
<<
/BaseFont /PBEFDG+Calibri
/DescendantFonts [ 56 0 R ]
/Encoding /Identity-H
/Subtype /Type0
/ToUnicode 60 0 R
/Type /Font
>>
endobj
56 0 obj
<<
/BaseFont /PBEFDG+Calibri
/CIDSystemInfo <<
/Ordering (Identity)
/Registry (Adobe)
/Supplement 0
>>
/CIDToGIDMap /Identity
/DW 1000
/FontDescriptor 57 0 R
/Subtype /CIDFontType2
/Type /Font
/W [ 3 [ 226 ] ]
>>
endobj
57 0 obj
<<
/Ascent 750
/CIDSet 58 0 R
/CapHeight 1000
/Descent -250
/Flags 4
/FontBBox [ -503 -307 1240 964 ]
/FontFamily (Calibri)
/FontFile2 59 0 R
/FontName /PBEFDG+Calibri
/FontStretch /Normal
/FontWeight 400
/ItalicAngle 0
/StemV 80
/Type /FontDescriptor
/XHeight 1000
>>
endobj
58 0 obj
<<
/Filter /FlateDecode
/Length 16
>>
stream
hj`  e 
endstream
endobj
59 0 obj
<<
/Filter /FlateDecode
/Length1 45524
/Length 13241
>>
stream
h޴[|UE>Bt "" @ PRHH# B WTTk/Q׆.*Xݵ+*(wߔ(L3sΜ33!R	Y}Tf}hr/=.њi]4o_QӛNi/`Z:<$M=dAW1w7*$j8ų.=^JYsqD"svyq	ȿ}sf|^=6dނy30DcP\Yv6r(\Q:LkM"cm'dTT^Q"QP;D@<=B
It&^(Vm0=FzޠޙMgC>ԴFsBm_ƍq}Í	4h.?isDؼG" rhMIKyhT*虙4fi]*@*kRͥyZHh1ND|^DKo)]Oh9%R1dx)něVIRiVoZG/Zb6=J;/T+tN1VƸ%cFmfd"yz=}Y^S=R$p`Z:ƪzk%.V[Ua9~)W#*EQ=qڠxMThl6W./g!"wv|e-zU!yPڝ2 =DǻxD2J0#(]8_gJ*Iz
or/=CBq?!ͳz#EڏcнN_?",Rk:f7EЫ-D0K`o;_P5h2MN2uI'dg9:#}ӆM28%yP׷5uU/1!]M.iXnt(lP\_ !7`'SS/aya܀|2vD,HR&R1~ﲮ/do)ٟ|vG .9|)-}#ח4%7UԍT}YWZ,?ߐҧR}؀75-u4H
xeYδWu}1ۥTԼY+J[t	t':-\ON	t񣰴ѡ'>+=Iښ<ǜ$AEC݄x愺h_\ˆ}@$#K}[Iݺd\c1%ʞ*%W_\"Pﻬ+z_VBn~Aydoc y)ݻ!}^.1]tCFV^?I%',Eg4s$zRJsUEYgJ'-h6/%!4kjQmnT"_Vl\ 1ݗ*o	'(sm9h7>ʗeZmA_~AFXdxN!Xr(Kd~.PX]''>VV:眷j*P'_JarXk
]OS~0rDיQV<\L#U-(ݗ/g1ӳDD_Oɒo[1B*
(0a˯Up(=}QRQ_H>|Ah'ahކލz?8.V$&K-#Z+::eQ(HtYW=I~c]FE.3'YѾuc*M]qYOZShR|" J@L,,kK3HXgP>SbXgBg+]ԉbL)..5ë#`S0LO@0)Pן$~{ދa439bN*cʢXCEKc{<;Cm"s?B=$PR'AcD^oЂl[.Iꠄ:,Lx7x2	@vЬr8(]$u.m!M|
Qu,EV䭇UCoTX)Ĕh'JDHͲ֏Թu/V[t<;&P5JJ.*,GK1J˒ԏ_7gsD]]C[c_,b`Rؔ]LrYרHm}.-ꇤPRj(S;Ϝ>1u4lo7	eXxbݷ*)8ctRuʁ-k SMN=	
N"LM
 ,ތtknr;"?`M|'S}é71J,Wh
Eᴣ]yе;Pw,D}5ZI\,gMe!}.؅T̰PiKP%}]N@֗Yȷf/vJ4Qq͂l	
t _cOdw7ZolD+OnGAX*y~P@9E֫x`WWHrUpOvJb<n}Z,,XOWGzzY"15<B#:	O7'm1a\06 zRu&]﹇⣎P8hgqG@kg
+{uM}\iLގo"!z6= l΁l@0Km~nCo#փk4@gijmV6TZ)v){}ƨt<owo6+20nj;{P6GCq@)Eu7ËU˵`[amv>*I;YD^){+ZK1V)f#L5ejoޅw2
(Ϙ~,c2qHḊ<Ư)"y3~Jqky5%c0-U:9lG@v "tہ醋=R_ZQIӤ~'P`Fz7.r1v)u 1WeS\a;=me ڶry
W2>ʆ.4e/kpJyGg5m&`ݶma9BzXO=D94I5QCkVnOQZжc}JcBCkR~X(MasEE@"uGcA'0R=h=,y).uFXfQG-FlVKt@3uXmq6Ts|'{B{{9v9Oc1Ql<O1&9¾`BdyN+kq)ʶکHsX@=?6QCOD &yE`"16Dw	5:Kx{=ӝVmZ&wkT$3Xv1fvDbߊ<ӑ4a <;;
|A3_zXߧP[ 5ܐz [G08" 7v^sN(?l4;c/6U&4.뚵R3I4u^ :gmLKk[XR;;=nmrMrJۜ (+Mkk3wkڦ{^#ڼ^Υ@5a-qYi91t't%:Kb~vK|-=hi5'kFUeA.a*ؓ?mt*z9ͦeBi!khLļ0
 Ηe, ʹ=PE3k68XMX7'8 F'i(C
)Y`]{Z?cށE;n8u%*c_B[hy120>YCV%l^zal7T` B`&P D-0^bPꆱf=OQt`P}i;0~v`"Yx~H5"@inh~D#=Ovʷad7y8IW9r51#Ou7{S;s</6]f5dg
i@&FCg?QJO.Ԩ
Dx_UX׫h8t&k»Rcqb<;PWۡ<xyqU%a5SxM0|s woH4'>,G=݊Q
{or/aأi	4.a~QGݣ7Z:MrkF>T SxH71l}nq?8$X_SӸGok$t;P)?x7ZR7X{3kFZԺۇ%	`' p+b%l!h&cppTv5^"=&l;0
@a3	NonͯV˃;n56"x8D	۳"9HwYB17ذƛS+;s({acVEe/ 녤)|up:.Zq |5a:Qg@K|7K+<SY1p\lx WsՐM;{*j>D<Kh?3AMl"J3w苷T	|AG:AӪuUwî+ ni$Sw L/:4\؎4ۥ[BL%Q 'Ȑhpg~@e_k(}Dj#}\uVJp̧xfobvs`(ŸMߒ [>Έü_ /}a{=$_H8q*jJA MbG?wxGQQ[U"+|*>j=q?E;p+},%cM<KWcNAGQ"~mMX+[h=}~oN|Vce{ل¶Z3hzs}Dz,ةr"o2:Kh,8#s Æ ^}їOϓb>E2ִݰnu.f=ޠ;0R)!ol9]^{fb.t p\{2`]8#M~&\>ΣSr^,u_R6K 6S;c^gI1vO=96{)lᨳ9"K`lƳUcy>v,iuqMk콮~#9_cX5h{[X=hl[3!fXR KXr<{w@`ޫ]km'#|oVl'ĩ=XiQk2C?RGоdyzS?%i_1%h&!J8g[`?DEV)[W,YAA۷#vg=ro5LBgmo46EwCea=P#E<g6ѝgY4mG<l-v=_W=
Fǂyw{}혊|+{N㭍hg#ä)Q{l;Lv՘J`'G9Y䩇g=!Ɯ3F܊t Bg|>+!bύvFn}vOj$Z -;^E|~'\o:9OeD4eO*$bEԾ?AvsH{~F]yŜ۽LZ 8ՙc}s@5Jd n;ÆRuj9g.̯GSB
hWdL`ڽh,9w+mos3ykX;9eb<h\Gd)fKS,ڜ[(G왊1ws'3_)}3 9 tGG04t?Zo7Bhmv6lH?
NPww+i!l?(ĎPV?2*0 6|NikI>O(Jkޣ!NDN7Z5>&p~ye?QJ?S*Mkj?Sl\]9>XT.,_KJ}:68ug:Z_S࿈sCq.CiPҤ4-Ϲ/Gxs"@+`;ַWZbY߃9c8m*%`ڰь4sz?Z54/NV?~+`|foT|b5J|k1-3XBIO7%QgK%Xc܊xlzřlwqs$n[{ḞM؀řZjk1VOSk׷Q!04J03'y^+q~Bwk>9vΊٰxN	{|m@7|	2>з<'A8_\ȳ!y.\l=!1\U|i[}!q&s{\bԐNu=2*`th/ۈ* U1McqgCUpU	[SeKOKXAmɽu8,~hd9!
H_^{>w{\rOADmشP8$y}/-oRg_})|nCWj(免a/_}/5$cΕ2]Q _C`;tZ],o Y.SH~O0X
C	*`/jծ
p\,s~ت~\0g?ޭU2BW;lU23ᇀ9]s2S/\7zBgxn<a}4G=W;Cto~p-+$BQVz\ApZomz{˽.N:>\!¡# m||hS67Ei=ܵj aa\ |G@'`:P|;s.*57b3ߗr?oCwՈ܋IPglnFa78rQd=_\̵3鞴]<~3_<|1Ŭ9Ya`^a?gdD8'BC=e?ጔŢ"QJuAN=j(Z++j"oZ_]Bq/J=8q?Ξ
_ ׫΁:JLJ@ߩkZ^]9E>ݏX@ŝKqNfu΀6^DW{.kVt!YiJ8Mq^SLb/_C;aw>y9녰ZR9*lh[%qLc4Eu.3B{KZ3i+pW>`m I܅wd{*Ԟ=c)׹yR3O:BM=*usFcT[@ԣ}7cK0=@Ҷ'j7^N
F2gĽByE2Yv{52D%N	(/F&xj޷<JÜu@6->ǆ%{2PBD~BO B<;o7 wMY>EWш;c^{c&b|;><aԣUgW{+' __9+qkh}{4h|#2^P`*	{FYɧ:mʴ[Hs/q?V~܍'Q&gAM}:j}j+c' K(SHj&Z)Q'	ҋ1G?=gR#|ex`I]˩G*rR'}/ezj4^mnZNz>B#Z rO1TݜGSnD0~MhxAw_;VV8.|Vy@O>Unq(:N-vy|޾dav\'<_ou+`	0L8@Ba
gܳQ[K:Vgr5h 窻7U? ?鿓أW4Dx󏐳!QGnއF@TNSzTAB5t\wo2±KcȻJci5~1GcBjk~	cICe?aֆ"3(8ءDyX5lD9/(TzPϵQ5C@1O8@Y̑o1iDu,>sSuZ@V3Y&&%LndLV0Yd,eb&,drL1dLf1dLLcRĤT&L1e2d&Ld2Il&YL3d,1L2f$(&#`2IaL2Ie2`&)Lbd D&gr-~L2&\ͤdr%L`ҝI7&3IW&]tf҉IG&$0gҞI;&qL|L2iR&2iŤ%L3iƤ)&L3i&1L2i>zL2fRI/bb21&$ȤI3LN39LW&'g&?1	&?0q&ǘ|[&09k&_1L>gO|c&d&g1Lg#L/Leg&m&bCLdL^gW`G&0y~&/1yLg?0y>&0i&O1yI%
&&O0d7r&31&2yL~!&2yILv0v&1=L1]Ld&w0v&1[lb&L3Y&k̄c6{6{6{vvvvvvvvvAO
M+4XB7UQB7*M=Th˕XXZy %J,Vb[B)@)W^1OJQIf+1KS f(1]b%)QT:P*QDyJ*1E*$%rV"KJSbcTbJ+1JJPbiJ
1TaC\R;"YAJ$*_TJ\D?}TkJR*UXO%TP
%º)qw]Dg%:)Q%U+NOkD%.UJl5-*[hD3lDlD#%.Qq1J4TJWDuT\^%<-!ʖR*d(ARAĨV*%(qZŝR+/%~Ude1TȄY~RG%NT{%+qL}ķJGZT/U\>SS%>Qq+OW#%|B(~eU6ypSsnڦ4M$t,5Ж ֲi5RR@EEq^VwpEp}ߛ_yoI9{r;-4x(śoД#iuCQJS^x_x),tn^Cb3;imFbjBLxb3SOR)Pد&Zqt1R<B0C)UέtԻN5tZvjU+)(nPf(VPH\!(*ש6Ѩڰ%mb1E][H@U ṚKShi/]>bj+GbhfE-L.)(FQJ/z*zŴt=dv')J!ED	ՅZgZXպZ )yWVhQ4V#U덈\պZj1EE1\w~"PUBT-Ud RHPW-hfj^Xjj/E:]އ7E-vE/Z'ET.uBkv5;bZEHץRP$S$Q$橈\蠚!6
+E{xBiDGaC()Q43fFРBj.k0-
w/cb~1|sߡp8_9|W-W#Gpc) 'g3巑ok1848qu2ɯ*گq#h_0VڃX9x\p`oyOWwg`'v؆s[qnTh<m/o6,2,44Ab	Fx6ȏ"qCh?pֽXcw]p';v\w[3V^3N^S-7lo(/uo9)_4*%J8ؠ!!aaCd+>*f@Y\W))JZ5~`xFK,`8XU|A¼㽍ސ7bh{+1/z`7Z5szev^UUzJMZrV(
9])s^LsNUJS)b$X9'+Wc$gebp29V|grU0O9Zrx,ŜHљ;a<;#ٕ|:|rK%Hś$)KKW%L	G$WBnS#>pCD{W^nf7vM{mBw8r)3_kKwM6&mYN[[t#fd&SIr0'Iڡ5N6eZ:ˈm&l,82d]>n7#t]pF]oHͅiiy;ļP_V]CQ+BL).ʢf.yeR&֧piV4Xje4)>Zz<ҴAϏYڟ>hbA޷hfN**p=\C, õ0B 90aA-̄*
(P4(0J`2\@B(08p0F(pHȅȆ,W0
p`a ~	ҡ4zAOݡt.:dɐ 6B{q`X0@hCDBĈVu *8E ?|y8Ylq/>O>3p>S';678u8
/<9x~{a]V*4C<	Ax6(<C~p.p;a&n&X7rX*F4r?Gs?Gs?Gs?Gs?Gs?Gs?Gs?Gs?Gs/`8 =c8 =c8 =c8 =c8 =c8 =c8 =c8 =9꟣9j9j9j9j9jw(o_z$L+e~Ʋ=̈]ηmFUb|9.Sdܑe&e5K߄<T-{̩3[nd	Iz5Kti`7\8{qRxluutK#%uG/֍kwɚ?cjRf.(6,=UG"=gwΫޒjGGǧm}ȸG]̉F5tJVWژh)"*jgǄˆv3ahoأ؞SZR5Rl6Z%OlAAAAAAAAAAAAAAAű8¿\>jm=o~D[[xl[;v=z6Vh>-aNS[[umw>6Gϵq?R<yY=Ac,-/>aă,3#X-l"ƪY½Jd%fű3sp]-Lǘ3<yeYyuH/1y35wTpOf#/Ýyϟ/#s#SW92~VcDmcsLUzVVSVY-UT֕yg:zjo}`6\^_7lҗƳl6Y.޺jg3sLS`fvm	euW3ꁇ+)r[ުia?piz!-۝xv跣V! W
endstream
endobj
60 0 obj
<<
/Filter /FlateDecode
/Length 215
>>
stream
hTPn0[dt4NwE1%࿯$8	:<ܑ؞Zr7{aeႣ#W`[Wt :GZ<Ե?i8G^;
-1!o7!'
,B?t,'د*~VJ{Awe0W7<MfaNH	>dO ׇjs
endstream
endobj
61 0 obj
<<
/BaseFont /TimesNewRomanPSMT
/Encoding /WinAnsiEncoding
/FirstChar 32
/FontDescriptor 62 0 R
/LastChar 151
/Subtype /TrueType
/Type /Font
/Widths [ 250 0 408 500 500 833 778 180 333 333 500 564 250 333 250 278 500 500 500 500 500 500 500 500 500 500 278 278 564 564 564 444 921 722 667 667 722 611 556 722 722 333 389 722 611 889 722 722 556 722 667 556 611 722 722 944 0 722 611 333 0 333 0 500 333 444 500 444 500 444 333 500 500 278 278 500 278 778 500 500 500 500 333 389 278 500 500 722 500 500 444 0 0 0 0 0 0 0 0 0 0 1000 0 0 0 0 0 0 0 0 0 0 0 333 333 444 444 0 500 1000 ]
>>
endobj
62 0 obj
<<
/Ascent 891
/CapHeight 1000
/Descent -216
/Flags 34
/FontBBox [ -568 -307 2000 1007 ]
/FontFamily (Times\040New\040Roman)
/FontName /TimesNewRomanPSMT
/FontStretch /Normal
/FontWeight 400
/ItalicAngle 0
/StemV 82
/Type /FontDescriptor
/XHeight 1000
>>
endobj
63 0 obj
<<
/BaseFont /TimesNewRomanPS-BoldMT
/Encoding /WinAnsiEncoding
/FirstChar 32
/FontDescriptor 64 0 R
/LastChar 120
/Subtype /TrueType
/Type /Font
/Widths [ 250 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 667 722 722 667 0 778 0 389 0 0 667 0 0 0 611 0 722 556 667 0 0 0 0 0 0 0 0 0 0 0 0 500 556 444 556 444 333 500 556 278 0 0 278 833 556 500 556 0 444 389 333 556 500 0 500 ]
>>
endobj
64 0 obj
<<
/Ascent 891
/CapHeight 1000
/Descent -216
/Flags 34
/FontBBox [ -558 -307 2000 1026 ]
/FontFamily (Times\040New\040Roman)
/FontName /TimesNewRomanPS-BoldMT
/FontStretch /Normal
/FontWeight 700
/ItalicAngle 0
/StemV 136
/Type /FontDescriptor
/XHeight 1000
>>
endobj
65 0 obj
<<
/BaseFont /TimesNewRomanPS-ItalicMT
/Encoding /WinAnsiEncoding
/FirstChar 32
/FontDescriptor 66 0 R
/LastChar 122
/Subtype /TrueType
/Type /Font
/Widths [ 250 0 0 0 0 0 778 0 0 0 0 0 250 333 250 0 500 500 500 500 500 500 0 0 0 0 0 0 0 0 0 0 0 611 611 667 722 611 611 722 722 333 444 0 556 833 667 722 611 722 611 500 556 722 611 833 0 556 0 0 0 0 0 0 0 500 500 444 500 444 278 500 500 278 0 444 278 722 500 500 500 0 389 389 278 500 444 667 444 444 389 ]
>>
endobj
66 0 obj
<<
/Ascent 891
/CapHeight 1000
/Descent -216
/Flags 98
/FontBBox [ -498 -307 1333 1023 ]
/FontFamily (Times\040New\040Roman)
/FontName /TimesNewRomanPS-ItalicMT
/FontStretch /Normal
/FontWeight 400
/ItalicAngle -15
/StemV 71.742
/Type /FontDescriptor
/XHeight 1000
>>
endobj
67 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
68 0 obj
<<
/Length 8714
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 303.24 75.8401 Tm
(4\040) Tj
/C2_0 1 Tf
0 Tc
-21.06 -2.262 Td
<0003> Tj
/TT0 1 Tf
-0.0006 Tw
12 0 0 12 72 708.96 Tm
[ (2013\054\040of\040whi) -7 (c) -1 (h\040one\055third\040was\040spent\040on\04010\040patent\055pro) ] TJ
-0.0002 Tc
-0.0014 Tw
20.97 0 Td
(tected\040cancer\040drugs\040al) Tj
0.0003 Tc
-0.0015 Tw
8.69 0 Td
(one\040\050Conti\040et\040al\056\0402013\051\056\040) Tj
0.0007 Tc
-29.66 -1.725 Td
[ (The\040m) 9 (arket\040is\040also\040politic) 5 (ally\040s) 5 (alient\056\040Antican) ] TJ
0.0005 Tc
-0.0021 Tw
18.195 0 Td
[ (cer\040drugs\040figure\040prom) 8 (inently\040in\040discussions\040over\040) ] TJ
0.0001 Tc
-0.0013 Tw
-18.195 -1.725 Td
[ (health\040reform\054\040alternately\040sym) 8 (bolizing\040wasteful) ] TJ
0.0002 Tc
-0.0002 Tw
18.965 0 Td
[ (\040spending\040and\040biom) 8 (edical\040progress\056\040benefits\040) ] TJ
0.0004 Tc
-0.0004 Tw
-15.965 -1.725 Td
[ (We\040find\040that\040anticancer\040d) 5 (r) -2 (ugs\222\040averag) 5 (e\040benef) ] TJ
0.0011 Tc
-0.0036 Tw
17.995 0 Td
[ (it\055\040an) 6 (d\040inf) 4 (l) -1 (ation) 6 (\055) -1 (a) 5 (d) 1 (justed\040laun) 6 (ch\040pric) 5 (es\040) ] TJ
0.0002 Tc
-0.0016 Tw
-20.995 -1.725 Td
(increased\040by\04010\040percent\040annually\054\040or\040an\040av) Tj
0.0003 Tw
16.88 0 Td
[ (erage\040of\040\0448\054500\040per\040year\054\040from) 8 (\0401995\040to\0402013\056\040W) 9 (e) -1 (\040) ] TJ
0.0009 Tc
-0.0013 Tw
-16.88 -1.725 Td
[ (review\040th) 6 (e\040institu) 6 (tion) 6 (al\040f) 4 (eatur) 4 (es\040of) 4 (\040th) 6 (e\040m) 9 (arket\040f) 4 (o) 1 (r\040antic) 5 (ancer\040d) 6 (r) -1 (ugs\054\040inc) 5 (l) -1 (uding\040generous\040third) 6 (\055) ] TJ
0.0002 Tc
0 -1.725 TD
[ (party\040coverage\040that\040insulates\040patients\040from) 8 (\040) ] TJ
0.0005 Tc
-0.0021 Tw
17.215 0 Td
(drug\040prices\054\040the\040presence) Tj
-0.0002 Tc
0.0002 Tw
9.945 0 Td
(\040of\040strong\040financial\040) Tj
0.0003 Tc
-0.0003 Tw
-27.16 -1.725 Td
[ (incentives\040f) 8 (or\040physicians\040and\040hospitals\040to\040use\040) ] TJ
0.0001 Tc
-0.0001 Tw
18.305 0 Td
(novel\040products\054\040and\040the\040lack\040of\040therapeutic\040) Tj
0.0002 Tc
-0.0014 Tw
-18.305 -1.725 Td
(substitutes\056\040We\040argue\040that\040under\040) Tj
0.001 Tw
13.105 0 Td
[ (these\040conditions\054\040m) 8 (a) -1 (nufacturers\040are\040ab) ] TJ
-0.0001 Tc
0.0001 Tw
15.36 0 Td
(le\040to\040set\040the\040prices\040of\040new\040) Tj
0.0001 Tc
-0.0021 Tw
-28.465 -1.725 Td
(products\040at\040or\040slightly\040above\040the\040) Tj
-0.0001 Tc
0.0001 Tw
13.11 0 Td
(prices\040of\040existing\040ther) Tj
-0.0005 Tc
-0.0011 Tw
8.69 0 Td
(apies\054\040giving\040rise\040to) Tj
0.0005 Tc
-0.0017 Tw
7.825 0 Td
(\040an\040upward\040trend\040in\040) Tj
0.0004 Tc
-0.0004 Tw
-29.625 -1.725 Td
[ (launch\040prices\056\040Governm) 8 (e) -6 (nt\055m) 8 (andated\040price\040discount) ] TJ
0.0003 Tw
20.915 0 Td
[ (s\040for\040certain\040classes\040of\040buyers\040m) 8 (a) -1 (y\040have\040also\040) ] TJ
-0.0001 Tc
-0.0011 Tw
-20.915 -1.725 Td
(contributed\040to\040launch\040price\040increases) Tj
0.0003 Tc
-0.0019 Tw
14.66 0 Td
[ (\040as\040firm) 8 (s\040sought\040to\040offset\040the\040) ] TJ
0.0001 Tc
-0.0013 Tw
11.635 0 Td
[ (growth\040in\040the\040discount\040segm) 8 (ent\040) ] TJ
0.0006 Tc
-0.0006 Tw
-26.295 -1.725 Td
[ (by\040setting\040higher\040prices\040f) 9 (o) 1 (r\040th) ] TJ
-0.0017 Tw
11.805 0 Td
[ (e\040rem) 9 (ainder\040of\040the\040m) 9 (arket\056\040\040) ] TJ
0 Tc
0 Tw
-11.805 -1.725 Td
(\040) Tj
/TT1 1 Tf
0.0002 Tc
-0.0002 Tw
0 -1.735 TD
[ (Drug\040Pricin) 6 (g\040Strategies\040) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
0 -1.715 TD
(\040) Tj
0.0007 Tc
-0.0014 Tw
3 -1.725 Td
[ (The\040process\040by\040which\040firm) 9 (s\040establish) 6 (\040the\040\223la) ] TJ
0.0003 Tc
-0.001 Tw
17.75 0 Td
(unch\040prices\224\040of\040new\054\040branded\040drugs\040\226\040the\040) Tj
0.0005 Tw
-20.75 -1.725 Td
[ (prices\040firm) 8 (s\040set\040imm) 8 (e) -1 (diately\040following\040US\040F) ] TJ
0.0006 Tc
0.001 Tw
17.83 0 Td
[ (ood\040and\040Drug\040Adm) 8 (i) -2 (nistratio) ] TJ
0.0005 Tc
-0.0017 Tw
11.31 0 Td
(n\040\050FDA\051\040approval\040\226\040is\040) Tj
0.0001 Tc
-0.0006 Tw
-29.14 -1.72 Td
(opaque\054\040and\040relatively\040little\040work\040has\040been\040done\040on\040the\040subject\056) Tj
0 Tc
0 Tw
7.98 0 0 7.98 374.58 341.94 Tm
(1) Tj
0.0002 Tc
-0.0002 Tw
12 0 0 12 378.6 336.42 Tm
[ (\040At\040the\040tim) 8 (e) -6 (\040of\040FDA\040approval\054\040) ] TJ
-25.55 -1.725 Td
[ (most\040drugs\040are\040on\055patent\054\040and\040so\040m) 8 (a) -1 (nufacturer) ] TJ
-0.001 Tw
[ (s\040are\040tem) 8 (porary\040monopolists\056\040They\040have\040wide\040) ] TJ
0.0005 Tc
-0.0005 Tw
0 -1.725 TD
[ (leeway\054\040though\040not\040unlim) 8 (ited\040) ] TJ
0.0003 Tc
-0.0028 Tw
11.975 0 Td
(power\054\040to\040set\040prices\056\040\040) Tj
-0.0003 Tw
-8.975 -1.725 Td
[ (Reekie\040\0501978\051\040and\040Lu\040and\040Com) 8 (a) -1 (nor\040\0501998\051\040st) ] TJ
0.0001 Tc
-0.0001 Tw
18.25 0 Td
(udied\040the\040determinants\040of\040drugs\222\040launch\040) Tj
0.0006 Tc
-0.0022 Tw
-21.25 -1.725 Td
[ (prices\040for\040d) 6 (r) 4 (ugs\040across\040multiple\040therapeutic\040cate) ] TJ
-0.0014 Tw
19.16 0 Td
[ (gories\056\040They) 6 (\040found\040that\040p) 6 (r) -1 (ices\040are\040h) 6 (i) -1 (g) 6 (h) 1 (er\040for\040) ] TJ
0.0002 Tc
-0.0002 Tw
-19.16 -1.725 Td
(drugs\040that\040offer\040significant\040bene) Tj
0 Tc
-0.0025 Tw
12.78 0 Td
[ (fits\040com) 8 (pared\040to\040existing\040produc) ] TJ
0.0001 Tc
-0.0001 Tw
12.935 0 Td
(ts\056\040Hedonic\040pricing\040studies\040of\040) Tj
0.0004 Tc
-0.0004 Tw
-25.715 -1.725 Td
(colorectal\040cancer\040\050Lucarelli\040) Tj
0.0005 Tc
-0.0017 Tw
11.245 0 Td
[ (and\040Nich) 6 (olson\0402009\051\040and\040anti\055ulc) ] TJ
0.0004 Tc
-0.0029 Tw
13.385 0 Td
(er\040drugs\040\050Suslow\0401996\073\040Berndt\054\040) Tj
-0.001 Tw
-24.63 -1.725 Td
[ (Bui\054\040Reiley\040and\040Urban\0401995\051\040find\040that\040m) 8 (a) -1 (nufacturer) ] TJ
0.0002 Tc
-0.0002 Tw
20.775 0 Td
(s\040set\040higher\040prices\040for\040higher\040quality\040drugs\054\040) Tj
0.0001 Tc
-0.0001 Tw
-20.775 -1.725 Td
(but\040studies\040of\040antidepressants\040) Tj
0 Tc
0 Tw
12 0 Td
(\050Chen\040and\040Rizzo\0402012\051\040and\040arth) Tj
0.0001 Tc
-0.0013 Tw
12.795 0 Td
(ritis\040drugs\040\050Cockburn\040and\040Anis\040) Tj
0.0003 Tc
-24.795 -1.725 Td
(2001\051\040actually\040find\040the\040opposite\056\040In) Tj
0.0002 Tc
-0.0035 Tw
14.055 0 Td
(\040most\040therapeutic\040categories\040) Tj
-0.0001 Tc
0.0001 Tw
11.445 0 Td
(physicians\040and\040patients\040learn\040) Tj
/C2_0 1 Tf
0 Tc
0 Tw
10.98 0 0 10.98 72 130.38 Tm
[ <0003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003> 81 <0003000300030003000300030003000300030003000300030003000300030003000300030003> ] TJ
ET
72 132.42 144 0.72 re
f
BT
/C2_0 1 Tf
10.98 0 0 10.98 216 130.38 Tm
<0003> Tj
/TT0 1 Tf
7.98 0 0 7.98 72 121.86 Tm
(1) Tj
0.0008 Tc
-0.002 Tw
12 0 0 12 76.02 116.3401 Tm
[ (\040Prior\040work\040on\040pricing\040in) 6 (\040the\040pharm) 9 (aceutical\040in) ] TJ
0.0003 Tc
-0.001 Tw
18.775 0 Td
[ (d) 5 (ustry\040has\040m) 8 (ostly\040focused\040on\040the\040effect\040of\040) ] TJ
0.0005 Tc
-0.0013 Tw
-19.11 -1.15 Td
[ (generic\040competition\040on\040price\040levels\040\050f) 9 (or\040exam) 8 (pl) ] TJ
0.0004 Tc
18.99 0 Td
(e\054\040Caves\040et\040al\056\0401991\051\040a) Tj
-0.0001 Tc
0.0001 Tw
8.86 0 Td
(nd\040post\055entry\040pricing\040) Tj
0.0001 Tc
-0.0001 Tw
-27.85 -1.15 Td
[ (dynam) 8 (i) -2 (cs\040\050Lu\040and\040Com) 8 (a) -1 (nor\0401998\051\056\040) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 469 8 re
S
0 1 1 RG
n
71 688 454 8 re
S
0 1 1 RG
n
71 667 442 8 re
S
1 0 0 RG
n
107 646 404 8 re
S
0 1 1 RG
n
71 626 441 8 re
S
0 1 1 RG
n
71 605 445 8 re
S
0 1 1 RG
n
71 584 420 8 re
S
0 1 1 RG
n
71 564 427 8 re
S
0 1 1 RG
n
71 543 468 8 re
S
0 1 1 RG
n
71 522 452 8 re
S
0 1 1 RG
n
71 501 467 8 re
S
0 1 1 RG
n
71 481 470 8 re
S
0 1 1 RG
n
71 460 275 8 re
S
0.9 0.9 0.9 RG
n
71 439 3 8 re
S
0 0 1 RG
n
71 419 124 8 re
S
0.9 0.9 0.9 RG
n
71 398 3 8 re
S
1 0 0 RG
n
107 377 413 8 re
S
0 1 1 RG
n
71 357 459 8 re
S
0 1 1 RG
n
71 336 455 8 re
S
0 1 1 RG
n
72 315 445 8 re
S
0 1 1 RG
n
72 295 245 8 re
S
1 0 0 RG
n
108 274 413 8 re
S
0 1 1 RG
n
72 253 444 8 re
S
0 1 1 RG
n
72 232 452 8 re
S
0 1 1 RG
n
72 212 448 8 re
S
0 1 1 RG
n
72 191 458 8 re
S
0 1 1 RG
n
71 170 450 8 re
S
0 1 1 RG
n
71 150 447 8 re
S
0.9 0.9 0.9 RG
n
72 130 146 8 re
S
0.5 0.5 0.5 RG
n
72 121 433 8 re
S
0 1 0 RG
n
72 102 438 8 re
S
0 1 0 RG
n
71 88 171 8 re
S
Q

endstream
endobj
69 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
70 0 obj
<<
/Length 7338
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 303.24 75.8401 Tm
(5\040) Tj
/C2_0 1 Tf
0 Tc
-21.06 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0001 Tc
-0.0013 Tw
12 0 0 12 72 708.96 Tm
(about\040drug\040quality\040partly\040through\040) Tj
0.0005 Tc
-0.0021 Tw
13.53 0 Td
[ (experience\054\040and\040so\040m) 8 (a) -1 (nufacturer) ] TJ
0.0003 Tc
-0.0003 Tw
12.995 0 Td
[ (s\040m) 8 (a) -1 (y\040find\040it\040advantageous\040to\040) ] TJ
0.0006 Tc
-0.002 Tw
-26.525 -1.725 Td
[ (introdu) 6 (ce\040high\055quality\040d) 6 (r) -1 (ugs\040at\040low\040prices\040so\040th) ] TJ
0.001 Tc
-0.001 Tw
[ (a) 5 (t) -1 (\040the\040d) 6 (r) -1 (ugs\040will\040pene) 5 (tra) 5 (t) 4 (e\040the\040m) 9 (arket\040m) 9 (o) 1 (re\040) ] TJ
0.0001 Tc
0 -1.725 TD
(quickly\040\050Chen\040and\040Rizzo\0402012\051\056\040\040) Tj
/TT1 1 Tf
0 Tc
0 Tw
0 -1.735 TD
(\040) Tj
0.0003 Tc
-0.0053 Tw
0 -1.725 TD
(Anticancer\040Drugs\040) Tj
/TT0 1 Tf
0 Tc
0 Tw
0 -1.715 TD
(\040) Tj
0.0004 Tc
-0.002 Tw
3 -1.725 Td
(Anticancer\040drugs\040are\040among\040the\040only\040life\055prol) Tj
0.0001 Tc
-0.0001 Tw
18.33 0 Td
[ (onging\040treatm) 8 (e) -1 (nts\040available\040for\040patients\040) ] TJ
0.0007 Tc
-0.0021 Tw
-21.33 -1.725 Td
[ (with\040m) 9 (etastatic\040tum) 9 (o) 1 (rs\054\040which\040m) 9 (eans\040that\040the\040tu) ] TJ
0.0002 Tc
-0.0002 Tw
19.105 0 Td
(mor\040has\040spread\040beyond\040its\040original\040site\040to\040a\040non\055) Tj
0.0009 Tc
-0.0023 Tw
-19.105 -1.725 Td
[ (adjacen) 6 (t\040location\056\040The\040v) 6 (ast\040m) 9 (ajority\040of\040patients\040with) ] TJ
0.0007 Tc
-0.0007 Tw
20.835 0 Td
[ (\040m) 9 (etastatic\040d) 6 (i) -1 (seas) 5 (e\040will\040d) 6 (i) -1 (e\040of\040can) 6 (cer\056\040It\040has\040) ] TJ
0.0005 Tc
-0.0005 Tw
-20.835 -1.725 Td
[ (becom) 8 (e) -1 (\040increasing) 6 (l) -2 (y\040co) 6 (mmon\040to\040adm) 8 (i) -2 (nister\040anticancer) ] TJ
-0.0004 Tc
-0.0008 Tw
21.855 0 Td
(\040drugs\040to\040patients\040w) Tj
0.0005 Tc
-0.0005 Tw
7.825 0 Td
(ith\040early\040stage\040disease\040) Tj
0.0007 Tc
-0.0015 Tw
-29.68 -1.725 Td
[ (after\040they\040h) 6 (a) 5 (ve\040undergon) 6 (e\040surgery\040o) 6 (r) -1 (\040radio) 6 (t) -1 (he) ] TJ
0.0004 Tc
-0.0004 Tw
[ (rapy) 5 (\056\040Because\040most\040newly\040ap) 5 (proved\040anticancer\040) ] TJ
-0.0011 Tw
0 -1.725 TD
(drugs\040are\040approved\040on\040the\040basis\040of\040) Tj
0.0012 Tc
-0.0012 Tw
13.97 0 Td
[ (th) 6 (eir\040ef) 4 (f) 4 (ectiv) 6 (e) 5 (n) 1 (ess\040in\040pa) 5 (tie) 5 (nts\040with\040m) 9 (etasta) 5 (tic\040d) 6 (i) -1 (sea) 5 (se\054\040our\040) ] TJ
0.0001 Tc
-0.0015 Tw
-13.97 -1.725 Td
(analysis\040focuses\040on\040this\040group\040of\040patients\056\040\040) Tj
-0.0001 Tw
3 -1.725 Td
[ (Rapid\040progress\040in\040the\040fields\040of\040tum) 8 (or) -7 (\040bi) ] TJ
0 Tc
0.0008 Tw
15.75 0 Td
(ology\054\040genetics\054\040and\040immunology\040has\040spurred\040the\040) Tj
0.0001 Tc
-0.0001 Tw
-18.75 -1.725 Td
[ (developm) 8 (ent\040of\040a\040num) 8 (be) -6 (r\040of\040new\040anticancer\040dr) -2 (ugs\056\040Al) -7 (m) 8 (ost\0401\054000\040anticancer\040drugs\040are\040currently\040) ] TJ
0.0003 Tc
-0.0011 Tw
T*
[ (in\040various\040phases\040of\040pre\055approval\040testing\054\040m) 8 (ore\040) ] TJ
0.0002 Tc
-0.0009 Tw
19.05 0 Td
(than\040the\040number\040for\040heart\040disease\054\040stroke\054\040and\040) Tj
0.0003 Tc
-0.0003 Tw
-19.05 -1.725 Td
[ (m) 8 (e) -1 (ntal\040illness\040com) 8 (bined\040\050IMS\0402014\073\040PhRMA\0402014\051) ] TJ
-0.0015 Tw
20.78 0 Td
[ (\056\040\040Many\040new\040drugs\040are\040approv) 5 (ed\040for\040the\040) ] TJ
0.001 Tc
0 Tw
-20.78 -1.725 Td
[ (trea) 5 (tm) 9 (ent\040of) 4 (\040tum) 9 (o) 1 (rs\040with\040particula) 5 (r) -1 (\040ge) 5 (ne) ] TJ
0.0004 Tc
-0.0004 Tw
16.135 0 Td
[ (tic\040m) 8 (a) -1 (rkers\056\040For\040example\054\040the\040FD) 8 (A\040approved\040) ] TJ
0.0005 Tc
0.0003 Tw
-16.135 -1.72 Td
[ (pertuzum) 8 (ab\040in\0402012\040for\040patients\040with\040m) 8 (e) -1 (tastatic\040) ] TJ
0.0006 Tc
-0.002 Tw
19.36 0 Td
[ (breast\040cancer\040linked\040to\040a\040defective\040H) 8 (E) 1 (R2\040gene\056\040) ] TJ
0.0008 Tc
-0.0043 Tw
-19.36 -1.725 Td
[ (Targeted\040therapies\040are\040m) 9 (o) 1 (re\040likely\040to\040succeed\040in\040) ] TJ
0.0005 Tc
-0.0038 Tw
19.435 0 Td
[ (clinical\040trials\040and\040m) 8 (a) -1 (y\040) ] TJ
-0.0017 Tw
9.105 0 Td
[ (face\040a\040less\040elastic\040dem) 8 (a) -1 (nd\040) ] TJ
0.0004 Tc
-0.0004 Tw
-28.54 -1.725 Td
[ (curve\054\040facilitating\040prem) 8 (ium\040pricing\040\050T) 6 (rusheim) 8 (\040and\040Berndt\0402012\051\056\040\040) ] TJ
0.0002 Tc
-0.0002 Tw
3 -1.725 Td
[ (The\040scientific\040knowledge\040em) 8 (bodied\040by\040new\040dr) ] TJ
0.0004 Tc
-0.0004 Tw
18.55 0 Td
[ (ugs\040is\040im) 8 (pressive\054\040but\040progress\040in\040basic\040) ] TJ
0.0006 Tc
-0.0013 Tw
-21.55 -1.725 Td
[ (science\040has\040not\040always\040b) 6 (een\040accom) 8 (p) 1 (anied\040by\040pro) ] TJ
-0.0031 Tw
19.575 0 Td
[ (portion) 6 (a) -1 (te\040improvem) 8 (e) -1 (nt) -7 (s\040in\040patient\040outcom) 8 (e) -1 (s\056\040) ] TJ
-0.0015 Tw
-19.575 -1.725 Td
[ (Gains\040in\040survival\040tim) 9 (e\040associated\040with\040recen) 6 (tly\040) ] TJ
0.0003 Tc
0.0007 Tw
18.975 0 Td
[ (approved\040anticancer\040d) 5 (r) -2 (ugs) 5 (\040are\040typ) 5 (i) -2 (cally\040m) 8 (easured\040) ] TJ
-0.0016 Tw
-18.975 -1.725 Td
[ (in\040m) 8 (onths\054\040not\040years\056\040\040) ] TJ
0.0001 Tc
-0.0017 Tw
3 -1.725 Td
(Most\040anticancer\040drugs\040are\040approved\040by\040the\040) Tj
0.0003 Tc
-0.0003 Tw
17.3 0 Td
[ (FDA\040on\040the\040basis\040of\040one\040or\040more\040random) 8 (ized\040) ] TJ
0.0008 Tc
-0.002 Tw
-20.3 -1.725 Td
[ (contro) 6 (lled\040trials\056\040Som) 9 (e\040trials\040h) 6 (a) ] TJ
0.0004 Tc
-0.0009 Tw
[ (ve\040an\040\223active\040control\224\073\040patients\040are\040rando) 5 (m) 8 (i) -2 (zed\040to\040receive\040th) 5 (e\040new\040) ] TJ
0.0005 Tc
-0.0005 Tw
T*
[ (drug\040or\040an\040alternative\040therapy\056\040W) 9 (h) 1 (en\040a\040drug\040is\040suf) 9 (f) ] TJ
0.0007 Tc
-0.0013 Tw
20.21 0 Td
[ (iciently\040nov) 6 (el\040that\040it\040has\040no\040close\040sub) 6 (stitu) 6 (tes\040o) 6 (r) -1 (\040) ] TJ
0.0001 Tc
-0.0007 Tw
-20.21 -1.725 Td
[ (it\040will\040be\040used\040in\040com) 8 (bination\040with\040existing\040drug) ] TJ
0.0002 Tc
-0.0002 Tw
19.44 0 Td
[ (s\054\040patients\040in\040the\040control\040arm) 8 (\040m) 8 (a) -1 (y\040be) -6 (\040random) 8 (ized\040) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 462 8 re
S
0 1 1 RG
n
72 688 436 8 re
S
0 1 1 RG
n
72 667 160 8 re
S
0.9 0.9 0.9 RG
n
72 646 3 8 re
S
0 0 1 RG
n
72 626 94 8 re
S
0.9 0.9 0.9 RG
n
72 605 3 8 re
S
1 0 0 RG
n
108 584 412 8 re
S
0 1 1 RG
n
72 564 460 8 re
S
0 1 1 RG
n
72 543 461 8 re
S
0 1 1 RG
n
71 522 465 8 re
S
0 1 1 RG
n
72 501 448 8 re
S
0 1 1 RG
n
72 481 446 8 re
S
0 1 1 RG
n
72 460 206 8 re
S
1 0 0 RG
n
108 439 428 8 re
S
0 1 1 RG
n
72 419 461 8 re
S
0 1 1 RG
n
72 398 449 8 re
S
0 1 1 RG
n
72 377 442 8 re
S
0 1 1 RG
n
72 357 411 8 re
S
0 1 1 RG
n
72 336 460 8 re
S
0 1 1 RG
n
72 315 469 8 re
S
0 1 1 RG
n
71 295 317 8 re
S
1 0 0 RG
n
107 274 414 8 re
S
0 1 1 RG
n
71 253 458 8 re
S
0 1 1 RG
n
71 232 469 8 re
S
0 1 1 RG
n
71 212 106 8 re
S
1 0 0 RG
n
107 191 428 8 re
S
0 1 1 RG
n
71 170 470 8 re
S
0 1 1 RG
n
71 150 471 8 re
S
0 1 1 RG
n
71 129 471 8 re
S
Q

endstream
endobj
71 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
72 0 obj
<<
/Length 8124
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 303.24 75.8401 Tm
(6\040) Tj
/C2_0 1 Tf
0 Tc
-21.06 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0001 Tc
-0.0007 Tw
12 0 0 12 72 708.96 Tm
(to\040receive\040the\040new\040drug\040or\040a\040placebo\056\040Trials) Tj
0.0007 Tc
[ (\040of\040antican) 6 (cer\040d) 6 (r) -1 (u) 6 (g) 1 (s\040usually\040m) 9 (easure\040p) 6 (atient\040) ] TJ
0 -1.725 TD
[ (outcom) 8 (e) -1 (s\040in\040term) 8 (s\040of\040the\040difference\040in\040surviv) ] TJ
0.0005 Tc
-0.0013 Tw
17.97 0 Td
[ (al\040between\040the\040treatm) 8 (ent\040and\040control\040arm) 8 (s\056\040) ] TJ
0.0003 Tc
-0.0003 Tw
-14.97 -1.725 Td
[ (Som) 8 (e) -1 (\040drugs\040are\040approved\040on\040the\040basis\040of\040single\055) ] TJ
0.0009 Tc
-0.0017 Tw
19.22 0 Td
[ (a) 5 (r) -1 (m) 9 (\040trials\056\040In\040single) 5 (\055) -1 (arm) 9 (\040tria) 5 (ls\054\040all\040patients\040) ] TJ
0.0003 Tc
-0.0008 Tw
-22.22 -1.725 Td
(receive\040the\040new\040drug\040and\040there\040is\040no\040control\040group) Tj
-0.0011 Tw
20.135 0 Td
(\056\040Single\055arm\040trials\040focus\040on\040short\055term\040patient\040) Tj
0.0001 Tc
-0.0001 Tw
-20.135 -1.725 Td
(safety\040rather\040than\040patient\040survival\054\040and\040so\040th) Tj
0.0003 Tc
-0.0003 Tw
17.5 0 Td
[ (ey\040have\040a\040m) 8 (uch\040s) -5 (horter\040duration\040com) 8 (pared\040to\040) ] TJ
0.0001 Tc
-0.0001 Tw
-17.5 -1.725 Td
[ (random) 8 (ized\040control\040trials\056\040The\040FDA\040grants\040appr) ] TJ
0.0005 Tc
0.0002 Tw
19.08 0 Td
[ (oval\040for\040m) 8 (a) -1 (ny\040leukem) 8 (i) -2 (a\040and\040lym) 8 (phom) 8 (a) -6 (\040drugs\040on\040) ] TJ
0.0003 Tc
-0.0003 Tw
-19.08 -1.725 Td
[ (the\040basis\040of\040single\055arm) 8 (\040trials\056\040Median\040survival\040) ] TJ
-0.0001 Tc
0.0001 Tw
18.61 0 Td
(among\040patients\040with\040these\040types\040of\040cancers\040is\040two\040) Tj
0.0007 Tc
0.0003 Tw
-18.61 -1.725 Td
[ (or\040m) 9 (o) 1 (re\040years\056\040Requiring\040m) 9 (anufacturers\040of) ] TJ
0.0005 Tc
-0.0005 Tw
17.055 0 Td
[ (\040leukem) 8 (i) -2 (a\040and\040lymphom) 8 (a) -1 (\040drugs\040to\040conduct\040) ] TJ
-0.0015 Tw
-17.055 -1.725 Td
[ (random) 8 (ized\040trials\040to\040m) 8 (e) -1 (a) -6 (sure\040survival\040benefits) ] TJ
-0.0002 Tc
-0.0014 Tw
(\040could\040significantly\040de) Tj
-0.0001 Tc
0.0001 Tw
27.38 0 Td
(lay\040the\040introduction\040of\040) Tj
-27.38 -1.725 Td
(potentially\040beneficial\040drugs\056\040Si) Tj
0.0001 Tc
-0.0011 Tw
12.275 0 Td
(ngle\055arm\040trials\040can\040show\040that\040a\040) Tj
0.0004 Tc
-0.0014 Tw
[ (drug\040is\040safe\040but\040cannot\040determ) 8 (ine\040) ] TJ
-0.0012 Tw
-12.275 -1.725 Td
[ (whether\040the\040drug\040im) 8 (proves\040life\040expectancy\056\040Physicia) ] TJ
-0.0001 Tc
0.0001 Tw
20.965 0 Td
(ns\040can\040observe\040survival) Tj
0.0002 Tc
-0.0014 Tw
9.355 0 Td
(\040in\040their\040own\040patient\040) Tj
-0.0012 Tw
-30.32 -1.725 Td
(populations\054\040but\040it\040is\040probably\040di) Tj
0.0001 Tc
-0.0001 Tw
13.005 0 Td
(fficult\040for\040individual\040physicians\040to) Tj
-0.0013 Tw
13.66 0 Td
(\040draw\040sound\040inferences\040about\040) Tj
0.0005 Tc
-0.0011 Tw
-26.665 -1.725 Td
[ (the\040quality\040o) 6 (f) 4 (\040a\040new\040drug\040because\040their\040patien) 6 (t) -2 (\040) ] TJ
0.0001 Tc
-0.0017 Tw
18.745 0 Td
[ (panels\040are\040not\040sufficiently\040large\056\040Unlik) 5 (e\040single\055) ] TJ
0.0007 Tc
-0.0019 Tw
-18.745 -1.725 Td
[ (arm) 9 (\040studies\054\040random) 9 (ized\040trials\040estab) 6 (l) ] TJ
0 Tc
0 Tw
14.635 0 Td
(ish\040efficacy\040as\040common\040knowledge\056\040\040) Tj
0.0005 Tc
-0.0013 Tw
-11.635 -1.725 Td
[ (Econom) 8 (ists\040have\040m) 8 (easured\040the\040value\040of\040an) ] TJ
0.0001 Tc
-0.0009 Tw
17.045 0 Td
(ticancer\040drugs\040by\040evaluating\040changes\040in\040life\040) Tj
-0.0001 Tc
-0.0011 Tw
-20.045 -1.725 Td
(expectancy\040and\040costs\040over\040ti) Tj
0.0003 Tc
-0.0003 Tw
11.275 0 Td
[ (m) 8 (e) -1 (\040\050Howard\040et\040al\056\0402010\054\040Lichte) ] TJ
0.0002 Tc
-0.001 Tw
(nberg\0402009a\073\0402009b\054\040Sun\040et\040al\056\0402010\073\040) Tj
0.0006 Tc
-0.0006 Tw
-11.275 -1.725 Td
[ (Woodward\040et\040al\056\0402007) 6 (\051\040or\040m) 8 (easuring\040patien) 6 (t) -2 (s\222) ] TJ
0.0008 Tc
-0.0033 Tw
18.42 0 Td
[ (\040willingn) 6 (ess\055to\055pay\040\050G) ] TJ
0.0009 Tc
-0.0025 Tw
9 0 Td
[ (oldm) 9 (an\040et\040al\056\0402010\073\040) ] TJ
0.0005 Tc
-27.42 -1.725 Td
[ (Lakdawalla\040et\040al\0402012\073\040Rom) 8 (l) -2 (ey\040et) ] TJ
-0.0001 Tc
0.0001 Tw
13.525 0 Td
(\040al\056\0402012\073\040Seabury\040et\040al\056\0402012\073) Tj
0 Tc
-0.0008 Tw
11.995 0 Td
[ (\040Snider\040et\040al\056\0402012\051\056\040A) 7 (\040common\040) ] TJ
0.0011 Tc
-0.0011 Tw
-25.52 -1.72 Td
[ (f) 4 (i) -1 (nding\040is\040th) 6 (at\040tha) 5 (t) -1 (\040the\040d) 6 (o) 1 (lla) 5 (r\055denom) 9 (inated\040b) 6 (enef) 4 (its) ] TJ
0.0001 Tc
-0.0008 Tw
20.28 0 Td
(\040associated\040with\040anticancer\040drugs\040are\040equal\040to\040) Tj
0.0007 Tc
-0.0023 Tw
-20.28 -1.725 Td
[ (or\040exceed\040th) 6 (e\040cost\040of\040an\040episode) ] TJ
0.0002 Tc
-0.0002 Tw
12.775 0 Td
[ (\040of\040treatm) 8 (e) -1 (nt\056\040\040However\054\040willi) ] TJ
0.0007 Tc
0.0009 Tw
11.855 0 Td
[ (ngness\055to\055p) 6 (ay\040estim) 9 (ates\040m) 9 (u) 1 (st\040be\040) ] TJ
0.0011 Tc
-0.0018 Tw
-24.63 -1.725 Td
[ (inte) 5 (rpre) 5 (ted\040c) 5 (autious) 5 (ly\040in\040light\040of) 4 (\040the\040f) 9 (act\040th) 6 (at) ] TJ
0.0006 Tc
-0.0006 Tw
[ (\040m) 8 (o) 1 (st\040patien) 6 (t) -2 (s\040m) 8 (i) -2 (stakenly\040b) 6 (e) -1 (lieve\040that\040anticancer\040) ] TJ
0.0004 Tc
-0.0024 Tw
T*
[ (drugs\040cure\040cancer\040\050W) 9 (eeks\040et\040al\056\040) ] TJ
0 Tc
0 Tw
12.8 0 Td
(2012\051\056\040In\040addition\054\040these\040past\040st) Tj
0.0003 Tc
-0.0003 Tw
12.525 0 Td
(udies\040do\040not\040address\040trends\040in\040) Tj
-0.0001 Tc
0.0001 Tw
-25.325 -1.725 Td
(launch\040prices\056\040If\040new\040drugs\040have\040higher\040prices\040per\040) Tj
0.0001 Tc
-0.0007 Tw
20.215 0 Td
(unit\040of\040benefit\054\040then\040we\040cannot\040assess\040the\040cost\055) Tj
-0.0001 Tw
-20.215 -1.725 Td
[ (effectivenes) 4 (s\040of\040anticancer\040drugs\040as\040a\040) ] TJ
0.0003 Tc
-0.0011 Tw
[ (class\040based\040on\040studies\040of) 8 (\040older\040drugs\056\040) ] TJ
0 Tc
2.75 Tw
T*
[ (\040\040) 2750 (\040) ] TJ
/TT1 1 Tf
0.0001 Tc
-0.0001 Tw
0 -1.735 TD
(Policies\040Governing\040Drug\040Coverage\040and\040Reimbursement\040) Tj
/TT0 1 Tf
0 Tc
0 Tw
0 -1.715 TD
(\040) Tj
0.0005 Tc
-0.0013 Tw
3 -1.725 Td
[ (Medicare\040is\040the\040m) 8 (o) 1 (st\040prom) 8 (inent\040US\040paye) ] TJ
0.0002 Tc
-0.0002 Tw
16.385 0 Td
(r\040for\040anticancer\040drugs\054\040followed\040by\040commercial\040) Tj
-0.0012 Tw
-19.385 -1.725 Td
[ (insurers\054\040and\040then\040state\040Medicaid\040program) 8 (s\056) ] TJ
0.0004 Tc
-0.0004 Tw
17.465 0 Td
[ (\040Medicare\040pays\040for\040physician\055adm) 8 (i) -2 (nistered\040) ] TJ
-0.0011 Tw
-17.465 -1.725 Td
[ (intravenous\040drugs\040through\040the\040m) 8 (e) -1 (dical\040\223Part\040B\224\040) ] TJ
0 Tc
0 Tw
19.305 0 Td
(benefit\056\040By\040law\054\040Medicare\040does\040not\040directly\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 422 8 re
S
0 1 1 RG
n
72 688 422 8 re
S
1 0 0 RG
n
107 667 435 8 re
S
0 1 1 RG
n
72 646 463 8 re
S
0 1 1 RG
n
72 626 430 8 re
S
0 1 1 RG
n
72 605 465 8 re
S
0 1 1 RG
n
72 584 463 8 re
S
0 1 1 RG
n
72 564 412 8 re
S
0 1 1 RG
n
71 543 439 8 re
S
0 1 1 RG
n
71 522 461 8 re
S
0 1 1 RG
n
71 501 464 8 re
S
0 1 1 RG
n
71 481 464 8 re
S
0 1 1 RG
n
71 460 451 8 re
S
0 1 1 RG
n
71 439 354 8 re
S
1 0 0 RG
n
107 419 417 8 re
S
0 1 1 RG
n
71 398 467 8 re
S
0 1 1 RG
n
71 377 426 8 re
S
0 1 1 RG
n
71 357 461 8 re
S
0 1 1 RG
n
71 336 465 8 re
S
0 1 1 RG
n
71 315 455 8 re
S
0 1 1 RG
n
71 295 451 8 re
S
0 1 1 RG
n
71 274 449 8 re
S
0 1 1 RG
n
71 253 466 8 re
S
0 1 1 RG
n
71 232 363 8 re
S
0.9 0.9 0.9 RG
n
71 212 75 8 re
S
0 0 1 RG
n
71 191 288 8 re
S
0.9 0.9 0.9 RG
n
71 170 3 8 re
S
1 0 0 RG
n
107 150 426 8 re
S
0 1 1 RG
n
71 129 418 8 re
S
0 1 1 RG
n
71 108 443 8 re
S
Q

endstream
endobj
73 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
74 0 obj
<<
/Length 8159
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 303.24 75.8401 Tm
(7\040) Tj
/C2_0 1 Tf
0 Tc
-21.06 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0002 Tc
-0.0002 Tw
12 0 0 12 72 708.96 Tm
[ (negotiate\040with\040drug\040m) 8 (a) -1 (nufacturers\040over\040prices\040) ] TJ
-0.0001 Tc
0.0001 Tw
18.66 0 Td
(for\040prescription\040drugs\040c) Tj
0.0002 Tc
-0.0014 Tw
9.355 0 Td
(overed\040under\040the\040Part\040B\040) Tj
0.0004 Tc
-0.0029 Tw
-28.015 -1.725 Td
(benefit\040or\040the\040oral\040anti) Tj
-0.0023 Tw
(cancer\040drugs\040largely\040covered\040under\040Me) Tj
0.0006 Tc
-0.0006 Tw
24.515 0 Td
[ (dicare\222s\040pharm) 8 (acy\040\223Part\040D\224\040benefit\056\040) ] TJ
-0.0001 Tc
-24.515 -1.725 Td
(Section\0401861\040of\040the\040Social\040Security\040Act\054\040wh) Tj
0.0005 Tc
-0.0021 Tw
17.55 0 Td
[ (ich\040requires\040that\040the\040Medicare\040program) 8 (\040cover\040) ] TJ
0.0007 Tc
-0.0019 Tw
-17.55 -1.725 Td
[ (\223reason) 6 (able\040and\040necess) 5 (ary\224\040m) 9 (edical\040services\054\040) ] TJ
0.0004 Tc
-0.0004 Tw
18.385 0 Td
[ (precludes\040cons) 5 (id) 5 (eration\040of\040cost\040or\040cos) 5 (t) -2 (\055) ] TJ
0.0001 Tc
-0.0001 Tw
-18.385 -1.725 Td
[ (effectiveness\040in\040coverage\040decisions\040\050Neum) 8 (a) -1 (nn\040) ] TJ
0.0003 Tc
-0.0003 Tw
18.795 0 Td
(2005\051\056\040Consequently\054\040Medicare\040covers\040all\040newly\040) Tj
0.0001 Tc
-0.0001 Tw
-18.795 -1.725 Td
(approved\040anticancer\040drugs\040for\040indi) Tj
0.0009 Tw
13.775 0 Td
[ (cations\040approved\040by\040the\040F) 6 (DA\056\040\040) ] TJ
0.0002 Tc
-0.0002 Tw
-10.775 -1.725 Td
(The\040private\040insurance\040plans\040that\040provide\040pr) Tj
0 Tc
0 Tw
17.165 0 Td
(escription\040drug\040coverage) Tj
0.0007 Tc
-0.0023 Tw
9.885 0 Td
[ (\040under\040Medicare\040\223P) 7 (art\040) ] TJ
0.0009 Tc
-0.0017 Tw
-30.05 -1.725 Td
[ (D\224\040are\040requ) 6 (ired\040to\040cov) 6 (er\040all\040d) 6 (r) ] TJ
0 Tc
-0.001 Tw
12.05 0 Td
(ugs\040in\040six\040protected\040classes\054\040on) Tj
0.0001 Tc
12.325 0 Td
(e\040of\040which\040is\040anticancer\040drugs\040) Tj
0.0006 Tc
-0.0018 Tw
-24.375 -1.725 Td
(\050Center\040for\040Medicare\040and\040Medica) Tj
0.0003 Tc
-0.0015 Tw
13.385 0 Td
(id\040Services\0402014\051\056\040Three\040quarte) Tj
-0.0001 Tc
-0.0009 Tw
12.58 0 Td
(rs\040of\040the\040population\040reside\040in\040) Tj
0.0001 Tc
-0.0017 Tw
-25.965 -1.725 Td
(states\040that\040require\040insurers\040) Tj
0.0003 Tc
-0.0013 Tw
10.72 0 Td
(to\040cover\040anticancer\040drugs\040for\040\223o) Tj
0 Tc
0 Tw
12.685 0 Td
[ (ff\040l) -7 (a) -1 (bel\054\224\040non\040F) 6 (DA\055approved\040uses\040) ] TJ
-23.405 -1.725 Td
(\050Bach\0402009\051\056\040\040) Tj
0.0007 Tc
-0.0007 Tw
3 -1.725 Td
[ (Insurers\040in\040s) 5 (t) -1 (ates\040withou) 6 (t\040thes) 5 (e\040requ) 6 (irem) 9 (ents) ] TJ
0.0012 Tc
-0.0024 Tw
17.8 0 Td
[ (\040and\040large\040em) 9 (ployers\040th) ] TJ
-0.0002 Tc
0.0002 Tw
9.395 0 Td
(at\040self\055insure\040have\040) Tj
0.0009 Tc
-0.0017 Tw
-30.195 -1.725 Td
[ (more\040leewa) 5 (y) 1 (\040to\040dete) 5 (rm) 9 (ine\040coverag) 6 (e\040polic) 5 (ies\054\040ye) 5 (t\054) ] TJ
0.0008 Tc
-0.0033 Tw
19.595 0 Td
(\040in\040the\040rare\040instances\040) Tj
0.0001 Tc
-0.0001 Tw
8.475 0 Td
(where\040third\055party\040payers\040) Tj
0.0006 Tc
-0.0006 Tw
-28.07 -1.725 Td
[ (have\040tried\040to) 6 (\040place\040m) 8 (eaningful\040restrictions\040on\040) ] TJ
0.0002 Tc
-0.0018 Tw
18.365 0 Td
[ (patients\222\040acces) 4 (s\040to\040anti) ] TJ
0.0007 Tc
-0.0007 Tw
9.02 0 Td
[ (cancer\040drugs\054\040th) 6 (ey) 6 (\040have\040) ] TJ
0.0005 Tc
-0.0008 Tw
-27.385 -1.725 Td
[ (relen) 6 (t) -2 (ed\040und) 6 (er\040pressure\040f) 9 (r) -1 (om) 8 (\040clinicians\040and\040patient\040advocacy\040groups\056\040In\040th) 6 (e\040early\0401990) 6 (s\054\040m) 8 (a) -1 (ny\040) ] TJ
0.0006 Tc
-0.0013 Tw
0 -1.725 TD
[ (insurers\040refu) 6 (sed\040to\040cover\040a\040breas) 5 (t\040can) 6 (cer\040treatm) 13 (ent\040consisting\040of\040higher\040than\040norm) 8 (a) -1 (l\040doses\040of\040) ] TJ
0.0002 Tc
-0.0002 Tw
T*
[ (anticancer\040drugs\040followed\040by\040a\040bone\040m) 8 (a) -1 (rrow\040transp) -1 (lant\056\040Breast\040cancer\040pa) ] TJ
0.0001 Tc
-0.0001 Tw
29.185 0 Td
(tient\040advocacy\040groups\040) Tj
-0.0009 Tw
-29.185 -1.725 Td
(waged\040a\040high\055profile\040campaign\040to\040secure\040covera) Tj
0.0005 Tc
-0.0005 Tw
19.21 0 Td
[ (ge\054\040and\040m) 8 (o) 1 (st\040insurers\040started\040paying\040f) 9 (o) 1 (r\040the\040) ] TJ
0.0009 Tc
-0.0009 Tw
-19.21 -1.72 Td
[ (treatm) 9 (ent\056\040Random) 9 (ized\040trials\040la) ] TJ
0.0003 Tc
-0.0011 Tw
12.555 0 Td
(ter\040found\040that\040it\040did\040not\040prolon) Tj
0 Tc
0 Tw
12.11 0 Td
(g\040survival\054\040and\040physicians\040and\040) Tj
0.0005 Tc
-0.0021 Tw
-24.665 -1.725 Td
(patients\040abandoned\040the\040proce) Tj
0 Tc
-0.001 Tw
11.64 0 Td
(dure\040\050Howard\040et\040al\056\0402011\051\056\040\040) Tj
0.0006 Tc
-0.0006 Tw
-8.64 -1.725 Td
[ (Oregon\222s\040Medicaid\040prog) 6 (ram) 8 (\040recently) 6 (\040proposed\040to) 6 (\040lim) 8 (it\040coverage\040of\040anticancer\040drugs\040o) 6 (n) 1 (\040) ] TJ
0.0003 Tc
-0.0025 Tw
-3 -1.725 Td
(the\040grounds\040that\040\223in\040no\040instance\040can\040it\040be\040just) Tj
0.0001 Tc
-0.0008 Tw
18.025 0 Td
(ified\040to\040spend\040\044100\054000\040in\040public\040resources\040to\040) Tj
0.0002 Tc
-0.0039 Tw
-18.025 -1.725 Td
(increase\040an\040individual\222s\040expected\040survival\040) Tj
0.0003 Tc
-0.0017 Tw
17.025 0 Td
[ (by\040three\040m) 8 (onths\040when\040hundreds\040of\040thousands\040of\040) ] TJ
0.0006 Tc
-0.0014 Tw
-17.025 -1.725 Td
[ (Oregonians\040are\040withou) 6 (t\040any\040for) -6 (m) 8 (\040of\040health\040) ] TJ
0.0004 Tc
-0.0012 Tw
17.3 0 Td
[ (insurance\224\040\050as\040reported\040in\040Landsem) 8 (\0402013\051\056\040The\040) ] TJ
0 Tc
-0.0007 Tw
-17.3 -1.725 Td
(proposal\040was\040withdrawn\040following\040a\040public\040backlash\056\040\040) Tj
0.0007 Tc
-0.001 Tw
3 -1.725 Td
[ (The\040case\040of) 4 (\040bevacizum) 9 (ab\040\040illus) 5 (t) -1 (r) 4 (ates) 5 (\040the\040lax) 6 (ity\040of) 9 (\040payers\222\040cov) 6 (erage\040po) 6 (lic) 5 (ies\056\040The\040FDA\040) ] TJ
0.0005 Tc
-0.0005 Tw
-3 -1.725 Td
[ (approved\040the\040drug\040for\040the\040treatm) 8 (ent\040) ] TJ
0 Tc
-0.001 Tw
14.44 0 Td
(of\040colorectal\040cancer\040in\0402004\040a) Tj
-0.0001 Tc
0.0001 Tw
11.855 0 Td
(nd\040then\040for\040treatment\040of\040breast\040) Tj
0.0004 Tc
-0.002 Tw
-26.295 -1.725 Td
(cancer\040in\0402008\040based\040on\040the\040resu) Tj
-0.0004 Tw
13.05 0 Td
[ (lts\040of\040a\040random) 8 (iz) -6 (ed\040trial\056\040Results\040from) 8 (\040two\040additional\040) ] TJ
-0.0014 Tw
-13.05 -1.725 Td
[ (random) 8 (ized\040trials\040were\040later\040released\040in\040) ] TJ
0.0001 Tc
-0.0001 Tw
(2009\056\040The\040trials\040found\040th) Tj
0.0002 Tc
-0.0002 Tw
25.91 0 Td
(at\040patients\040receiving\040) Tj
0.0005 Tc
-0.0005 Tw
-25.91 -1.725 Td
[ (bevacizum) 8 (a) -1 (b\040experienced\040a\040statis) ] TJ
0.001 Tc
-0.0018 Tw
13.355 0 Td
[ (tica) 5 (lly\040sign) 6 (if) 4 (ica) 5 (n) 1 (t\040gain\040in\040\223p) 6 (rogress) 5 (i) -1 (on\055f) 9 (r) -1 (ee\040surv) 6 (iva) 5 (l) -1 (\054) 6 (\224\040which\040) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 453 8 re
S
0 1 1 RG
n
72 688 469 8 re
S
0 1 1 RG
n
72 667 430 8 re
S
0 1 1 RG
n
72 646 408 8 re
S
0 1 1 RG
n
72 626 461 8 re
S
0 1 1 RG
n
72 605 315 8 re
S
1 0 0 RG
n
108 584 433 8 re
S
0 1 1 RG
n
72 564 439 8 re
S
0 1 1 RG
n
72 543 452 8 re
S
0 1 1 RG
n
72 522 446 8 re
S
0 1 1 RG
n
72 501 69 8 re
S
1 0 0 RG
n
108 481 417 8 re
S
0 1 1 RG
n
72 460 457 8 re
S
0 1 1 RG
n
72 439 444 8 re
S
0 1 1 RG
n
72 419 455 8 re
S
0 1 1 RG
n
72 398 446 8 re
S
0 1 1 RG
n
72 377 458 8 re
S
0 1 1 RG
n
72 357 440 8 re
S
0 1 1 RG
n
71 336 444 8 re
S
0 1 1 RG
n
71 315 273 8 re
S
1 0 0 RG
n
107 295 423 8 re
S
0 1 1 RG
n
71 274 439 8 re
S
0 1 1 RG
n
71 253 438 8 re
S
0 1 1 RG
n
71 232 437 8 re
S
0 1 1 RG
n
72 212 262 8 re
S
1 0 0 RG
n
108 191 415 8 re
S
0 1 1 RG
n
72 170 464 8 re
S
0 1 1 RG
n
71 150 414 8 re
S
0 1 1 RG
n
71 129 411 8 re
S
0 1 1 RG
n
71 108 453 8 re
S
Q

endstream
endobj
75 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
76 0 obj
<<
/Length 8293
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 303.24 75.8401 Tm
(8\040) Tj
/C2_0 1 Tf
0 Tc
-21.06 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0005 Tc
-0.0005 Tw
12 0 0 12 72 708.96 Tm
[ (m) 8 (easures\040the\040period\040of\040tim) 8 (e) -1 (\040where\040the\040cancer\040is\040) ] TJ
0 Tc
0 Tw
19.3 0 Td
(under\040control\054\040but\040differen) Tj
0.0002 Tc
-0.0002 Tw
10.55 0 Td
(ces\040in\040overall\040survival\040) Tj
0.0006 Tc
-0.0006 Tw
-29.85 -1.725 Td
[ (were\040sm) 8 (all\040and\040not\040statistically) ] TJ
0.0002 Tc
12.39 0 Td
[ (\040significant\056\040Based\040on\040these\040findings\054\040the\040F) 6 (DA\040revoked\040coverage\040) ] TJ
-0.0018 Tw
-12.39 -1.725 Td
(for\040bevacizuab\222s\040breast\040cancer) Tj
0 Tc
-0.001 Tw
12.135 0 Td
(\040indication\040in\0402011\056\040However\054\040an) Tj
0.0004 Tc
-0.0014 Tw
13.135 0 Td
(\040expert\040panel\040convened\040by\040the\040) Tj
0 Tc
0 Tw
-25.27 -1.725 Td
(National\040Comprehensive\040Cancer\040Network\040\0502010\051\054\040a\040) Tj
0.0003 Tc
0.0022 Tw
20.91 0 Td
[ (consortium\040of\040m) 8 (a) -1 (jor\040cancer\040) 8 (centers\054\040voted\040) ] TJ
-0.0004 Tw
-20.91 -1.725 Td
[ (against\040rem) 8 (oving\040bevacizum) 8 (a) -1 (b\040from\040its\040list\040of\040) ] TJ
-0.0019 Tw
18.635 0 Td
(appropriate\040breast\040cancer\040drugs\056\040Faced\040with\040these\040) Tj
0.0009 Tc
-0.0009 Tw
-18.635 -1.725 Td
[ (conf) 4 (licting\040d) 6 (ecis) 5 (i) -1 (ons\054\040Me) 5 (dicar) 4 (e\040and\040m) 9 (ajor\040m) 9 (u) 1 (ltista) ] TJ
0.0006 Tc
-0.0026 Tw
[ (te\040insur) 4 (a) -1 (nc) 4 (e\040plans\040anno) 6 (unced\040they\040would\040) ] TJ
0.0001 Tc
-0.0034 Tw
0 -1.725 TD
[ (continue\040to\040cover\040bevacizum) 8 (a) ] TJ
0.0008 Tc
-0.0041 Tw
11.96 0 Td
[ (b\040) -8 (for\040breast\040cancer\040patien) 6 (t) -1 (s\056) 6 (\040) ] TJ
0.0004 Tc
-0.0004 Tw
-8.96 -1.725 Td
[ (Som) 8 (e) -1 (\040drug\040industry\040critics\040hold\040up\040the\040Britis) 4 (h\040National\040Health\040Service\040as\040a\040m) 8 (odel\040for\040) ] TJ
0.0009 Tc
-0.0013 Tw
-3 -1.725 Td
[ (restrain) 6 (ing\040d) 6 (r) -1 (ug\040pric) 5 (es\056\040Brita) 5 (in\222s\040Na) 5 (tiona) 5 (l\040Ins) 5 (titu) 6 (te\040f) 4 (o) 1 (r\040Clinic) 5 (al\040Ef) 4 (f) 4 (ective) 5 (n) 1 (ess\040evalu) 6 (ates\040the\040cos) 5 (t) -1 (\055) ] TJ
0.0001 Tc
-0.0001 Tw
T*
[ (effectiveness\040of\040new\040drugs\040and\040has\040restricted\040) 3 (National\040Health\040Service\040funding\040for\040cancer\040drugs\040) ] TJ
0.0004 Tc
-0.0004 Tw
T*
(where\040the\040benefits\040are\040sm) Tj
0.0006 Tc
-0.0014 Tw
10.22 0 Td
[ (all\040in\040relation\040to\040costs\056\040T) 6 (h) 1 (e\040Britis) ] TJ
0.0001 Tc
-0.0009 Tw
13.14 0 Td
[ (h\040governm) 8 (e) -1 (nt\040uses\040the\040threat\040of\040non\055) ] TJ
0.0003 Tc
-0.0028 Tw
-23.36 -1.725 Td
(coverage\040to\040negotiate\040discounts\040w) Tj
0.0006 Tc
-0.0022 Tw
13.55 0 Td
[ (ith\040drug\040m) 8 (a) -1 (nufacturers\056\040However\054) ] TJ
0.0003 Tc
-0.0003 Tw
13.525 0 Td
[ (\040restrictions\040on\040p) 5 (a) -1 (tient\040access\040) ] TJ
0.0005 Tc
-0.0005 Tw
-27.075 -1.725 Td
[ (are\040unpopular\054\040and\040Prim) 8 (e\040Minis) 5 (t) -2 (er\040David\040Cam) 8 (e) ] TJ
-0.0012 Tw
19.02 0 Td
[ (ron\040created\040a\040200\040m) 8 (illion\040pound\040Cancer\040Drugs\040) ] TJ
0 Tc
0 Tw
-19.02 -1.725 Td
(Fund\040in\0402011\040to\040pay\040for\040non\055covered\040cancer\040drugs\040) Tj
0.0001 Tc
-0.0017 Tw
20.3 0 Td
[ (outside\040of\040norm) 8 (a) -1 (l\040fund) ] TJ
0.0002 Tc
-0.0002 Tw
9.135 0 Td
(ing\040channels\040\050Fleck\040) Tj
0.0003 Tc
-0.0003 Tw
-29.435 -1.725 Td
(2013\051\056\040\040) Tj
0.0002 Tc
-0.001 Tw
T*
[ (\040) -2751 (The\040oncologists\040who\040provide\040care\040to\040cancer) ] TJ
0.0008 Tc
-0.0018 Tw
20.445 0 Td
[ (\040p) 6 (atie) 5 (n) 1 (ts\040f) 4 (ace\040f) 4 (i) -1 (na) 5 (ncial\040incen) 6 (tives\040to\040) ] TJ
0.0002 Tc
-0.0012 Tw
-20.445 -1.725 Td
[ (adm) 8 (i) -2 (nister\040intravenous\040anticancer\040drugs\056\040In\040m) 8 (ost\040) ] TJ
0.0003 Tc
-0.0019 Tw
19.74 0 Td
(industries\054\040there\040is\040not\040) Tj
0 Tc
0 Tw
9.08 0 Td
(much\040difference\040between\040) Tj
0.0004 Tc
-0.0014 Tw
-28.82 -1.725 Td
(wholesale\040and\040retail\040prices\054\040and\040so) Tj
-0.0001 Tc
0.0001 Tw
13.72 0 Td
(\040they\040send\040consistent\040signals\056\040) Tj
0.0005 Tc
-0.0017 Tw
(But\040wholesale\040and\040retail\040prices\040) Tj
0.0002 Tc
-0.0002 Tw
-13.72 -1.72 Td
[ (for\040drugs\040can\040diverge\040system) 8 (atically\054\040provi) ] TJ
-0.0018 Tw
17.11 0 Td
(ding\040incentives\040for\040dys) Tj
0 Tc
0 Tw
9.135 0 Td
(functional\040behavior\056\040) Tj
0.0002 Tc
-0.0012 Tw
-26.245 -1.725 Td
(Oncologists\040and\040hospitals\040buy\040intravenous\054\040physicia) Tj
0.0005 Tc
-0.003 Tw
20.78 0 Td
[ (n\055adm) 8 (i) -2 (nistered\040drugs\040from) 8 (\040wholesalers\040and\040) ] TJ
0.0009 Tc
-0.0023 Tw
-20.78 -1.725 Td
[ (bill\040insur) 4 (ers\056) 6 (\040They\040prof) 4 (it\040on\040the\040spre) 5 (a) 5 (d) 1 (\040between) ] TJ
0.0007 Tc
-0.0014 Tw
18.94 0 Td
[ (\040th) 6 (e\040reim) 9 (burse) 5 (d\040price\040and\040the\040wholesale\040cost\056\040) ] TJ
0.0002 Tc
-0.0009 Tw
-18.94 -1.725 Td
(Medical\040oncology\040practices\040derive\040more\040than\04050\040pe) Tj
0.0007 Tc
-0.0014 Tw
20.525 0 Td
[ (rcent\040of\040their\040revenues\040from) 9 (\040drugs\040\050Akscin\040et\040) ] TJ
-0.0007 Tw
-20.525 -1.725 Td
[ (al\056\0402007\051\054\040an) 6 (d\040m) 9 (any\040oncologists\040rep) 6 (o) 1 (rt\040th) 6 (at\040th) 6 (ey\040face\040) ] TJ
0.0003 Tc
-0.0003 Tw
[ (financial\040incentiv) 5 (es\040to\040adm) 8 (i) -2 (nister\040anticancer\040) ] TJ
0.0002 Tc
-0.0002 Tw
T*
(drugs\040\050Malin\040et\040al\056\0402013\051\056\040Oncol) Tj
0.0003 Tc
-0.0015 Tw
(ogists\222\040drug\040choices\040are\040responsive\040) Tj
-0.0004 Tw
27.17 0 Td
[ (to\040profit\040m) 8 (a) -1 (rgins\040\050Conti\040et\040al\056\040) ] TJ
ET
0.977 g
412.8 209.52 61.02 13.98 re
f
BT
0 g
/TT0 1 Tf
12 0 0 12 72 212.22 Tm
[ (2012\073\040Jacob) 5 (son\040et\040al\056\04020) 5 (06\073\0402010\051\056\040T) 6 (he\040use\040of\040irinotecan\227b) 5 (rand\040nam) 8 (e) -1 (\040Cam) 8 (ptosar) ] TJ
/TT1 1 Tf
0 Tc
0 Tw
9 0 0 9 464.82 212.22 Tm
(\227) Tj
/TT0 1 Tf
0.0004 Tc
12 0 0 12 473.82 212.22 Tm
(decreased\040) Tj
0.0001 Tc
-0.0008 Tw
-33.485 -1.725 Td
(following\040the\040expiration\040of\040its\040patent\054\040even\040t) Tj
-0.0007 Tw
17.555 0 Td
(hough\040the\040price\040dropped\040by\040more\040than\04080\040percent\054\040) Tj
0.0002 Tc
-0.0018 Tw
-17.555 -1.725 Td
(possibly\040reflecting\040declines\040in\040) Tj
0.0012 Tc
-0.0012 Tw
[ (th) 6 (e\040sp) 6 (read\040be) 5 (twee) 5 (n\040the\040re) 5 (im) 9 (bursem) 9 (ent\040leve) 5 (l\040and\040oncolo) 6 (g) 1 (ists) 5 (\222\040) ] TJ
-0.0001 Tc
-0.0009 Tw
T*
(acquisition\040cost\040\050Conti\040et\040al\056\0402012\051\056\040) Tj
0.0002 Tc
-0.0012 Tw
3 -1.725 Td
[ (Insurers\040use\040cost\055sharing\040\226\040i\056e\056\054\040copaym) 8 (en) ] TJ
0.0006 Tc
-0.0022 Tw
16.77 0 Td
[ (ts\054\040coinsurance\054\040and\040deductibles\040\226\040to\040m) 8 (ake\040) ] TJ
0.0001 Tc
-0.0007 Tw
-19.77 -1.725 Td
(patient\040demand\040responsive\040to\040the\040cost\040of\040health\040ca) Tj
0.0004 Tc
-0.0041 Tw
19.94 0 Td
(re\054\040but\040cost\040sharing\040is\040) Tj
-0.002 Tw
8.78 0 Td
(not\040always\040effective\040in\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 467 8 re
S
0 1 1 RG
n
72 688 461 8 re
S
0 1 1 RG
n
72 667 450 8 re
S
0 1 1 RG
n
72 646 455 8 re
S
0 1 1 RG
n
72 626 463 8 re
S
0 1 1 RG
n
72 605 445 8 re
S
0 1 1 RG
n
72 584 278 8 re
S
1 0 0 RG
n
108 564 412 8 re
S
0 1 1 RG
n
72 543 460 8 re
S
0 1 1 RG
n
72 522 458 8 re
S
0 1 1 RG
n
72 501 456 8 re
S
0 1 1 RG
n
72 481 468 8 re
S
0 1 1 RG
n
72 460 454 8 re
S
0 1 1 RG
n
72 439 450 8 re
S
0 1 1 RG
n
72 419 37 8 re
S
1 0 0 RG
n
108 398 384 8 re
S
0 1 1 RG
n
72 377 469 8 re
S
0 1 1 RG
n
72 357 457 8 re
S
0 1 1 RG
n
72 336 414 8 re
S
0 1 1 RG
n
72 315 460 8 re
S
0 1 1 RG
n
72 295 446 8 re
S
0 1 1 RG
n
72 274 465 8 re
S
0 1 1 RG
n
72 253 471 8 re
S
0 1 1 RG
n
72 232 470 8 re
S
0 1 1 RG
n
72 212 451 8 re
S
0 1 1 RG
n
72 191 453 8 re
S
0 1 1 RG
n
71 170 443 8 re
S
0 1 1 RG
n
71 150 172 8 re
S
1 0 0 RG
n
107 129 408 8 re
S
0 1 1 RG
n
72 108 456 8 re
S
Q

endstream
endobj
77 0 obj
<<
/BaseFont /ArialMT
/Encoding /WinAnsiEncoding
/FirstChar 151
/FontDescriptor 78 0 R
/LastChar 151
/Subtype /TrueType
/Type /Font
/Widths [ 1000 ]
>>
endobj
78 0 obj
<<
/Ascent 905
/CapHeight 1000
/Descent -211
/Flags 32
/FontBBox [ -665 -325 2000 1006 ]
/FontFamily (Arial)
/FontName /ArialMT
/FontStretch /Normal
/FontWeight 400
/ItalicAngle 0
/StemV 88
/Type /FontDescriptor
/XHeight 1000
>>
endobj
79 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
80 0 obj
<<
/Length 9082
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 303.24 75.8401 Tm
(9\040) Tj
/C2_0 1 Tf
0 Tc
-21.06 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0004 Tc
-0.0012 Tw
12 0 0 12 72 708.96 Tm
[ (reducing\040patients\222\040dem) 8 (a) -1 (nd\040for\040anticancer\040drugs\056\040Most) ] TJ
0.0008 Tc
-0.0008 Tw
21.415 0 Td
[ (\040em) 9 (ployer\055bas) 5 (ed\040in) 6 (surance\040po) 6 (licies\040hav) 6 (e\040an) 6 (\040) ] TJ
0.0003 Tc
-0.0003 Tw
-21.415 -1.725 Td
[ (annual\040out\055of\055pocket\040m) 8 (a) -6 (xim) 8 (u) -5 (m\054\040beyond\040which\040the\040in) ] TJ
0.0001 Tc
-0.0001 Tw
21.3 0 Td
[ (surer\040assum) 8 (e) -1 (s\040100\040percent\040of\040the\040cost\040of\040) ] TJ
0.0009 Tc
-0.0037 Tw
-21.3 -1.725 Td
[ (care\056\040M) 5 (any\040patien) 6 (t) -1 (s\040with\040late\040stage\040cancer\040reach) 6 (\040) ] TJ
0.0003 Tc
-0.001 Tw
19.41 0 Td
[ (the\040m) 8 (a) -1 (xi) -7 (m) 8 (u) -5 (m\040fairly\040quickly\054\040in\040which\040case\040the\040) ] TJ
0.0011 Tc
-19.41 -1.735 Td
[ (insure) 5 (r\040bea) 5 (r) 4 (s\040the\040f) 4 (u) 1 (ll\040co) 6 (s) 5 (t) -1 (\040of) 4 (\040antican) 6 (c) 5 (er\040dr) ] TJ
0.0006 Tc
-0.0013 Tw
16.63 0 Td
[ (ugs\040for\040the\040rem) 8 (a) -1 (inder\040of\040the\040benefit\040year\056) ] TJ
/TT1 1 Tf
0 Tc
0 Tw
7.02 0 0 7.02 468.12 651.72 Tm
(2) Tj
/TT0 1 Tf
12 0 0 12 471.66 646.7401 Tm
(\040) Tj
0.0006 Tc
-0.0016 Tw
-33.305 -1.745 Td
[ (Consequently\054\040patients\040m) 8 (a) -1 (y\040be\040indifferent\040betw) ] TJ
0.0001 Tc
-0.0001 Tw
18.945 0 Td
(een\040a\040drug\040that\040costs\040\04420\054000\040and\040one\040that\040costs\040) Tj
0 Tc
0 Tw
-18.945 -1.725 Td
(\044100\054000\056\040\040) Tj
0.0003 Tc
-0.0033 Tw
3 -1.725 Td
[ (An\040analysis\040of\040private\040insurance\040claim) 8 (s) ] TJ
-0.0008 Tw
15.735 0 Td
(\040data\040from\0401997\040to\0402005\040found\040that\040the\040annual\040) Tj
0.0005 Tc
-0.0013 Tw
-18.735 -1.725 Td
[ (m) 8 (e) -1 (dian\040out\055of\055pocket\040cost\040for\040the\040intravenous\040dr) ] TJ
0.0004 Tc
-0.0004 Tw
19.385 0 Td
[ (ug\040rituxim) 8 (a) -6 (b\040was\040\044431\040per\040year\040\050Goldm) 8 (an\040et\040al\056\040) ] TJ
0.0002 Tc
-0.0002 Tw
-19.385 -1.725 Td
[ (2010\051\056\040Patients\222\040costs\040w) 7 (e) -1 (re\040less\040than\0402\040percent\040) ] TJ
0.0004 Tc
-0.0004 Tw
18.685 0 Td
(of\040total\040spending\040on\040ritu) Tj
-0.0002 Tc
0.0027 Tw
9.615 0 Td
[ (xim) 8 (a) -1 (b\056\040Patients\222\040out\055of\055) ] TJ
0.0001 Tc
-0.0001 Tw
-28.3 -1.725 Td
(pocket\040costs\040for\040oral\040agents\054\040which\040are\040covered\040) Tj
0.0009 Tc
-0.0009 Tw
19.025 0 Td
[ (u) 6 (nder\040insu) 6 (rers\222\040pharm) 9 (acy\040) ] TJ
0.0005 Tc
-0.003 Tw
10.465 0 Td
(benefit\054\040are\040higher\056\040) Tj
-0.0001 Tc
-0.0009 Tw
-29.49 -1.725 Td
(Still\054\040a\040separate\040analysis\040of\040cl) Tj
0.0001 Tc
-0.0001 Tw
11.66 0 Td
[ (aim) 8 (s) -1 (\040found\040that\040cancer\040patients\222\040) ] TJ
0.0002 Tc
-0.0002 Tw
13.02 0 Td
(out\055of\055pocket\040costs\040were\0405\040percent\040) Tj
0.0005 Tc
-0.0005 Tw
-24.68 -1.725 Td
[ (of\040total\040drug) 6 (\040costs\054\040and\040o) 6 (n) 1 (ly\04034\040percent\040of\040patien) 6 (t) 3 (s\040faced\040per\040claim) 8 (\040copaym) 8 (ents\040in\040excess\040of\040\04450\040) ] TJ
0.0001 Tc
-0.0017 Tw
0 -1.725 TD
(\050Raborn\040et\040al\056\0402012\051\056) Tj
0 Tc
0 Tw
7.98 0 0 7.98 171.6 465.72 Tm
(\040) Tj
0.0004 Tc
-0.0004 Tw
12 0 0 12 108 439.5 Tm
[ (Even\040when\040patients\040face\040large\040out\055of) 8 (\055pocket\040) ] TJ
0.0005 Tc
-0.0005 Tw
17.935 0 Td
[ (costs\040for\040antican) 6 (cer\040drugs) ] TJ
0.0003 Tc
-0.0019 Tw
10.25 0 Td
(\054\040they\040have\040several\040) Tj
0.0006 Tc
-0.0014 Tw
-31.185 -1.725 Td
[ (options\040f) 4 (o) 1 (r\040r) 4 (e) -1 (ducing\040th) 6 (eir\040liabilities\056\040Patien) 6 (t) -2 (s\040wi) ] TJ
0.0004 Tc
-0.001 Tw
19.085 0 Td
[ (th\040private\040insurance\040can\040apply\040for\040aid\040from) 8 (\040drug\040) ] TJ
0.001 Tc
-19.085 -1.725 Td
[ (m) 9 (anufacturers\222\040co) 6 (\055pay\040as) 5 (sistan) 6 (ce\040pro) 6 (g) 1 (ram) 9 (s\054\040which\040) ] TJ
0.0003 Tc
-0.0003 Tw
20.495 0 Td
(offset\040patients\222\040out\040of\055pocket\040costs\054\040typically\040) Tj
0.0006 Tc
-0.0014 Tw
-20.495 -1.725 Td
[ (on\040generous\040term) 8 (s\056\040For\040exam) 8 (ple\054\040Dendreon\222s\040pa) ] TJ
0.0002 Tc
-0.0009 Tw
[ (tient\040assistance\040program) 8 (\040covers\040up\040to\040\0446\054000\040of\040) ] TJ
0.0001 Tc
-0.0026 Tw
0 -1.72 TD
[ (patients\222\040copaym) 8 (ents\054\040coinsurance\054\040and\040deductible) ] TJ
-0.0001 Tw
20.1 0 Td
(s\040for\040its\040\04493\054000\040prostate\040therapy\040sipuleucel\055T\054\040) Tj
0.0006 Tc
-0.0014 Tw
-20.1 -1.725 Td
[ (boasting\040\22375) 6 (\040percen) 6 (t\040of\040patien) 6 (t) -2 (s\040receiving\040Prove) ] TJ
0.0005 Tc
0.0003 Tw
19.275 0 Td
[ (n) 6 (g) 1 (e\040\133the\040trad) 6 (e\040nam) 8 (e) -1 (\040for\040sipuleucel\055T\135\040are\040) ] TJ
0 Tc
-0.0016 Tw
-19.275 -1.725 Td
[ (expected\040to\040have\040m) 8 (i) -2 (ni) -7 (mal\040to\040no\040out\055of\055poc) ] TJ
0.0001 Tc
-0.0009 Tw
17.05 0 Td
(ket\040costs\056\224\040\050Dendreon\0402014\051\056\040The\040program\040even\040) Tj
0.0005 Tc
-0.0012 Tw
-17.05 -1.725 Td
[ (reim) 8 (burses\040patients\040for\040the\040costs\040they\040incur\040duri) ] TJ
0.0001 Tc
-0.0008 Tw
19.025 0 Td
[ (ng\040travel\040to\040oncology\040clinics\056\040These\040f) 8 (unds\040flow\040) ] TJ
0.0003 Tc
-0.0013 Tw
-19.025 -1.725 Td
[ (directly\040from\040pharm) 8 (ace) -6 (utical\040com) 8 (p) -5 (anies\040to\040patie) ] TJ
-0.0017 Tw
19.355 0 Td
(nts\040and\040are\040not\040captured\040in\040insurers\222\040records\056\040) Tj
0.0001 Tc
-0.0001 Tw
-19.355 -1.725 Td
[ (Patient\040assistance\040program) 8 (s\040lower\040the\040elasticity\040of) ] TJ
0.0004 Tc
-0.0004 Tw
19.99 0 Td
[ (\040patient\040dem) 8 (a) -1 (nd\054\040enabling\040m) 8 (a) -1 (nufac) -6 (turers\040to\040set\040) ] TJ
-19.99 -1.725 Td
(higher\040prices\040\050Howard\0402014\051\056\040The\040federal\040gov) Tj
0.0001 Tc
-0.0001 Tw
18.415 0 Td
[ (ernm) 8 (ent\040does\040not\040allow\040assistance\040program) 8 (s\040) ] TJ
0.0007 Tc
-0.0017 Tw
-18.415 -1.725 Td
[ (affiliated\040with\040a\040pharm) 9 (aceutical\040m) 9 (anufacturer\040to) ] TJ
-0.0014 Tw
19.3 0 Td
[ (\040aid\040Med) 6 (i) -1 (care\040and\040Medic) 5 (aid\040enro) 6 (lle) 5 (es) 5 (\040on\040the\040) ] TJ
0.0003 Tc
-0.0003 Tw
-19.3 -1.725 Td
[ (grounds\040that\040these\040program) 8 (s\040provide\040an\040il) ] TJ
0.0005 Tc
-0.0035 Tw
16.605 0 Td
[ (legal\040inducem) 8 (ent\040for\040patients\040to\040receive) ] TJ
-0.0001 Tc
0.0015 Tw
10.98 0 0 10.98 460.86 191.16 Tm
(\040care\054\040) Tj
0.0007 Tc
0 Tw
12 0 0 12 487.38 191.16 Tm
(but\040) Tj
-0.0014 Tw
-34.615 -1.725 Td
[ (m) 8 (a) -1 (nufacturers\040are\040allowed\040to\040donate\040f) 9 (unds\040a) ] TJ
0.0002 Tc
-0.001 Tw
17.715 0 Td
(nd\040steer\040Medicare\040and\040Medicaid\040patients\040to\040) Tj
0.0003 Tc
-0.0013 Tw
-17.715 -1.725 Td
[ (program) 8 (s\040operated\040by\040independent\040f) 8 (oundations\056\040Patient) ] TJ
0.0001 Tc
-0.0007 Tw
22.105 0 Td
(s\040can\040also\040use\040death\040as\040a\040backstop\040against\040) Tj
/C2_0 1 Tf
0 Tc
0 Tw
10.98 0 0 10.98 72 116.58 Tm
[ <0003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003> 81 <0003000300030003000300030003000300030003000300030003000300030003000300030003> ] TJ
ET
72 118.62 144 0.72 re
f
BT
/C2_0 1 Tf
10.98 0 0 10.98 216 116.58 Tm
<0003> Tj
/TT0 1 Tf
7.98 0 0 7.98 72 108.0601 Tm
(2) Tj
0.0002 Tc
-0.0002 Tw
12 0 0 12 76.02 102.54 Tm
[ (\040Som) 8 (e) -1 (\040plans\040do\040not\040count\040spending\040on\040prescripti) ] TJ
0.0003 Tc
-0.0003 Tw
19.28 0 Td
[ (on\040drugs\040tow) 8 (a) -1 (rds\040the\040out\055of\055pocket\040maxim) 8 (u) -5 (m) 8 (\054\040a\040) ] TJ
-0.0001 Tc
0.0001 Tw
-19.615 -1.15 Td
(practice\040prohibited\040by\040the\040Afford) Tj
0.0002 Tc
-0.0002 Tw
13.21 0 Td
(able\040Care\040Act\040beginning\040in\0402014\056\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 468 8 re
S
0 1 1 RG
n
72 688 450 8 re
S
0 1 1 RG
n
72 667 458 8 re
S
0 1 1 RG
n
72 646 402 8 re
S
0 1 1 RG
n
72 625 459 8 re
S
0 1 1 RG
n
72 605 54 8 re
S
1 0 0 RG
n
108 584 411 8 re
S
0 1 1 RG
n
72 563 465 8 re
S
0 1 1 RG
n
72 543 453 8 re
S
0 1 1 RG
n
72 522 447 8 re
S
0 1 1 RG
n
71 501 466 8 re
S
0 1 1 RG
n
72 480 462 8 re
S
0.5 0.5 0.5 RG
n
72 460 101 8 re
S
1 0 0 RG
n
108 439 430 8 re
S
0 1 1 RG
n
72 418 462 8 re
S
0 1 1 RG
n
71 398 463 8 re
S
0 1 1 RG
n
71 377 460 8 re
S
0 1 1 RG
n
71 356 469 8 re
S
0 1 1 RG
n
71 336 432 8 re
S
0 1 1 RG
n
71 315 437 8 re
S
0 1 1 RG
n
71 294 458 8 re
S
0 1 1 RG
n
71 273 449 8 re
S
0 1 1 RG
n
71 253 467 8 re
S
0 1 1 RG
n
71 232 435 8 re
S
0 1 1 RG
n
71 211 449 8 re
S
0 1 1 RG
n
71 191 434 8 re
S
0 1 1 RG
n
72 170 422 8 re
S
0 1 1 RG
n
72 149 467 8 re
S
0.9 0.9 0.9 RG
n
72 116 146 8 re
S
0.5 0.5 0.5 RG
n
72 108 470 8 re
S
0 1 1 RG
n
72 88 320 8 re
S
Q

endstream
endobj
81 0 obj
<<
/BaseFont /PBEFNJ+Calibri
/Encoding /WinAnsiEncoding
/FirstChar 50
/FontDescriptor 82 0 R
/LastChar 50
/Subtype /TrueType
/Type /Font
/Widths [ 507 ]
>>
endobj
82 0 obj
<<
/Ascent 750
/CapHeight 1000
/Descent -250
/Flags 32
/FontBBox [ -503 -307 1240 964 ]
/FontFamily (Calibri)
/FontFile2 83 0 R
/FontName /PBEFNJ+Calibri
/FontStretch /Normal
/FontWeight 400
/ItalicAngle 0
/StemV 80
/Type /FontDescriptor
/XHeight 1000
>>
endobj
83 0 obj
<<
/Filter /FlateDecode
/Length1 46484
/Length 13597
>>
stream
h޴[|UE>B4 ]ADD@!@(	$B/KE*}׆.*X]QA
ɻ(|9ߜ)wfܙsf&dQ}*#Ftߟ|Es
=:L)Z(sDF?"Us~eD="_.Qg_QR9B)H`ڱ=1	*FD!ܮt΢e<)·uJj6h>)X6?)}2y[0xW%@t/,?Q3L4;O bD9[PZZiIqd6tLӴ-L7v(F6]l cYO9idHsEdLYFiB/THvHѻ_	_̡zSDqh~`jZvF&&Q[|j9n/77T9~4@LdHh2S?Jizfͦ94W"n:~ 4yMy4XHh1-{![i)-+h9+*R1Uxp5]7s-TL֬zh=chm:Z|#|CMw3mxDVN+F{Aw668YzGQzRezMK+UQ54[Wܶrˠ_c׏rRR{R鉛kZCUkѽr&]Q=s
1՞J[oUfkMhݑU^~wb"~A|;aڅ5<iVo.DTIxOSGw*c2y@`<O{1Ӽy<>s*z^:7-z7/Q~WA3j@&|M))CM2y	yc5raC3NO:0e@siKz]vl.ضM&$4_7N`f6kzpp~ >?dfd`QP ӄ*Yv,ISDR	~` ``1!;|CZ0/:*P$7/M@zh4WQ7~PpPq]".h]P
cCcz
K!+9`Z(+;7=-1))Oh*+3δ.Puo=	Tߥ޴ംI! ʭBt	u
:-9\LKu	ё!'9!(P#5Ɨ31&F		uCѾ$˺=)T@,;WTXI)ݺ|+1MrLDU{6W>eAqy0-MۘPJHJݐ ݐjL	;xBM`yBӸ^4]A.+4]~T3EԓfRڧN+	OYML
y	NqI*Zsq\3E`0~S!"K$/Z `%(HLK?gRW''9UV:眶j:5WS 8-
u
z&`י!QV2\LTBC)Y6k~3srFɘZ![Bh	0wIתCT8̈*с`fN9
  4~hލz-8 H./WO/eN+KTu{Ur~T#42ǤsOjEX]bət5cr+MWqORd-+9 48>iXe*V
.cŉΠ=%΄ֺbLiz+-㏋U2)dW^(>XLe zF3sRy~T.%z(Z\d`MSѼ$IP.aH7PYQ׃r^Т<[)Iꠄ:^	H1XLEx7x*P^~h<5B׮t7
P&>XA('Wkt'EAD6`4>Qk1%HfYuǇ\ytyy*t NEGu\U/r1{htpf*ɏPu{K8#zeZ?J} xER]8ħ1)<VqJ]^WtՏHVұjhSO?u4lg7	o;(x%o0	NSmK0=9C0v.M] 'MLRB 5ވtonp;"?`MV*|jeO]wQvS(wTdų <\#%7CSy$5Ӗv-rjoM@QVRɟ(lLr?a6МS.L{)`XeH[hzV'ahR#8B : cۉOdw[lHC`%N*MAX/Y]~\#]Q4T%ΣVVqmmb|XXoP/kY,fP8%Ѥ>NMI[L0/a<;`h m	M>(w%da;=/b}Kb6V:xƠWG5ƔH>8'cmr5ޡwܹ!' `!L`[k"^=pJL2io?F*yUx1$]?I9ErDInG4P{} g%ً$&gsp'W#k+uűbNFmOB'W7-
hculsbHFsmL|6iPHW;RS;j^5n51/Ts&^㈪N֡~dMj0=Fa<@``o: <)*sny3lWOLKH"1le}T.4ބ2]ܼF%?:BWܵlX9X_>چkwڬ0w6S;Y9zw<Xauex.K_c<멏&'8Y_eM<֘`d-[;ǩD[hwZ>sdݱn)d^?փAO(b;k_w=(`0qA`9P+}%a4²Ȝ0:ڍh	OZe<\4szX/E9&g#MckջG?e:t[0]PsVs%xGȊ|x}֋[;FUcٿv^hvZ!BZeC 4.Bw. [oe'5ﻌDC]eXhqkV`gem5xY$3v[1fvb߈<38a#<uVAwfY` wO6v/kXA[0p 7v޹ND(?lL;c/6U4.uzR3I4uV]tVLΛ[oS[;=n-EjMuJ[0(K:+k3wsk.cN#޼^`XO`lQF˱L8cxǷnn=Et]'iW6_|%k£FUe<p]7/XU'~77ЦE4̫)0tPR`,2U4G묋i5'uOKnz̹8hK;~B|<$NO΁k6|܆t`%и0WTa~c:DSP!z]mUfv Ӂ P
7u-1V)`(uȴѨO(
>tUm?0^u<u?U}dLs74?d~i";kʆ6xYrVmL9r51#O6u7{S[s<6]i54g*9ד 9k4Ra:qD(<k;sq#)I𾪰Wp LxoJǏxvCB3̣(xc.Cf4k
Qt7|h?0Ѵ yVQP~aW<:Mgt+F>T {4SFxD7)j}np?>pX_SӸk$tOP%?x;[oLX{skF瀽tbǀ=E`SB6JGNoOi\Rۑ,jܽH%N;Ml[02Da3O6>y?%hvgҍzH71?a{c\5='`o`6N\^,ؘuaR^DC0u20̝$E4A/L;	X[gc{/16A 0;:n7Z,Oyh~63ca6!\Ӣ/}z{/AݪI?e4h2-)Ƈ]KQcM`ԡc+lU
`L0+)1
z%ь10Ȍ?V}o]R	s)ѹZc>$7{c~ kE9m`n8̫n~1Q{/̾'z\qӮǾ-{G}Ԝ}}~{G\yYq~g?}WZh\<?1#(v}o_Z)k&fBߦw;_>NK㉪=|6%<<zsA<tdvY;OJt>9':#XsF09s a#g /PȾ?Ky],s?HÚͤm=vY[ 7{@`=9d80}?Kjόj	Rsi8ܓkuirjys:/O{(}AHlxN1쀣|ݽ|잘zjl'mᨳgs`omĳXE~fOGuWX|]'aTvj{Og>@ͥٮAx<ZoǾ 
jxoG5
xo3ف
ovY+{`ӢWTCSnо4yzR?i_1{4@ e(Ϭ9QUNVǕ4~gcl#n|=ff.s6\|SqYO[0Th~>	-4˺ߤqcNavޢR|!@tu&'geh97[!mW{?/k{6w0Y<{1!,Wݢ[Ϟ=Sv&v:Xy7֥uLv՘`'G9Y䩇gtvRC>=Vszr3h9Set`v}69	=7AFls5~
Tsh+<Xԙ ;SmA*ߧxuDY?@/vjJgjrv9gso֚s3׺fSk$Wg@_}:"y
y/_Y՘hܗT`Tڽh,`w#mWkKrw濁<b^`/0nNc٨3qS&$i*`M=S.syT?yy|.-'?Q}]>C攆XkF( ̈́]΃-1 XMgnt[EmxẢ4j~e1 6L|ŔJikA_(J5ggAj	;4Og>HYggj_2Tg*v3:w),_ʸ:9:I"{aT||0VQGk*>7sA<0 Mm~}~<}w8Z[5侄96ob|R`geV-;5߆fYk^
1^0~1t{Q7cF|6YK(mMRJS9?s:G&W`o5ws+$mB=3wqsU7a{JʇMXLv51'_][-{v&1lA9.8(κK]Nװ}>xf>+Vg5ڀn-H29з<	ЧB
8]3T'?B3/T8zA3c$P[e[I}xkdOYG&S_I=/F;GDFWWy1ߙxu5}|vF5]?@ޖ{G-6ē{Dn`g8dj*|fHy]]_og_}|^G |<Ϗz2"r-<%E[;>Hwv/;@!x[uQ2 Ù)+v_ˁBpWI:>f?^	,Wjlǜ?W˝S6{w?Θַ~1J`<v~x%,8e>`i#p^^k|Nx3<n>f}䜋z4_moDx>qTeΖH:»37)&dxeɬWr8r1H[+EFyrl~l
o
3Yi=*a| ~+NwjCK0+=\wp# (;3Xwh.ӿkX"/-;t~}z(>9&G_ANl
r=3/sM?[k}.	ſf>yl֎|DlI|bs3h{"G\!pFbna	݁kfIN=jZ+h7dmWEߴ۰E|/B|SY9X)ϤޝES8BZw.jm7.G-2CiJ$uAPbm/WC;a7>[y=9A-(^J(6^-~jPB8=ƻ$M徲r t\doI[;6E:kK.1S{Rs'f,#kQg=uPsF#9lPsg`[*V]=Q1rҩv8({꾡Ps^`7OEK
rԝG&x*\o0s yzbihCړP/Xq4B,l7 vreʥ5Kxĝ0/O-Wށә|u3;{z}ܰJho p}l/~ߠg!ƻhz&Fd<!=A"5J@6hʱ[Hx_|?|+t3(?&MF]19u4? =*nrZϙIm~e(d%Iίϟ1}Mb~Az=4#s5w6Ve!BHo^6wUcx*}6hr>'3>WFSnD(Dy&<;w4@GjwD3X|^\{4Tw|k4Hh[oOm(jHs{%Et"{3 dwɨKI:C{F[\Qr{SwGxn8<իs \=tm{^|40FuFՃ5>KW}57aw{<\FPH =t!Ft{շ%Dc/mzLT__U3jƔSF{5\U3 ?xzg3G/a_Eb~J*X=uinY%dk	FBrBB2!K,X"!Y dyB
#dYBf
!Tt!%BLR$PH|!SL2Y$!L'$Wx!ㄌ2FHBd	%dB2LP!B,$]HABR"dB.OH_!}\*KrB.CȅB&!*B:	(BVH6BZ9OH+!BZ
i!s4TH!4r!4R_H=!u#$N_O#b	1B#+$,ZHBUȿS/B~ {!Ǆ|'[!G򍐯|%䰐/|!s!	T'B>C߅MBOBwW!?9(-!o
7ׄW,d?
yIȋB
yABgAByJȓBǄT
GKBv
yHȃBrOȽBCv!ۄ-d)![.6!
,d[lrNȍB6Y/dr!krB"f!f!f!f!f!f!f!f!f!f!f!f!f!f!f!f!f!fP????????????????????????????????===X;X;X;X;X;X;X;X;X;ƠǘjlݿlM!Vе@5Z\]ٺU:t+XXVy Z,b[CkP+T
1_yZIh1[Y!fj1CR-kQR*XiQEZk1U):dD-&hEX-hh-b#p-2V8b h121"2q8DHqu-|L~:e_-j[KźZ\KŅZtׅu|-jEZtҢtHe"E[]t8OVZ$jѲHZ4l9
\-ieS-hec-iqKТV6Тt\]-⵨klTȆ!CRp$FUiqB:W-~l>9?Z|1}Q-oZ+_jN}C'Z|G:C-Ͼ@7Qa wMڦi-]&HW
)`ZBmYZht
YP.v."nH7k7;;yOϙ)sf2{Siߦx0!&ޠx]IxMIx 5Bqe~}Ըbŋ/P)g)x)I=Aq:ţԸStRTF!-(Yv)>Ž5LCM.;)6[i[h)6б(nz::]Kqz:v5rŕt
uSz^JK(.B5ZC\@qbkDGqbcR@hӗy(*z9tgQ,R(4N_LH!ZisE|3)t^3E]Y#@QO=(QR̥CQCol6,zU4t%LtdbTFLQ+LV]XG*a3K	$ŊDN1=ubb1ND+U"%ރK((PORM1JF>KL@T,3#K"U,"rgbQXbQf&E>^T
'v
Pl`AzP1i~4F(TdIk	yNaR,tMqFXi1MEQHA"@)4ORjM/('{E75}qch>ñOQ>ø&郸f}xޅ.EGmBC&a/n̖^CjlI_6:`?hc\ (?s3g^cIz
xOم<XK;b	ѾC8m
t@;<h8GzT߰\&+{a3nh&݅9#o3̗nEo(߄nX7`v\zyWb+bʤu1c1b6IŁK:UUJM^jmЖVҶ-vY./ggΒwkX=F^
Ak0P Xt؀!|S||>xLgϮ-4ҽg4{˭Pq|&.jCMr^nuyrk<U-ׄٮ*yVJt͔gtW,*rTyZh<U&U"*'N'N'<xybNqfRp%,e%&O`ɻxS_0Ԕċ''֤IDSD8T)a;	_&Dq'06K+<,G~<&7$0^qf9j9nmL=&mBwS'8=c2JFAEۈuS*<&dBd6{܆aY&r猛bz&y0y$yGEYŦGM/jXSu3j/BqEdjW]ˊRKSgߖZYҾ
ZAvYQ;jgj<֜j@]
uCcl8{__a`xDg.`p`%6X`)gY ?,E
a|8MPu0ja.́0f2T@9L0&CP`"aC7Bc`4|pHy0r!!2!S`(0  AB
$C_HDH ;
} ,`āb 1QDBEcmW_?||_qcLz|
|]pށ#6	o
8 /K^/<<34<Ixv<
;C'lm-@Ã Apla#wp;-p3lFZp\	W:ep)\Ep!լ~*19?cs19?cs1pk pk pk pk pk pk pk pk 19?scs}19>s_$C[vЖ8E2_<>;ӳ|Vج̈GF[mE?U`<Qb)B0n۷<Z2yPKya}Ggow2ϒu+;[Y¬q^oOS ?=N1@IDɖAs/Unȴ&Q)$3\>kT׉Q!#KZƧ[RmT-բ>בq'#ZNug"tδĤSF8acأ!fwcl4Vw)ǘ!+`ơ#3MҸ[?$us{ͱF~a@S-w X~g[p4~1gX^j96PN-׮(7w!
Vx,0>?-g:]ν.|sWWWTo`;8O7<C}.Щw~ShStw^ͤcL'fxS?vbvޠ"GW]:>aM^!7d'ZoN[<fUgs:KGIO8ۀy/XAkɿ./h4Fh4FW%h4Fh4Fh4Fh4Fh4Fh4L`<GV&%!鄘_-?c`W"#?9==wpu8o;Gϖvrv,8[@ooY޲#ԧ5"Z/-s_-UoYD{Oo9ɽe#{˸maY,GyYVF@[1J>(E,GƲ|945fk^}=z6/zxj! }l>U4?_QS5]\z-~͎Ropjօ--iަ1[P1hl;Zo8~G#૭oXPhmt%|Ejs]E?OaEl<269pZ7z/mv8,W0g:"wt=91߱z{>|K?oC5? u
endstream
endobj
84 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
85 0 obj
<<
/Length 7883
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (10) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0001 Tc
-0.0001 Tw
12 0 0 12 72 708.96 Tm
[ (m) 8 (e) -1 (dical\040debt\056\040Most\040patients\040considering\040whet) ] TJ
0.0006 Tc
-0.0013 Tw
18.16 0 Td
[ (her\040to\040use\040anticancer\040drugs\040have\040short\040lif) 9 (e\040) ] TJ
0.0006 Tw
-18.16 -1.725 Td
[ (expectan) 6 (cies) 5 (\056\040They\040m) 8 (a) -1 (y\040be\040willi) ] TJ
0.0003 Tc
-0.0011 Tw
12.915 0 Td
(ng\040to\040exhaust\040their\040assets\040to\040b) Tj
0.0009 Tc
-0.0019 Tw
11.775 0 Td
[ (uy\040sm) 9 (all\040gains\040in\040hea) 5 (lth\056\040Health\040) ] TJ
0.0007 Tc
-0.0011 Tw
-24.69 -1.725 Td
[ (care\040p) 6 (r) -1 (oviders\040m) 9 (u) 1 (st\040write\055off\040debt\040in) 6 (\040excess\040of\040th) 6 (e\040deceden) 6 (t\222s) 5 (\040esta) 5 (te\056\040\040) ] TJ
-0.0007 Tw
3 -1.725 Td
[ (Not\040surprisingly\054\040the\040e) 5 (l) -1 (a) 5 (stic) 5 (ity\040) ] TJ
-0.0001 Tc
0.0001 Tw
12.365 0 Td
[ (of\040dem) 8 (a) -1 (nd\040with\040respect\040to\040pa) ] TJ
0.0004 Tc
-0.002 Tw
11.575 0 Td
(tients\222\040out\055of\055pocket\040costs\040is\040) Tj
-0.0004 Tw
-26.94 -1.725 Td
[ (low\056\040Goldman\040et\040al\056\040\0502006\051\040estim) 8 (a) -1 (te\040that\040sp) ] TJ
0.0002 Tc
-0.0008 Tw
17.305 0 Td
(ending\040on\040cancer\040drugs\040declines\040by\0400\0561\040percent\040in\040) Tj
-0.0022 Tw
-17.305 -1.725 Td
(response\040to\040a\04010\040percent\040increase\040) Tj
-0.0001 Tc
-0.0024 Tw
13.44 0 Td
(in\040patient\040coinsurance\056\040For\040th) Tj
0.0003 Tc
-0.0003 Tw
11.685 0 Td
[ (e\040sake\040of\040com) 8 (parison\054\040spending\040on\040) ] TJ
-25.125 -1.725 Td
(drugs\040used\040to\040treat\040arthritis\040) Tj
-0.0002 Tc
-0.0008 Tw
10.975 0 Td
(declines\040by\0402\0561\040percent\040and\040spendi) Tj
0.0002 Tc
-0.0002 Tw
13.77 0 Td
(ng\040on\040drugs\040used\040to\040treat\040kidney\040) Tj
0.0001 Tc
-0.0001 Tw
-24.745 -1.725 Td
(failure\040declines\040by\0400\0567\040percent\040when\040patient) Tj
0 Tc
-0.0014 Tw
17.475 0 Td
(\040coinsurance\040increases\040by\04010\040percent\056\040\040\040) Tj
0 Tw
-17.475 -1.725 Td
(\040) Tj
/TT1 1 Tf
-0.0002 Tc
0.0002 Tw
0 -1.735 TD
(Trends\040in\040Launch\040Prices\040) Tj
/TT0 1 Tf
0 Tc
0 Tw
3 -1.715 Td
(\040) Tj
0.0002 Tc
-0.0002 Tw
0 -1.725 TD
(We\040evaluate\040pricing\040trends\040for\04058\040anticance) Tj
0.0001 Tc
-0.0001 Tw
17.435 0 Td
(r\040drugs\040approved\040in\040the\040US\040between\0401995\040and\040) Tj
0.0003 Tc
-0.0003 Tw
-20.435 -1.725 Td
[ (2013\040\050CenterW) 9 (atch\0402014\051\056\040W) 9 (e) -1 (\040restrict\040attention\040to\040dr) ] TJ
0.0002 Tc
-0.0002 Tw
[ (ugs\040administered\040with\040the\040prim) 8 (ary\040intent\040of\040) ] TJ
0.0009 Tc
-0.0021 Tw
T*
[ (extending\040su) 6 (rvival\040tim) 9 (e\040for\040cancer\040) ] TJ
0.0001 Tc
-0.0007 Tw
13.97 0 Td
(patients\040and\040drugs\040for\040which\040survival\040benefits\040have\040been\040) Tj
0.0004 Tc
-0.0004 Tw
-13.97 -1.725 Td
[ (estim) 8 (ated\040in\040trials\040or\040m) 8 (odeling\040studies\056\040W) 9 (e) -1 (\040do\040not\040) ] TJ
0.0002 Tc
-0.001 Tw
20.16 0 Td
[ (consider\040drugs\040adm) 8 (i) -2 (nistered\040to\040treat\040pain\040or\040) ] TJ
0.0004 Tc
-20.16 -1.725 Td
[ (drugs\040that\040are\040adm) 8 (i) -2 (nistered\040to\040alleviate\040the\040side) ] TJ
0.0005 Tc
-0.0005 Tw
18.86 0 Td
[ (\040ef) 9 (fects\040of\040cancer\040treatm) 8 (e) -1 (nts\056\040Details\040ab) 6 (out\040the\040) ] TJ
0 Tc
-0.0008 Tw
-18.86 -1.725 Td
(selection\040of\040drugs\054\040references\040for\040survival\040benefi) Tj
0.0005 Tc
-0.0017 Tw
19.355 0 Td
(ts\054\040and\040other\040details\040abou) Tj
0.0004 Tc
-0.0016 Tw
9.97 0 Td
(t\040the\040data\040are\040provided\040) Tj
0 Tc
0 Tw
-29.325 -1.725 Td
[ (in\040an\040appendix\054\040available\040upon\040request\040from) 8 (\040the\040lead\040author\056\040) ] TJ
0.0001 Tc
-0.0001 Tw
3 -1.72 Td
(The\040FDA\040approves\040drugs\040for\040specific\040uses\054\040or\040) Tj
0.0003 Tc
-0.0013 Tw
18.47 0 Td
[ (indications\054\040w) 8 (hich\040are\040described\040in\040each\040) ] TJ
0.0006 Tc
-21.47 -1.725 Td
[ (drug\222s\040\223p) 6 (rod) 6 (u) 1 (ct\040lab) 6 (e) -1 (l\056\224\040We\040focus\040on\040the\040benefits) ] TJ
0.0005 Tc
19.38 0 Td
[ (\040associated\040with\040each\040d) 6 (r) 4 (ug\222s\040first\040FD) 8 (A\055approved\040) ] TJ
0.0003 Tc
-0.0011 Tw
-19.38 -1.725 Td
(indication\056\040Once\040a\040drug\040is\040FDA\055approved\054\040physicians\040) Tj
-0.0014 Tw
21.585 0 Td
(are\040free\040to\040use\040the\040drug\040for\040any\040patient\040with\040) Tj
0.0005 Tc
-0.0005 Tw
-21.585 -1.725 Td
[ (any\040condition\054\040but\040m) 8 (a) -1 (nufacturers\040m) 8 (a) -1 (y\040not\040prom) 8 (ote\040) ] TJ
-0.0001 Tc
0.0008 Tw
20.55 0 Td
[ (the\040drug\040for\040\223off\040label\224\040indications\056\040W) 9 (e) -1 (\040did\040) ] TJ
0.0006 Tc
-0.0006 Tw
-20.55 -1.725 Td
[ (not\040consid) 6 (er\040the\040surv) 6 (ival\040benefits\040ass) 5 (o) 1 (ciated\040) ] TJ
0.0001 Tc
-0.0026 Tw
17.89 0 Td
(with\040indications\040approve) Tj
0.0005 Tc
-0.0005 Tw
9.89 0 Td
[ (d\040by) 6 (\040the\040FDA\040af) 4 (ter\040the\040) ] TJ
0.0004 Tc
-0.0014 Tw
-27.78 -1.725 Td
(initial\040approval\040of\040the\040drug\056\040In\040) Tj
0.0012 Tw
12.305 0 Td
[ (m) 8 (ost\040cases\054\040the\040benef) ] TJ
0.0002 Tc
-0.0002 Tw
8.495 0 Td
[ (its\040associated\040with\040) 1 (these\040indications\040are\040) ] TJ
-0.0012 Tw
-20.8 -1.725 Td
[ (unknown\040to\040m) 8 (a) -1 (nufacturers\040at\040the\040ti) ] TJ
0.0003 Tc
-0.0015 Tw
13.97 0 Td
(me\040of\040launch\040and\040are\040) Tj
0 Tc
-0.0033 Tw
8.63 0 Td
(thus\040difficult\040to\040inco) Tj
0.0005 Tc
-0.0005 Tw
8.135 0 Td
(rporate\040into\040their\040) Tj
0.0011 Tc
-0.0011 Tw
-30.735 -1.725 Td
[ (initial\040p) 6 (r) -1 (ic) 5 (in) 6 (g\040decis) 5 (i) -1 (ons\056) 6 (\040) ] TJ
0.0004 Tc
-0.0004 Tw
3 -1.725 Td
[ (Forty\055one\040of) 8 (\040the\04058\040drugs\040in\040our\040sam) 8 (ple\040were\040approved\040on\040the\040basis\040of\040random) 8 (ized\040) ] TJ
0.0005 Tc
-0.0013 Tw
-3 -1.725 Td
[ (controlled\040trials\056\040W) 9 (e) -1 (\040obtained\040inform) 8 (ation\040on\040the\040) ] TJ
0.0011 Tc
-0.0011 Tw
[ (incr) 4 (em) 9 (ental\040surv) 6 (ival\040b) 6 (enef) 4 (its\040of) 4 (\040th) 6 (ese\040drugs\040) ] TJ
-0.0017 Tw
T*
[ (f) 4 (r) -1 (om) 9 (\040the\040res) 5 (u) 1 (lts\040of) 4 (\040thes) 5 (e\040trials\056\040Drugs) 5 (\040are\040typ) 6 (i) -1 (ca) 5 (ll) ] TJ
0.0008 Tc
-0.0022 Tw
19.575 0 Td
[ (y\040tested\040against\040the\040n) 6 (ext\040best\040th) 6 (erapy\040available\040) ] TJ
0.001 Tc
-0.0026 Tw
-19.575 -1.725 Td
[ (at\040the\040tim) 9 (e\040the\040tr) 4 (ial\040was\040initiated\056\040In\040som) 9 (e\040cases) ] TJ
0.0004 Tc
-0.0016 Tw
18.94 0 Td
(\040the\040next\040best\040thera) Tj
-0.0001 Tc
-0.0011 Tw
7.56 0 Td
(py\040is\040\223nothing\224\054\040and\040so\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 420 8 re
S
0 1 1 RG
n
72 688 451 8 re
S
0 1 1 RG
n
71 667 335 8 re
S
1 0 0 RG
n
107 646 427 8 re
S
0 1 1 RG
n
71 626 449 8 re
S
0 1 1 RG
n
71 605 471 8 re
S
0 1 1 RG
n
71 584 454 8 re
S
0 1 1 RG
n
71 564 397 8 re
S
0.9 0.9 0.9 RG
n
71 543 3 8 re
S
0 0 1 RG
n
71 522 129 8 re
S
0.9 0.9 0.9 RG
n
107 501 3 8 re
S
1 0 0 RG
n
107 481 433 8 re
S
0 1 1 RG
n
71 460 466 8 re
S
0 1 1 RG
n
71 439 442 8 re
S
0 1 1 RG
n
71 419 454 8 re
S
0 1 1 RG
n
71 398 453 8 re
S
0 1 1 RG
n
71 377 462 8 re
S
0 1 1 RG
n
72 357 291 8 re
S
1 0 0 RG
n
108 336 416 8 re
S
0 1 1 RG
n
72 315 468 8 re
S
0 1 1 RG
n
72 295 470 8 re
S
0 1 1 RG
n
72 274 456 8 re
S
0 1 1 RG
n
72 253 444 8 re
S
0 1 1 RG
n
72 232 441 8 re
S
0 1 1 RG
n
72 212 452 8 re
S
0 1 1 RG
n
72 191 119 8 re
S
1 0 0 RG
n
108 170 400 8 re
S
0 1 1 RG
n
72 150 451 8 re
S
0 1 1 RG
n
72 129 460 8 re
S
0 1 1 RG
n
72 108 431 8 re
S
Q

endstream
endobj
86 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
87 0 obj
<<
/Length 9810
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (11) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0005 Tc
0.0011 Tw
12 0 0 12 72 708.96 Tm
[ (patien) 6 (t) -2 (s\040receive\040a\040placeb) 6 (o\056\040W) 9 (e) -1 (\040m) 8 (easured\040benefits\040) ] TJ
-0.0013 Tw
19.935 0 Td
[ (by\040subtracting\040m) 8 (e) -1 (dian\040overall\040surv) 6 (ival\040in\040the\040) ] TJ
0.0008 Tc
-0.0008 Tw
-19.935 -1.725 Td
[ (control\040arm) 9 (\040from) 9 (\040m) 9 (edian\040overall\040survival\040in) ] TJ
0.0006 Tc
-0.0006 Tw
17.55 0 Td
[ (\040the\040treatm) 8 (e) -1 (nt\040arm\056\040W) 9 (e) ] TJ
0.0005 Tc
0.002 Tw
9.18 0 Td
(\040used\040progression\055free\040) Tj
0.0003 Tc
-0.0003 Tw
-26.73 -1.725 Td
[ (survival\040\050the\040period\040of\040tim) 8 (e) -1 (\040the\040cancer\040is\040unde) ] TJ
0.0002 Tc
-0.0002 Tw
18.385 0 Td
(r\040control\051\040when\040trials\040did\040not\040report\040overall\040) Tj
0.0004 Tc
0 Tw
-18.385 -1.725 Td
(survival\056) Tj
0 Tc
7.98 0 0 7.98 113.64 652.38 Tm
(3) Tj
0.0004 Tc
-0.0011 Tw
12 0 0 12 117.66 646.86 Tm
[ (\040Survival\040benefits\040equal\040the\040gain\040in\040m) 8 (e) -1 (dian) ] TJ
0.0002 Tc
-0.0009 Tw
17.135 0 Td
(\040overall\040survival\040or\054\040when\040trials\040did\040not\040) Tj
-0.0002 Tw
-20.94 -1.725 Td
(report\040overall\040survival\040or\040when\040) Tj
0.0004 Tc
-0.0024 Tw
12.635 0 Td
(overall\040survival\040was\040higher\040in\040th) Tj
0.0006 Tc
-0.0006 Tw
12.915 0 Td
[ (e\040control\040arm) 8 (\054) 1 (\040progression\055free\040) ] TJ
0 Tc
0.001 Tw
-25.55 -1.725 Td
[ (survival\040\050the\040period\040of\040tim) 8 (e) -1 (\040wh) ] TJ
0.0008 Tc
-0.0008 Tw
12.41 0 Td
[ (ere\040th) 6 (e\040cancer\040is\040u) 6 (nder\040control\051\056) ] TJ
0 Tc
0 Tw
7.98 0 0 7.98 372.9 610.98 Tm
(4) Tj
0.0002 Tc
-0.0002 Tw
12 0 0 12 376.92 605.46 Tm
[ (\040Drug\040m) 8 (a) -1 (nufacturers\040may\040focus\040) ] TJ
0.0001 Tc
-0.0001 Tw
-25.41 -1.725 Td
[ (on\040progression\055free\040survival\040for\040practical\040reasons) 8 (\056\040Trials\040designed\040to\040detect\040differences\040in\040) ] TJ
0.0004 Tc
-0.0004 Tw
0 -1.725 TD
[ (progress) 5 (i) -2 (on\055free\040surviv) 5 (al\040are\040shorter\040\050progress) 5 (i) -2 (on\040) ] TJ
0.0008 Tc
-0.0016 Tw
20.02 0 Td
[ (precedes\040death\051\040and\040req) 6 (u) 1 (ire\040a\040sm) 9 (aller\040sam) 9 (p) 1 (le\040) ] TJ
0.0002 Tc
-0.0002 Tw
-20.02 -1.725 Td
(size\040because\040the\040variation\040in\040progr) Tj
0.0008 Tc
-0.0026 Tw
13.695 0 Td
[ (e) 5 (s) 5 (sion\055f) 4 (r) -1 (ee\040su) 6 (r) 4 (v) 1 (ival\040is\040typ) 6 (i) 4 (cally\040lower\040than\040the\040va) 5 (riation\040in\040) ] TJ
0.0002 Tc
-0.0012 Tw
-13.695 -1.725 Td
(overall\040survival\056\040There\040is\040considerable\040deba) Tj
0.0001 Tc
-0.0009 Tw
17.44 0 Td
(te\040in\040the\040oncology\040community\040about\040whether\040) Tj
0.0002 Tc
-0.0002 Tw
-17.44 -1.725 Td
(progression\055free\040survival\040is\040a\040good\040proxy\040for\040overa) Tj
0.0004 Tc
-0.002 Tw
20.36 0 Td
(ll\040survival\056\040Our\040view\040) Tj
0 Tc
-0.0016 Tw
8.525 0 Td
(is\040that\040even\040if\040) Tj
-0.0001 Tc
0.0001 Tw
-28.885 -1.725 Td
(progression\055free\040survival\040benefits\040are\040only\040weakly\040) Tj
0.0009 Tc
-0.0042 Tw
20.325 0 Td
[ (corre) 5 (lated\040with\040overa) 5 (ll\040su) ] TJ
0.0001 Tc
-0.0001 Tw
10.19 0 Td
(rvival\040benefits\054\040data\040) Tj
0 Tc
0 Tw
-30.515 -1.725 Td
(on\040progression\055free\040survival\040benefits\040provide\040a\040us) Tj
0.0003 Tc
-0.0015 Tw
19.83 0 Td
(eful\040signal\040of\040product\040qua) Tj
-0.0004 Tw
10.275 0 Td
[ (lity\040to\040a\040m) 8 (a) -1 (nufacturer\040) ] TJ
-30.105 -1.725 Td
[ (who\040m) 8 (ust\040set\040a\040price\040for\040a\040new\040drug\040in\040the\040abse) ] TJ
-0.0002 Tc
0.0002 Tw
18.86 0 Td
[ (nce\040of\040infor) -7 (m) 8 (ation\040on\040ove) ] TJ
0.0013 Tc
-0.0038 Tw
10.375 0 Td
[ (r) 4 (all\040su) 6 (rviva) 5 (l) -1 (\040benef) 4 (its\040) ] TJ
0.0001 Tc
-0.0001 Tw
-29.235 -1.725 Td
(and\040to\040practicing\040physicians\040who\040) Tj
0.0008 Tc
-0.0028 Tw
13.42 0 Td
[ (m) 9 (u) -4 (st\040decide\040whether\040to\040use\040it\056) ] TJ
0.0001 Tc
-0.0001 Tw
11.945 0 Td
(\040In\040our\040data\054\040we\040observe\040both\040) Tj
0.0002 Tc
-0.0002 Tw
-25.365 -1.725 Td
(overall\040survival\040and\040progression) Tj
0.0006 Tc
-0.0012 Tw
12.86 0 Td
[ (\055free\040survival\040for\04020\040drugs\056\040The\040averag) 6 (e\040ab) 6 (solute\040d) 6 (i) -2 (fference\040) ] TJ
0.0001 Tc
-0.0001 Tw
-12.86 -1.725 Td
(between\040overall\040and\040progression\055fr) Tj
0.0007 Tc
-0.0032 Tw
13.97 0 Td
[ (ee\040surviva) 5 (l) -1 (\040is\040le) 5 (ss\040than\040one\040mont) ] TJ
0.0001 Tc
-0.0001 Tw
(h\040for\040five\040of\040these\040drugs\040and\040) Tj
0.0004 Tc
0 Tw
-13.97 -1.725 Td
[ (less\040than\040tw) 8 (o\040m) 8 (onths\040for\04013\040of\040the\040drugs\056\040\040\040\040) ] TJ
0.0002 Tc
-0.0008 Tw
3 -1.72 Td
(For\040the\04017\040drugs\040that\040were\040approved\040on\040th) Tj
-0.0002 Tc
-0.0014 Tw
16.775 0 Td
(e\040basis\040of\040single\055arm\040) Tj
0.0006 Tc
-0.0006 Tw
8.545 0 Td
(trials\054\040we\040obtained\040) Tj
0.0003 Tc
-0.0003 Tw
-28.32 -1.725 Td
[ (estim) 8 (ates\040of\040survival\040benefits\040from) 8 (\040post\055approval\040) ] TJ
0 Tc
-0.001 Tw
19.885 0 Td
(trials\040\050N\040\075\0406\051\040and\040cost\055e) Tj
0.001 Tc
9.535 0 Td
[ (f) 4 (f) 4 (ectivenes) 5 (s\040studie) 5 (s\040tha) 5 (t) -1 (\040) ] TJ
0.0003 Tc
-0.0003 Tw
-29.42 -1.725 Td
[ (use\040sim) 8 (ulation\040m) 8 (odels\040to\040project\040survival\040\050N\040) ] TJ
0.0009 Tc
-0.0009 Tw
18.025 0 Td
[ (\07511\051\056\040Cost\055ef) 4 (f) 4 (ectiven) 6 (ess\040s) 5 (t) -1 (u) 6 (d) 1 (ies\040typ) 6 (i) -1 (ca) 5 (lly\040report\040) ] TJ
0.0004 Tc
-0.0004 Tw
-18.025 -1.725 Td
[ (benefits\040in\040term) 8 (s\040of\040mean\040life\040) ] TJ
0.0002 Tc
-0.0002 Tw
11.995 0 Td
[ (expectancy\040or\040m) 8 (ean\040quality\055adjusted\040life\040years\056\040W) 9 (e) -1 (\040converted\040) ] TJ
0.0003 Tc
-0.0003 Tw
-11.995 -1.725 Td
[ (these\040quantities\040to\040m) 8 (e) -1 (dian\040survival\040gains\040assu) 6 (m) 8 (i) -2 (ng\040survival\040tim) 8 (e) -1 (\040is\040distributed\040exponentially\056) ] TJ
-0.0094 Tc
0 Tw
7.98 0 0 7.98 517.9199 259.1401 Tm
(\0405) Tj
0 Tc
12 0 0 12 523.86 253.6201 Tm
(\040\040) Tj
/C2_0 1 Tf
10.98 0 0 10.98 72 213.1801 Tm
[ <0003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003> 81 <0003000300030003000300030003000300030003000300030003000300030003000300030003> ] TJ
ET
72 215.22 144 0.72 re
f
BT
/C2_0 1 Tf
10.98 0 0 10.98 216 213.1801 Tm
<0003> Tj
/TT0 1 Tf
7.98 0 0 7.98 72 204.66 Tm
(3) Tj
0.0007 Tc
-0.0007 Tw
12 0 0 12 76.02 199.14 Tm
[ (\040Trials\040repo) 6 (rt\040m) 9 (edians\054\040because\040m) 9 (easurem) 9 (ent\040of\040) 1 (m) 9 (eans\040is\040possible\040on) 6 (ly\040after\040all\040patien) 6 (ts\040in\040th) 6 (e\040) ] TJ
0.001 Tc
-0.001 Tw
-0.335 -1.15 Td
[ (trial\040a) 5 (r) -1 (e\040dea) 5 (d\056\040Som) 9 (e\040tria) 5 (ls\040are\040no) 6 (t\040po) 6 (wered\040to\040) ] TJ
0.0004 Tc
-0.002 Tw
18.22 0 Td
[ (detect\040chang) 5 (e) -1 (s\040in\040overa) ] TJ
0.0012 Tc
-0.0024 Tw
9.35 0 Td
[ (ll\040su) 6 (rviva) 5 (l) -1 (\054\040but\040r) 4 (eport\040it\040) ] TJ
0 Tc
0 Tw
-27.57 -1.15 Td
(anyway\056\040) Tj
7.98 0 0 7.98 72 163.2601 Tm
(4) Tj
0.0007 Tc
-0.0007 Tw
12 0 0 12 76.02 157.7401 Tm
[ (\040Trials\040repo) 6 (rt\040m) 9 (edians\054\040because\040m) 9 (easurem) 9 (ent\040of\040) 1 (m) 9 (eans\040is\040possible\040on) 6 (ly\040after\040all\040patien) 6 (ts\040in\040th) 6 (e\040) ] TJ
0.001 Tc
-0.001 Tw
-0.335 -1.15 Td
[ (trial\040a) 5 (r) -1 (e\040dea) 5 (d\056\040Som) 9 (e\040tria) 5 (ls\040are\040no) 6 (t\040po) 6 (wered\040to\040) ] TJ
0.0004 Tc
-0.002 Tw
18.22 0 Td
[ (detect\040chang) 5 (e) -1 (s\040in\040overa) ] TJ
0.0012 Tc
-0.0024 Tw
9.35 0 Td
[ (ll\040su) 6 (rviva) 5 (l) -1 (\054\040but\040r) 4 (eport\040it\040) ] TJ
0 Tc
0 Tw
-27.57 -1.15 Td
(anyway\056\040) Tj
7.98 0 0 7.98 72 121.86 Tm
(5) Tj
0.0002 Tc
-0.0002 Tw
12 0 0 12 76.02 116.3401 Tm
[ (\040If\040we\040assume\040survival\040tim) 8 (e\040is\040distributed\040e) ] TJ
0.0001 Tc
-0.0017 Tw
17.165 0 Td
(xponentially\054\040it\040is\040possibl) Tj
0.0006 Tc
10.06 0 Td
[ (e\040to\040convert\040m) 8 (eans\040to\040) ] TJ
0.0003 Tc
-0.0003 Tw
-27.56 -1.15 Td
[ (m) 8 (e) -1 (dians\040without\040estim) 8 (a) -1 (ting\040ancillary\040shape\040para) ] TJ
-0.002 Tw
19.295 0 Td
[ (m) 8 (e) -1 (ters\056\040Median\040survival\040is\040equal\040to\040m) 8 (ean\040) ] TJ
0.0008 Tc
-19.295 -1.15 Td
[ (surviva) 5 (l) -1 (\040m) 9 (u) 1 (ltiplied\040by\040ln) 6 (\0502\051\056\040\040) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 457 8 re
S
0 1 1 RG
n
72 688 430 8 re
S
0 1 1 RG
n
72 667 429 8 re
S
0 1 1 RG
n
72 646 441 8 re
S
0 1 1 RG
n
71 626 459 8 re
S
0 1 1 RG
n
71 605 460 8 re
S
0 1 1 RG
n
72 584 431 8 re
S
0 1 1 RG
n
72 564 459 8 re
S
0 1 1 RG
n
72 543 447 8 re
S
0 1 1 RG
n
72 522 427 8 re
S
0 1 1 RG
n
72 501 414 8 re
S
0 1 1 RG
n
72 481 464 8 re
S
0 1 1 RG
n
71 460 469 8 re
S
0 1 1 RG
n
71 439 453 8 re
S
0 1 1 RG
n
71 419 448 8 re
S
0 1 1 RG
n
71 398 444 8 re
S
0 1 1 RG
n
71 377 462 8 re
S
0 1 1 RG
n
71 357 208 8 re
S
1 0 0 RG
n
107 336 395 8 re
S
0 1 1 RG
n
71 315 472 8 re
S
0 1 1 RG
n
71 295 450 8 re
S
0 1 1 RG
n
71 274 444 8 re
S
0 1 1 RG
n
71 253 458 8 re
S
0.9 0.9 0.9 RG
n
72 213 146 8 re
S
0.5 0.5 0.5 RG
n
72 204 458 8 re
S
0 1 0 RG
n
72 185 444 8 re
S
0 1 0 RG
n
71 171 43 8 re
S
0.5 0.5 0.5 RG
n
72 163 458 8 re
S
0 1 1 RG
n
72 143 444 8 re
S
0 1 0 RG
n
71 130 43 8 re
S
0.5 0.5 0.5 RG
n
72 121 436 8 re
S
0 1 0 RG
n
72 102 431 8 re
S
0 1 0 RG
n
72 88 141 8 re
S
Q

endstream
endobj
88 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
89 0 obj
<<
/Length 8199
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (12) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0005 Tc
-0.0005 Tw
12 0 0 12 108 708.96 Tm
[ (We\040calculated\040the\040\223ep) 6 (isode\040treatm) 8 (ent\040pri) ] TJ
0.0001 Tc
-0.0008 Tw
16.295 0 Td
[ (ce\224\040for\040each\040drug\054\040which\040equals\040each\040drug) 5 (\222s\040) ] TJ
0.0002 Tc
-0.0002 Tw
-19.295 -1.725 Td
[ (monthly\040cos) 4 (t) -2 (\040to\040th) 5 (e\040Med) 5 (i) -2 (care\040program\040in\0402013\040do) ] TJ
0.0004 Tc
-0.0004 Tw
19.88 0 Td
[ (llars\040\050see\040Bach\0402009\040for\040details\051\040m) 8 (ultiplied\040by\040) ] TJ
-19.88 -1.725 Td
[ (the\040typical\040duration\040of\040treatm) 8 (e) -1 (nt\040in\040months\056\040) ] TJ
0.0006 Tc
-0.0031 Tw
17.61 0 Td
(Medicare\040costs\040represent\040) Tj
0.0004 Tc
-0.0004 Tw
10.19 0 Td
[ (the\040actual\040dollar\040am) 8 (ounts\040) ] TJ
0.0013 Tc
-0.0025 Tw
-27.8 -1.725 Td
[ (Medica) 5 (re\054\040th) 6 (e\040larg) 6 (est\040pub) 6 (lic\040in) ] TJ
0.0002 Tc
-0.0002 Tw
12.195 0 Td
[ (surance\040program) 8 (\054\040pays\040for\040drugs\056\040In\040m) 8 (ost\040cases\040Medicare\040) ] TJ
0.0005 Tc
-0.0021 Tw
-12.195 -1.725 Td
[ (reim) 8 (bursements\040will\040be\040greater\040) ] TJ
-0.0002 Tc
-0.0014 Tw
12.665 0 Td
(than\040the\040prices\040hosp) Tj
0.0003 Tc
-0.0003 Tw
7.965 0 Td
[ (itals\054\040physicians\040and\040pharm) 8 (a) -1 (cies\040pay\040to\040) ] TJ
0.0001 Tc
0.0011 Tw
-20.63 -1.725 Td
[ (wholesalers\056\040W) 9 (e) -1 (\040do\040not\040believe) ] TJ
0.0005 Tc
-0.0015 Tw
[ (\040that\040rebates\040\226\040ref) 9 (unds\040from) ] TJ
-0.0002 Tc
0.0018 Tw
23.54 0 Td
(\040manufacturers\040to\040hospitals\054\040) Tj
0.0002 Tc
-0.001 Tw
-23.54 -1.725 Td
[ (physicians\054\040pharm) 8 (acies\040and\040third\040party\040insurers\040\226\040) ] TJ
0.0004 Tc
-0.0018 Tw
19.83 0 Td
[ (are\040large\040in\040the\040m) 8 (a) -1 (rket\040for\040new\040anticancer\040) ] TJ
0.0002 Tc
-0.0009 Tw
-19.83 -1.725 Td
[ (drugs\054\040but\040pricing\040is\040opaque\040and\040rebate\040arrangem) 8 (e) ] TJ
0.0005 Tc
-0.0021 Tw
19.995 0 Td
(nts\040are\040closely\040guarded\056\040) Tj
0.0002 Tc
-0.0002 Tw
9.69 0 Td
(Medicare\040has\040adjusted\040) Tj
0.0007 Tc
-0.0007 Tw
-29.685 -1.725 Td
[ (its\040paym) 9 (ent\040for) -6 (m) 9 (ulae\040over\040tim) 9 (e\040to\040better\040align\040) ] TJ
0.0003 Tc
-0.0003 Tw
18.61 0 Td
[ (reimbursem) 8 (e) -1 (nt) -7 (\040and\040wholesale\040prices\056\040F) 7 (or\040this\040) ] TJ
-0.0023 Tw
-18.61 -1.725 Td
[ (reason\054\040our\040price\040series\040m) 8 (a) -1 (y\040understa) ] TJ
-0.0001 Tc
0.0001 Tw
14.83 0 Td
(te\040increases\040in\040providers\222\040acquisi) Tj
-0.0011 Tw
13.11 0 Td
(tion\040prices\056\040As\040we\040describe\040) Tj
0.0002 Tc
-0.0018 Tw
-27.94 -1.725 Td
(below\054\040drug\040acquisition\040costs\040vary\040between\040pr) Tj
0.0004 Tc
-0.0004 Tw
18.355 0 Td
[ (oviders\040and\040pharm) 8 (acies\054\040and\040Medicare\040paym) 8 (ent\040) ] TJ
0.0007 Tc
-0.0021 Tw
-18.355 -1.725 Td
[ (rates\040do\040no) 6 (t\040account\040for\040differences\040in\040acquis) 5 (itio) ] TJ
0.0005 Tc
-0.0013 Tw
19.3 0 Td
[ (n\040costs\040acros) 5 (s\040various\040categories\040of\040b) 6 (uyers\056) 6 (\040) ] TJ
0.0003 Tc
-0.0003 Tw
-16.3 -1.725 Td
[ (Our\040approach\040accounts\040f) 8 (or\040differences\040in\040the\040) 5 (duration\040of\040treatm) 8 (e) -1 (nt\040across\040drugs\040and\040is\040) ] TJ
0.0006 Tw
-3 -1.725 Td
[ (consistent\040w) 8 (ith\040the\040notion\040of\040m) ] TJ
0.0008 Tc
-0.0018 Tw
12.41 0 Td
[ (easuring\040the\040price\040of\040a\040treatm) 9 (ent\040) ] TJ
-0.0001 Tc
-0.0011 Tw
(episode\054\040as\040advocated\040by\040Berndt\040) Tj
0.0004 Tc
-0.002 Tw
-12.41 -1.725 Td
(et\040al\056\040\0502000\051\040and\040Busch\040et\040al) Tj
-0.0024 Tw
11.255 0 Td
(\056\040\0502001\051\056\040However\054\040a\040drug\222s\040trea) Tj
-0.0004 Tw
12.825 0 Td
[ (tm) 8 (ent\040episode\040price\040is\040not\040a\040) ] TJ
0.0007 Tc
-0.0007 Tw
-24.08 -1.725 Td
[ (com) 9 (p) 1 (rehensive\040m) 9 (easure\040of\040the\040im) 9 (pac) -5 (t) -1 (\040of\040that\040dr) ] TJ
0.0005 Tc
-0.001 Tw
19.085 0 Td
[ (ug\040on\040health\040care\040costs\056\040T) 6 (h) 1 (e\040im) 8 (pact\040of\040a\040drug\040on\040) ] TJ
0.0008 Tc
-0.002 Tw
-19.085 -1.725 Td
[ (tota) 5 (l\040costs\040d) 6 (epends\040on\040whether\040it\040is\040a) 5 (\040substitute) ] TJ
0.001 Tc
-0.001 Tw
18.78 0 Td
[ (\040o) 6 (r) -1 (\040com) 9 (p) 1 (lem) 9 (e) -5 (nt\040to\040ex) 6 (istin) 6 (g) 1 (\040trea) 5 (tm) 9 (ents\040and\040) ] TJ
0.0008 Tc
-0.0015 Tw
-18.78 -1.725 Td
[ (whether\040it\040in) 6 (creas) 5 (es\040or\040d) 6 (ecreases\040th) 6 (e\040inciden) 6 (ce\040of\040) ] TJ
0.0003 Tc
-0.0003 Tw
19.99 0 Td
[ (side\040effects\054\040som) 8 (e) -1 (\040of\040which\040can\040be\040quite\040costly\040) ] TJ
0.0011 Tc
-0.0036 Tw
-19.99 -1.72 Td
[ (to\040tr) 4 (eat\056\040\040) ] TJ
0 Tc
0 Tw
0 -1.725 TD
(\040) Tj
/TT1 1 Tf
0.0004 Tc
-0.0004 Tw
0 -1.73 TD
[ (Prices\040vs\056\040S) 5 (urviva) 5 (l) -2 (\040Bene) 4 (fits\040Ov) 4 (er\040Time\040) ] TJ
0 Tc
0 Tw
0 -1.725 TD
(\040) Tj
/TT0 1 Tf
0.0005 Tc
-0.0005 Tw
3 -1.72 Td
[ (Figure\0401\040plots\040treatm) 8 (e) -1 (nt\040episode\040prices\040in) ] TJ
0.0003 Tc
-0.0003 Tw
16.56 0 Td
[ (\0402013\040dollars\040against\040increm) 8 (ental\040survival\040) ] TJ
-0.001 Tw
-19.56 -1.725 Td
(benefits\054\040both\040on\040the\040natural\040log\040scale\056\040The\040) Tj
-0.0009 Tw
17.275 0 Td
(average\040drug\040price\040is\040\04465\054900\040\050in\0402013\040dollars\051\040and\040) Tj
-0.0011 Tw
-17.275 -1.725 Td
(the\040average\040survival\040benefit\040is\0400\05646\040years\056\040The\040) Tj
0.0002 Tc
-0.0027 Tw
18.665 0 Td
[ (m) 8 (a) -1 (rkers\040identify\040drugs\040) ] TJ
-0.0002 Tw
9.295 0 Td
(based\040on\040the\040source\040of\040) Tj
0.0011 Tc
-0.0011 Tw
-27.96 -1.725 Td
[ (surviva) 5 (l) -1 (\040ben) 6 (ef) 4 (it\040data) 5 (\072\040ov) 6 (erall\040surv) 6 (iva) 5 (l) -1 (\040f) 4 (r) -1 (om) 9 (\040a\040ra) ] TJ
0 Tc
0 Tw
18.85 0 Td
[ (ndom) 8 (i) -2 (zed\040trial\054\040progression) ] TJ
0.0005 Tc
-0.0005 Tw
10.97 0 Td
[ (\055free\040surv) 6 (ival\040from) 8 (\040a\040) ] TJ
0.0006 Tc
-0.0006 Tw
-29.82 -1.725 Td
[ (random) 8 (ized\040trial\054\040and\040ov) 6 (erall\040surv) 6 (ival\040from) 8 (\040) ] TJ
-0.0012 Tw
17.46 0 Td
[ (a\040modeling\040s) 5 (t) -2 (udy) 6 (\056\040There\040is\040a\040positiv) 6 (e\040correlation\054\0400\0569\054\040) ] TJ
-0.0006 Tw
-17.46 -1.725 Td
[ (between\040treatm) 8 (ent\040episode\040prices\040an) ] TJ
0.0012 Tc
-0.0012 Tw
14.495 0 Td
[ (d\040increm) 9 (ental\040surv) 6 (ival\040b) 6 (enef) 4 (its\056) 6 (\040) ] TJ
0.0002 Tc
-0.0002 Tw
-11.495 -1.725 Td
(A\040regression\040of\040the\040natural\040l) Tj
0.0005 Tc
-0.0005 Tw
11.195 0 Td
[ (ogarithm) 8 (\040of\040prices\040on\040increm) 8 (enta) ] TJ
0.0009 Tc
-0.0021 Tw
13.27 0 Td
[ (l\040lif) 4 (e\040year) 4 (s\040ga) 5 (ined\040ind) 6 (i) -1 (cates\040) ] TJ
0.0001 Tc
-0.0001 Tw
-27.465 -1.725 Td
(that\040prices\040increase\040by\040120\040percent\040\050with\040a\04095\040pe) Tj
0.0004 Tc
-0.0029 Tw
19.35 0 Td
(rcent\040confidence\040interval) Tj
-0.0001 Tc
0.0001 Tw
(\040ranging\040from\04074\040to\040166\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
1 0 0 RG
n
108 708 409 8 re
S
0 1 1 RG
n
72 688 461 8 re
S
0 1 1 RG
n
72 667 457 8 re
S
0 1 1 RG
n
72 646 423 8 re
S
0 1 1 RG
n
72 626 437 8 re
S
0 1 1 RG
n
72 605 418 8 re
S
0 1 1 RG
n
72 584 440 8 re
S
0 1 1 RG
n
72 564 466 8 re
S
0 1 1 RG
n
72 543 444 8 re
S
0 1 1 RG
n
72 522 468 8 re
S
0 1 1 RG
n
72 501 452 8 re
S
0 1 1 RG
n
72 481 441 8 re
S
1 0 0 RG
n
108 460 415 8 re
S
0 1 1 RG
n
72 439 464 8 re
S
0 1 1 RG
n
72 419 423 8 re
S
0 1 1 RG
n
72 398 463 8 re
S
0 1 1 RG
n
72 377 430 8 re
S
0 1 1 RG
n
72 357 466 8 re
S
0 1 1 RG
n
72 336 43 8 re
S
0.9 0.9 0.9 RG
n
72 315 3 8 re
S
0 0 1 RG
n
72 294 188 8 re
S
0.9 0.9 0.9 RG
n
72 274 3 8 re
S
1 0 0 RG
n
108 253 402 8 re
S
0 1 1 RG
n
72 232 456 8 re
S
0 1 1 RG
n
72 212 445 8 re
S
0 1 1 RG
n
72 191 459 8 re
S
0 1 1 RG
n
72 170 468 8 re
S
0 1 1 RG
n
72 150 327 8 re
S
1 0 0 RG
n
108 129 427 8 re
S
0 1 1 RG
n
72 108 469 8 re
S
Q

endstream
endobj
90 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
91 0 obj
<<
/Length 8275
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (13) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0008 Tc
-0.0022 Tw
12 0 0 12 72 708.96 Tm
[ (percen) 6 (t\051\040for\040each\040additio) 6 (nal\040life\040year\040gained\040\050o) ] TJ
0.0009 Tc
-0.0015 Tw
18.575 0 Td
[ (r\0401) 6 (4) 1 (\045\040per\040m) 9 (o) 1 (nth\040gained) 6 (\051\056\040The\040effect\040in\040dollar\040) ] TJ
0.0004 Tc
-0.001 Tw
-18.575 -1.725 Td
[ (term) 8 (s\040is\040\04475\054000\040per\040year\040gained\040\050with\040a\04095\040) ] TJ
0.0007 Tw
17.61 0 Td
[ (percent\040confidence\040interval\040from) 8 (\040\04412\054000\040to\040) ] TJ
0.0002 Tc
0 Tw
-17.61 -1.725 Td
(\044137\054000\051\056\040) Tj
0.0007 Tc
-0.0014 Tw
3 -1.725 Td
[ (Newer\040drugs\040are\040not\040ass) 5 (o) 1 (ciated\040with) 6 (\040greater\040su) ] TJ
0.0001 Tc
-0.0001 Tw
18.69 0 Td
[ (rvival\040benefits\040com) 8 (pared\040to\040older\040drugs\056\040A\040) ] TJ
-0.0008 Tw
-21.69 -1.725 Td
[ (regression\040w) 7 (ith\040life\040years\040gained\040as\040the\040depe) ] TJ
-0.0001 Tc
-0.0015 Tw
17.69 0 Td
(ndent\040variable\040and\040year) Tj
0.0001 Tc
-0.0013 Tw
9.36 0 Td
(\040of\040approval\040as\040the\040) Tj
0.0004 Tc
-27.05 -1.725 Td
[ (explanatory\040variable\040yields\040a\040sm) 8 (all\040and\040insignifi) ] TJ
0.0002 Tc
-0.0002 Tw
19.22 0 Td
(cant\040coefficient\040\0500\056005\040years\040of\040life\040gained\054\040with\040) Tj
-0.0001 Tc
-0.0009 Tw
-19.22 -1.725 Td
(a\04095\040percent\040confidence\040interval\040from) Tj
0.0003 Tc
-0.001 Tw
(\040\0550\056024\040to\0400\056034\040years\040of\040life\040gained\051\056\040) Tj
0.0006 Tc
-0.0006 Tw
3 -1.725 Td
[ (Prices\040hav) 6 (e) -1 (\040increas) 5 (ed\040ov) 6 (er\040tim) 8 (e) -1 (\056\040A\040regre) ] TJ
0.0005 Tc
-0.0005 Tw
16.19 0 Td
[ (ssion\040of\040the\040natural\040logarithm) 8 (\040of\040price\040on\040) ] TJ
0.0008 Tc
-0.0018 Tw
-19.19 -1.725 Td
[ (approval\040y) 6 (e) 5 (ar\040ind) 6 (i) -1 (cates\040that\040prices\040in) 6 (creas) 5 (ed) ] TJ
0 Tc
0 Tw
17.685 0 Td
(\040by\04012\040percent\040per\040y) Tj
0.0006 Tc
-0.0031 Tw
7.965 0 Td
[ (ear\040\050with\040a\04095\040percen) 6 (t\040) ] TJ
0.0003 Tc
-0.0009 Tw
-25.65 -1.725 Td
(confidence\040interval\040from\0407\040to\04017\040percent\051\056\040The\040re) Tj
0.0005 Tc
-0.0035 Tw
19.525 0 Td
(sult\040is\040robust\040to\040the\040incl) Tj
0.0001 Tc
-0.0001 Tw
9.36 0 Td
(usion\040of\040a\040control\040for\040) Tj
0.0002 Tc
-0.0027 Tw
-28.885 -1.725 Td
(survival\040benefits\056\040\040) Tj
0.0007 Tc
-0.0012 Tw
3 -1.725 Td
[ (For\040the\040rem) 9 (ainder\040of\040the\040paper\040we\040focus\040on\040tren) ] TJ
0.0001 Tc
-0.0001 Tw
19.085 0 Td
(ds\040in\040the\040price\040per\040life\040year\040gained\054\040which\040) Tj
0.0002 Tc
-0.0008 Tw
-22.085 -1.725 Td
[ (equals\040the\040price\040per\040treatm) 8 (e) -1 (nt\040episode\040\050in\0402013\040do) ] TJ
0.0003 Tc
-0.0011 Tw
19.995 0 Td
(llars\051\040divided\040by\040survival\040benefits\056\040The\040price\040) Tj
-19.995 -1.725 Td
(per\040life\040year\040gained\040can\040be\040t) Tj
0 Tc
-0.0012 Tw
11.11 0 Td
(hought\040of\040as\040a\040\223benefit\055adjusted\224\040) Tj
0.0002 Tc
-0.0014 Tw
13.465 0 Td
(price\056\040The\040sample\040average\040is\040) Tj
-0.0002 Tw
-24.575 -1.725 Td
(\044150\054100\040per\040year\040of\040life\040gained\040\050with\040a\040standard) Tj
-0.0014 Tw
19.525 0 Td
(\040deviation\040of\040\044130\054500\051\056\040This\040value\040is\040in\040the\040) Tj
0.0004 Tc
-0.0004 Tw
-19.525 -1.725 Td
[ (range\040of\040estim) 8 (ates\040of\040the\040willingn) 5 (ess) 5 (\055) -2 (to\055pay\040for\040) ] TJ
0.0001 Tc
-0.0008 Tw
19.185 0 Td
[ (a\040quality\055ad) 5 (j) -2 (u) 5 (s) -1 (ted\040life\040year\040\050Hirth\040et\040al\056\0402000\051\056\040) ] TJ
0.0007 Tc
-0.0015 Tw
-19.185 -1.725 Td
(Figure\0402\040plots\040drugs\222\040price\040per\040lif) Tj
-0.0006 Tw
13.28 0 Td
[ (e\040y) 6 (ear\040gained\040against\040d) 6 (r) -1 (ugs) 5 (\222\040a) ] TJ
0.0001 Tc
-0.0001 Tw
11.91 0 Td
(pproval\040date\056\040There\040is\040an\040upward\040) Tj
0.0003 Tc
-0.0003 Tw
-25.19 -1.725 Td
(trend\056\040A\040regression\040of\040the\040price\040per\040) Tj
0.0001 Tc
-0.0001 Tw
14.22 0 Td
(life\040year\040gained\040on\040approval\040ye) Tj
-0.0013 Tw
12.415 0 Td
(ar\040indicates\040that\040benefit\055\040and\040) Tj
-0.0001 Tw
-26.635 -1.72 Td
(inflation\055adjusted\040launch\040prices) Tj
-0.0003 Tc
-0.0004 Tw
12.615 0 Td
(\040increased\040by\040\0448\054500\040\050with\040a\04095\040pe) Tj
0.0003 Tc
13.765 0 Td
[ (rcent\040confidence\040interval\040from) 8 (\040) ] TJ
-26.38 -1.725 Td
(\0442\054900\040to\040\04414\054100\051\040per\040year\056) Tj
0 Tc
0 Tw
7.98 0 0 7.98 208.32 321.24 Tm
(6) Tj
0.0006 Tc
-0.0013 Tw
12 0 0 12 212.34 315.72 Tm
(\040The\040intercept\040\0501995\040is\040zero\040on\040th) Tj
0.0001 Tc
-0.0001 Tw
13.305 0 Td
(e\040x\055axis\051\040is\040\04454\054100\040\05095\040percent\040) Tj
0.0004 Tc
-0.002 Tw
-25 -1.725 Td
(confidence\040interval\072\040\055\04416\054700\040to) Tj
-0.0013 Tw
12.83 0 Td
(\040\044124\054900\051\056\040Put\040another\040way\054\040in\0401995\040patients\040and\040their\040insurers\040) Tj
-0.0008 Tw
-12.83 -1.725 Td
[ (paid\040\04454\05410) 5 (0\040for\040a\040year\040of\040life\056\040A\040decade\040later\054\040) ] TJ
0.0002 Tc
-0.0002 Tw
18.745 0 Td
[ (2) 5 (005\054\040they\040paid\040\044139\054100\040for\040the\040sam) 8 (e) -1 (\040benefit\056\040By\040) ] TJ
-0.0001 Tc
0.0001 Tw
-18.745 -1.725 Td
(2013\054\040they\040paid\040\044207\054000\056\040) Tj
0.0002 Tc
-0.0007 Tw
3 -1.725 Td
(Figure\0403\040shows\040trends\040in\040the\040price\040per\040life\040year) Tj
-0.0002 Tc
-0.0014 Tw
18.64 0 Td
(\040classified\040by\040different) Tj
0.0001 Tc
-0.0001 Tw
8.965 0 Td
(\040types\040of\040anticancer\040) Tj
0 Tc
0 Tw
-30.605 -1.725 Td
(drugs\056\040Upward\040trends\040are\040appare) Tj
0.0002 Tc
-0.0002 Tw
13.025 0 Td
[ (nt\040for\040m) 8 (ost\040disease\040types\056\040\040) ] TJ
/TT1 1 Tf
0 Tc
0 Tw
-13.025 -1.73 Td
(\040) Tj
11.75 Tc
0 -1.725 TD
(\040\040) Tj
/C2_0 1 Tf
0 Tc
10.98 0 0 10.98 72 130.38 Tm
[ <0003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003> 81 <0003000300030003000300030003000300030003000300030003000300030003000300030003> ] TJ
ET
72 132.42 144 0.72 re
f
BT
/C2_0 1 Tf
10.98 0 0 10.98 216 130.38 Tm
<0003> Tj
/TT0 1 Tf
7.98 0 0 7.98 72 121.86 Tm
(6) Tj
0.0005 Tc
-0.0005 Tw
12 0 0 12 76.02 116.3401 Tm
[ (\040The\040m) 8 (a) -1 (rginal\040effect\040from\040a\040generalized\040lin) 6 (ear) ] TJ
0.0004 Tc
-0.0015 Tw
18.41 0 Td
[ (\040m) 8 (odel\040with\040a\040log\040link\040and\040a\040gamm) 8 (a\040va) -6 (riance\040) ] TJ
-0.0013 Tw
-18.745 -1.15 Td
(function\040is\040\0448\054500\040\05095\040percent\040c) Tj
0.0002 Tc
12.72 0 Td
(onfidence\040interval\072\040\0441\054800\040to\040\04415\054300\051\056\040) Tj
0.0003 Tc
-0.0003 Tw
15.89 0 Td
(Details\040of\040this\040approach\040) Tj
-0.0001 Tc
0.0001 Tw
-28.61 -1.15 Td
(are\040available\040in\040the\040appendix\040to\040be\040availabl) Tj
0.0001 Tc
-0.0011 Tw
17.135 0 Td
(e\040with\040this\040paper\040at\040http\072\057\057www\056e\055jep\056org\076\056\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 443 8 re
S
0 1 1 RG
n
72 688 425 8 re
S
0 1 1 RG
n
72 667 55 8 re
S
1 0 0 RG
n
108 646 431 8 re
S
0 1 1 RG
n
72 626 416 8 re
S
0 1 1 RG
n
72 605 464 8 re
S
0 1 1 RG
n
72 584 362 8 re
S
1 0 0 RG
n
108 564 393 8 re
S
0 1 1 RG
n
72 543 415 8 re
S
0 1 1 RG
n
72 522 450 8 re
S
0 1 1 RG
n
71 501 89 8 re
S
1 0 0 RG
n
107 481 432 8 re
S
0 1 1 RG
n
72 460 455 8 re
S
0 1 1 RG
n
72 439 434 8 re
S
0 1 1 RG
n
72 419 447 8 re
S
0 1 1 RG
n
71 398 455 8 re
S
0 1 1 RG
n
71 377 464 8 re
S
0 1 1 RG
n
71 357 460 8 re
S
0 1 1 RG
n
71 336 466 8 re
S
0 1 1 RG
n
71 315 456 8 re
S
0 1 1 RG
n
72 295 461 8 re
S
0 1 1 RG
n
72 274 468 8 re
S
0 1 1 RG
n
72 253 128 8 re
S
1 0 0 RG
n
108 232 428 8 re
S
0 1 1 RG
n
72 212 284 8 re
S
0.9 0.9 0.9 RG
n
72 191 3 8 re
S
0.9 0.9 0.9 RG
n
72 170 288 8 re
S
0.9 0.9 0.9 RG
n
72 130 146 8 re
S
0.5 0.5 0.5 RG
n
72 121 443 8 re
S
0 1 0 RG
n
72 102 460 8 re
S
0 1 0 RG
n
72 88 413 8 re
S
Q

endstream
endobj
92 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
93 0 obj
<<
/Length 8441
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (14) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT1 1 Tf
0.0001 Tc
-0.0001 Tw
12 0 0 12 72 708.9 Tm
(Price\040Per\040Life\055Year\040Gained\040and\040Drug\040Attributes\040) Tj
0 Tc
0 Tw
0 -1.725 TD
(\040) Tj
/TT0 1 Tf
0.0005 Tc
-0.0013 Tw
3 -1.72 Td
[ (We\040used\040least\040squares\040regression\040to\040determ) 8 (in) ] TJ
0.0007 Tc
-0.0007 Tw
17.995 0 Td
[ (e\040if) 4 (\040the\040relation) 6 (s) 5 (hip\040) ] TJ
0.0001 Tc
-0.0017 Tw
7.995 0 Td
(between\040the\040price\040per\040) Tj
-0.0001 Tw
-28.99 -1.725 Td
(life\040year\040gained\040\050in\0402013\040dollars\051\040and\040approval\040year\040) Tj
0.0004 Tc
-0.0016 Tw
20.8 0 Td
(is\040robust\040to\040the\040inclusion\040of\040controls\040for\040other\040) Tj
0.0007 Tc
-0.0007 Tw
-20.8 -1.725 Td
[ (drug\040attribu) 6 (t) 4 (es\056\040Table\0401\040p) 6 (r) -1 (esents\040reg) 6 (r) -1 (ession\040es) 5 (tim) 9 (ates\040\050s) 5 (am) 9 (ple\040m) 9 (eans\040and\040other\040summ) 9 (ary\040) ] TJ
-0.0022 Tw
T*
[ (statistics\040for\040the\040drug\040attributes\040are\040p) 6 (r) 4 (esente) ] TJ
0.0002 Tc
-0.0027 Tw
17.44 0 Td
(d\040in\040the\040appendix\054\040availa) Tj
0.0004 Tc
-0.0004 Tw
9.8 0 Td
[ (ble\040upon\040request\040from) 8 (\040the\040) ] TJ
0.0012 Tc
-0.0006 Tw
-27.24 -1.725 Td
[ (lead\040au) 6 (thor\051\056) 6 (\040\040W) 10 (e\040used\040the\040natur) 4 (al\040log) 6 (arithm) 9 (\040of) 4 (\040) ] TJ
0.0006 Tc
-0.0018 Tw
18.995 0 Td
(the\040price\040per\040life\040year\040) Tj
0.0001 Tc
-0.0001 Tw
8.805 0 Td
(gained\040as\040the\040dependent\040) Tj
0.0002 Tc
-0.0002 Tw
-27.8 -1.725 Td
(variable\040because\040the\040price\040per\040life\040year\040gained\040) Tj
0.0008 Tc
-0.0015 Tw
18.605 0 Td
[ (is\040skewed\056\040Results\040a) 5 (r) -1 (e\040qua) 5 (lita) 5 (tive) 5 (l) -1 (y\040sim) 9 (ila) 5 (r\040if) 4 (\040we\040) ] TJ
0.0007 Tc
-0.0007 Tw
-18.605 -1.725 Td
[ (use\040untran) 6 (sform) 9 (ed\040prices\040as\040the\040dep) 6 (e) 5 (ndent\040variab) ] TJ
-0.0012 Tw
19.715 0 Td
[ (le\056\040Because\040of\040the\040m) 8 (odest\040sam) 8 (p) 1 (le\040size\054\040we\040did\040) ] TJ
0.0013 Tc
-19.715 -1.725 Td
[ (not\040attem) 9 (p) 1 (t\040to\040contro) 6 (l\040f) 4 (o) 1 (r\040all\040) ] TJ
0.0001 Tc
-0.0017 Tw
11.56 0 Td
[ (drug\040attributes\040sim) 8 (ultaneously\056\040\040) ] TJ
0.0005 Tc
-0.0005 Tw
-8.56 -1.725 Td
[ (The\040m) 8 (odel\040in\040Colum) 8 (n) 1 (\040A\054\040the\040baseline\040specifica) ] TJ
-0.0001 Tc
0.0001 Tw
18.83 0 Td
(tion\054\040indicates\040that\040benefit\055\040and\040inflation\055) Tj
0.0002 Tc
-0.0002 Tw
-21.83 -1.725 Td
(adjusted\040launch\040prices\040increased) Tj
0.0003 Tc
-0.001 Tw
12.915 0 Td
(\04010\040percent\040per\040year\040over\040the\040st) Tj
0.0002 Tc
0.0008 Tw
12.355 0 Td
[ (udy\040period\056\040The\040m) 8 (odel\040in\040Colum) 8 (n\040) ] TJ
0.0011 Tc
-0.0011 Tw
-25.27 -1.725 Td
[ (B\040adds\040contr) 4 (o) 1 (ls\040f) 4 (o) 1 (r\040the\040g) 6 (astro) 6 (inte) 5 (stin) 6 (al\040com) 9 (p) 1 (licat) ] TJ
0.0003 Tc
-0.0013 Tw
19.665 0 Td
(ion\040and\040neutropenia\040rates\056\040The\040gastrointestinal\040) Tj
0.0006 Tc
-0.0031 Tw
-19.665 -1.725 Td
[ (com) 8 (p) 1 (lication\040rate\040is\040the\040aver) ] TJ
0.0001 Tc
-0.0001 Tw
11.33 0 Td
[ (age\040of\040the\040nausea\054\040vom) 8 (iting\054\040and\040diarrhea\040rates\040experienced\040by\040) ] TJ
-11.33 -1.725 Td
(patients\040on\040the\040drug\056\040The\040neutrope) Tj
-0.0003 Tc
-0.0007 Tw
13.725 0 Td
(nia\040rate\040is\040the\040proportion\040of) Tj
0.0001 Tc
-0.0013 Tw
10.905 0 Td
(\040patients\040who\040experience\040high\055) Tj
-0.0008 Tw
-24.63 -1.725 Td
(grade\040neutropenia\054\040a\040deficit\040of\040white\040blood\040cells\040) Tj
0.0005 Tw
19.355 0 Td
[ (which\040puts\040patients\040at\040risk\040of\040infection\056\040W) 9 (e) -1 (\040set\040) ] TJ
0.0004 Tc
-0.0004 Tw
-19.355 -1.725 Td
[ (m) 8 (i) -2 (ssing\040values\040to\040\2230\224\056\040D) 8 (a) -1 (ta\040on\040the\040side\040effects\040) ] TJ
0.0012 Tc
-0.0012 Tw
18.72 0 Td
[ (ex) 6 (perien) 6 (ced\040b) 6 (y) 1 (\040patien) 6 (t) -1 (s\040in) ] TJ
0.0005 Tc
-0.0017 Tw
10.465 0 Td
[ (\040the\040control\040arm) 8 (s\040of\040) ] TJ
0.001 Tc
-29.185 -1.725 Td
[ (trials\040a) 5 (r) -1 (e\040in) 6 (c) 5 (onsisten) 6 (tly\040r) 4 (eported\056\040W) 10 (e\040contro) 6 (lled\040f) 9 (o) 1 (r\040absolu) 6 (te\040r) 4 (ather\040than\040r) 4 (e) 5 (lative\040sid) 6 (e\040ef) 4 (f) 4 (ect\040rates\054\040) ] TJ
0.0003 Tc
0.0003 Tw
0 -1.72 TD
[ (which\040m) 8 (a) -1 (y\040be\040why\040the\040coefficient\040on\040the\040gastroin) ] TJ
-0.0029 Tw
19.77 0 Td
(testinal\040complication\040rate\040is\040\223wrong\040signed\056\224\040In\040) Tj
0.0008 Tc
-0.0016 Tw
-19.77 -1.725 Td
[ (general\054\040side\040effect\040rates\040are\040sim) 9 (ilar\040f) 9 (o) 1 (r\040) ] TJ
0 Tc
0 Tw
15.885 0 Td
(newer\040and\040older\040drugs\040\050Niraula\040et\040al\056\0402012\051\056\040) Tj
/TT1 1 Tf
-12.885 -1.725 Td
(\040) Tj
/TT0 1 Tf
0.0006 Tc
-0.0006 Tw
[ (The\040m) 8 (odel\040in\040Colum) 8 (n) 1 (\040C\040includes\040a\040control\040fo) ] TJ
0.0004 Tc
-0.0016 Tw
18.415 0 Td
[ (r\040adm) 8 (i) -2 (nistration\040route\072\040intravenous\040versus\040) ] TJ
0.0001 Tc
-0.0001 Tw
-21.415 -1.725 Td
[ (oral\056\040Oral\040drugs\040are\040m) 8 (ore\040convenient\040for\040patient) ] TJ
0.0004 Tc
-0.0029 Tw
19.105 0 Td
[ (s\040than\040physician\055adm) 8 (i) -2 (nist) ] TJ
0.0001 Tc
-0.0001 Tw
10.215 0 Td
(ered\040intravenous\040drugs\054\040) Tj
0.0009 Tc
-0.0012 Tw
-29.32 -1.725 Td
[ (but\040patients) 5 (\222) 4 (\040out\055of) 4 (\055) -1 (pock) 6 (et\040cos) 5 (t) -1 (s\040ar) 4 (e\040typically\040hig) 6 (h) 1 (er\040f) 4 (o) 1 (r\040ora) 5 (l) -1 (\040drugs\056\040The\040p) 6 (o) 1 (sitiv) 6 (e\040coef) 4 (f) 4 (i) -1 (cien) 6 (t\040on\040) ] TJ
0.0008 Tc
-0.0008 Tw
0 -1.725 TD
[ (the\040in) 6 (traven) 6 (ous\040adm) 9 (i) -1 (nistrati) ] TJ
0.0002 Tc
-0.0027 Tw
11.17 0 Td
(on\040route\040is\040insignificant\056\040\040) Tj
0.0006 Tc
-0.0013 Tw
-8.17 -1.725 Td
[ (The\040m) 8 (odel\040in\040Colum) 8 (n) 1 (\040D\040explores\040the\040hypothesis\040) ] TJ
-0.0001 Tc
0.0001 Tw
19.665 0 Td
(that\040increases\040in\040prices\040reflect\040increased\040) Tj
0 Tc
0 Tw
-22.665 -1.725 Td
[ (production\040costs\056\040W) 9 (e) -1 (\040test\040this\040hypothesis\040indi) ] TJ
0.0006 Tc
-0.0022 Tw
18.135 0 Td
[ (rectly\040by\040exam) 8 (ining\040the\040link\040between\040several\040) ] TJ
0.0002 Tc
-0.0002 Tw
-18.135 -1.725 Td
(proxies\040for\040production\040costs\040and\040pr) Tj
0.0006 Tc
-0.0018 Tw
13.97 0 Td
(ices\056\040Biologic\040drugs\040are\040typically) Tj
0.0003 Tc
-0.0028 Tw
13.2 0 Td
[ (\040m) 8 (ore\040expensive\040to\040develop\040) ] TJ
0.0008 Tc
-0.0011 Tw
-27.17 -1.725 Td
[ (and\040produce\040than\040traditio) 6 (nal\040anticancer\040drugs\056\040M) 5 (u) 1 (ltip) 6 (roduct\040f) 9 (i) -1 (rm) 9 (s\040\226\040fir) -6 (m) 9 (s\040that\040s) 5 (ell\040two\040or\040m) 9 (o) 1 (re\040) ] TJ
0.0006 Tc
-0.0012 Tw
T*
[ (anticancer\040d) 6 (r) -1 (ugs\040\226\040are\040able\040to\040sp) 6 (read) 6 (\040the\040fixed\040) ] TJ
0.0001 Tc
-0.0001 Tw
[ (costs\040associated\040with\040m) 8 (a) -1 (rketing\040oncology\040drugs\040) ] TJ
0.0002 Tc
-0.0002 Tw
T*
[ (across\040products\040and\040m) 8 (a) -1 (y\040have\040equipm) 8 (ent\040that\040can\040) ] TJ
-0.0009 Tw
[ (be\040used\040to\040m) 8 (a) -1 (nufacture\040two\040or\040m) 8 (or) -7 (e) -1 (\040products\056\040) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 236 8 re
S
0.9 0.9 0.9 RG
n
72 688 3 8 re
S
1 0 0 RG
n
108 667 417 8 re
S
0 1 1 RG
n
72 646 469 8 re
S
0 1 1 RG
n
72 626 427 8 re
S
0 1 1 RG
n
72 605 452 8 re
S
0 1 1 RG
n
72 584 451 8 re
S
0 1 1 RG
n
72 564 459 8 re
S
0 1 1 RG
n
72 543 459 8 re
S
0 1 1 RG
n
72 522 292 8 re
S
1 0 0 RG
n
108 501 422 8 re
S
0 1 1 RG
n
72 481 469 8 re
S
0 1 1 RG
n
72 460 460 8 re
S
0 1 1 RG
n
72 439 438 8 re
S
0 1 1 RG
n
72 419 442 8 re
S
0 1 1 RG
n
72 398 458 8 re
S
0 1 1 RG
n
72 377 447 8 re
S
0 1 1 RG
n
72 357 466 8 re
S
0 1 1 RG
n
72 336 467 8 re
S
0 1 1 RG
n
72 315 403 8 re
S
0 1 1 RG
n
111 295 420 8 re
S
0 1 1 RG
n
72 274 466 8 re
S
0 1 1 RG
n
71 253 458 8 re
S
0 1 1 RG
n
71 232 258 8 re
S
1 0 0 RG
n
107 212 430 8 re
S
0 1 1 RG
n
71 191 436 8 re
S
0 1 1 RG
n
71 170 462 8 re
S
0 1 1 RG
n
71 150 457 8 re
S
0 1 1 RG
n
71 129 456 8 re
S
0 1 1 RG
n
71 108 465 8 re
S
Q

endstream
endobj
94 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
95 0 obj
<<
/Length 8387
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (15) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0006 Tc
-0.0014 Tw
12 0 0 12 72 708.96 Tm
[ (The\040coefficients\040on\040th) 6 (e\040cost\055sh) 6 (i) -2 (fters\040are\040ins) 5 (i) -2 (gni) ] TJ
0.0004 Tc
-0.002 Tw
18.78 0 Td
[ (ficant\056\040These\040findings\040are\040consistent\040w) 8 (ith\040the\040) ] TJ
0.0009 Tc
-0.004 Tw
-18.78 -1.725 Td
[ (observation\040that\040there\040is\040a\040larg) 6 (e\040gap\040between\040the\040) ] TJ
0 Tc
-0.0016 Tw
19.52 0 Td
(generic\040and\040brand\040launch) Tj
0.0006 Tc
-0.0006 Tw
[ (\040prices\040of\040antican) 6 (cer\040) ] TJ
-19.52 -1.725 Td
[ (drugs\072\040for\040ex) 6 (am) 8 (ple\054\040over\04080\040percen) 6 (t\040in\040the\040case\040of\040) ] TJ
0.0004 Tc
-0.001 Tw
20.075 0 Td
[ (irino) 5 (t) -2 (ecan\040\050Conti\040et\040al\0402) 5 (012\051\056\040The\040prices\040of\040on\055) ] TJ
0 Tc
-0.0007 Tw
-20.075 -1.725 Td
(patent\040anticancer\040drugs\040do\040not\040appear\040to\040be) Tj
-0.0012 Tw
17.19 0 Td
[ (\040closely\040related\040to\040m) 8 (a) ] TJ
0 Tw
8.545 0 Td
(rginal\040production\040costs\056\040) Tj
0.0006 Tc
0.0001 Tw
-22.735 -1.725 Td
[ (The\040m) 8 (odel\040in\040Colum) 8 (n) 1 (\040E\040exam) 8 (ines\040the\040rela) ] TJ
0.0001 Tc
-0.0001 Tw
16.915 0 Td
[ (tionship\040between\040the\040source\040of\040infor) -7 (m) 8 (ation\040) ] TJ
0.0005 Tc
-0.0005 Tw
-19.915 -1.725 Td
[ (about\040surv) 6 (iv) 6 (al\040benefits\040and\040prices\056\040W) 9 (e) -1 (\040would\040e) ] TJ
0.0008 Tc
-0.0008 Tw
18.77 0 Td
[ (xpect\040th) 6 (at\040phys) 5 (ician) 6 (s\040would) 6 (\040be\040m) 9 (o) 1 (re\040willing\040to\040) ] TJ
0.0002 Tc
-0.0002 Tw
-18.77 -1.725 Td
[ (prescribe\040drugs\040about\040which\040they\040have\040m) 8 (ore\040in) ] TJ
0.0005 Tc
-0.0015 Tw
18.74 0 Td
[ (form) 8 (ation\056\040This\040regression\040includes\040controls\040for\040) ] TJ
0.0004 Tc
-0.0012 Tw
-18.74 -1.725 Td
(whether\040the\040drug\040was\040approved\040on\040th) Tj
0.0006 Tc
-0.0006 Tw
14.825 0 Td
[ (e\040basis\040of\040a\040random) 8 (ized\040trial\040a) ] TJ
0.0001 Tc
-0.0001 Tw
12 0 Td
(nd\040if\040survival\040benefits\040are\040) Tj
0.0009 Tc
-0.0009 Tw
-26.825 -1.725 Td
[ (m) 9 (easured\040in\040term) 9 (s\040of\040progression) ] TJ
0.0006 Tc
-0.0006 Tw
13.335 0 Td
[ (\055free\040rath) 6 (er\040th) 6 (an) 6 (\040overall\040surv) 6 (ival\056\040The\040co) 6 (efficients\040are\040of\040the\040) ] TJ
-0.0022 Tw
-13.335 -1.725 Td
[ (expected\040sig) 6 (n) 1 (\040but\040are\040no) 6 (t\040significan) 6 (t\056\040\040) ] TJ
-0.0002 Tw
3 -1.725 Td
[ (The\040m) 8 (odels\040in\040colum) 8 (n) 1 (s\040F\055H\040conside) 4 (r) -1 (\040whether\040d) 6 (r) 4 (ugs\040with\040f) 4 (e) -1 (w\040close\040subs) 5 (titu) 6 (tes\040com) 8 (m) 8 (a) -1 (nd\040) ] TJ
0.0002 Tc
-3 -1.725 Td
[ (higher\040prices\056\040Characterizing\040the\040degree\040of\040com) 8 (p) ] TJ
-0.0012 Tw
19.52 0 Td
(etition\040between\040anticancer\040drugs\040is\040difficult\056\040) Tj
0.0011 Tc
-0.0017 Tw
-19.52 -1.725 Td
[ (Som) 9 (e\040com) 9 (p) -4 (ete\054\040but\040m) 9 (o) 1 (st\040are\040us) 5 (ed\040in\040a\040com) 9 (p) 1 (le) ] TJ
0.0006 Tc
-0.0026 Tw
18.36 0 Td
[ (m) 8 (e) -6 (ntary\040m) 8 (a) -1 (nner\054\040either\040in\040a\040co\055adm) 8 (inistered\040) ] TJ
0.0003 Tc
-0.0003 Tw
-18.36 -1.725 Td
[ (multidrug\040\223cocktail\224\040regim) 8 (e) -1 (n\040or\040in\040a\040sequence\040of) ] TJ
0.0006 Tc
-0.0039 Tw
19.575 0 Td
(\040therapy\040lines\040\050first\055l) Tj
-0.0007 Tw
8.19 0 Td
[ (ine\040therapy\054\040seco) 6 (nd\055lin) 6 (e\040) ] TJ
-0.0016 Tw
-27.765 -1.725 Td
[ (therapy\054\040etc\056\051\040Som) 8 (e) -1 (\040drugs\040are\040approv) ] TJ
0.0002 Tc
-0.0012 Tw
14.745 0 Td
(ed\040to\040treat\040all\040patients\040diagnosed) Tj
0.0001 Tc
-0.0021 Tw
12.915 0 Td
(\040with\040late\055stage\040cancer\040in\040a\040) Tj
-0.0001 Tw
-27.66 -1.725 Td
(specific\040body\040part\054\040while\040other\040dr) Tj
0.0003 Tc
-0.0003 Tw
13.28 0 Td
[ (ugs\040have\040narrower\040indications\056\040The\040m) 8 (ode) -6 (l\040in\040Colum) 8 (n\040F\040includes\040) ] TJ
-13.28 -1.725 Td
[ (a\040contro) 5 (l\040for\040whether\040th) 5 (e\040drug\040was\040co) 5 (mpared\040ag) ] TJ
0.0007 Tc
-0.0007 Tw
19.155 0 Td
[ (ainst\040a\040placeb) 6 (o\040\050or\040\223bes) 9 (t\040supportiv) 6 (e\040care\224\051\040o) 6 (r) -1 (\040) ] TJ
0.0003 Tc
-0.0003 Tw
-19.155 -1.725 Td
(against\040another\040drug\056\040Drugs\040tested\040against\040place) Tj
-0.0019 Tw
19.135 0 Td
(bos\040occupy\040unique\040niches\040) Tj
0.0002 Tc
-0.0002 Tw
10.555 0 Td
(in\040the\040product\040space\040) Tj
0.0004 Tc
-0.0004 Tw
-29.69 -1.72 Td
[ (com) 8 (pared\040to\040drugs\040tes) 5 (t) -2 (ed) 5 (\040agains) 5 (t\040\223active\224\040con) 5 (t) -2 (rols\056\040Presum) 8 (ably\040the\040FDA\040and\040ethical\040review\040) ] TJ
0.0001 Tc
-0.0008 Tw
0 -1.725 TD
[ (boards\040would\040not\040allow\040a\040m) 8 (a) -1 (nufacturer\040to\040test) ] TJ
0.0005 Tc
-0.0005 Tw
18.36 0 Td
[ (\040an) 6 (\040anticancer\040d) 6 (r) -1 (ug\040agains) 5 (t\040a\040placebo\040un) 6 (less\040the\040) ] TJ
0.0007 Tc
-0.0021 Tw
-18.36 -1.725 Td
[ (drug\040had\040no\040direc) 5 (t) -1 (\040subs) 5 (titutes\056\040The\040c) 5 (o) 1 (ef) 4 (f) 4 (i) -1 (cient\040is) ] TJ
0.0011 Tc
-0.0023 Tw
19.275 0 Td
[ (\040positiv) 6 (e\040and\040signif) 4 (i) -1 (can) 6 (t\040a) 5 (t) -1 (\040the\04010\040pe) 5 (rc) 5 (ent\040lev) 6 (el\056\040) ] TJ
0.0003 Tc
0.0003 Tw
-19.275 -1.725 Td
[ (The\040m) 8 (odel\040in\040colum) 8 (n\040G\040includes\040controls\040for\040whethe) ] TJ
0.0001 Tc
-0.0011 Tw
21.16 0 Td
(r\040the\040drug\040was\040granted\040pr) Tj
0.0003 Tc
-0.0028 Tw
10.025 0 Td
(iority\040review\040status\040) Tj
0 Tc
0 Tw
-31.185 -1.725 Td
(by\040the\040FDA\056\040Priority\040review\040is\040granted\040to\040drugs) Tj
0.0006 Tc
-0.0006 Tw
[ (\040that\040dem) 8 (onstrate\040\223significant\040im) 8 (provem) 8 (e) -1 (nts\040in\040) ] TJ
0 Tc
0 Tw
T*
[ (the\040safety\040or\040effectiveness\040of\040the\040treatm) 8 (ent\054\040diagnosis\054\040or\040prevention\040of\040serious\040conditions\040when\040) ] TJ
0.0003 Tc
-0.0023 Tw
T*
[ (com) 8 (pared\040to\040standard\040applications\056\224\040The\040m) 8 (odel\040) ] TJ
-0.0003 Tw
19.18 0 Td
(indicates\040that\040drugs\040aw) Tj
0.0002 Tc
-0.0027 Tw
9.195 0 Td
(arded\040priority\040review\040) Tj
0.0001 Tc
-0.0017 Tw
-28.375 -1.725 Td
(status\040command\040significantly\040highe) Tj
0.0006 Tc
-0.0026 Tw
14.195 0 Td
[ (r\040prices\056\040The\040model\040in\040colum) 8 (n) 1 (\040) ] TJ
0.0005 Tc
-0.0015 Tw
12.295 0 Td
(H\040includes\040a\040variable\040equal\040to\040) Tj
0.0012 Tc
-0.0012 Tw
-26.49 -1.725 Td
[ (the\040natu) 6 (ral\040logarithm) 9 (\040of) 4 (\040the\040num) ] TJ
0.0004 Tc
-0.0009 Tw
12.965 0 Td
[ (ber\040of\040drugs\040previously\040approved\040for\040the\040tum) 8 (or\040site\040\050National\040) ] TJ
0.0001 Tc
-0.0013 Tw
-12.965 -1.725 Td
(Cancer\040Institute\0402014\051\056\040The\040coeffici) Tj
-0.0001 Tc
0.0001 Tw
14.3 0 Td
(ent\040is\040negative\040and\040significant\056\040It) Tj
0.0003 Tc
-0.0003 Tw
13.05 0 Td
(\040is\040unclear\040if\040this\040result\040can\040) Tj
0.0009 Tc
-0.0012 Tw
-27.35 -1.725 Td
[ (be\040inte) 5 (rpre) 5 (te) 5 (d\040as\040a\040pure) 5 (l) -1 (y) 6 (\040com) 9 (p) 1 (etitive) 5 (\040effect\040becau) 6 (se\040anticance) 5 (r\040drugs\040a) 5 (r) -1 (e\040o) 6 (f) 4 (ten\040used\040in\040a\040) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 443 8 re
S
0 1 1 RG
n
72 688 455 8 re
S
0 1 1 RG
n
72 667 464 8 re
S
0 1 1 RG
n
72 646 424 8 re
S
1 0 0 RG
n
108 626 411 8 re
S
0 1 1 RG
n
72 605 453 8 re
S
0 1 1 RG
n
72 584 456 8 re
S
0 1 1 RG
n
72 564 447 8 re
S
0 1 1 RG
n
72 543 450 8 re
S
0 1 1 RG
n
72 522 183 8 re
S
1 0 0 RG
n
108 501 429 8 re
S
0 1 1 RG
n
72 481 448 8 re
S
0 1 1 RG
n
72 460 436 8 re
S
0 1 1 RG
n
72 439 451 8 re
S
0 1 1 RG
n
71 419 463 8 re
S
0 1 1 RG
n
71 398 472 8 re
S
0 1 1 RG
n
71 377 448 8 re
S
0 1 1 RG
n
71 357 456 8 re
S
0 1 1 RG
n
71 336 443 8 re
S
0 1 1 RG
n
71 315 452 8 re
S
0 1 1 RG
n
71 295 462 8 re
S
0 1 1 RG
n
71 274 470 8 re
S
0 1 1 RG
n
72 253 456 8 re
S
0 1 1 RG
n
72 232 460 8 re
S
0 1 1 RG
n
72 212 444 8 re
S
0 1 1 RG
n
72 191 463 8 re
S
0 1 1 RG
n
72 170 452 8 re
S
0 1 1 RG
n
72 150 460 8 re
S
0 1 1 RG
n
72 129 428 8 re
S
Q

endstream
endobj
96 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
97 0 obj
<<
/Length 8167
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (16) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0003 Tc
-0.0003 Tw
12 0 0 12 72 708.96 Tm
[ (com) 8 (ple) -6 (m) 8 (e) -1 (nt) -7 (ary\040m) 8 (a) -1 (nner\056\040The\040FDA\040gr) -7 (ants\040orphan\040) ] TJ
-0.0011 Tw
19.75 0 Td
(drug\040status\040to\040drugs\040used\040to\040treat\040rare\040) Tj
-19.75 -1.725 Td
(conditions\056\040The\040coefficient\040on\040orphan\040drug\040st) Tj
-0.0003 Tc
-0.0013 Tw
18.03 0 Td
(atus\040\050Model\040G\051\040is\040) Tj
-0.0002 Tc
0.0002 Tw
7.27 0 Td
(not\040significant\056\040) Tj
0.0006 Tc
-0.0009 Tw
-22.3 -1.725 Td
[ (The\040m) 8 (odel\040in\040colum) 8 (n) 1 (\040I\040includes\040controls\040for\040whether\040a\040drug\040w) 8 (a) -1 (s\040approved\040for\040use\040in\040) ] TJ
0.0005 Tc
-0.0005 Tw
-3 -1.725 Td
[ (patients\040with\040specific\040genetic\040biom) 8 (arkers\040\050U) ] TJ
0.0001 Tc
-0.0001 Tw
17.695 0 Td
[ (S\040Food\040and\040Drug\040Adm) 8 (i) -2 (nistration\0402014\051\040or\040as\040a\040) ] TJ
-0.0002 Tc
-0.0008 Tw
-17.695 -1.725 Td
(second\055line\040drug\054\040for\040use\040in\040pati) Tj
0.0001 Tc
-0.0013 Tw
12.72 0 Td
(ents\040whose\040disease\040has\040progresse) Tj
0.0002 Tc
-0.0002 Tw
13.22 0 Td
(d\040after\040an\040init) Tj
0.0004 Tc
-0.0029 Tw
5.355 0 Td
(ial\040course\040of\040) Tj
0.0007 Tc
0.0013 Tw
-31.295 -1.725 Td
[ (treatm) 9 (ent\056\040Dem) 9 (and\040m) 9 (ay\040be\040less\040elas) ] TJ
0.0002 Tc
-0.0012 Tw
14.385 0 Td
(tic\054\040and\040prices\040higher\054\040for\040dr) Tj
0.0003 Tc
-0.0003 Tw
11.135 0 Td
[ (ugs\040targeted\040at\040narrow) 8 (\040patient\040) ] TJ
-0.001 Tw
-25.52 -1.725 Td
(subgroups\056\040The\040coefficient\040on\040the\040gene\040test\040variable) Tj
0.0001 Tc
-0.0008 Tw
20.665 0 Td
(\040is\040negative\054\040contrary\040to\040our\040expectation\056\040\040) Tj
0.0009 Tc
-0.0027 Tw
-20.665 -1.725 Td
[ (The\040discuss) 5 (i) 4 (on\040up\040until\040this\040point\040has) 5 (\040im) 9 (plicitly\040a) 5 (ssu) ] TJ
0.0007 Tc
-0.0007 Tw
20.995 0 Td
[ (m) 9 (ed\040that\040patien) 6 (t) -1 (s\222\040v) 6 (aluation\040of) 4 (\040gains\040in\040lif) 4 (e\040) ] TJ
-0.0001 Tc
0.0001 Tw
-20.995 -1.725 Td
[ (expectancy\040from) 8 (\040a\040new\040a) -6 (nticancer\040drug\040is\040independe) ] TJ
0.0001 Tc
-0.0026 Tw
(nt\040of\040its\040clinical\040cont) Tj
0.0004 Tc
-0.0016 Tw
29.235 0 Td
(ext\056\040It\040does\040not\040depend\040) Tj
0.0001 Tc
-29.235 -1.725 Td
(on\040the\040type\040of\040cancer\040or\040how\040long\040) Tj
-0.0001 Tw
13.72 0 Td
(patients\040expect\040to\040live\040if\040they\040do\040not\040receive\040a\040new\040drug\056\040This\040) Tj
0.0002 Tc
-0.0018 Tw
-13.72 -1.725 Td
(approach\040treats\040anticancer\040drugs\040) Tj
-0.0003 Tc
0.0003 Tw
13.165 0 Td
(as\040bundles\040of\040comparable\040attr) Tj
0.0005 Tc
-0.0015 Tw
11.77 0 Td
[ (ibutes\056\040The\040model\040in\040colum) 8 (n) 1 (\040J\040) ] TJ
0.0003 Tc
-0.0003 Tw
-24.935 -1.725 Td
(includes\040a\040control\040for\040base) Tj
0.0009 Tc
-0.0013 Tw
10.555 0 Td
[ (lin) 6 (e\040surv) 6 (iv) 6 (al\040\050i\056e\056\054\040surv) 6 (ival\040in\040the\040co) 6 (ntrol\040o) 6 (r) -1 (\040comparato) 6 (r) -1 (\040arm) 9 (\040of\040the\040) ] TJ
0.0001 Tc
-0.0008 Tw
-10.555 -1.725 Td
(study\040we\040used\040to\040assess\040survival\040benefits\051\056\040Re) Tj
-0.0017 Tw
18.22 0 Td
(sults\040indicate\040that\040the\040longer\040patients\040survive\040) Tj
-0.0026 Tw
-18.22 -1.725 Td
(without\040the\040drug\054\040the\040lowe) Tj
0.0004 Tc
-0.0004 Tw
10.52 0 Td
(r\040the\040drug\040price\056\040Patients\222\040and\040) Tj
-0.0002 Tc
0.0002 Tw
12.09 0 Td
(physicians\222\040willi) Tj
0 Tc
0 Tw
6.635 0 Td
[ (ngness\055to\055pay\040m) 8 (a) -1 (y\040) ] TJ
-0.0006 Tw
-29.245 -1.725 Td
(depend\040on\040absolute\040survival\040as\040well\040as\040relative\040su) Tj
0.0004 Tc
-0.0004 Tw
19.715 0 Td
[ (rvival\040gains\056\040They\040m) 8 (a) -1 (y\040place\040a\040higher\040value\040on\040) ] TJ
0.0001 Tc
-0.0001 Tw
-19.715 -1.725 Td
[ (a\040drug\040that\040extends\040survival\040tim) 8 (e) ] TJ
0.0011 Tw
13.075 0 Td
[ (\040by\0406\040m) 8 (onths\040from\040a\040base\040of\0408\040) ] TJ
-0.0001 Tw
12.2 0 Td
[ (m) 8 (onths\040than\040one\040that\040extends\040) ] TJ
0.0003 Tc
0.0002 Tw
-25.275 -1.725 Td
[ (survival\040time\040by\0406\040m) 8 (ont) -7 (hs\040from) 8 (\040a\040base\040of\04012\040m) 8 (o) ] TJ
0.0002 Tc
-0.0002 Tw
(nths\056\040The\040model\040in\040column\040K\040includes\040a\040control\040) Tj
0.0007 Tc
-0.0015 Tw
0 -1.725 TD
[ (f) 4 (o) 1 (r\040the\040tum) 9 (o) -4 (r\055spec) 5 (i) -1 (f) 4 (i) -1 (c\040morta) 5 (lity\040rate\054) 6 (\040which\040we) ] TJ
-0.0032 Tw
18.745 0 Td
(\040calculated\040by\040dividing\040th) Tj
0.0013 Tc
-0.0029 Tw
10.17 0 Td
[ (e\040num) 9 (b) 1 (er\040of) 4 (\040deaths\040) ] TJ
0.0005 Tc
-0.0019 Tw
-28.915 -1.72 Td
[ (attributed\040to\040the\040tum) 8 (o) 1 (r\040by\040disease\040incidence\056\040The\040) ] TJ
0.0009 Tc
-0.0016 Tw
19.745 0 Td
[ (c) 5 (o) 1 (ef) 4 (f) 4 (i) -1 (cient\040on) 6 (\040the\040m) 9 (o) 1 (rtality\040rate\040is\040pos) 5 (itive\040bu) 6 (t\040) ] TJ
0.0003 Tc
-0.0003 Tw
-19.745 -1.725 Td
(is\040not\040significant\056) Tj
0 Tc
0 Tw
7.98 0 0 7.98 154.98 321.24 Tm
(7) Tj
12 0 0 12 159 315.72 Tm
(\040) Tj
0.0003 Tc
-0.0003 Tw
-4.25 -1.725 Td
[ (The\040coefficient\040on\040approval\040year\040is\040econom) 8 (ica) 4 (lly\040and\040statistically\040significant\040in\040all\04011\040) ] TJ
-3 -1.725 Td
(specifications\040in\040Table\0401\056\040Thus\054\040our\040basic\040findi) Tj
-0.0028 Tw
18.59 0 Td
(ng\040that\040benefit\055\040and\040in) Tj
-0.0001 Tc
0.0001 Tw
8.83 0 Td
[ (flation) 5 (\055) -2 (adjus) 4 (t) -2 (ed\040launch\040) ] TJ
0.0002 Tc
-0.0012 Tw
-27.42 -1.725 Td
(prices\040increased\040by\040about\04010\040percen) Tj
0.0003 Tc
-0.0033 Tw
14.3 0 Td
(t\040annually\040appears\040robust\040to\040the\040) Tj
-0.0003 Tw
12.77 0 Td
(inclusion\040of\040controls\040for\040the\040) Tj
0 Tc
0 Tw
-27.07 -1.725 Td
(various\040drug\040attributes\040described\040above\056\040\040) Tj
3 -1.725 Td
(\040) Tj
/TT1 1 Tf
11.75 Tc
-3 -1.73 Td
(\040\040) Tj
/C2_0 1 Tf
0 Tc
10.98 0 0 10.98 72 130.38 Tm
[ <0003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003> 81 <0003000300030003000300030003000300030003000300030003000300030003000300030003> ] TJ
ET
72 132.42 144 0.72 re
f
BT
/C2_0 1 Tf
10.98 0 0 10.98 216 130.38 Tm
<0003> Tj
/TT0 1 Tf
7.98 0 0 7.98 72 121.86 Tm
(7) Tj
0.0009 Tc
-0.0016 Tw
12 0 0 12 76.02 116.3401 Tm
[ (\040Morta) 5 (l) -1 (ity\040ra) 5 (tes\040ar) 4 (e\040m) 9 (easured\040with\040su) 6 (bstantial\040er) ] TJ
0.0007 Tc
-0.0014 Tw
19.305 0 Td
[ (r) 4 (o) 1 (r\056\040Idea) 5 (lly\054\040we\040would\040like\040to\040m) 9 (easure\040m) 9 (o) 1 (rtality\040) ] TJ
0.0004 Tc
-0.0004 Tw
-19.64 -1.15 Td
[ (am) 8 (ong\040patients\040diagnosed\040with\040late\055stage\040disease\054) ] TJ
-0.0009 Tw
19.885 0 Td
[ (\040but\040we\040do\040not\040have\040data\040on\040tum) 8 (or\040incidence\040by\040) ] TJ
-0.002 Tw
-19.885 -1.15 Td
(stage\040at\040diagnosis\056\040\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 418 8 re
S
0 1 1 RG
n
72 688 378 8 re
S
1 0 0 RG
n
108 667 407 8 re
S
0 1 1 RG
n
72 646 438 8 re
S
0 1 1 RG
n
72 626 437 8 re
S
0 1 1 RG
n
72 605 452 8 re
S
0 1 1 RG
n
72 584 446 8 re
S
0 1 1 RG
n
72 564 460 8 re
S
0 1 1 RG
n
72 543 462 8 re
S
0 1 1 RG
n
72 522 461 8 re
S
0 1 1 RG
n
72 501 447 8 re
S
0 1 1 RG
n
72 481 445 8 re
S
0 1 1 RG
n
72 460 435 8 re
S
0 1 1 RG
n
72 439 444 8 re
S
0 1 1 RG
n
72 419 464 8 re
S
0 1 1 RG
n
72 398 446 8 re
S
0 1 1 RG
n
72 377 463 8 re
S
0 1 1 RG
n
72 357 441 8 re
S
0 1 1 RG
n
72 336 461 8 re
S
0 1 1 RG
n
72 315 90 8 re
S
1 0 0 RG
n
108 295 412 8 re
S
0 1 1 RG
n
72 274 442 8 re
S
0 1 1 RG
n
71 253 461 8 re
S
0 1 1 RG
n
71 232 198 8 re
S
0.9 0.9 0.9 RG
n
107 212 3 8 re
S
0.9 0.9 0.9 RG
n
71 191 288 8 re
S
0.9 0.9 0.9 RG
n
72 130 146 8 re
S
0.5 0.5 0.5 RG
n
72 121 468 8 re
S
0 1 0 RG
n
72 102 469 8 re
S
0 1 0 RG
n
72 88 94 8 re
S
Q

endstream
endobj
98 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
99 0 obj
<<
/Length 6868
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (17) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT1 1 Tf
0.0007 Tc
-0.0007 Tw
12 0 0 12 72 708.9 Tm
[ (Sensitivity\040C) 8 (h) 1 (ecks) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
7.245 0 Td
(\040) Tj
/TT1 1 Tf
-7.245 -1.725 Td
(\040) Tj
/TT0 1 Tf
0.001 Tc
-0.002 Tw
3 -1.72 Td
[ (W) 5 (e\040perf) 4 (ormed\040sever) 4 (al\040se) 5 (nsitiv) 6 (ity\040che) 5 (cks\056\040W) 10 (e\040re\055estim) 9 (ated\040the\040baseline\040m) 9 (o) -4 (del\040\050Colum) 9 (n\040) ] TJ
0.0001 Tc
0.0004 Tw
-3 -1.725 Td
[ (A\051\040on\040the\040subsam) 8 (ple\040of\040drugs\040approved\040on\040the\040ba) ] TJ
0.0003 Tc
-0.0009 Tw
19.69 0 Td
[ (sis\040of\040random) 8 (i) -2 (zed\040trials\040and\040for\040which\040we\040had\040) ] TJ
-0.0003 Tw
-19.69 -1.725 Td
[ (trial\055based\040estim) 8 (ates\040of\040overall\040survival\056\040W) 9 (e) ] TJ
0.0009 Tc
-0.0016 Tw
17.655 0 Td
[ (\040also\040re\055estim) 9 (ated\040the\040base) 5 (line\040model\040on\040th) 6 (e\040) ] TJ
0.0005 Tc
-0.0005 Tw
-17.655 -1.725 Td
[ (subsam) 8 (ple\040of\040drugs\040with\040prices\040below) 8 (\040the\04090) ] TJ
0.0004 Tc
0 Tw
7.98 0 0 7.98 286.32 610.98 Tm
(th) Tj
0.0002 Tc
-0.0002 Tw
12 0 0 12 292.56 605.46 Tm
[ (\040percentile\040\050\04494\054) 5 (000\051\040to\040de) ] TJ
0.0008 Tc
-0.0008 Tw
10.575 0 Td
[ (term) 9 (ine\040the\040sensitiv) 6 (ity\040of\040) ] TJ
0.0006 Tc
-0.0012 Tw
-28.955 -1.725 Td
[ (results\040to\040extrem) 8 (e\040values\056\040In\040both\040cas) 5 (es\040the\040coe) ] TJ
0.0001 Tc
-0.0017 Tw
18.75 0 Td
(fficients\040on\040approval\040date) Tj
0.0008 Tc
-0.0008 Tw
10.185 0 Td
[ (\040in) 6 (dicate\040that\040p) 6 (r) -1 (ices\040) ] TJ
0.0002 Tc
-0.0009 Tw
-28.935 -1.725 Td
(increased\040by\040about\04010\040percent\040annually\040and\040were\040) Tj
0.0003 Tc
-0.0003 Tw
19.77 0 Td
(significant\040at\040the\0401\040percent\040level\054\040consistent\040) Tj
-0.0012 Tw
-19.77 -1.725 Td
[ (with\040the\040results\040from) 8 (\040the\040baseline\040m) 8 (o) -5 (del\056\040) ] TJ
/TT2 1 Tf
0 Tc
0 Tw
0 -1.735 TD
(\040) Tj
0 -1.725 TD
(Explaining\040Pricing\040Trends\040) Tj
2.75 Tc
T*
(\040\040) Tj
/TT0 1 Tf
0.0009 Tc
-0.0009 Tw
3 -1.715 Td
[ (Our\040em) 9 (pirical\040resu) 6 (lts\040su) 6 (ggest\040) ] TJ
0 Tc
0 Tw
(that\040the\040launch\040prices\040of\040) Tj
0.0002 Tc
-0.0018 Tw
21.8 0 Td
(anticancer\040drugs\054\040even\040when\040) Tj
0.0001 Tc
-0.0009 Tw
-24.8 -1.725 Td
(adjusted\040for\040inflation\040and\040survival\040benefits\054\040have) Tj
0 Tc
-0.0025 Tw
19.36 0 Td
(\040increased\040substantially\040) Tj
0.0012 Tw
9.58 0 Td
[ (over\040tim) 8 (e) -1 (\056\040We\040offer\040two\040) ] TJ
0.0001 Tc
-0.0001 Tw
-28.94 -1.725 Td
(explanations\040grounded\040in\040our\040obs) Tj
0.0004 Tc
-0.0004 Tw
[ (ervations\040of\040m) 8 (a) -1 (rket\040behavior\054\040econom) 8 (ic\040theory\054\040and\040current\040) ] TJ
-0.0028 Tw
T*
(regulatory\040policy\056\040\040) Tj
-0.0003 Tw
3 -1.725 Td
(Our\040discussion\040focuses\040on\040branded\040drugs\222\040la) Tj
0.0005 Tc
-0.0035 Tw
17.725 0 Td
[ (unch\040prices\056\040If\040m) 8 (a) -6 (nufacturers\040m) 8 (a) -1 (ke\040large\040) ] TJ
0.0004 Tc
-0.0018 Tw
-20.725 -1.725 Td
(changes\040to\040drugs\222\040prices\040in\040the\040years\040follo) Tj
0.0004 Tw
16.695 0 Td
[ (wing\040launch\054\040our\040focus\040m) 8 (a) -1 (y\040be\040m) 8 (i) -2 (splaced\056\040We\040) ] TJ
-0.002 Tw
-16.695 -1.72 Td
[ (analyzed\040the\040Center\040for\040Medicare\040an) 5 (d\040Medicaid\040) ] TJ
0.0005 Tc
-0.0005 Tw
19.35 0 Td
[ (Services) 5 (\222\040Average\040Sales) 5 (\040Price\040files\040for\040a\040subset\040) ] TJ
-0.001 Tw
-19.35 -1.725 Td
[ (of\040the\040drugs\040in\040our\040sam) 8 (p) 1 (le\040to\040determ) 8 (ine\040if\040launc) ] TJ
0.0008 Tc
-0.0036 Tw
19.025 0 Td
[ (h\040prices\040are\040a\040sufficient\040statis) 5 (tic\040for\040po) 6 (st\055launch\040) ] TJ
0.0004 Tc
-0.0029 Tw
-19.025 -1.725 Td
(prices\056\040The\040files\040capture\040prices) Tj
-0.0014 Tw
12.25 0 Td
[ (\040for\040the\040m) 8 (ostly\040intravenous\040dr) ] TJ
0.0005 Tc
-0.0005 Tw
11.855 0 Td
[ (ugs\040reim) 8 (bursed\040under\040Medicare\222s\040) ] TJ
0.0003 Tc
-0.0003 Tw
-24.105 -1.725 Td
[ (Part\040B\040outpatient\040m) 8 (e) -1 (dical\040benefit\056\040We\040exclude) ] TJ
0.0001 Tc
-0.0009 Tw
18.475 0 Td
[ (d\040three\040drugs\040\226\040gem) 8 (c) -1 (itabine\054\040irinotecan\054\040and\040) ] TJ
0.0009 Tc
-0.0013 Tw
-18.475 -1.725 Td
[ (oxalip) 6 (latin\040\226) 6 (\040that\040exp) 6 (erie) 5 (n) 1 (ced\040la) 5 (rge\040d) 6 (eclin) 6 (es\040in\040p) 6 (r) 4 (ice\040f) 4 (o) 1 (llowin) 6 (g) 1 (\040patent\040exp) 6 (i) -1 (ra) 5 (tion\040and\040g) 6 (eneric\040) ] TJ
0.0011 Tc
-0.0019 Tw
T*
[ (entry\056\040W) 10 (e\040calcula) 5 (ted\040ann) 6 (u) 1 (aliz) 5 (ed\040gro) 6 (w) 3 (th\040rates\040in) ] TJ
0.0012 Tc
-0.0028 Tw
19.08 0 Td
[ (\040the\040rem) 9 (ainin) 6 (g\040sam) 9 (p) 1 (le\040) ] TJ
0.0004 Tc
0.0008 Tw
(of\04019\040drugs\056\040The\040average\040) Tj
0.0001 Tc
-0.0001 Tw
-19.08 -1.725 Td
(annualized\040growth\040rate\040in\040real\040prices\040after\040) Tj
0.0002 Tc
-0.0008 Tw
16.91 0 Td
(launch\040was\0401\040percent\056\040The\04025th\054\04050th\054\040and\04075th\040) Tj
-0.0014 Tw
-16.91 -1.725 Td
(percentiles\040were\040\0550\0567\040percent\054\0400\0569\040) Tj
-0.0002 Tc
-0.0018 Tw
13.555 0 Td
(percent\054\040and\0404\040percent\056\040The\040resu) Tj
0 Tc
0 Tw
12.79 0 Td
(lts\040are\040consistent\040with\040Lu\040and\040) Tj
0.0001 Tc
-0.0008 Tw
-26.345 -1.725 Td
[ (Com) 8 (a) -1 (nor\222s\040\0501998\051\040finding\040that\040the\040prices\040of\040i) -2 (nnovative\040drugs\040do\040not\040change\040m) 8 (uch\040aft) -7 (e) -1 (r\040launch\056\040) ] TJ
-0.0001 Tc
0.0001 Tw
T*
(Launch\040prices\040are\040where\040the\040action\040is\056\040) Tj
/TT1 1 Tf
0 Tc
0 Tw
0 -1.73 TD
(\040) Tj
11.75 Tc
0 -1.725 TD
(\040\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 89 8 re
S
0.9 0.9 0.9 RG
n
72 688 3 8 re
S
1 0 0 RG
n
108 667 421 8 re
S
0 0 1 RG
n
72 646 458 8 re
S
0 1 1 RG
n
72 626 424 8 re
S
0 1 1 RG
n
72 605 470 8 re
S
0 1 1 RG
n
72 584 444 8 re
S
0 1 1 RG
n
72 564 448 8 re
S
0 1 1 RG
n
72 543 199 8 re
S
0.9 0.9 0.9 RG
n
72 522 3 8 re
S
0 0 1 RG
n
72 501 139 8 re
S
0.9 0.9 0.9 RG
n
72 481 72 8 re
S
1 0 0 RG
n
108 460 401 8 re
S
0 1 1 RG
n
72 439 466 8 re
S
0 1 1 RG
n
72 419 448 8 re
S
0 1 1 RG
n
72 398 91 8 re
S
1 0 0 RG
n
108 377 411 8 re
S
0 1 1 RG
n
72 357 425 8 re
S
0 1 1 RG
n
72 336 461 8 re
S
0 1 1 RG
n
72 315 459 8 re
S
0 1 1 RG
n
72 295 453 8 re
S
0 1 1 RG
n
72 274 435 8 re
S
0 1 1 RG
n
72 253 446 8 re
S
0 1 1 RG
n
72 232 460 8 re
S
0 1 1 RG
n
72 212 430 8 re
S
0 1 1 RG
n
72 191 460 8 re
S
0 1 1 RG
n
72 170 459 8 re
S
0 1 1 RG
n
72 150 185 8 re
S
0.9 0.9 0.9 RG
n
72 129 3 8 re
S
0.9 0.9 0.9 RG
n
72 108 288 8 re
S
Q

endstream
endobj
100 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
101 0 obj
<<
/Length 8152
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (18) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT1 1 Tf
0.001 Tc
-0.001 Tw
12 0 0 12 72 708.9 Tm
[ (Referenc) 5 (e\040p) 6 (ricing) 6 (\040) ] TJ
0 Tc
0 Tw
0 -1.725 TD
(\040) Tj
/TT0 1 Tf
0.0004 Tc
-0.0004 Tw
3 -1.72 Td
[ (W) 9 (r) -2 (iting\040to\040criticize\040the\040\223astronom) 8 (ical\224\040pr) ] TJ
0.0002 Tc
-0.0018 Tw
16.46 0 Td
(ices\040of\040new\040antican) Tj
0.0004 Tc
-0.0029 Tw
(cer\040drugs\054\040a\040group\040of\040) Tj
0.0002 Tc
-0.0012 Tw
-19.46 -1.725 Td
[ (over\040100\040prom) 8 (inent\040oncologists\040\050Experts\040in\040) ] TJ
0.0003 Tc
-0.0015 Tw
17.61 0 Td
[ (Chronic\040Myeloid\040Leukem) 8 (i) -2 (a\0402013\051\040proposed\040) ] TJ
0.0005 Tc
0.0005 Tw
-17.61 -1.725 Td
[ (the\040following\040m) 8 (odel\040of\040m) 8 (a) -1 (nufacturers\222\040pri) ] TJ
0 Tc
0 Tw
16.855 0 Td
(ce\040setting\040behavior\072\040\223How\040are\040the\040prices\040of\040) Tj
-16.855 -1.725 Td
[ (cancer\040drugs\040decided\077) -6 (\040Of\040the\040m) 8 (a) -1 (ny\040com) 8 (plex\040f) ] TJ
0.0004 Tc
-0.0012 Tw
18.405 0 Td
[ (actors\040involved\054\040price\040often\040seem) 8 (s\040to\040follow\040) ] TJ
0.0012 Tc
-0.0018 Tw
-18.405 -1.725 Td
[ (a\040sim) 9 (p) 1 (le\040f) 4 (o) 1 (rmula\072\040sta) 5 (r) -1 (t\040with\040the\040p) 6 (r) -1 (ic) 5 (e\040f) 4 (o) 1 (r\040th) ] TJ
0.0004 Tc
-0.001 Tw
17.22 0 Td
[ (e\040m) 8 (o) -5 (st\040recent\040similar\040drug\040on\040the\040m) 8 (a) -1 (rket\040and\040) ] TJ
-0.0009 Tw
-17.22 -1.725 Td
(price\040the\040new\040one\040within\04010\05520\040percent\040of\040that) Tj
0.0002 Tc
-0.0018 Tw
18.5 0 Td
(\040price\040\050usually\040highe) Tj
0.0014 Tc
-0.0014 Tw
8.19 0 Td
[ (r\051\056) 6 (\224\040In) 6 (dustry\040in) 6 (sid) 6 (ers\040) ] TJ
0.0003 Tc
-0.0011 Tw
-26.69 -1.725 Td
(echo\040this\040theory\040of\040price\040setting\040behavior) Tj
0.0002 Tc
-0.0002 Tw
16.39 0 Td
[ (\056\040For\040exam) 8 (ple\054\040from\040Hutchison\040\0502010\051\072\040\223Gold\040) ] TJ
-0.0001 Tc
0.0013 Tw
-16.39 -1.725 Td
(\133CEO\040of\040Dendreon\135\040says\040that\040) Tj
0.0001 Tc
-0.0001 Tw
11.91 0 Td
(the\040cost\040of\040Provenge\040was\040based\040on\040the\040\140overall\040landscape\222\040) Tj
0.0007 Tc
-0.0015 Tw
-11.91 -1.725 Td
[ (of\040treatm) 9 (ent\040prices\040for\040cancer\056\224\040From) 9 (\040Marc) ] TJ
0 Tc
0 Tw
17.245 0 Td
[ (us\040\0502004\051\072\040\223A\040spokeswom) 8 (an\040for\040AstraZeneca\040) ] TJ
0.0006 Tc
-0.0016 Tw
-17.245 -1.725 Td
[ (justified\040the\040price\040of\040Ires) 5 (sa\040as\040) ] TJ
/C2_1 1 Tf
0 Tc
0 Tw
12 0 Td
<078d> Tj
/TT0 1 Tf
0.0002 Tc
-0.0012 Tw
0.33 0 Td
(in\040line\040with\040other\040cancer\040trea) Tj
0.0004 Tc
-0.002 Tw
11.465 0 Td
[ (tments\056\222\224\040F) 7 (r) -2 (om\040Silber\040\0502005\051\072\040) ] TJ
0.0007 Tc
-0.0007 Tw
-23.795 -1.725 Td
[ (\223The\040retail\040p) 6 (r) -1 (ice\040of\040the\040d) 6 (r) -1 (ug\040will\040b) 6 (e\040\044) 6 (5\054416\040per\040) ] TJ
0.0003 Tc
-0.0015 Tw
18.97 0 Td
(month\054\040an\040amount\040that\040Onyx\040said\040is\040in\040the\040) Tj
-0.0004 Tw
-18.97 -1.725 Td
(range\040of\040similarly\040specia) Tj
0.0002 Tc
-0.0039 Tw
9.86 0 Td
(lized\040cancer\040drugs\056\224\040\040\040) Tj
0.0006 Tc
-0.0022 Tw
-6.86 -1.725 Td
[ (The\040theory\040that\040m) 8 (a) -1 (nufacturers\040set\040the\040prices\040) ] TJ
-0.0003 Tc
0.0003 Tw
(of\040new\040drugs\040based\040on\040the\040prices\040of\040existing\040) Tj
0.0008 Tc
-0.0028 Tw
-3 -1.725 Td
[ (therap) 6 (ies\040\050n) 6 (ot\040necess) 5 (arily\040com) 9 (p) 1 (etitors\051\054\040rather\040th) ] TJ
0.0002 Tc
-0.0002 Tw
19.325 0 Td
[ (an\040som) 8 (e) -1 (\040intrinsic\040standard\040of\040product\040value\054\040is\040) ] TJ
0.0003 Tc
-0.0003 Tw
-19.325 -1.725 Td
[ (consistent\040w) 8 (ith\040reference\040price\040m) 8 (odels\040of\040de) ] TJ
0.0005 Tc
-0.003 Tw
17.665 0 Td
[ (m) 8 (a) -1 (nd\056\040Reference\040pricing\040) ] TJ
0.0008 Tc
-0.0008 Tw
10.105 0 Td
[ (m) 9 (o) 1 (dels\040depart\040from) 9 (\040the\040) ] TJ
0.0003 Tc
-0.0013 Tw
-27.77 -1.725 Td
[ (standard\040econom) 8 (i) -2 (c\040m) 8 (ode) -6 (l\040of\040consumer\040behavior) ] TJ
-0.0037 Tw
[ (\040by\040allowing\040consum) 8 (ers\222\040) ] TJ
0.0001 Tc
-0.0026 Tw
29.35 0 Td
(purchase\040decisions\040to\040) Tj
0.0002 Tc
-0.001 Tw
-29.35 -1.72 Td
(depend\040on\040a\040pricing\040anchor\054\040or\040refe) Tj
-0.0022 Tw
14.025 0 Td
(rence\040price\054\040rather\040than\040on\040an\040) Tj
0.0003 Tc
-0.0015 Tw
[ (internal\040com) 8 (parison\040of\040price\040and\040) ] TJ
0.0006 Tc
-0.0001 Tw
-14.025 -1.725 Td
[ (willingn) 6 (ess\055to\055pay\040\050Th) 6 (a) -1 (ler\0401985\051\056\040Co) 6 (nsum) 8 (ers\040m) 8 (a) -6 (y\040determ) 8 (ine\040reference\040p) 6 (r) -1 (ices\040based\040on) 6 (\040observed\040) ] TJ
0.0002 Tc
-0.001 Tw
T*
[ (past\040prices\040or\040the\040prices\040of\040si) -7 (m) 8 (ilar\054) ] TJ
0 Tc
-0.0008 Tw
13.805 0 Td
(\040but\040not\040necessarily\040substitute\054\040goods\056\040\040) Tj
0.0007 Tc
-0.0021 Tw
-13.805 -1.725 Td
[ (\040) -2751 (Oncologists\040are\040in\040a\040stro) 6 (ng\040positio) 6 (n\040to\040inf) 4 (l) -1 (ue) ] TJ
-0.0006 Tw
20.805 0 Td
[ (nce\040the\040m) 8 (a) -1 (rket\040share\040of) 4 (\040antica) 4 (ncer\040drugs\056\040) ] TJ
0.0003 Tc
-0.0011 Tw
-20.805 -1.725 Td
[ (Although\040oncologists\040do\040not\040face\040direct\040incentiv) 5 (es\040) ] TJ
0.0006 Tc
-0.0013 Tw
20.355 0 Td
[ (to\040avoid\040co) 6 (stly\040drugs\054\040th) 6 (ey\040m) 8 (a) -1 (y\040balk\040at\040) ] TJ
0.0004 Tc
-0.0029 Tw
-20.355 -1.725 Td
(prescribing\040drugs\040with\040prices\040th) Tj
0.0009 Tc
-0.0009 Tw
12.67 0 Td
[ (ey\040perceiv) 6 (e\040as\040ex) 6 (ploitativ) 6 (e\040\227) 6 (\040in) ] TJ
0.0002 Tc
-0.0012 Tw
12.91 0 Td
(\040the\040language\040of\040theory\054\040drugs\040) Tj
0.0003 Tc
-0.001 Tw
-25.58 -1.725 Td
(with\040prices\040above\040the\040reference\040price\040level\056\040An\040) Tj
0.0002 Tc
-0.0027 Tw
18.91 0 Td
(extensive\040literature\040in\040) Tj
0.001 Tc
-0.0035 Tw
8.915 0 Td
[ (econom) 9 (ics\040and\040m) 9 (arketing\040) ] TJ
0.0001 Tc
-0.0001 Tw
-27.825 -1.725 Td
(describes\040how\040perceptions\040of\040fairness\040influence\040c) Tj
0.0004 Tc
-0.0014 Tw
19.66 0 Td
[ (onsum) 8 (ers\222\040attitudes\040towards\040prices\040and\040m) 8 (a) -1 (rket\040) ] TJ
0.0002 Tc
-0.0012 Tw
-19.66 -1.725 Td
[ (behavior\040\050for\040exam) 8 (ple\054\040Frey\040and\040Pomm) 8 (erehne) ] TJ
0.0003 Tc
-0.0009 Tw
18.435 0 Td
[ (\0401993\073\040Mas\0402006\073\040Maxwell\0402002\073\040Kahnem) 8 (a) -1 (n\040et\040al\056\040) ] TJ
0 Tc
-0.0012 Tw
-18.435 -1.725 Td
(1986\073\040Piron\040and\040Fernandez\0401995\051\056\040) Tj
0.0002 Tc
3 -1.725 Td
(There\040is\040a\040\223zone\040of\040indiffer) Tj
0.0001 Tc
-0.0001 Tw
10.86 0 Td
[ (ence\224\040around\040a\040reference\040price\040such\040that\040consum) 8 (ers\040ignore\040) ] TJ
0.0009 Tc
-0.0009 Tw
-13.86 -1.725 Td
[ (sm) 9 (all\040deviations\040from) 9 (\040the\040refere) ] TJ
0.0005 Tc
-0.0055 Tw
12.78 0 Td
[ (nce\040price\040\050Kalyanaram) 8 (\040) ] TJ
-0.0013 Tw
9.345 0 Td
(and\040Little\0401994\051\056\040The\040zone\040of\040indifference\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 0 1 RG
n
72 708 89 8 re
S
0.9 0.9 0.9 RG
n
72 688 3 8 re
S
1 0 0 RG
n
108 667 392 8 re
S
0 1 1 RG
n
71 646 426 8 re
S
0 1 1 RG
n
71 626 412 8 re
S
0 1 1 RG
n
71 605 434 8 re
S
0 1 1 RG
n
71 584 425 8 re
S
0 1 1 RG
n
71 564 424 8 re
S
0 1 1 RG
n
71 543 419 8 re
S
0 1 1 RG
n
71 522 424 8 re
S
0 1 1 RG
n
71 501 428 8 re
S
0 1 1 RG
n
71 481 432 8 re
S
0 1 1 RG
n
71 460 432 8 re
S
0 1 1 RG
n
71 439 223 8 re
S
1 0 0 RG
n
107 419 428 8 re
S
0 1 1 RG
n
71 398 456 8 re
S
0 1 1 RG
n
71 377 449 8 re
S
0 1 1 RG
n
71 357 459 8 re
S
0 1 1 RG
n
71 336 471 8 re
S
0 1 1 RG
n
71 315 467 8 re
S
0 1 1 RG
n
71 295 352 8 re
S
1 0 0 RG
n
107 274 414 8 re
S
0 1 1 RG
n
71 253 434 8 re
S
0 1 1 RG
n
71 232 453 8 re
S
0 1 1 RG
n
71 212 460 8 re
S
0 1 1 RG
n
72 191 461 8 re
S
0 1 1 RG
n
72 170 466 8 re
S
0 1 1 RG
n
72 150 167 8 re
S
1 0 0 RG
n
108 129 414 8 re
S
0 1 1 RG
n
72 108 470 8 re
S
Q

endstream
endobj
102 0 obj
<<
/BaseFont /PBEFBF+TimesNewRomanPSMT
/DescendantFonts [ 103 0 R ]
/Encoding /Identity-H
/Subtype /Type0
/ToUnicode 107 0 R
/Type /Font
>>
endobj
103 0 obj
<<
/BaseFont /PBEFBF+TimesNewRomanPSMT
/CIDSystemInfo <<
/Ordering (Identity)
/Registry (Adobe)
/Supplement 0
>>
/CIDToGIDMap /Identity
/DW 1000
/FontDescriptor 104 0 R
/Subtype /CIDFontType2
/Type /Font
/W [ 1933 [ 333 ] ]
>>
endobj
104 0 obj
<<
/Ascent 891
/CIDSet 105 0 R
/CapHeight 1000
/Descent -216
/Flags 6
/FontBBox [ -568 -307 2000 1007 ]
/FontFamily (Times\040New\040Roman)
/FontFile2 106 0 R
/FontName /PBEFBF+TimesNewRomanPSMT
/FontStretch /Normal
/FontWeight 400
/ItalicAngle 0
/StemV 82
/Type /FontDescriptor
/XHeight 1000
>>
endobj
105 0 obj
<<
/Filter /FlateDecode
/Length 18
>>
stream
hj`ae:  ژ 
endstream
endobj
106 0 obj
<<
/Filter /FlateDecode
/Length1 36536
/Length 11242
>>
stream
h{	xT{ι$aH 30@HBB0Ȅ,K}(բ`)"R"PA4En`[~{0l{~=}bDGKHP1Y9-ǕOEȓ@|$b\oO>OuDwDFsnsR1HgL8xCA; H,&;Ϙl9D̙7y"Ō@4ѽ̝V='Ν:ᯝC$vjM!*zeɭo{-4'2sC΅v
}$٠l,a\) 14{>LN~^XGD{qCw6gDKQfL'YOzi(=D4`:L9^$TD)ĩ0
N1Fe.KD9TCIk~o-7#U,#tac(RQjtu3ow`=T
Ԃbi`6I-bQ
U
֜MiຌnߌGsw75FSQүh9ZzC[0b]h %Z"hv5 t}vUt?Fu:N_8֛v2Tm+F}m'o`PXf	/aeճV=1le6?\vrp3=:bHDXu9nAнt^F;ŸM߱o	v&/]JB>Cُ<)kZm@1({f)Lu^`>R6fjձ[)O/w>nCII	i܌^n<kͺLuEeb֠x_?8\G;0
$!bhh._b:?%Zm>DtMle5Ƃvuf}5]K;/kiD5} 6DsuvA<{}#<n煼O[Ǐ?D1Y,K$oiiWз/J]iTSm7o|CsyLꁖކV܊pc,Pmq2?!!]F7	lb-efoo= ~Osn<碧|0G7ï_b|?])&k=xU|q-CtmvX{Y{SQ}l\b3f?ZzeVϡ(_q[iG.ڊ66#fbC>>63lw')*z?1VvWC5?bݴ;|(䆬DEk-Aߠ~&VbobGMeixK:U}^3
*.xYw񪶉N?d!5Zg~e;!qON	jo(Ȟ`cuv0[!a}
Fօf#I>N<iaK72;οF+`
Vi
ˡt7WOJ /2h4eӕEꇵqrr xp9e\¦@_ɩ͢,im[}S!Pw/@ꗱOzʪnYC2UCo
]	߽اB#X"׸	\]>oOyh_%ݯe>HkR Z"t<|V
ɻޜ΄<4Bhs+h:1C.4ԇn+x=]2yg裿ۥ6Q?Pj7 ;͕k㑊-zҧRQO=f:Jms$եC,NV
mF{(e!
}3Qpи˽oޗ陝#3#{Z])>o۷k&U	=bc.CgQ/T.LODĈA%g	U2ߙ)H9-*eJlJ|y+B:V9UE
_L(dQj_qd"'._8563Wfk3)oSo'
dB"P<qJh䔔̌+"P|JBQrj|3eohoOF}ʺTl+CbbE:-
x^XX~[dl-n;'B[FGƦoE@Ium	*^!,C]|YEy-C>'wS2z/Q;Ӿ6DoH	oožڱP~bbQ=v{}Όؓ=mG3OcjSrU6i\l!CKӥ3R|)_CPLaumB?'!=~M'21	_tJ.ib4;Pzz{w B(8P{gf,!MG#1+eaSR$xBKF[~MJS0+"īeLzY4e%girwiԲxFK@T+llTe۲gKl"0!-덮,J3KPr+,O(M%KOy3Y0Os*JB	եַ"6%'f3O\f)/L3g4Y@.llemmq%V%~_Imu:s$/__ښjg+C%++ЉXӠ=~|Ԟ [>|6Zǖ9Ճ*tF\~
2TJOz*ܭ'-Q
PuT	c4[a	NGfU'%EHP"S4ӄqGTH?O+ʰlELþcR#F!n,wjK)W?NKC@0r`!Yp]E(AOP]O)pJ?%:RwSꈴϙ'd<ҥto>-A@D*JZ"=.Z&}5?{!1AK"a <y<לw`lZ(FeS
~.Ӣ^hL2,mR+稹'~٦D/Vd[鶝[Qb~hE71Mv?!~7VAy/* ҍ)4DDoKhh0h{=BgON	jwPM#2Bn2?A(g?4AYr伳;#] ~aQOÚJP<Hr ΁
I@/ ]<:4(7	;7K)CY916Ǭ5O@+ [mtGZ^<6˵ ˖%yơbǲ"_Pu5(y+IޗTUx=<kCUzk¡N{TkȚr;&E4A_HоMj~e]k(A1]CtT5;͏f;F[qJDu}'MkFkWre>"<,lVG	yZ{ )_k] Pv6#v10v%5#R	Y>hMEټïrxTZWQ&sFRR>+@J6p/.|	|Mmq)$I]#xC\IM:ÇY@O ?rr-u*
z
1Լ|̸s/jiҩʱeY{GqQ&=<H}mhK??Ju(`^WoDZN$.e8xdZ;M+N%E#UtaŘ9uЋyH'Ӏ0~CJYP
?ʑrt?>s@ߡPr|u^\锨qJTx@F2ъgU^Dʕ>?*~\ꢏ7?UvE"Q(%/}Y
FfWZQ{+}LϢ	ʞqu2ҨG\5eP<p?b>u#ĶOzyLd~;L^]`c3Rڑn]
:Xhcn"sT%Q	}?tP*/MB~(^)H;2@ĭ#4@@3E=샿KR@{mNoާʗX`^ 6T[7;G{U[#)x2d*hcmWN`i/v Ƶ$
~7[z-pgmi#W`~tAgPm6 /:q+<zy>}eNB}P_my@B|k!]	z2>,bm/;b??rJ*RScCԜn:}d) &-t	wh^RU$>h⇵4PBGz ~Jwl"Q	<l1Jhk{kh\dZ}	ȵ+.{CGh;K}A%K:k6Yr4Qk#|ego
$ F=xo؜Qͩ5m	 zU'p?A!jnBMZ{DXc=pUƩ'~|+J {
Yãvyr??*Semd|xC#؇W?:9Og5ujǡHKRҖܷ*.ǡRJYگz/u(@bGoDVmdFy	'2kA	K
ᎇ{J=GЯֳdEtsu信SslTE|.1D"Z\\Lwۺ<::RO~G;H9y@".=bvG?e8h{={`QB-}mi~Qq$ Ag@^7;kvr}xaNq*oS
J[nc9o}Ckd)${\˽'?I$Ze^kᏇ?^މ\ryMI8g|2HݝT}Yq|s}hԙ9.ʔgCrfP<gja;x=i29g|J+#_YHJ{=Uw.^|5REcƒߵ`D:kiy	#Wsԉ;T3TN@RyLdN>=Х"ul|eＳFGBe"6Jv{PK^LӲ0gY淒ug5&(
*F?lQw[-V;d_M;/F@jֽsǹ/OCzK!d<WC{$M:5Ni3ISw +U_GThW֘ME3+eP+'2.m@G;v-u?P'@Iڪ&M^:o%X RjK;X}Ovw˥2"tg9uE{Ƒp L!6o	Qg0+iV4.i vxh \A@s|׎w»qr@+~F;7Νhh |xt; > ¾SPuV).'f閟g^\i3{^c {si4>2z[𒕷	n>NiQ$`U[ hyܮݍ@e?uiss4⽠o\@k@|軀<ok\9-m-FonlZTd.AF誫!;ʷ .j^ȵ)V>TO/ґ~(d*?!3B(OB|d2P~MްT@ҩ1a}rS'>2:"w!ڰ2pN_¦Iw[v_Q?1uOwor8Q*5ƾMu۶E7@C:0LW{!hOAK9{t1c=53^znA0F=|Y@ydT#+?콻˅1XJ{#< uwj^yE2}uN]Q6:#pp*!`3Rv%΢v=KsYj;0[iv7tf*MQ3iAǪanMF0˖p6vj>X̴er*_/O=J9is5i;QMv'a7U?Eq?+aGA#ߧ G6&eE4=y޳:iE{snZ}w2)tɽ=Nu&w<cM{8lcb.%7-}Y CWޙo.S;7Ծ@môd(I8b?ld[P. !$Ƽ3ጻ3θ8v:/~_+M۽s[xV,r=wxJ3xmֶ)Y| H8sbi$wB+e~)<\x9eHg^pd:oHlif{/ڶj?m)+/ebOz+6m6Z;=`P_[l{oưԶHi QGxt9  `/{*j5l77HCˀqʦ(n>FBƨw4j})FPz#u|[2~]$mob!p+ ýa|GÍ=C6~ i`l%"z#p>g E]#`8̦í|l9fZ;]%|0n/h: eyu;}eDNaN Jj9XƗ}c	zܓT7J{ϱzPzc*3(E[2`|OΞƑ9v`S똃lWϳqVrKmeuظFq'vJPn(uүtmBQ/3^{6W8xאC{
>RT˭=y5{#Kۊ:]e\Yynb8.ꏺo]tN~dl[m _z
ua~J)@=dy8; sRd<j:m:u&A_cθB4ee)a>SԙEuڳX#l}-6*r-~s-IF`-zJ\nj?}sW+mIYh۾HɓkPl%CMm'(z10"JoiʿE8D=WӻMJE;gys~@@rgsVYPg>JGL.U,4~S#{>N3ĳT .rK0hnIu=cG];fP^ h}c5~ws}/i/`g4՟G+5PqȿS !" &jGix/h-S5xv8AG;	j6ݬ-.	ցP4--gE]ɋdnx R˱{fтX.}p8Jݬ\{9YA a7
l~J/i|">'D>;f-r`>fQ=GcIyC6Zvm(`e#d)v[?,`0;>[~v1RwXGAW}=z?n{O`ӻ~IcT6";y
:!dupЭebj:ע)~5G7m.g&M0r7ENEVLi!"YQQ|in  qq!|#*H㘆V.fyds0A1mo9Obb%#6iL;UNLN۾EjvAs1~	ph(4199{@n
6.bmeħDBdRyXꘚ%1"!j!"KJuf}կHpѯך-q#qzȨ7ǌ31Ҩ6j%cXq5qKDB/.;.72Nؖeb|܈oP4q}*
QJ|	#]<#4%|eHc'LR o##9'
>|:|}H@c _'.ێRq2/oNZBilK[Ƃy9T|UnU[yyymFGFtUoղYnY[5vnV=aiU[<Lg(t_]nt
Q@@, h|7^l/|`P/z8YIgt|W_C!r̀@ٻK\Uxc*|~
pJUbUBW̭4bY2^h	b]|zzRRCXTCö]}շsP7C=u+0}
N}SqG<#
<iֆRZ!_;\}3R<ߧxL|/sMg@k[o;T}㼞g	^O_61NԷ&/xy}AE(Ҽuaf8 17T8oἻORipނ+6D/m9 [d!FTL?T6!*>;߽IPFP8лgY
u`ө3i'S˖k,Es@[2W=AV>4RUU';_сP9W߂RGǽ=!;N_&O;}ypF<}`:6>Ϩs#⩌:y`CHcӽUV?b1՛2Wz	ޒlE#"cwXNoI!:ʂ~kٻ۳slJ6;jWM u$x(WW/WjNt'cnMVu`:v<%Hbh)w%kk'R1X(
M/sC#//:Fc2hYr(|?1lU`eT6f;2m-):ǧ6=_ێecC;:VrXQ<wE~~W\HRQȯ)-ٍEM( I"TR^lJ6M-.ړj%z>ϨDӭ:
5R$㝨*378( ;٤Mv6ͦ8uSvIZmM^ք,MYdLJ_OP_Zh)-4E_D
DS"hUxCE_wϹ眹r0<OX,:xP5#<'w8R[N"N9y{l-O#1F'|`֦LUX	UNja;5u$?ånTFR;z8]F׵έ,/2z~c&[ⓥxc^2<WZ/;2I!KaCԶ\rKpaS.{ ?6(p҈pWw;]XՄ
vu]A47@H+LӴ8`o!fave*/OWԊUSv[j<\UBI]ROg׶shnYa$/ɧ3y/3Ohib6-Q-0)OȐǧ]Oݰ		#ϰx5F>@VEP13c+P596QpMX >x3ȷW1grvjs&
,ޙTnTw Cfڀ[79V_fsyq'lPCU]jzKՏEh'>*sPf!)uu8x[ZW D;;#رܕkw^n~a7}FXGqrZ]ޚl~$غ~˞((l/,o
˭۶vmkn(-"[Y3{w<]__߮q}]p-AAAAAAAW      &x{^8bPk𽫋bA}k^lGK4]]D7suQgziW_9 Q>Բ0!(<b	Xp,)Q罎=	8(^oF/b_,(;Q%8^Q+,J0wwNE{!K։CJnK;ıcheJiΑ6T961IES%9<+z]0I`APڻ=ط:}l|Ǟ;?~x6NϠ»XWa%^*V|]9P~Sryܱ	ƝS x=
endstream
endobj
107 0 obj
<<
/Filter /FlateDecode
/Length 217
>>
stream
hTPn0[@zbTh\bHŉLK"mOԞ[䅝0`0nap'AFru-W΁WxP<dliKn' 4<+&`z*^idE#B]M(HX۹q{/ݴsFK;R  . kF
endstream
endobj
108 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
109 0 obj
<<
/Length 8928
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (19) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0006 Tc
-0.0036 Tw
12 0 0 12 72 708.96 Tm
[ (gives\040m) 8 (a) -1 (nufacturers\040the\040ability\040to\040se) ] TJ
-0.0001 Tc
0.0001 Tw
14.47 0 Td
(t\040the\040prices\040of\040new\040drugs\040slight) Tj
0.0003 Tc
-0.0003 Tw
12.33 0 Td
(ly\040above\040the\040prices\040of\040existing\040) Tj
0.0002 Tc
-0.0002 Tw
-26.8 -1.725 Td
[ (drugs\040without\040reducing\040quantity\040dem) 8 (a) -1 (nded\056\040As\040co) ] TJ
0.0003 Tc
0.0007 Tw
19.965 0 Td
[ (stlier\040drugs\040com) 8 (e) -1 (\040to\040market\054\040oncologists\040) ] TJ
-0.0012 Tw
-19.965 -1.725 Td
[ (becom) 8 (e) -1 (\040habituated\040to\040higher\040prices\054\040giving\040m) 8 (a) -1 (nufact) ] TJ
0.001 Tc
-0.0022 Tw
21.025 0 Td
[ (ur) 4 (ers\040lee) 5 (w) 3 (ay\040to\040set\040e) 5 (v) 1 (en) ] TJ
0.0003 Tc
-0.0015 Tw
(\040higher\040prices\040in\040the\040) Tj
-0.0011 Tw
-21.025 -1.725 Td
[ (future\056\040The\040characteristics\040of\040the\040m) 8 (a) -6 (rket\040for\040an) ] TJ
0.0001 Tc
-0.0001 Tw
18.6 0 Td
(ticancer\040drugs\054\040including\040) Tj
-0.0001 Tc
0.0001 Tw
10.165 0 Td
(patent\040protection\040that\040) Tj
0.0005 Tc
0.0011 Tw
-28.765 -1.725 Td
[ (protects\040producers\040from) 8 (\040direct\040) ] TJ
0.0002 Tc
-0.0002 Tw
12.335 0 Td
[ (com) 8 (p) -5 (etition\040and\040generous\040third\040party\040paym) 8 (ent\054\040allow\040this\040dynam) 8 (i) -2 (c\040) ] TJ
0.0004 Tc
-0.0004 Tw
-12.335 -1.725 Td
[ (to\040persist\056\040T) 6 (hese\040characteristics\040) ] TJ
0.0006 Tc
-0.001 Tw
12.75 0 Td
[ (are\040present\040in\040other\040m) 8 (e) -1 (dical\040product\040m) 8 (a) -1 (rkets\054\040but\040not\040to\040the\040sam) 8 (e) -1 (\040) ] TJ
0.0004 Tc
-0.0018 Tw
-12.75 -1.725 Td
[ (degree\040as\040in\040the\040anticancer\040drug\040m) 8 (a) -1 (rket\056\040\040) ] TJ
0.001 Tc
-0.001 Tw
3 -1.725 Td
[ (Over\040tim) 9 (e\054\040the\040use\040of) 4 (\040ref) 4 (erence\040p) 6 (r) -1 (ic) 5 (e) 5 (s\040lead) ] TJ
0.0008 Tc
-0.0033 Tw
16.94 0 Td
[ (s\040to\040f) 4 (o) 1 (rward\055look) 6 (ing\040price\040co) 6 (mplem) 9 (entarities\040) ] TJ
0.0001 Tc
-0.0013 Tw
-19.94 -1.725 Td
[ (between\040m) 8 (a) -6 (nufacturers\056\040When\040a\040new\040) ] TJ
0.0004 Tc
-0.002 Tw
(drug\040enters\040with\040a\040price\040in\040ex) Tj
0.0007 Tc
-0.0017 Tw
26.71 0 Td
[ (cess\040of\040the\040referenc) 5 (e\040pric) 5 (e\054\040it\040) ] TJ
0.0003 Tc
-0.0019 Tw
-26.71 -1.725 Td
(re\055establishes\040price\040levels\054\040freeing\040) Tj
0.0008 Tc
-0.0033 Tw
13.86 0 Td
[ (up) 6 (\040the\040next\040entrant\040to\040set\040its\040) 1 (price\040even\040higher\056\040Kah) 6 (n) 1 (em) 9 (an\040et\040) ] TJ
0.0003 Tc
-0.0003 Tw
-13.86 -1.725 Td
[ (al\056\040\0501986\051\040w) 8 (r) -2 (ite\054\040\223\133P\135rice\040incr) ] TJ
-0.0016 Tw
(eases\040that\040are\040not\040ju) Tj
-0.0028 Tw
19.545 0 Td
(stified\040by\040increasing\040) Tj
-0.0019 Tw
8.36 0 Td
(costs\040are\040judged\040less\040) Tj
0.0001 Tc
-0.0001 Tw
-27.905 -1.725 Td
(objectionable\040when\040competitors\040have\040led\040the\040wa) Tj
-0.0009 Tw
19.275 0 Td
[ (y\056\224\040Shortly\040after\040the\040FDA\040approved\040bevazicim) 8 (a) -1 (b\040) ] TJ
0.0002 Tc
0.0014 Tw
-19.275 -1.725 Td
[ (and\040erlotinib\054\040one\040W) 9 (a) ] TJ
0.0004 Tc
-0.0004 Tw
8.66 0 Td
[ (ll\040St\056\040analyst\040noted\072\040\223Com) 8 (panies\040will\040) ] TJ
0.0001 Tc
-0.0009 Tw
14.975 0 Td
(be\040looking\040at\040these\040products\040to\040help\040) Tj
0.0007 Tc
-0.0007 Tw
-23.635 -1.725 Td
[ (them) 9 (\040determine\040the\040p) 6 (r) -1 (ic) 5 (ing\040of) 4 (\040their\040o) 6 (w) 3 (n\040drugs\205T) ] TJ
0.0009 Tc
-0.0023 Tw
20.02 0 Td
[ (arceva\040and) 6 (\040other\040drug) 6 (s\040will\040likely\040ta) 5 (ke\040their\040) ] TJ
0.0005 Tc
-0.0005 Tw
-20.02 -1.725 Td
[ (cue\040from) 8 (\040Er) -6 (bitux\040and\040A) 8 (v) 1 (astin\224\040\050Grif) 9 (f) 4 (ith\0402004\051\056\040) ] TJ
0.0002 Tc
-0.0018 Tw
19.045 0 Td
(According\040to\040textbook\040m) Tj
0 Tc
0 Tw
10.025 0 Td
(onopoly\040pricing\040theory\054\040) Tj
0.0005 Tc
-0.0012 Tw
-29.07 -1.725 Td
[ (the\040price\040of\040Erbitux\040\050generic\040nam) 8 (e) -1 (\040cetuxim) 8 (a) -1 (b\051\040s) ] TJ
0.0002 Tc
-0.0002 Tw
19.13 0 Td
(hould\040have\040had\040no\040direct\040) Tj
0.0005 Tc
-0.003 Tw
10.14 0 Td
(bearing\040on\040th) Tj
0.0002 Tc
-0.0002 Tw
5.27 0 Td
(e\040price\040of\040) Tj
-0.0009 Tw
-34.54 -1.725 Td
[ (Tarceva\040\050generic\040nam) 8 (e) -1 (\040e) -6 (r) -2 (lotinib\051\054\040a\040lung\040and\040pa) ] TJ
-0.0002 Tw
18.995 0 Td
(ncreatic\040cancer\040drug\054\040b) Tj
-0.0002 Tc
0.0018 Tw
9.11 0 Td
[ (ecause\040cetuxim) 8 (a) -1 (b\040was\040not\040) ] TJ
0.0012 Tc
-0.0022 Tw
-28.105 -1.725 Td
[ (a\040com) 9 (p) 1 (etitor) 4 (\040at\040the\040tim) 9 (e\056\040\040) ] TJ
0.0008 Tc
-0.0036 Tw
3 -1.72 Td
[ (If\040a\040) -8 (m) 9 (anufacturer\040sets\040a\040p) 6 (r) -1 (ice\040that\040is\040p) 6 (erceive) ] TJ
-0.0001 Tc
-0.0011 Tw
(d\040as\040exploitative\054\040in\040th) Tj
0.0002 Tc
-0.0014 Tw
26.795 0 Td
[ (e\040s) 4 (e) -1 (nse\040that\040the\040price\040) ] TJ
0.0009 Tc
-0.0037 Tw
-29.795 -1.725 Td
[ (exceeds\040the\040reference\040p) 6 (r) -1 (ice\040to\040a\040large\040degree\054\040) ] TJ
0.0005 Tc
-0.0005 Tw
18.24 0 Td
[ (it\040risks\040provokin) 6 (g) 1 (\040a\040backlash) 6 (\056\040One\040exam) 8 (ple\040of\040) ] TJ
0.0007 Tc
-0.0007 Tw
-18.24 -1.725 Td
[ (where\040this\040h) 6 (appened\040inv) 6 (o) 1 (lved\040a\040seco) 6 (nd\055lin) 6 (e\040treat) ] TJ
0.0004 Tw
19.55 0 Td
[ (m) 8 (e) -1 (nt\040for\040m) 8 (e) -6 (tastatic\040colo) 6 (rectal\040can) 6 (cer\054\040ziv\055) ] TJ
0.0003 Tc
-0.0003 Tw
-19.55 -1.725 Td
[ (aflibercept\040\050brand\040nam) 8 (e) -1 (\040Zaltrap\051\056\040When\040appr) ] TJ
0.0002 Tc
-0.0007 Tw
17.94 0 Td
(oved\040by\040the\040FDA\040in\0402012\054\040its\040price\040was\040double\040that\040) Tj
0.0004 Tc
-0.0004 Tw
-17.94 -1.725 Td
[ (of\040bevacizum) 8 (a) -1 (b\054\040its\040closest\040com) 8 (petitor\054\040at\040bev) ] TJ
0.0002 Tc
-0.0002 Tw
18.27 0 Td
[ (acizum) 8 (a) -1 (b\222s\040common\040dosing\040level\056\040Oncologists\040did\040) ] TJ
0.0004 Tc
-0.0014 Tw
-18.27 -1.725 Td
(not\040view\040ziv\055aflibercept\040as\040particularly\040innova) Tj
0.0005 Tc
-0.0021 Tw
18.47 0 Td
[ (tive\054\040and\040three\040prom) 8 (inent\040physicians\040at\040the\040) ] TJ
0.0007 Tc
-0.0019 Tw
-18.47 -1.725 Td
[ (Mem) 9 (o) 1 (rial\040Sloan\040Ketterin) 6 (g) 1 (\040cancer\040cen) ] TJ
0.0003 Tc
-0.0011 Tw
14.99 0 Td
(ter\040wrote\040an\040opinion\040piece\040in\040the\040) Tj
/TT1 1 Tf
-0.0011 Tc
0.0011 Tw
(New\040York\040Times) Tj
/TT0 1 Tf
0.0006 Tc
-0.0006 Tw
19.745 0 Td
(\040\050Bach\040et\040) Tj
-0.0001 Tc
0.0001 Tw
-34.735 -1.725 Td
(al\056\0402012\051\040stating\040that\040they\040would\040) Tj
0.0004 Tc
-0.0004 Tw
13.19 0 Td
[ (refrain\040from) 8 (\040using\040ziv\055aflibercep) ] TJ
-0.002 Tw
13.08 0 Td
(t\040at\040their\040center\040) Tj
-0.0003 Tw
(because\040of\040its\040) Tj
0.0005 Tc
-0.0013 Tw
-26.27 -1.725 Td
[ (price\056\040One\040month\040later\040the\040m) 8 (a) -1 (nufacturer\054\040Sanof) ] TJ
0.0001 Tc
-0.0009 Tw
18.885 0 Td
(i\054\040announced\040that\040it\040would\040provide\040purchasers\040) Tj
-0.0001 Tw
-18.885 -1.725 Td
(with\040a\04050\040percent\040discount) Tj
0.001 Tc
-0.0018 Tw
10.555 0 Td
[ (\040of) 4 (f) 4 (\040the\040lis) 5 (t\040price\056\040\040\040) ] TJ
0.0006 Tc
-0.0006 Tw
-7.555 -1.725 Td
[ (According\040to\040one\040W) 9 (a) -1 (ll\040Street\040analyst\054\040\223m) ] TJ
0.0002 Tc
-0.0002 Tw
16.52 0 Td
(arket\040structure\040effectively\040provides\040no\040) Tj
0.0008 Tc
-0.0008 Tw
-19.52 -1.725 Td
[ (m) 9 (echanism) 9 (\040for\040price\040con) 6 (t) -1 (rol\040in\040oncology\040othe) ] TJ
0.0009 Tc
-0.0025 Tw
18.28 0 Td
[ (r\040th) 6 (an\040com) 9 (p) 1 (anies\222\040goodw) ] TJ
0.0006 Tc
-0.0022 Tw
10.13 0 Td
(ill\040and\040tolerance\040for\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 468 8 re
S
0 1 1 RG
n
72 688 434 8 re
S
0 1 1 RG
n
72 667 466 8 re
S
0 1 1 RG
n
71 646 451 8 re
S
0 1 1 RG
n
71 626 471 8 re
S
0 1 1 RG
n
71 605 467 8 re
S
0 1 1 RG
n
71 584 198 8 re
S
1 0 0 RG
n
107 564 424 8 re
S
0 1 1 RG
n
71 543 462 8 re
S
0 1 1 RG
n
71 522 458 8 re
S
0 1 1 RG
n
71 501 436 8 re
S
0 1 1 RG
n
71 481 469 8 re
S
0 1 1 RG
n
71 460 458 8 re
S
0 1 1 RG
n
71 439 453 8 re
S
0 1 1 RG
n
71 419 465 8 re
S
0 1 1 RG
n
71 398 463 8 re
S
0 1 1 RG
n
71 377 466 8 re
S
0 1 1 RG
n
71 357 123 8 re
S
1 0 0 RG
n
107 336 425 8 re
S
0 1 1 RG
n
71 315 443 8 re
S
0 1 1 RG
n
71 295 437 8 re
S
0 1 1 RG
n
71 274 464 8 re
S
0 1 1 RG
n
71 253 466 8 re
S
0 1 1 RG
n
71 232 429 8 re
S
0 1 1 RG
n
71 212 463 8 re
S
0 1 1 RG
n
71 191 460 8 re
S
0 1 1 RG
n
71 170 449 8 re
S
0 1 1 RG
n
71 150 218 8 re
S
1 0 0 RG
n
107 129 385 8 re
S
0 1 1 RG
n
71 108 438 8 re
S
Q

endstream
endobj
110 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
111 0 obj
<<
/Length 8506
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (20) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0002 Tc
-0.0002 Tw
12 0 0 12 72 708.96 Tm
(adverse\040publicity\224\040\050Anand\0402007\051\056\040The\040observatio) Tj
0.0004 Tc
-0.0016 Tw
19.605 0 Td
[ (n\040begs\040the\040question\072\040W) 9 (h) -5 (at\040is\040to\040stop\040a\040) ] TJ
-0.0004 Tw
-19.605 -1.725 Td
[ (m) 8 (a) -1 (nufacturer\040from) 8 (\040setting\040the\040price\040of\040a\040dr) ] TJ
0.0002 Tc
0.0008 Tw
17.02 0 Td
[ (ug\040at\040\0441\054000\054000\040or\040m) 8 (ore\077) -6 (\040Dr) ] TJ
0.0005 Tc
0.002 Tw
11.865 0 Td
[ (ug\040m) 8 (a) -1 (nufacturers\222\040are\040) ] TJ
0.0003 Tc
-0.0008 Tw
-28.885 -1.725 Td
[ (able\040to\040set\040higher\040prices\040f) 8 (or\040new\040drugs\054\040but\040they) ] TJ
0 Tc
-0.001 Tw
19.05 0 Td
[ (\040must\040be\040m) 8 (i) -2 (ndful\040of\040phys) ] TJ
0.0007 Tc
-0.0023 Tw
10.02 0 Td
(icians\222\040ability\040to\040exact\040) Tj
0.0005 Tc
-0.0055 Tw
-29.07 -1.725 Td
[ (retribution\040when\040) -10 (m) 8 (a) -1 (nufacturer) ] TJ
0 Tc
0 Tw
12.22 0 Td
[ (s\222\040violate\040physicians\222\040norm) 8 (s) ] TJ
0.0001 Tc
-0.0013 Tw
11.24 0 Td
(\040of\040fairness\040in\040pricing\056\040) Tj
0 Tc
0 Tw
-20.46 -1.725 Td
(\040) Tj
/TT1 1 Tf
-0.0005 Tc
0.0005 Tw
-3 -1.73 Td
(Pricing\040Discounts\040) Tj
/TT0 1 Tf
0 Tc
0 Tw
3 -1.72 Td
(\040) Tj
0.0004 Tc
-0.0012 Tw
0 -1.725 TD
[ (Recent\040increases\040in\040the\040launch\040prices) 5 (\040of) ] TJ
-0.0003 Tw
15.825 0 Td
[ (\040anticancer\040drugs\040m) 8 (a) -1 (y\040be\040an\040unintended\040) ] TJ
0 Tc
-0.0007 Tw
-18.825 -1.725 Td
(consequence\040of\040policies\040to\040expand\040access\040to\040pr) Tj
-0.0008 Tw
18.635 0 Td
(ice\040discounts\056\040The\040so\055called\040340B\040drug\040pricing\040) Tj
0.0006 Tc
-0.0022 Tw
-18.635 -1.725 Td
[ (program) 8 (\054\040authorized\040by\040Congress\040) ] TJ
0.0005 Tc
-0.0017 Tw
13.585 0 Td
[ (in\0401992\054\040requires\040drug\040m) 8 (a) -1 (nufacturer) ] TJ
0.0002 Tc
-0.0002 Tw
14.415 0 Td
(s\040to\040provide\040deep\040discounts\040) Tj
0.0001 Tc
-0.0001 Tw
-28 -1.725 Td
(to\040340B\055qualified\040buyers\056\040At\040the\040) Tj
0 Tc
0 Tw
13.22 0 Td
[ (program) 8 (\222) -2 (s\040inception\054\040only\040federall) ] TJ
0.0002 Tc
-0.0002 Tw
13.66 0 Td
(y\040qualified\040health\040centers\054\040) Tj
0 Tc
-0.0025 Tw
-26.88 -1.725 Td
(specialized\040public\040health\040) Tj
0.0002 Tc
-0.0018 Tw
10.135 0 Td
(clinics\054\040and\040disproportionate\040share\040) Tj
0.0004 Tc
-0.0004 Tw
(hospitals\040\050hospitals\040whose\040patient\040) Tj
0.0001 Tc
-0.0001 Tw
-10.135 -1.725 Td
[ (population\040includes\040a\040high\040proportion\040of\040low\055inco) 3 (m) 8 (e) -1 (\040patients\051\040qualified\040for\040340B\040discounts\056\040) ] TJ
T*
(Discounts\040are\040set\040relative\040to\040the\040average\040price\040w) Tj
0.0005 Tc
-0.0015 Tw
19.16 0 Td
[ (holesalers\054\040retail\040pharm) 8 (acies\054\040and\040providers\040pay\040) ] TJ
0.0003 Tc
-0.0003 Tw
-19.16 -1.725 Td
[ (m) 8 (a) -1 (nufacturers\040to\040purchase\040drugs\054\040called\040the\040) ] TJ
0.0001 Tc
-0.0001 Tw
17.635 0 Td
(\223Average\040Manufacturer\040Price\224\056\040The\040340B\040price\040) Tj
0.0005 Tc
-0.0012 Tw
-17.635 -1.725 Td
[ (discount\040for\040branded\040drugs\040m) 8 (u) 1 (st\040be\040at\040least\040) ] TJ
-0.0002 Tc
0.0002 Tw
17.445 0 Td
(23\0561\040percent\040of\040the\040Averag) Tj
0.0001 Tc
-0.0026 Tw
10.685 0 Td
(e\040Manufacturer\040Price\056\040) Tj
0.0008 Tc
-0.0024 Tw
-28.13 -1.725 Td
[ (Providers\040th) 6 (at\040purch) 6 (ase\040drugs\040throug) 6 (h\040a\040gove) ] TJ
0.0005 Tc
-0.0005 Tw
18.11 0 Td
[ (rnment\055designated\040distribu) 6 (to) 6 (r\040m) 8 (a) -1 (y\040receiv) 6 (e) -1 (\040) ] TJ
0.0007 Tc
-0.0003 Tw
-18.11 -1.725 Td
[ (additional\040d) 6 (i) 4 (scounts\054\040tho) 6 (ugh\040these\040are\040relativ) 6 (ely\040s) 5 (m) 9 (all\054\040totalin) 6 (g) 1 (\040\04467\040m) 9 (illio) 6 (n\040in\0402013\040\050Drug\040) ] TJ
0.0002 Tc
-0.0002 Tw
0 -1.72 TD
(Discount\040Monitor\0402014\051\056\040Participatio) Tj
0.0004 Tc
-0.0004 Tw
14.83 0 Td
[ (n\040in\040the\040340B\040program) 8 (\040is\040attrac) 5 (tive\040f) 8 (or\040health\040care\040providers\040) ] TJ
-0.0014 Tw
-14.83 -1.725 Td
[ (because\040they\040do\040not\040hav) 5 (e) -1 (\040to\040pass\040the\040discount\040on) 5 (\040) ] TJ
-0.0017 Tw
(to\040insurers\056\040They\040profit\040on\040the\040spread\040between\040) Tj
-0.0004 Tw
0 -1.725 TD
[ (third\040party\040payers\222\040drug\040reim) 8 (burse) -6 (m) 8 (e) -1 (nt) ] TJ
0.0002 Tc
-0.001 Tw
15.72 0 Td
(\040rates\040and\040the\040340B\040discounted\040price\056) Tj
0 Tc
0 Tw
7.98 0 0 7.98 438.24 300.54 Tm
(8) Tj
12 0 0 12 442.26 295.0201 Tm
(\040\040) Tj
0.0001 Tc
-0.0009 Tw
-27.855 -1.725 Td
(Since\0401992\054\040Congress\040and\040federal\040regulators\040have\040) Tj
-0.0001 Tw
20.045 0 Td
(broadened\040eligibility\040to\040include\040critical\040) Tj
0.0005 Tc
-0.0005 Tw
-23.045 -1.725 Td
[ (access\040hosp) 6 (i) 3 (tals\054\040free\055s) 5 (tanding\040cancer\040hospitals\054\040) ] TJ
0.0002 Tc
-0.0002 Tw
19.305 0 Td
[ (s) 4 (o) -5 (m) 8 (e) -1 (\040comm) 8 (unity\040hospitals\054\040and\040outpatient\040) ] TJ
-19.305 -1.725 Td
(clinics\040affiliated\040with\040disproportionate\040share\040) Tj
0.0001 Tc
-0.0001 Tw
17.92 0 Td
(hospitals\056\040Mergers\040between) Tj
-0.0001 Tc
0.0001 Tw
10.97 0 Td
(\040340B\040providers\040and\040) Tj
0.0003 Tc
-0.0003 Tw
-28.89 -1.725 Td
(non\055340B\040providers\054\040a\040predictable\040effect\040of\040the\040in) Tj
0.0005 Tc
-0.0021 Tw
19.775 0 Td
[ (centives\040inherent\040in\040the\040program) 8 (\054\040have\040also\040) ] TJ
0.0004 Tc
-0.0004 Tw
-19.775 -1.725 Td
[ (expanded\040the\040program) 8 (\222s\040reach\056\040Due\040to\040changes\040in\040) ] TJ
0.0008 Tc
-0.0016 Tw
20.025 0 Td
[ (elig) 6 (ibility\040r) 4 (u) 1 (les\040and\040m) 9 (ergers\054\040the\040nu) 6 (mber\040of) 4 (\040) ] TJ
0.0004 Tc
-0.0014 Tw
-20.025 -1.725 Td
[ (providers\040in\040the\040340B\040program) 8 (\040increased\040) ] TJ
0.0002 Tc
-0.0007 Tw
16.61 0 Td
[ (from) 8 (\0408\054605\040in\0402001\040to\04016\054572\040in\0402011\040\050US\040General\040) ] TJ
/C2_0 1 Tf
0 Tc
0 Tw
10.98 0 0 10.98 72 144.1801 Tm
[ <0003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003> 81 <0003000300030003000300030003000300030003000300030003000300030003000300030003> ] TJ
ET
72 146.22 144 0.72 re
f
BT
/C2_0 1 Tf
10.98 0 0 10.98 216 144.1801 Tm
<0003> Tj
/TT0 1 Tf
7.98 0 0 7.98 72 135.66 Tm
(8) Tj
0.0004 Tc
0.0003 Tw
12 0 0 12 76.02 130.14 Tm
[ (\040W) 9 (hen\040calcu) 5 (lating\040average\040sales\040p) 5 (r) -2 (ices\040for\040pur) ] TJ
0.0005 Tc
-0.0005 Tw
18.46 0 Td
[ (poses\040of\040Medicare\040reim) 8 (bursem) 8 (e) -1 (nt\054\040regulations\040) ] TJ
0.0002 Tc
-0.0002 Tw
-18.795 -1.15 Td
[ (instruct\040m) 8 (a) -1 (nufacturers\040to\040exclude\040sales\040to\040340B\040) ] TJ
0.0005 Tc
-0.0005 Tw
19.245 0 Td
[ (providers\056\040\040Hence\040Medicare\040reim) 8 (bursem) 8 (e) -1 (nt\040rates\040) ] TJ
0.0001 Tc
-0.0007 Tw
-19.245 -1.15 Td
(are\040not\040affected\040by\040growth\040in\040the\040340B\040discount) Tj
0.0003 Tc
-0.0003 Tw
19.11 0 Td
[ (\040program) 8 (\054\040though\040providers\222\040acquisition\040costs\040are\040) ] TJ
0.0008 Tc
0 Tw
-19.11 -1.15 Td
[ (reduced\056) 6 (\040) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 417 8 re
S
0 1 1 RG
n
72 688 454 8 re
S
0 1 1 RG
n
72 667 457 8 re
S
0 1 1 RG
n
72 646 390 8 re
S
0.9 0.9 0.9 RG
n
107 626 3 8 re
S
0 0 1 RG
n
71 605 90 8 re
S
0.9 0.9 0.9 RG
n
107 584 3 8 re
S
1 0 0 RG
n
107 564 384 8 re
S
0 1 1 RG
n
72 543 450 8 re
S
0 1 1 RG
n
72 522 470 8 re
S
0 1 1 RG
n
72 501 449 8 re
S
0 1 1 RG
n
72 481 453 8 re
S
0 1 1 RG
n
72 460 444 8 re
S
0 1 1 RG
n
72 439 460 8 re
S
0 1 1 RG
n
72 419 442 8 re
S
0 1 1 RG
n
72 398 444 8 re
S
0 1 1 RG
n
72 377 424 8 re
S
0 1 1 RG
n
72 357 434 8 re
S
0 1 1 RG
n
72 336 468 8 re
S
0 1 1 RG
n
72 315 460 8 re
S
0 1 1 RG
n
72 295 376 8 re
S
1 0 0 RG
n
108 274 430 8 re
S
0 1 1 RG
n
72 253 437 8 re
S
0 1 1 RG
n
71 232 448 8 re
S
0 1 1 RG
n
71 212 447 8 re
S
0 1 1 RG
n
71 191 452 8 re
S
0 1 1 RG
n
71 170 447 8 re
S
0.9 0.9 0.9 RG
n
72 144 146 8 re
S
0.5 0.5 0.5 RG
n
72 135 450 8 re
S
0 1 0 RG
n
72 116 467 8 re
S
0 1 0 RG
n
72 102 468 8 re
S
0 1 0 RG
n
72 88 44 8 re
S
Q

endstream
endobj
112 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
113 0 obj
<<
/Length 7909
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (21) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0003 Tc
-0.0011 Tw
12 0 0 12 72 708.96 Tm
(Accounting\040Office\0402011\051\056\040Industry\040sources\040predict\040th) Tj
0.0001 Tc
-0.0001 Tw
21.195 0 Td
[ (at\040the\040volum) 8 (e) -1 (\040of\040dr) -7 (ug\040sales\040under\040the\040340B\040) ] TJ
0.0008 Tc
-0.0008 Tw
-21.195 -1.725 Td
[ (program) 9 (\040will\040increase\040from) 9 (\040\0446\040billio) 6 (n\040in\0402010\040to) ] TJ
0.0002 Tc
-0.001 Tw
19.335 0 Td
(\040\04412\040billion\040in\0402016\040\050Biotechnology\040Industry\040) Tj
0.0001 Tc
-0.0001 Tw
-19.335 -1.725 Td
(Organization\0402013\051\056) Tj
0 Tc
0 Tw
7.98 0 0 7.98 168.66 673.08 Tm
(9) Tj
12 0 0 12 172.68 667.5601 Tm
(\040\040) Tj
0.0004 Tc
-0.001 Tw
-5.39 -1.725 Td
[ (Because\040the\040340B\040discount\040is\040based\040o) 5 (n\040a\040dr) ] TJ
-0.0003 Tw
[ (ug\222s\040average\040p) 5 (r) -2 (ice\054\040the\040program\040presents\040) ] TJ
0.0005 Tc
-0.0021 Tw
-3 -1.725 Td
[ (m) 8 (a) -1 (nufacturers\040with\040an\040in) ] TJ
0.0004 Tc
-0.0004 Tw
9.965 0 Td
(centive\040to\040set\040higher\040launch) Tj
0.0002 Tc
-0.0009 Tw
11 0 Td
(\040prices\040to\040offset\040discounts\056\040Increases\040in\040the\040) Tj
0.0005 Tc
-0.0005 Tw
-20.965 -1.725 Td
[ (num) 8 (b) 1 (er\040of\040340B\055eliglble\040provide) ] TJ
-0.0001 Tc
0.0001 Tw
13.2 0 Td
[ (rs\040have\040m) 8 (a) -1 (gnifi) -7 (ed\040the\040incentive) ] TJ
-0.0011 Tw
(\054\040possibly\040leading\040to\040upward\040) Tj
0.0002 Tc
-0.0002 Tw
-13.2 -1.725 Td
(pressure\040in\040the\040prices\040paid\040by\040non\055eligible\040) Tj
0.0001 Tc
-0.0001 Tw
17.03 0 Td
[ (providers\040\050Conti\040and\040Bach\0402013\051\056\040The\040340B\040program) 8 (\040) ] TJ
0.0006 Tc
-0.0006 Tw
-17.03 -1.725 Td
[ (also\040splits) 5 (\040th) 6 (e\040m) 8 (a) -1 (rket\040into\040price\055elastic\040and\040) ] TJ
0 Tc
0 Tw
17.36 0 Td
[ (price\055inelastic\040segm) 8 (ents\056\040Just\040as\040branded\040drug\040) ] TJ
0.0005 Tc
-0.0005 Tw
-17.36 -1.725 Td
[ (m) 8 (a) -1 (nufacturers\040increas) 5 (e\040p) 6 (r) -1 (ices\040fo) ] TJ
0.0001 Tc
-0.0013 Tw
(llowing\040generic\040entry\040to\040captu) Tj
0.0008 Tc
-0.0024 Tw
24.955 0 Td
[ (re\040revenues\040from) 9 (\040brand\055loyal\040) ] TJ
0.0004 Tc
-0.0004 Tw
-24.955 -1.725 Td
[ (custom) 8 (ers\040\050Frank\040and\040Salkever\0401997\051\054\040m) 8 (a) -1 (nufactur) -3 (ers\040of\040recently\040launched\040drugs\040m) 8 (a) -1 (y\040cede\040large\040) ] TJ
-0.0028 Tw
0 -1.725 TD
[ (discounts\040to\040their\040price\055sensitive\040segm) 8 (ent\040) ] TJ
0 Tc
-0.001 Tw
16.8 0 Td
(but\040increase\040prices\040to\040non\055340B\040providers\056\040) Tj
0.0005 Tc
-0.0012 Tw
-13.8 -1.725 Td
[ (The\040federal\040Medicaid\040program) 8 (\040has\040its\040own\040se) ] TJ
0 Tc
-0.0007 Tw
18.08 0 Td
(t\040of\040drug\040pricing\040rules\056\040In\040exchange\040for\040) Tj
0.0003 Tc
-0.0015 Tw
-21.08 -1.725 Td
[ (for) -7 (m) 8 (ulary\040coverage\040by\040state\040Me) ] TJ
-0.0003 Tw
12.775 0 Td
[ (dicaid\040program) 8 (s\054\040branded\040m) 8 (a) -1 (nuf) ] TJ
0.0007 Tc
-0.0032 Tw
12.985 0 Td
(acturers\040give\040rebates\040to\040the\040) Tj
0.0002 Tc
-0.001 Tw
-25.76 -1.725 Td
[ (federal\040governm) 8 (e) -1 (nt\040on\040sales\040to\040Medicaid\040patients\056) ] TJ
0.0006 Tc
-0.0006 Tw
[ (\040Sim) 8 (ilar\040to\040the\040340B\040program) 8 (\054\040the\040rebate\040is\040) ] TJ
0.0001 Tc
T*
(based\040on\040the\040Average\040Manufacturer\040Price\056\040\040If\040a\040) Tj
0.0004 Tc
-0.0004 Tw
18.99 0 Td
[ (m) 8 (a) -1 (nufacturer\040increases\040the\040price\040of\040a\040drug\040over\040) ] TJ
0.0005 Tc
-0.001 Tw
-18.99 -1.725 Td
[ (and\040above\040the\040rate\040of\040inflation\054\040it\040m) 8 (u) 1 (st\040pay\040a\040larg) ] TJ
0.0003 Tc
-0.0003 Tw
19.47 0 Td
[ (er\040rebate\056\040This\040aspect\040of\040the\040program) 8 (\040provides\040) ] TJ
0.0009 Tc
-0.0012 Tw
-19.47 -1.725 Td
[ (incentives\040f) 9 (o) 1 (r\040f) 4 (i) -1 (rm) 9 (s\040to\040set\040highe) 5 (r\040pr) 4 (ices\040in) 6 (itially\054) 6 (\040rathe) 5 (r) -1 (\040than\040increas) 5 (ing\040pr) 4 (ices\040af) 4 (te) 5 (r\040lau) 6 (n) 1 (ch\056\040) ] TJ
0.0003 Tc
-0.001 Tw
T*
[ (Although\040Medicaid\040acco) 5 (unts\040for\040less\040than\04010\040percen) ] TJ
0.0005 Tc
-0.0005 Tw
20.855 0 Td
[ (t\040of\040spending\040on\040cancer\040treatm) 8 (ent\040\050Howard\040et\040) ] TJ
0.0007 Tc
-0.0007 Tw
-20.855 -1.72 Td
[ (al\056\0402004\051\054\040enrollm) 9 (ent\040in\040the\040program) 9 (\040is\040grow) ] TJ
0 Tc
0 Tw
17.75 0 Td
(ing\054\040presenting\040manufacturers\040with\040additional\040) Tj
0.0002 Tc
-0.0018 Tw
-17.75 -1.725 Td
(incentives\040to\040increase\040prices) Tj
-0.0001 Tc
0.0001 Tw
11.245 0 Td
(\040to\040non\055Medicaid\040patients\056\040) Tj
0.0005 Tc
-0.0013 Tw
-8.245 -1.725 Td
[ (The\040United\040Kingdom) 8 (\040and\040other\040European\040c) ] TJ
0 Tc
-0.0025 Tw
17.33 0 Td
(ountries\040negotiate\040drug\040prices\040with\040) Tj
0.0003 Tc
-0.0003 Tw
-20.33 -1.725 Td
[ (m) 8 (a) -1 (nufacturers\056\040Although\040negotiated\040) ] TJ
0.0005 Tc
-0.003 Tw
14.66 0 Td
(discounts\040are\040not\040legislatively\040li) Tj
0.0001 Tc
-0.0009 Tw
12.725 0 Td
(nked\040to\040the\040US\040price\054\040the\040US\040) Tj
0.0005 Tc
-0.0017 Tw
-27.385 -1.725 Td
[ (price\040m) 8 (a) -1 (y\040serve\040as\040an\040opening\040bid\040in\040negotiations) ] TJ
-0.0002 Tc
0.0002 Tw
19.775 0 Td
(\054\040and\040discounts\040are\040often\040) Tj
0.0005 Tc
-0.0021 Tw
9.995 0 Td
(expressed\040as\040a\040percent\040) Tj
0.0001 Tc
-0.0001 Tw
-29.77 -1.725 Td
(of\040the\040US\040list\040price\040in\040contracts\056\040As\040pressure) Tj
0.0004 Tc
-0.0016 Tw
[ (\040has\040mounted\040on\040governm) 8 (e) -1 (nts\040to\040reign\040in\040health\040) ] TJ
-0.0004 Tw
T*
[ (spending\054\040E) 6 (uropean\040health\040system) 8 (s\040have\040adopted\040a\040) ] TJ
0.0002 Tc
-0.0002 Tw
20.55 0 Td
[ (m) 8 (ore\040aggressive\040bargaining\040stance\054\040backed\040by\040) ] TJ
/C2_0 1 Tf
0 Tc
0 Tw
10.98 0 0 10.98 72 116.58 Tm
[ <0003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003> 81 <0003000300030003000300030003000300030003000300030003000300030003000300030003> ] TJ
ET
72 118.62 144 0.72 re
f
BT
/C2_0 1 Tf
10.98 0 0 10.98 216 116.58 Tm
<0003> Tj
/TT0 1 Tf
7.98 0 0 7.98 72 108.0601 Tm
(9) Tj
0.0003 Tc
-0.0015 Tw
12 0 0 12 76.02 102.54 Tm
(\040This\040figure\040includes\040anticancer) Tj
-0.0003 Tc
-0.0009 Tw
12.61 0 Td
(\040and\040non\055cancer\040drugs\056\040Industry\040) Tj
0.0001 Tc
-0.0013 Tw
12.93 0 Td
(sources\040indicate\040that\040the\040two\040) Tj
0.0004 Tc
-0.0029 Tw
-25.875 -1.15 Td
(therapeutic\040classes\040ha) Tj
0.0001 Tc
-0.0001 Tw
8.665 0 Td
(ving\040the\040largest\040340B\040sales\040are\040anti) Tj
-0.0002 Tc
0.0002 Tw
14 0 Td
(cancer\040drugs\040and\040anti\055infectives\056\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 464 8 re
S
0 1 1 RG
n
72 688 450 8 re
S
0 1 1 RG
n
72 667 106 8 re
S
1 0 0 RG
n
108 646 406 8 re
S
0 1 1 RG
n
72 626 457 8 re
S
0 1 1 RG
n
72 605 447 8 re
S
0 1 1 RG
n
72 584 462 8 re
S
0 1 1 RG
n
72 564 431 8 re
S
0 1 1 RG
n
72 543 442 8 re
S
0 1 1 RG
n
72 522 464 8 re
S
0 1 1 RG
n
72 501 408 8 re
S
1 0 0 RG
n
108 481 405 8 re
S
0 1 1 RG
n
72 460 441 8 re
S
0 1 1 RG
n
72 439 447 8 re
S
0 1 1 RG
n
72 419 456 8 re
S
0 1 1 RG
n
72 398 457 8 re
S
0 1 1 RG
n
72 377 436 8 re
S
0 1 1 RG
n
72 357 471 8 re
S
0 1 1 RG
n
72 336 434 8 re
S
0 1 1 RG
n
72 315 263 8 re
S
1 0 0 RG
n
108 295 376 8 re
S
0 1 1 RG
n
72 274 469 8 re
S
0 1 1 RG
n
72 253 467 8 re
S
0 1 1 RG
n
72 232 443 8 re
S
0 1 1 RG
n
72 212 470 8 re
S
0.9 0.9 0.9 RG
n
72 116 146 8 re
S
0.5 0.5 0.5 RG
n
72 108 450 8 re
S
0 1 1 RG
n
72 88 430 8 re
S
Q

endstream
endobj
114 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
115 0 obj
<<
/Length 8418
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (22) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0002 Tc
-0.0018 Tw
12 0 0 12 72 708.96 Tm
(a\040credible\040threat\040of\040) Tj
-0.0001 Tc
0.0001 Tw
7.775 0 Td
(non\055coverage\054\040potentially\040) Tj
0.0004 Tc
-0.0012 Tw
10.465 0 Td
[ (leading\040m) 8 (a) -1 (nufac) -6 (turers\040to\040set\040higher\040US\040prices\056) ] TJ
0.0038 Tc
0 Tw
7.98 0 0 7.98 513.1799 714.48 Tm
(10) Tj
0 Tc
12 0 0 12 521.22 708.96 Tm
(\040) Tj
0.0006 Tc
-0.0006 Tw
-37.435 -1.725 Td
[ (The\040United\040Kingdom) 8 (\040and\040m) 8 (a) -1 (ny\040other\040) ] TJ
0.0001 Tc
-0.0001 Tw
15.275 0 Td
(countries\040do\040not\040divulge\040negot) Tj
0.0003 Tc
-0.0023 Tw
12.17 0 Td
(iated\040drug\040prices\054\040and\040so\040we\040) Tj
0.0007 Tc
-0.0007 Tw
-27.445 -1.725 Td
[ (are\040unab) 6 (l) -1 (e\040to\040determ) 9 (ine\040whether\040lau) 6 (n) 1 (ch\040prices\040h) 6 (a) ] TJ
0.0001 Tc
-0.0008 Tw
19.63 0 Td
(ve\040increased\040outside\040the\040US\056\040There\040is\040anecdotal\040) Tj
0.0009 Tc
-0.0021 Tw
-19.63 -1.725 Td
[ (evidence\040that\040they\040hav) 6 (e\056\040For\040exam) 9 (ple\054\040a\040num) 9 (ber\040of) ] TJ
0.0005 Tc
-0.0012 Tw
20.265 0 Td
[ (\040signatories\040to\040a\040statem) 8 (ent\040calling\040attention\040to\040) ] TJ
0 Tc
0 Tw
-20.265 -1.725 Td
[ (the\040\223unsustainable\224\040prices\040of\040) 5 (new\040anticancer\040drugs\040were\040European\040physicians\040\050Experts\040in\040) ] TJ
0.0002 Tc
-0.0002 Tw
0 -1.725 TD
[ (Chronic\040Myeloid\040Leukem) 8 (i) -2 (a\0402013\051\056\040) ] TJ
/TT1 1 Tf
0 Tc
0 Tw
0 -1.735 TD
(\040) Tj
/TT2 1 Tf
0.0001 Tc
-0.0001 Tw
0 -1.72 TD
(Other\040potential\040causes) Tj
0.0007 Tc
-0.0023 Tw
9.055 0 Td
[ (\040of\040price\040increa) 6 (ses) 5 (\040) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
-9.055 -1.72 Td
(\040) Tj
0.0002 Tc
-0.0018 Tw
0 -1.725 TD
[ (\040) -2752 (What\040about\040\223obvious\224\040explanat) ] TJ
0.0004 Tc
-0.0029 Tw
15.58 0 Td
(ions\040for\040pricing\040trends\054\040such) Tj
0.0001 Tc
-0.0001 Tw
11.195 0 Td
(\040as\040shifts\040in\040patient\040or\040) Tj
0.0003 Tc
-0.0006 Tw
-26.775 -1.725 Td
[ (physician\040dem) 8 (a) -1 (nd\077) -6 (\040Changes\040on\040the\040dem) 8 (a) -1 (nd\040side\040of\040the\040m) 8 (a) -1 (rke) -6 (t) -2 (\040seem) 8 (\040inconsistent\040with\040observed\040) ] TJ
0 Tc
0 Tw
T*
[ (pricing\040trends\056\040The\040incom) 8 (e) -1 (\040elasticity\040of\040the\040dem) 8 (a) ] TJ
0.0005 Tc
-0.0015 Tw
19.6 0 Td
(nd\040for\040health\040care\040is\040not) Tj
0 Tc
-0.0012 Tw
(\040large\040enough\040to\040account\040) Tj
0.0003 Tc
-0.0031 Tw
-19.6 -1.725 Td
(for\040changes\040in\040prices\040or\040health\040care\040spe) Tj
0.0002 Tc
-0.0012 Tw
15.575 0 Td
[ (nding\040generally\040\050New) 7 (house\0401992\051\056\040Moreover\054\040patient\040) ] TJ
-0.0002 Tw
-15.575 -1.725 Td
(cost\055sharing\040is\040higher\040now\040than\040it\040was\040in\0401995\040as) Tj
-0.0022 Tw
19.53 0 Td
[ (\040consum) 8 (ers\040have\040shifted\040to\040high\055deductible\040) ] TJ
-0.001 Tw
-19.53 -1.725 Td
(plans\040\050Berndt\040and\040Newhouse\0402012\073\040Kaiser\040Fa) Tj
0 Tc
18.225 0 Td
[ (m) 8 (ily\040Foundation\040and\040Health\040Research\040\046\040) ] TJ
0.0003 Tc
-18.225 -1.725 Td
(Educational\040Trust\0402013\051\056\040The\040structure\040of\040insurers) Tj
0.0005 Tc
-0.0005 Tw
20.025 0 Td
[ (\222\040paym) 8 (ents\040to\040physicians\040has\040rem) 8 (a) -1 (ined\040largely\040) ] TJ
0.0004 Tc
-0.0014 Tw
-20.025 -1.725 Td
[ (unchanged\054\040but\040paym) 8 (ent\040levels\040for\040physician\055adm) 8 (i) ] TJ
-0.0003 Tw
20.21 0 Td
(nistered\040anticancer\040drugs\040have\040declined\040) Tj
0.0002 Tc
-0.0014 Tw
-20.21 -1.725 Td
(following\040passage\040of\040the\040Medi) Tj
0 Tc
0 Tw
(care\040Modernization\040Act\040\050J) Tj
0.0002 Tc
-0.0012 Tw
22.635 0 Td
(acobson\040et\040al\056\0402006\073\0402010\051\056\040\040) Tj
0.0001 Tc
-0.0007 Tw
-22.635 -1.72 Td
[ (\040) -2751 (On\040the\040supply\040side\054\040it\040is\040unlikely\040that\040ch) ] TJ
0.0002 Tc
-0.0002 Tw
18.915 0 Td
[ (anges\040in\040developm) 8 (ent\040and\040production\040costs\040alone\040) ] TJ
0.0001 Tc
-0.0001 Tw
-18.915 -1.725 Td
(can\040explain\040launch\040pricing\040trends\056\040The\040FDA\040has\040re) Tj
0.0002 Tc
-0.0002 Tw
20.19 0 Td
(duced\040barriers\040to\040approval\054\040and\040advances\040in\040) Tj
-0.0014 Tw
-20.19 -1.725 Td
(genetics\040have\040facilitated\040drug\040di) Tj
-0.0002 Tc
0.0002 Tw
12.775 0 Td
(scovery\056\040The\040generic\040versions\040of\040) Tj
0.0006 Tc
-0.0018 Tw
13.265 0 Td
[ (anticancer\040drugs\040cos) 5 (t) -2 (\040much\040less\040) ] TJ
0.0001 Tc
-0.0001 Tw
-26.04 -1.725 Td
(than\040the\040branded\040versions\054\040suggesting\040that\040prod) Tj
0.0005 Tc
-0.0017 Tw
18.855 0 Td
(uction\040costs\040are\040low\040rela) Tj
0.0003 Tc
-0.0003 Tw
9.72 0 Td
(tive\040to\040pre\055patent\040) Tj
0.0007 Tc
-0.004 Tw
-28.575 -1.725 Td
[ (expiration\040p) 6 (r) -1 (ice\040levels\056\040Pharm) 9 (aceu) ] TJ
0.0011 Tc
-0.0023 Tw
13.825 0 Td
[ (tical\040m) 9 (anufactures\040often\040c) 5 (l) -1 (aim) 9 (\040th) ] TJ
0.0008 Tc
-0.0018 Tw
13.165 0 Td
[ (at\040they\040set\040drug\040p) 6 (r) 4 (ices\040to\040) ] TJ
0.0004 Tc
-0.0004 Tw
-26.99 -1.725 Td
[ (recoup\040research\040and\040developm) 8 (ent\040costs\056\040Manufact) ] TJ
0.0005 Tc
-0.0005 Tw
19.995 0 Td
[ (urers\222\040research\040and\040developm) 8 (ent\040costs\040m) 8 (a) -1 (y\040) ] TJ
0.0001 Tw
-19.995 -1.725 Td
[ (have\040increased\040over\040tim) 8 (e) -6 (\056\040As\040m) 8 (o) 1 (re\040drugs\040com) 8 (e) -1 (\040to) ] TJ
0.0007 Tc
-0.0007 Tw
19.8 0 Td
[ (\040m) 9 (arket\054\040the\040num) 9 (b) 1 (er\040of\040unexploited\040targets\040for\040) ] TJ
0.0005 Tc
-0.0015 Tw
-19.8 -1.725 Td
[ (anticancer\040therapy\040shrin) 6 (k) 1 (s\054\040requiring) 6 (\040firm) 8 (s\040to) ] TJ
-0.0005 Tw
18.045 0 Td
[ (\040invest\040m) 8 (o) 1 (re\040to\040develop\040new) 8 (\040drugs\056\040Lacking\040) ] TJ
0.0004 Tc
0.0004 Tw
-18.045 -1.725 Td
[ (m) 8 (easures\040of\040research\040and\040developm) 8 (ent\040costs\054\040we) ] TJ
0.0009 Tc
-0.0016 Tw
[ (\040are\040unab) 6 (l) -1 (e\040to\040evaluate\040th) 6 (e\040claim) 9 (\040em) 9 (pirically\056\040) ] TJ
/C2_0 1 Tf
0 Tc
0 Tw
10.98 0 0 10.98 72 154.44 Tm
[ <0003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003000300030003> 81 <0003000300030003000300030003000300030003000300030003000300030003000300030003> ] TJ
ET
72 156.48 144 0.72 re
f
BT
/C2_0 1 Tf
10.98 0 0 10.98 216 154.44 Tm
<0003> Tj
/TT0 1 Tf
0.0038 Tc
7.98 0 0 7.98 72 145.92 Tm
(10) Tj
0.0005 Tc
-0.0019 Tw
12 0 0 12 80.04 140.4001 Tm
[ (\040The\040British\040National\040He) 4 (alth\040Se) 4 (rvice\040and\040ot) ] TJ
0 Tc
0 Tw
17.36 0 Td
(her\040national\040health\040sy) Tj
0.0006 Tc
-0.0006 Tw
8.575 0 Td
[ (stem) 8 (s\040do\040not\040disclose\040) ] TJ
0.0004 Tc
-0.0012 Tw
-26.605 -1.15 Td
[ (negotiated\040prices\054\040and\040so\040we\040cannot\040determ) 8 (in) ] TJ
-0.002 Tw
18.02 0 Td
(e\040whether\040the\040spread\040) Tj
-0.0003 Tw
8.495 0 Td
[ (between\040dom) 8 (e) -1 (stic\040and\040) ] TJ
-26.515 -1.15 Td
(international\040drug\040pric) Tj
-0.0019 Tw
8.945 0 Td
(es\040has\040increased\056\040\040) Tj
/C2_0 1 Tf
0 Tc
0 Tw
10.02 0 0 10.02 72 100.6201 Tm
<0003> Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 452 8 re
S
0 1 1 RG
n
72 688 466 8 re
S
0 1 1 RG
n
72 667 465 8 re
S
0 1 1 RG
n
72 646 464 8 re
S
0 1 1 RG
n
72 626 431 8 re
S
0 1 1 RG
n
72 605 170 8 re
S
0.9 0.9 0.9 RG
n
72 584 3 8 re
S
0 0 1 RG
n
72 563 199 8 re
S
0.9 0.9 0.9 RG
n
72 543 3 8 re
S
1 0 0 RG
n
108 522 391 8 re
S
0 1 1 RG
n
72 501 461 8 re
S
0 1 1 RG
n
72 481 470 8 re
S
0 1 1 RG
n
72 460 445 8 re
S
0 1 1 RG
n
72 439 443 8 re
S
0 1 1 RG
n
72 419 415 8 re
S
0 1 1 RG
n
72 398 465 8 re
S
0 1 1 RG
n
72 377 434 8 re
S
0 1 1 RG
n
72 357 407 8 re
S
1 0 0 RG
n
108 336 429 8 re
S
0 1 1 RG
n
72 315 453 8 re
S
0 1 1 RG
n
72 295 467 8 re
S
0 1 1 RG
n
72 274 427 8 re
S
0 1 1 RG
n
72 253 444 8 re
S
0 1 1 RG
n
72 232 449 8 re
S
0 1 1 RG
n
72 212 461 8 re
S
0 1 1 RG
n
72 191 430 8 re
S
0 1 1 RG
n
72 170 452 8 re
S
0.9 0.9 0.9 RG
n
72 154 146 8 re
S
0.5 0.5 0.5 RG
n
72 145 424 8 re
S
0 1 0 RG
n
72 126 428 8 re
S
0 1 0 RG
n
72 112 193 8 re
S
0.9 0.9 0.9 RG
n
72 100 2 8 re
S
Q

endstream
endobj
116 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
117 0 obj
<<
/Length 7543
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (23) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0003 Tc
-0.0011 Tw
12 0 0 12 72 708.96 Tm
[ (However\054\040research\040and\040developm) 8 (ent\040costs\040are\040su) ] TJ
-0.0009 Tw
[ (nk\040at\040the\040tim) 8 (e\040of\040product\040launch\054\040and\040so\040they\040) ] TJ
0.0001 Tc
0 -1.725 TD
(ought\040not\040to\040factor\040into\040the\040pr) Tj
-0.0001 Tw
11.78 0 Td
[ (icing\040decisions\040of\040a\040profit\055m) 8 (a) -1 (xi) ] TJ
0.0005 Tc
0.0005 Tw
[ (m) 8 (i) -2 (zing\040fir) -6 (m) 8 (\040once\040the\040product\040has\040) ] TJ
0.0007 Tc
0.0003 Tw
-11.78 -1.725 Td
[ (been\040developed\056\040\040W) 10 (e\040believe\040th) ] TJ
0 Tc
-0.001 Tw
12.555 0 Td
(e\040direction\040of\040causation\040runs\040fr) Tj
0.0006 Tc
-0.0006 Tw
12.245 0 Td
[ (om) 8 (\040prices\040to\040research\040and\040) ] TJ
0.0008 Tc
-0.0024 Tw
-24.8 -1.725 Td
[ (developm) 9 (ent\040costs\040\226\040as\040p) 6 (r) -1 (ices\040increas) 5 (es\054\040m) 9 (anuf) ] TJ
0.0005 Tc
-0.0005 Tw
18.85 0 Td
(acturers\040are\040willing\040to\040) Tj
0.0001 Tc
0.0015 Tw
9.005 0 Td
[ (spend\040m) 8 (ore\040to\040discover\040) ] TJ
0 Tc
-0.0006 Tw
-27.855 -1.725 Td
(new\040drugs\040\226\040rather\040than\040the\040other\040way\040around\056\040) Tj
/TT1 1 Tf
0 Tw
0 -1.735 TD
(\040) Tj
0.0005 Tc
0 -1.725 TD
[ (Discussion) 7 (\040) ] TJ
/TT0 1 Tf
0 Tc
0 -1.715 TD
(\040) Tj
0.0008 Tc
-0.0011 Tw
3 -1.725 Td
[ (W) 5 (e\040f) 4 (i) -1 (nd\040that\054\040contro) 6 (lling) 6 (\040f) 4 (o) 1 (r\040inf) 4 (l) -1 (ation) 6 (\040and\040surviva) 5 (l) -1 (\040benef) 4 (its\054\040th) 6 (e\040launch\040p) 6 (r) -1 (ices\040of) 4 (\040new\040) ] TJ
-0.0001 Tw
-3 -1.725 Td
[ (anticancer\040d) 6 (r) -1 (ugs\040have\040in) 6 (creas) 5 (ed\040over\040tim) 9 (e\056\040W) 10 (e\040do\040) ] TJ
0.0002 Tc
-0.0002 Tw
20.19 0 Td
(not\040anticipate\040that\040US\040payers\040and\040providers\040) Tj
0.0005 Tc
-0.001 Tw
-20.19 -1.725 Td
[ (will\040chang) 6 (e) -1 (\040their\040policies\040in\040a\040way\040th) 6 (at\040will\040f) ] TJ
0.0007 Tc
-0.0007 Tw
17.855 0 Td
[ (undam) 9 (entally\040change\040pricing) 6 (\040dynam) 9 (i) -1 (cs\054\040at\040least\040in\040) ] TJ
0.0001 Tc
-0.0001 Tw
-17.855 -1.725 Td
[ (the\040near\040term\056\040The\040Am) 8 (e) -6 (r) -2 (ican\040Society\040of\040Clin) ] TJ
0.0003 Tc
-0.0003 Tw
17.825 0 Td
[ (ical\040Oncology\054\040the\040m) 8 (a) -1 (in\040professional\040group\040for\040) ] TJ
-0.0002 Tc
-0.0023 Tw
-17.825 -1.725 Td
(physicians\040who\040treat\040cancer\040patient) Tj
0.0001 Tc
-0.0001 Tw
14.05 0 Td
[ (s\054\040is\040encouraging\040its\040m) 8 (e) -1 (mbers\040to\040consider\040costs\040when\040they\040) ] TJ
0.0003 Tc
-0.001 Tw
-14.05 -1.725 Td
(choose\040drugs\054\040but\040these\040efforts\040are\040mostly\040focuse) Tj
0.0002 Tc
-0.0002 Tw
19.495 0 Td
[ (d\040on\040costs\040to\040patients\040rather\040than\040system) 8 (\055wide\040) ] TJ
-0.0001 Tc
0.0001 Tw
-19.495 -1.725 Td
(costs\056\040Efforts\040to\040increase\040the\040sensitivity\040of\040) Tj
0.0002 Tc
-0.0002 Tw
16.995 0 Td
[ (physician\040dem) 8 (a) -1 (nd\040to\040drug\040prices\040still\040rely\040on\040) ] TJ
0.0003 Tc
-0.0019 Tw
-16.995 -1.725 Td
(physicians\222\040sense\040of\040fairness\040rather\040than\040thei) Tj
0.0002 Tc
-0.001 Tw
17.715 0 Td
(r\040pocketbooks\056\040A\040Congressional\040advisory\040board\054\040the\040) Tj
0.0004 Tc
-0.0004 Tw
-17.715 -1.725 Td
[ (Medicare\040Paym) 8 (ent\040Advisory\040Comm) 8 (i) -7 (ssion\054\040recently\040held\040a\040hearing\040on\040reform) 8 (ing\040rei) -7 (m) 8 (bursem) 8 (ent\040) ] TJ
0 -1.725 TD
[ (for\040physician\055adm) 8 (i) -2 (nistered\040drugs\056\040M) 5 (a) -1 (ny\040comm) 8 (ittee\040) ] TJ
0.0009 Tc
0.0001 Tw
[ (m) 9 (e) -5 (m) 9 (b) 1 (ers\040voiced\040supp) 6 (ort\040for\040propo) 6 (sals\040th) 6 (at\040) ] TJ
0.0002 Tc
-0.0018 Tw
0 -1.72 TD
[ (would\040reduce\040Medicare\040reim) 8 (burse) -6 (m) 8 (e) -1 (nt) ] TJ
0.0005 Tc
-0.0012 Tw
15.685 0 Td
(\040for\040drugs\040if\040there\040are\040less\040cost) Tj
0.0001 Tc
12.08 0 Td
(ly\040alternatives\040that\040have\040a\040) Tj
0.0005 Tc
-0.0005 Tw
-27.765 -1.725 Td
[ (\223sim) 8 (ilar\040health\040effect\224\040\050InsideH) ] TJ
-0.0002 Tc
0.0002 Tw
12.635 0 Td
(ealthPolicy\0402014\051\056\040However\054\040newl) Tj
0.0002 Tc
-0.0002 Tw
13.69 0 Td
(y\055approved\040anticancer\040drugs\040) Tj
0.0005 Tc
-0.0005 Tw
-26.325 -1.725 Td
[ (are\054\040by\040defin) 6 (ition\054\040un) 6 (ique\054\040and\040will\040p) 6 (r) 4 (obably\040be\040u) 6 (n) ] TJ
0.0004 Tc
-0.0004 Tw
[ (affected\040if\040Medicare\040im) 8 (plem) 8 (ents\040the\040policy\056) 5 (\040) ] TJ
-0.0017 Tw
3 -1.725 Td
[ (To\040supporters\040of\040the\040US\040health\040care\040system) 8 (\054\040) ] TJ
-0.0003 Tw
17.74 0 Td
[ (new\040anticancer\040drugs\040are\040a\040potent\040sym) 8 (bol\040of\040) ] TJ
-0.0023 Tw
-20.74 -1.725 Td
[ (progress\040and\040represent\040the\040type\040of) 6 (\040innovation\040that\040would\040be\040squelc) ] TJ
-0.0024 Tw
26.55 0 Td
(hed\040if\040Medicare\040and\040other\040US\040) Tj
0.0002 Tc
-0.0002 Tw
-26.55 -1.725 Td
[ (insurers\040denied\040coverage\040to\040costly\040treatm) 8 (ents) ] TJ
0.0006 Tc
-0.0006 Tw
18.02 0 Td
[ (\040\050for\040exam) 8 (ple\054\040Gingrich\040) ] TJ
-0.0001 Tc
0.0001 Tw
9.695 0 Td
(2009\051\056\040To\040critics\054\040the\040) Tj
0 Tc
0 Tw
-27.715 -1.725 Td
(pricing\040of\040new\040anticancer\040drugs\040represents\040the\040) Tj
0.0002 Tc
-0.0009 Tw
18.69 0 Td
[ (worst\040excesses\040of\040a\040system) 8 (\040that\040provides\040few\040) ] TJ
0.0003 Tc
-0.0003 Tw
-18.69 -1.725 Td
[ (checks\040on\040drug\040com) 8 (pani) -7 (e) -1 (s\222\040pricing\040power\040and\040prioritizes\040gains\040in\040health\054\040however\040sm) 8 (all\054\040over\040) ] TJ
0.0005 Tc
-0.0005 Tw
0 -1.725 TD
[ (cost\040control\056\040Policym) 8 (akers\040are\040qu) ] TJ
0.0003 Tc
-0.0013 Tw
13.36 0 Td
(ick\040to\040agree\040that\040the\040health\040) Tj
0 Tc
0 Tw
10.83 0 Td
[ (system) 8 (\040should\040discourage\040use\040of\040) ] TJ
0.0007 Tc
-0.0019 Tw
-24.19 -1.725 Td
[ (ineffective\040treatm) 9 (ents\054\040but\040it\040is\040) ] TJ
0 Tc
-0.0016 Tw
12.445 0 Td
(unclear\040how\040regulators\054\040insurers\054\040) Tj
0.0001 Tc
-0.0001 Tw
13.33 0 Td
(and\040physicians\040should\040approach\040) Tj
0.0012 Tc
-0.0012 Tw
-25.775 -1.725 Td
[ (trea) 5 (tm) 9 (ents\040that\040ar) 4 (e\040m) 9 (o) 1 (re\040costly\040bu) 6 (t\040a) 5 (l) ] TJ
0.0011 Tc
-0.0031 Tw
[ (so\040of) 4 (f) 4 (er\040small\040increm) 9 (ental\040ben) 6 (ef) 4 (its\056\040\040) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0 1 1 RG
n
72 708 451 8 re
S
0 1 1 RG
n
72 688 454 8 re
S
0 1 1 RG
n
72 667 423 8 re
S
0 1 1 RG
n
72 646 449 8 re
S
0 1 1 RG
n
72 626 224 8 re
S
0.9 0.9 0.9 RG
n
72 605 3 8 re
S
0 0 1 RG
n
72 584 57 8 re
S
0.9 0.9 0.9 RG
n
72 564 3 8 re
S
1 0 0 RG
n
108 543 409 8 re
S
0 1 1 RG
n
72 522 452 8 re
S
0 1 1 RG
n
72 501 457 8 re
S
0 1 1 RG
n
72 481 441 8 re
S
0 1 1 RG
n
72 460 449 8 re
S
0 1 1 RG
n
72 439 455 8 re
S
0 1 1 RG
n
72 419 420 8 re
S
0 1 1 RG
n
72 398 464 8 re
S
0 1 1 RG
n
72 377 461 8 re
S
0 1 1 RG
n
72 357 457 8 re
S
0 1 1 RG
n
72 336 459 8 re
S
0 1 1 RG
n
72 315 455 8 re
S
0 1 1 RG
n
72 295 454 8 re
S
1 0 0 RG
n
108 274 427 8 re
S
0 1 1 RG
n
72 253 463 8 re
S
0 1 1 RG
n
72 232 435 8 re
S
0 1 1 RG
n
72 212 442 8 re
S
0 1 1 RG
n
72 191 453 8 re
S
0 1 1 RG
n
72 170 448 8 re
S
0 1 1 RG
n
72 150 465 8 re
S
0 1 1 RG
n
72 129 354 8 re
S
Q

endstream
endobj
118 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
119 0 obj
<<
/Length 8561
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (24) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0003 Tc
-0.0011 Tw
12 0 0 12 108 708.96 Tm
[ (The\040optim) 8 (istic\040view\040of\040recent\040trends\040in\040) ] TJ
0.0001 Tc
-0.0021 Tw
(cancer\040drug\040development\040is\040that\040although\040) Tj
0.0004 Tc
-0.0011 Tw
-3 -1.725 Td
[ (individual\040drugs\040m) 8 (a) -1 (ny\040not\040be\040associated\040with\040la) ] TJ
0.0009 Tc
-0.0015 Tw
19.085 0 Td
[ (rg) 6 (e\040gains\040in\040su) 6 (rviva) 5 (l) -1 (\054\040the\040w) 8 (o) 1 (rk\040tha) 5 (t) -1 (\040goe) 5 (s\040into\040) ] TJ
0.0005 Tc
-0.0017 Tw
-19.085 -1.725 Td
(developing\040a\040new\040drug\040contributes) Tj
-0.0003 Tc
-0.0005 Tw
13.84 0 Td
(\040to\040the\040stock\040of\040knowledge\040a) Tj
0.0002 Tc
-0.0002 Tw
11.265 0 Td
[ (bout\040cancer\040biology\056\040E) 6 (ventually\054\040) ] TJ
0.0009 Tc
-0.0017 Tw
-25.105 -1.725 Td
[ (scien) 6 (tis) 5 (ts\040will\040use\040the\040inf) 9 (o) 1 (rm) 9 (ation\040gle) 5 (aned\040f) 4 (r) -1 (om) 9 (\040) ] TJ
0.0004 Tc
-0.0004 Tw
19.29 0 Td
[ (the\040developm) 8 (ent\040of\040existing\040drugs\040to\040develop\040) ] TJ
0.0002 Tc
-0.0002 Tw
-19.29 -1.725 Td
[ (new\040drugs\040with\040m) 8 (uch\040greater\040benefits\056\040The\040pe) ] TJ
0.0005 Tc
-0.0021 Tw
18.33 0 Td
[ (ssim) 8 (i) -2 (stic\040view\040is\040th) ] TJ
0.0002 Tc
-0.0027 Tw
7.635 0 Td
(at\040current\040coverage\054\040) Tj
0.0003 Tc
-0.0015 Tw
-25.965 -1.725 Td
[ (reim) 8 (bursement\054\040and\040patent\040policies\040\050Budi) ] TJ
0.0004 Tw
16.52 0 Td
[ (sh\054\040Roin\040and\040W) 9 (illiam) 8 (s\0402013\051\040di) -7 (vert\040drug\040) ] TJ
-0.0029 Tw
-16.52 -1.725 Td
[ (m) 8 (a) -1 (nufacturers\222\040attention\040away\040) ] TJ
0.0005 Tc
-0.0005 Tw
12.41 0 Td
[ (from) 8 (\040developing\040drugs\040that\040yield\040truly\040m) 8 (eaningful\040survival\040) ] TJ
-0.0021 Tw
-12.41 -1.725 Td
[ (benefits\056\040If\040insurers\040res) 5 (t) -2 (ricted) ] TJ
0.0001 Tc
11.725 0 Td
[ (\040coverage\040to\040drugs\040that\040im) 8 (prove) ] TJ
0.0004 Tc
-0.0004 Tw
12.685 0 Td
[ (d\040survival\040tim) 8 (e\040by\040an\040ec) -6 (onom) 8 (i) -2 (cally\040) ] TJ
0.0002 Tc
-0.0002 Tw
-24.41 -1.725 Td
(significant\040amount\054\040perhaps\040ther) Tj
0.0008 Tc
-0.0008 Tw
12.885 0 Td
[ (e\040would\040be\040m) 9 (o) 1 (re\040of\040them) 9 (\056\040) ] TJ
/TT1 1 Tf
0 Tc
0 Tw
-12.885 -1.735 Td
(\040) Tj
0.0007 Tc
0 -1.15 TD
[ (References) 5 (\040) ] TJ
/TT0 1 Tf
0 Tc
0 -1.14 TD
(\040) Tj
0.0004 Tc
-0.0004 Tw
0 -1.15 TD
[ (Akscin\054\040John\054\040Thom) 8 (as\040R\056\040Barr\054\040and\040Elaine\040L\056\040T) 6 (o) ] TJ
0.0001 Tc
-0.0001 Tw
19.355 0 Td
(wle\056\040\0402007\056\040\040\223Key\040Practice\040Indicators\040in\040Office\055) Tj
-19.355 -1.15 Td
(Based\040Oncology\040Practices\072\0402007\040Report\040on\0402006\040Data\056\224\040\040) Tj
/TT2 1 Tf
-0.0001 Tc
0.0001 Tw
22.83 0 Td
(Journal\040of\040Clinical\040Oncology\040) Tj
/TT0 1 Tf
0.0004 Tc
-0.0004 Tw
11.995 0 Td
(3\0504\051\072\040200\055) Tj
0 Tc
0 Tw
-34.825 -1.15 Td
(3\056\040) Tj
T*
(\040) Tj
0.0001 Tc
-0.0001 Tw
T*
(Anand\054\040Geeta\056\0402007\056\040\223Prescribing\040Caution\072\040From) Tj
0.0005 Tc
-0.0013 Tw
19.605 0 Td
[ (\040Wall\040Street\054\040a\040W) 9 (a) -1 (rning\040About\040Cancer\055Drug\040) ] TJ
-0.0015 Tw
-19.605 -1.15 Td
(Prices\073\040Morgan\040Stanley\040Analyst\040Creates\040Stir) Tj
-0.0001 Tc
-0.0011 Tw
17.7 0 Td
(\040in\040Industry\040As\040He\040Sees\040a\040Backlash\056\224\040\040) Tj
/TT2 1 Tf
0.0017 Tc
-0.0017 Tw
15.27 0 Td
[ (W) 5 (a) 2 (ll\040Str) 6 (eet\040) ] TJ
0.0002 Tc
-0.0002 Tw
-32.97 -1.15 Td
(Journal\054\040March\04015\056) Tj
/TT0 1 Tf
-0.0001 Tc
0.0001 Tw
[ (\040http\072\057\057online\056wsj\056com) 8 (\057) ] TJ
0.0001 Tc
-0.0001 Tw
16.8 0 Td
(news\057articles\057SB117391934158537592\040\040) Tj
0 Tc
0 Tw
-16.8 -1.15 Td
(\040) Tj
0.0004 Tc
-0.0011 Tw
T*
[ (Bach\054\040Peter\040B\056\0402009\056\040\223Lim) 8 (its\040on\040Medicare\047) 6 (s\040Ab) ] TJ
0.0005 Tc
-0.0013 Tw
18.895 0 Td
[ (ility\040to\040Control\040Rising\040Spen) 6 (ding\040on\040Cancer\040) ] TJ
0.0002 Tc
-0.0002 Tw
-18.895 -1.15 Td
(Drugs\056\224\040\040) Tj
/TT2 1 Tf
-0.0001 Tc
0.0001 Tw
3.64 0 Td
(New\040England\040Journal\040of\040Medicine) Tj
/TT0 1 Tf
0 Tc
0 Tw
13.78 0 Td
(\040360\0506\051\072\040626\05533\056\040) Tj
-17.42 -1.145 Td
(\040) Tj
0.0004 Tc
-0.001 Tw
T*
[ (Bach\054\040Peter\040B\056\054\040Leonard\040B\056\040Saltz\054\040and) 5 (\040Robert\040E\056) ] TJ
0.0006 Tc
-0.0027 Tw
19.055 0 Td
[ (\040W) 9 (ittes\056\0402012\056\040\223In\040Cancer\040Care\054\040Cost\040Matters\056\224\040) ] TJ
/TT2 1 Tf
-0.0001 Tc
0.0001 Tw
-19.055 -1.15 Td
[ (The\040New\040Yo) -5 (rk\040Times\054) ] TJ
/TT0 1 Tf
0.0003 Tc
-0.0003 Tw
8.56 0 Td
[ (\040October\04014\056\040http\072\057\057www\056ny) -5 (tim) 8 (es\056co) -5 (m) 8 (\0572012\05710\05715\057) ] TJ
/CS0 cs
0.294 0.675 0.776 scn
-0.0025 Tc
0 Tw
20.28 0 Td
(\040\040\040) Tj
0 g
0 Tc
-28.84 -1.15 Td
(\040) Tj
-0.0012 Tw
T*
(Conti\054\040Rena\040M\056\054\040Peter\040B\056\040Bach\056\0402013\056\040\223Cost\040Cons) Tj
0.0001 Tc
-0.0009 Tw
19.775 0 Td
[ (equences\040of\040the\040340B\040Drug\040Discount\040Program) 8 (\056\224\040) ] TJ
/TT2 1 Tf
-0.0017 Tw
-19.775 -1.15 Td
(Journal\040of\040the\040American) Tj
0.0002 Tc
-0.0002 Tw
9.745 0 Td
(\040Medical\040Association) Tj
/TT0 1 Tf
-0.0003 Tc
0.0003 Tw
8.445 0 Td
(\040309\05019\051\072\0401995\0556\056\040) Tj
0 Tc
0 Tw
-18.19 -1.15 Td
(\040) Tj
T*
(Berndt\054\040Ernst\040R\056\054\040David\040Cutler\054\040Richard\040G\056\040Frank\054) Tj
0.0001 Tc
-0.0001 Tw
(\040Zvi\040Griliches\054\040Joseph\040P\056\040Newhouse\054\040and\040Jack\040) Tj
0.0002 Tc
-0.0002 Tw
T*
(E\056\040Triplett\054\0402000\056\040\223Medical\040Care\040Pr) Tj
-0.0001 Tc
0.0001 Tw
14.11 0 Td
(ices\040and\040Output\054\224\040Chap\056\0403\054\040In\040) Tj
/TT2 1 Tf
0.0003 Tc
-0.0003 Tw
11.91 0 Td
(Handbook\040of\040Health\040) Tj
0.0002 Tc
0 Tw
-26.02 -1.15 Td
(Economics\054\040) Tj
/TT0 1 Tf
-0.0001 Tc
-0.0006 Tw
(Vol\056\0401A\056\040edited\040by\040J\056P\056\040Newhouse\040and\040A\056C\056) Tj
0.0004 Tc
-0.0004 Tw
22.3 0 Td
[ (\040Cul) -7 (yer\056\040Am) 8 (sterdam) 8 (\072) -2 (\040Elsevier\040Science\040) ] TJ
-0.0016 Tc
0 Tw
-22.3 -1.15 Td
[ (B\056V\056) -7 (\040) ] TJ
0 Tc
T*
(\040) Tj
0.0001 Tc
-0.0001 Tw
T*
(Berndt\054\040Ernst\040R\056\054\040and\040Joseph\040P\056\040Newhouse\056) Tj
0.0002 Tc
-0.0002 Tw
17.195 0 Td
[ (\0402012\056\040\040\223Pricing\040and\040Reim) 8 (bursem) 8 (e) -1 (nt\040in\040US\040) ] TJ
0.0005 Tc
-0.0005 Tw
-17.195 -1.15 Td
[ (Pharm) 8 (aceutical\040Markets\056) 6 (\224\040Chap\056\0408\040in\040) ] TJ
/TT2 1 Tf
0.0002 Tc
-0.0002 Tw
15.02 0 Td
(The\040Oxford\040Handbook\040of\040the\040Economics\040of\040the\040) Tj
0.0003 Tc
-0.0003 Tw
-15.02 -1.15 Td
(Biopharmaceutical\040Industry) Tj
/TT0 1 Tf
0 Tc
-0.0008 Tw
11.255 0 Td
(\054\040edited\040by\040P\056M\056\040Danzon\040and\040S\056) Tj
-0.0002 Tc
0.0002 Tw
12.495 0 Td
(N\056\040Nicholson\056\040New\040York\054\040NY\072\040) Tj
-23.75 -1.15 Td
[ (Oxford\040Uni) -7 (versity\040Press\056\040) ] TJ
0 Tc
0 Tw
T*
(\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
1 0 0 RG
n
108 708 390 8 re
S
0 1 1 RG
n
72 688 446 8 re
S
0 1 1 RG
n
71 667 461 8 re
S
0 1 1 RG
n
72 646 451 8 re
S
0 1 1 RG
n
72 626 409 8 re
S
0 1 1 RG
n
72 605 395 8 re
S
0 1 1 RG
n
72 584 433 8 re
S
0 1 1 RG
n
72 564 464 8 re
S
0 1 1 RG
n
72 543 280 8 re
S
0.9 0.9 0.9 RG
n
72 522 3 8 re
S
0.9 0.9 0.9 RG
n
72 508 59 8 re
S
0.9 0.9 0.9 RG
n
72 495 3 8 re
S
0.9 0.9 0.9 RG
n
72 481 459 8 re
S
0.9 0.9 0.9 RG
n
72 467 465 8 re
S
0.9 0.9 0.9 RG
n
72 453 12 8 re
S
0.9 0.9 0.9 RG
n
72 439 3 8 re
S
0.9 0.9 0.9 RG
n
72 426 450 8 re
S
0.9 0.9 0.9 RG
n
72 412 452 8 re
S
0.9 0.9 0.9 RG
n
72 398 396 8 re
S
0.9 0.9 0.9 RG
n
72 384 3 8 re
S
0.9 0.9 0.9 RG
n
72 370 435 8 re
S
0.9 0.9 0.9 RG
n
72 357 290 8 re
S
0.9 0.9 0.9 RG
n
71 343 3 8 re
S
0.9 0.9 0.9 RG
n
71 329 456 8 re
S
0.9 0.9 0.9 RG
n
71 315 356 8 re
S
0.9 0.9 0.9 RG
n
72 301 3 8 re
S
0.9 0.9 0.9 RG
n
72 288 470 8 re
S
0.9 0.9 0.9 RG
n
71 274 306 8 re
S
0.9 0.9 0.9 RG
n
71 260 3 8 re
S
0.9 0.9 0.9 RG
n
71 246 461 8 re
S
0.9 0.9 0.9 RG
n
71 232 414 8 re
S
0.9 0.9 0.9 RG
n
71 219 455 8 re
S
0.9 0.9 0.9 RG
n
71 205 26 8 re
S
0.9 0.9 0.9 RG
n
71 191 3 8 re
S
0.9 0.9 0.9 RG
n
71 177 416 8 re
S
0.9 0.9 0.9 RG
n
71 163 408 8 re
S
0.9 0.9 0.9 RG
n
71 150 435 8 re
S
0.9 0.9 0.9 RG
n
71 136 123 8 re
S
0.9 0.9 0.9 RG
n
71 122 3 8 re
S
Q

endstream
endobj
120 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
121 0 obj
[ /ICCBased 122 0 R ]
endobj
122 0 obj
<<
/Alternate /DeviceRGB
/Filter /FlateDecode
/N 3
/Length 2597
>>
stream
hޜwTTϽwz0z.0. Qf Ml@DEHb!(`HPb0dFJ|yyǽgs{. $O./ 'z8WGб x 0Y驾A@$/7z	HeOOҬT  _lN:K"N3"$F/JPrb[䥟}Qd[Sl1x{#bG\NoX3I[ql2 $8xtr p/8pCfq.Knjm͠{r28?.)ɩL^6 g,qm"[Z[Z~Q7%"
3R `̊j[~ : w! $E}kyhyRm333:}=#vʉe
tqX)I)B>==<8Xȉ9<QDhʸ8Qyl£sy0OZk( 5Hݠ>yP:8p΍Lg	kk	Ѐ $t!0V87`ɀ2A.
@JPA#h'@8.:	``a!2D!UH2 dA>P ECqB**Z:]B=h~L2	5pN:|ó@QC!H,G6 H9R ]H/rAw(Q(OTJCm@*QGQ-(j	MF+6h/*t:].G7Зw7Xa<1:L1 s3bXyeb~19 vGĩp+5qy^oó|=?'Htv`Ba3BDxHxE$Չ "XA<NB%#ɐI.HtttL&kdy'|V"a$%(Q%.1(B/%$V2G\i)SjT)aYitttUI[&_E1
BѠPX-z%8CաzQEoYeYUgdGhMEKNІh(/qZYcI˒%srrrBV;rn;)2*\RV**O(W)VSUVQPNUޯ|QyZ⨒RrVeJjU-S=.Kw'+=5%5O5ZZڼzzz#C#VL[cFSUW3WY^OWkN[G;L{vNNC]nnm=C/QM}XB?^Jl`i58`0z)oiaCaa(Ϩ腱qn^O&&I&&LeLWvjo22mN6w7hir2βZP,|-Yt[|[XNYiZE[U[3F15ziw666&6N.YY^|NݎiWk7bO?d?tsxvlppsJp:ę<b+Z&V]=ν}cyOna/e/W
Wx+}|a{|Z[=O> P44077&9$An0;T2421t.54ld+s;#V]=iY9FgM֚k&=%Ō:nc1gcbcfX.}lGv{c)LŖN퉛w/p+/<j$.$%&㒣OdxTԂԑ4i3|o~C:&S@L	u[Uo3C3OfIgwdO|;W-wsz17jl8c͉̈́3+{%lKWr[$
llGmnacOkE&EEY׾2⫅;K,KhtiN=e²{^-_V^Oo§s]?TWީrjVQ=w}`嚢zԶiו8>k׍
E<hؤT7E7--֢o:}$dwZUQ
ۡ΁S+Nuwv}ojȞ)9K8v\ι/]~pq==/]~bS+vWN_zZu}}m?Xo~FM]:^zmלּ302tw8rx.佤{/gܟ!a#G叕cșQѾ'AOƞӇfܧn>[ly邟~_Y53rW򯎼^{7so}x>|쇊z>yz  
endstream
endobj
123 0 obj
<<
/Length 9025
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (25) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
-0.0001 Tc
-0.0006 Tw
12 0 0 12 72 708.96 Tm
(Berndt\054\040Ernst\040R\056\054\040Linda\040T\056\040Bui\054\040David\040R\056) Tj
0.0003 Tc
-0.001 Tw
16.245 0 Td
[ (\040Reiley\054\040and\040Glen\040L\056\040Urban\056\0401995\056\040\223Inform) 8 (a) -1 (tion\054\040) ] TJ
-0.0015 Tw
-16.245 -1.15 Td
(Marketing\040and\040Pricing\040in\040the\040) Tj
-0.0001 Tc
0.0001 Tw
(US\040Anti\055Ulcer\040Drug\040Market\056\224\040) Tj
/TT1 1 Tf
0.0002 Tc
-0.0002 Tw
23.99 0 Td
(American\040Economic\040Review) Tj
/TT0 1 Tf
0.0004 Tc
-0.0004 Tw
11.275 0 Td
(\04085\0502\051\072\040) Tj
0 Tw
-35.265 -1.15 Td
(100\0555\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 -1.15 TD
(\040) Tj
0 g
0.0002 Tc
-0.0018 Tw
T*
(Biotechnology\040Industry\040Organization\056\0402013\056\040) Tj
/TT1 1 Tf
-0.0001 Tc
0.0001 Tw
17.945 0 Td
(The\040340B\040Drug\040Discount\040Program\056) Tj
/TT0 1 Tf
0 Tc
0 Tw
14.19 0 Td
(\040) Tj
-32.135 -1.15 Td
(http\072\057\057www\056bio\056org\057sites\057de) Tj
0.0002 Tc
-0.0002 Tw
[ (fault\057files\057340B\040percent20W) 9 (hite\040percent20Paper\040) ] TJ
-0.0004 Tc
0.0054 Tw
T*
(percent20FINAL\056pdf\040\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
T*
(\040) Tj
0 g
0.0007 Tc
-0.0003 Tw
T*
[ (Budish\054\040Eric\054\040Benjam) 9 (in\040N\056\040Roin\054\040Heidi\040W) 10 (illiam) 9 (s\056\0402013\056\040\223Do\040Fixed\040Paten) 6 (t) 4 (\040Term) 9 (s\040Distort\040) ] TJ
0.0001 Tc
-0.0017 Tw
T*
[ (Innovation\077) -6 (\040Evidence\040from) 8 (\040Can) ] TJ
0.0004 Tc
-0.0004 Tw
12.795 0 Td
(cer\040Clinical\040Trials\056\224\040) Tj
/TT1 1 Tf
-0.0001 Tc
0.0001 Tw
8.17 0 Td
[ (National\040Bureau\040of\040E) 6 (c) -1 (onomic\040Research) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
(\040) Tj
-0.0001 Tc
0.0001 Tw
-20.965 -1.15 Td
(working\040paper\04019430\056\040) Tj
0 Tc
0 Tw
T*
(\040) Tj
0.0001 Tc
-0.0001 Tw
T*
(Busch\054\040Susan\040H\056\054\040Ernst\040R\056\040Berndt\054\040and\040Richar) Tj
-0.0007 Tw
(d\040G\056\040Frank\056\040\0402001\056\040\223Creating\040Price\040Indexes\040for\040) Tj
-0.0001 Tc
-0.0015 Tw
T*
(Measuring\040Productivity\040in\040Mental) Tj
0 Tc
-0.001 Tw
13.585 0 Td
(\040Health\040Care\056\224\040Chap\056\0405\040in\040) Tj
/TT1 1 Tf
0.0001 Tc
-0.0013 Tw
10.385 0 Td
(Frontiers\040in\040Health\040Policy\040Research\054\040) Tj
0 Tc
0 Tw
-23.97 -1.15 Td
(Vol\056\0404\054\040edited\040by\040) Tj
/TT0 1 Tf
0.0004 Tc
-0.0014 Tw
6.775 0 Td
[ (A\056M\056\040Garber\056\040Cam) 8 (bridge\054\040MA\072\040MIT\040Press\040) ] TJ
0.0007 Tc
-0.0007 Tw
17.165 0 Td
[ (f) 9 (o) 1 (r\040the\040Natio) 6 (n) 1 (al\040Bureau\040o) 6 (f) 4 (\040Econom) 9 (i) -1 (c\040) ] TJ
0 Tw
-23.94 -1.15 Td
[ (Research\056) 6 (\040) ] TJ
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
T*
(\040) Tj
0 g
0.0003 Tc
-0.0007 Tw
T*
[ (Cavalli\054\040F) 7 (r) -2 (anco\056\040\0402013\056\040\040\223An\040Appeal\040to\040W) 9 (orld\040Leaders\072\040S) 7 (t) -2 (op\040Cancer\040Now\056\224\040) ] TJ
/TT1 1 Tf
-0.0004 Tw
30.295 0 Td
(The\040Lancet) Tj
/TT0 1 Tf
0 Tc
0 Tw
(\040) Tj
0.0006 Tc
-0.0056 Tw
-30.295 -1.15 Td
(381\0509865\051\072\040425\0556\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
T*
(\040) Tj
0 g
0.0003 Tc
-0.0003 Tw
T*
[ (Caves\054\040Richard\040E\056\054\040Michael\040D\056\040W) 9 (hinston\054\040and\040) ] TJ
0.0002 Tc
-0.0002 Tw
[ (Mark\040A\056\040Hurwitz\056\0401991\056\040\223P) 6 (atent\040Expiration\054\040Entry\040) ] TJ
0.0009 Tc
-0.0029 Tw
T*
[ (and\040Com) 9 (p) 1 (etition\040in\040the\040US\040Phar) -6 (m) 9 (aceutic) 5 (al\040) ] TJ
0.0005 Tc
-0.0005 Tw
[ (Indu) 6 (stry\072\040An\040Exp) 6 (l) -2 (ora) 4 (t) -2 (ory\040Ana) 4 (l) -2 (ysis\056\224\040) ] TJ
/TT1 1 Tf
-0.0001 Tc
0 Tw
32.195 0 Td
(Brookings\040) Tj
0.0002 Tc
-0.0002 Tw
-32.195 -1.15 Td
(Papers\040on\040Economic\040Activity\056\040Microeconomics\040) Tj
/TT0 1 Tf
-0.0008 Tc
0 Tw
19.055 0 Td
(1\05548) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
(\056\040) Tj
-19.055 -1.15 Td
(\040) Tj
0 g
0.0008 Tc
-0.0033 Tw
T*
(Center\040for\040Medicare\040\046\040Medica) Tj
0.0001 Tc
-0.0001 Tw
12.385 0 Td
(id\040Services\056\0402014\056\040CMS\040proposes\040program\040changes\040for\040Medicare\040) Tj
-12.385 -1.15 Td
(Advantage\040and\040Prescription\040Drug\040Benefit\040Progr) Tj
0.0009 Tw
19.08 0 Td
[ (am) 8 (s\040for\040Contract\040Year\0402015\040\050CMS\0554159\055P\051\056\040) ] TJ
0.0003 Tc
-0.0003 Tw
-19.08 -1.145 Td
[ (January\0406\056\040http\072\057\057www\056cm) 8 (s\056gov\057Ne) -6 (wsroom) 8 (\057Med) ] TJ
0 Tw
19.305 0 Td
[ (iaReleaseDatabase\057Fact\055S) 7 (heets\0572014\055Fact\055) ] TJ
0.0002 Tc
-0.0002 Tw
-19.305 -1.15 Td
[ (sheets\055item) 8 (s) -6 (\057) -2 (2014\05501\05506\056htm) 8 (l) -2 (\040\040) ] TJ
/CS0 cs
0.753 0.314 0.302 scn
0 Tc
0 Tw
12.475 0 Td
(\040) Tj
0.212 0.373 0.569 scn
-12.475 -1.15 Td
(\040) Tj
0 g
0.0002 Tc
-0.0002 Tw
T*
[ (CenterW) 9 (a) -1 (tch\056\0402014\056\040FDA\040Approved\040Drugs\040for\040Oncology) ] TJ
/CS0 cs
0.753 0.314 0.302 scn
0 Tc
0 Tw
(\056\040) Tj
0 g
[ (http\072\057\057www\056centerwatch\056co) -5 (m) 8 (\057drug\055) ] TJ
0.0004 Tc
T*
[ (inform) 8 (ation\057fda\055approved\055) ] TJ
0.0001 Tc
10.665 0 Td
(drugs\057therapeutic\055area\05712\057) Tj
/CS0 cs
0.753 0.314 0.302 scn
-0.005 Tc
(\040\040) Tj
0.212 0.373 0.569 scn
0 Tc
-10.665 -1.15 Td
(\040) Tj
0 g
0.0002 Tc
-0.0002 Tw
T*
[ (Chen\054\040Jie\054\040and\040John\040A\056\040Rizzo\056\0402012\056) 5 (\040\223Pricing\040Dynam) 8 (i) -2 (cs\040and\040Product\040Quality) 5 (\072\040The\040Case\040of\040) ] TJ
T*
(Antidepressant\040Drugs\056\224\040) Tj
/TT1 1 Tf
0.0006 Tc
-0.0006 Tw
9.635 0 Td
[ (Empirical\040E) 6 (c) -1 (onomics) ] TJ
/TT0 1 Tf
-0.0004 Tc
0.0004 Tw
8.64 0 Td
(\04042\0501\051\072\040279\055300\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-18.275 -1.15 Td
(\040) Tj
0 g
0.0003 Tc
-0.0023 Tw
T*
(Conti\054\040Rena\040M\056\054\040Arielle\040C\056\040Bern) Tj
-0.0003 Tw
12.8 0 Td
[ (stein) 5 (\054\040Victoria\040M) 5 (\056\040Villaflor\054\040R) 7 (i) -2 (chard\040L\056\040Schilsky\054\040Meredith\040B\056\040) ] TJ
0.0001 Tc
-0.0007 Tw
-12.8 -1.15 Td
(Rosenthal\054\040and\040Peter\040B\056\040Bach\056\040\0402013\056\040\040\223Preva) Tj
0.0002 Tc
-0.0002 Tw
17.945 0 Td
[ (lence\040of\040Off\055Label\040Use\040and\040S) 6 (pending\040in\0402010\040) ] TJ
0.0004 Tc
-0.002 Tw
-17.945 -1.15 Td
[ (Am) 8 (ong\040Patent\055Protected\040Che) -6 (m) 8 (otherapies\040in) ] TJ
0.0001 Tc
-0.0001 Tw
17.635 0 Td
(\040a\040Population\055Based\040Cohort\040of\040Medical\040) Tj
0.0007 Tc
0 Tw
-17.635 -1.15 Td
[ (Oncologists\056) 6 (\224\040) ] TJ
/TT1 1 Tf
0.0001 Tc
-0.0017 Tw
5.725 0 Td
(Journal\040of\040Clinical\040Oncology\040) Tj
/TT0 1 Tf
-0.0003 Tc
0.0003 Tw
12 0 Td
(31\0509\051\072\0401134\0559\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-17.725 -1.15 Td
(\040) Tj
0 g
0.0001 Tc
-0.0007 Tw
T*
(Conti\054\040Rena\040M\056\054\040and\040Peter\040B\056\040Bach\056\0402013\056\040\223C) Tj
0.0003 Tc
-0.0003 Tw
17.995 0 Td
(ost\040Consequences\040of\040the\040340B\040Drug\040Discount\040) Tj
0.0007 Tc
0 Tw
-17.995 -1.15 Td
[ (Program) 9 (\056\224\040) ] TJ
/TT1 1 Tf
0.0002 Tc
-0.0018 Tw
4.385 0 Td
(Journal\040of\040the\040Americ) Tj
-0.0027 Tw
8.75 0 Td
(an\040Medical\040Association) Tj
/TT0 1 Tf
-0.0003 Tc
0.0003 Tw
9.44 0 Td
(\040309\05019\051\072\0401995\0556\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-22.575 -1.15 Td
(\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0.9 0.9 0.9 RG
n
72 708 429 8 re
S
0.9 0.9 0.9 RG
n
72 695 458 8 re
S
0.9 0.9 0.9 RG
n
72 681 34 8 re
S
0.9 0.9 0.9 RG
n
72 667 3 8 re
S
0.9 0.9 0.9 RG
n
72 653 388 8 re
S
0.9 0.9 0.9 RG
n
72 639 367 8 re
S
0.9 0.9 0.9 RG
n
72 626 108 8 re
S
0.9 0.9 0.9 RG
n
72 612 3 8 re
S
0.9 0.9 0.9 RG
n
72 598 426 8 re
S
0.9 0.9 0.9 RG
n
72 584 445 8 re
S
0.9 0.9 0.9 RG
n
72 570 109 8 re
S
0.9 0.9 0.9 RG
n
72 557 3 8 re
S
0.9 0.9 0.9 RG
n
72 543 444 8 re
S
0.9 0.9 0.9 RG
n
72 529 468 8 re
S
0.9 0.9 0.9 RG
n
72 515 468 8 re
S
0.9 0.9 0.9 RG
n
71 501 50 8 re
S
0.9 0.9 0.9 RG
n
71 488 3 8 re
S
0.9 0.9 0.9 RG
n
71 474 421 8 re
S
0.9 0.9 0.9 RG
n
71 460 90 8 re
S
0.9 0.9 0.9 RG
n
71 446 3 8 re
S
0.9 0.9 0.9 RG
n
71 432 466 8 re
S
0.9 0.9 0.9 RG
n
71 419 439 8 re
S
0.9 0.9 0.9 RG
n
71 405 257 8 re
S
0.9 0.9 0.9 RG
n
71 391 3 8 re
S
0.9 0.9 0.9 RG
n
71 377 463 8 re
S
0.9 0.9 0.9 RG
n
71 363 444 8 re
S
0.9 0.9 0.9 RG
n
71 350 437 8 re
S
0.9 0.9 0.9 RG
n
71 336 153 8 re
S
0.9 0.9 0.9 RG
n
71 322 3 8 re
S
0.9 0.9 0.9 RG
n
71 308 449 8 re
S
0.9 0.9 0.9 RG
n
71 295 260 8 re
S
0.9 0.9 0.9 RG
n
71 281 3 8 re
S
0.9 0.9 0.9 RG
n
71 267 434 8 re
S
0.9 0.9 0.9 RG
n
71 253 301 8 re
S
0.9 0.9 0.9 RG
n
71 239 3 8 re
S
0.9 0.9 0.9 RG
n
71 226 452 8 re
S
0.9 0.9 0.9 RG
n
71 212 438 8 re
S
0.9 0.9 0.9 RG
n
71 198 403 8 re
S
0.9 0.9 0.9 RG
n
72 184 284 8 re
S
0.9 0.9 0.9 RG
n
71 170 3 8 re
S
0.9 0.9 0.9 RG
n
71 157 438 8 re
S
0.9 0.9 0.9 RG
n
71 143 358 8 re
S
0.9 0.9 0.9 RG
n
72 129 3 8 re
S
Q

endstream
endobj
124 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
125 0 obj
<<
/Length 9383
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (26) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0006 Tc
-0.0014 Tw
12 0 0 12 72 708.96 Tm
[ (Conti\054\040Rena\040M\054\040Mered) 6 (ith) 6 (\040B\056\040Rosenthal\054\040Blase\040) ] TJ
0.0002 Tc
-0.0008 Tw
18.475 0 Td
[ (N\056\040Polite\054\040Pe) 4 (ter) 3 (\040B\056\040Bach\054\040and\040Ya\055Chen\040Tina\040Shih\056\040) ] TJ
0.0004 Tc
-0.0004 Tw
-18.475 -1.15 Td
[ (2012\056\040\223Infused\040Chem) 8 (otherapy\040Use\040in\040the\040) ] TJ
0.0001 Tc
-0.0034 Tw
16.64 0 Td
(Elderly\040After\040Patent\040Expiration\056\224\040) Tj
/TT1 1 Tf
0.0002 Tc
-0.0002 Tw
13.465 0 Td
(American\040Journal\040of\040) Tj
0.0003 Tc
-0.0003 Tw
-30.105 -1.15 Td
(Managed\040Care\040) Tj
/TT0 1 Tf
0.0001 Tc
-0.0001 Tw
(18\0505\051\072\040e173\0558\056\040) Tj
0 Tc
0 Tw
0 -1.15 TD
(\040) Tj
0.0001 Tc
-0.0001 Tw
T*
[ (Cockburn\054\040Iain\040M\056\054\040and\040Aslam) 8 (\040H\056\040Anis\056\040\0402001\056\040\223Hedonic\040Analysis\040of\040Arthritis\040Drugs\056\224\040Chap\056\04011\040) ] TJ
0.0011 Tc
0 Tw
T*
(in\040) Tj
/TT1 1 Tf
0.0005 Tc
-0.0017 Tw
1.03 0 Td
(Medical\040Care\040Output\040and\040Productivity) Tj
/TT0 1 Tf
-0.0001 Tc
0.0001 Tw
15.505 0 Td
(\054\040edited\040by\040E\056\040Berndt\040and\040D\056\040Cutler\056\040Chicago\054\040IL\072\040) Tj
-16.535 -1.15 Td
(University\040of\040Chicago\040Press\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
T*
(\040) Tj
0 g
0.0001 Tc
-0.0013 Tw
T*
(Dendreon\056\0402014\056\040Patient\040Access\056\040http\072\057\057www\056dendre) Tj
0 Tc
0 Tw
20.835 0 Td
[ (on\056com) 8 (\057patient\137resources\057patient\137access\057\040) ] TJ
-20.835 -1.15 Td
(\040) Tj
T*
(Drug\040Discount\040Monitor\056\0402014\056\040340B\040Sales\040Totaled\040) Tj
0.0001 Tc
-0.0001 Tw
20.525 0 Td
(\0447\0565\040Billion\040in\0402013\054\040Apexus\040Says\056\040February\040) Tj
0.0002 Tc
-0.0002 Tw
-20.525 -1.15 Td
(14\056\040http\072\057\057drugdiscountmonitor\056co) Tj
0.0001 Tc
0 Tw
13.47 0 Td
[ (m) 8 (\057) -2 (2014\05702\057340b\055sales\055totaled\0557\0555\055) ] TJ
0 Tc
13.945 0 Td
(billion\055in\0552013\055apexus\055says\057) Tj
/CS0 cs
0.58 0.212 0.204 scn
-0.0017 Tc
0.0001 Tw
11.5 0 Td
(\040\040\040\040) Tj
0 g
0 Tc
0 Tw
-38.915 -1.15 Td
(\040) Tj
0.0003 Tc
-0.0011 Tw
T*
[ (Experts\040in\040Chronic\040Myeloid\040Leukem) 8 (i) -2 (a\056\0402013\056\040\223T) ] TJ
0.0002 Tc
-0.0002 Tw
19.495 0 Td
(he\040Price\040of\040Drugs\040for\040Chronic\040Myeloid\040) Tj
0.0004 Tc
-0.0004 Tw
-19.495 -1.15 Td
[ (Leukem) 8 (i) -2 (a\040\050CML\051\040is\040a\040Reflection\040of\040the\040Unsust) ] TJ
-0.0011 Tw
18.695 0 Td
[ (ainable\040Prices\040of\040Cancer\040Drugs\072\040From) 8 (\040the\040) ] TJ
-18.695 -1.15 Td
(Perspective\040of\040a\040Large\040Group\040of\040CML\040Experts\056\224\040) Tj
/TT1 1 Tf
0 Tw
19.52 0 Td
(Blood) Tj
/TT0 1 Tf
-0.0001 Tc
0.0001 Tw
2.39 0 Td
(\040121\05022\051\072\0404439\05542\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-21.91 -1.15 Td
(\040) Tj
0 g
0.0003 Tc
-0.0003 Tw
T*
[ (Fleck\054\040Leonard\056\040\0402013\056\040\042Just\040Caring\072\040Can\040W) 9 (e) -1 (\040Af) ] TJ
0.0002 Tc
-0.0002 Tw
19.315 0 Td
[ (ford\040the\040Ethical\040and\040Econom) 8 (ic\040Costs\040of\040) ] TJ
-19.315 -1.15 Td
[ (Circum) 8 (venting\040Cancer\040Drug\040Resistance\077) -6 (\224) -1 (\040) ] TJ
/TT1 1 Tf
0 Tc
-0.0016 Tw
17.055 0 Td
(Journal\040of\040Personalized\040Medicine) Tj
/TT0 1 Tf
0.0004 Tc
-0.0004 Tw
13.58 0 Td
(\0403\0503\051\072\040124\05543\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-30.635 -1.15 Td
(\040) Tj
0 g
0.0002 Tc
-0.0002 Tw
T*
(Frank\054\040Richard\040G\056\054\040and\040David\040S\056\040Salkever\056\040) Tj
0.0004 Tc
-0.002 Tw
17.17 0 Td
[ (1997\056\040\223Generic\040E) 6 (ntry\040and\040the\040Pricing\040of\040) ] TJ
0.001 Tc
0 Tw
-17.17 -1.15 Td
[ (Pharm) 9 (aceuticals\056\224\040) ] TJ
/TT1 1 Tf
-0.0001 Tc
0.0001 Tw
7.5 0 Td
(Journal\040of\040Economics\040and\040Management\040Strategy) Tj
/TT0 1 Tf
0.0005 Tc
-0.0005 Tw
19.58 0 Td
(\0406\0501\051\072\04075\05590) Tj
/CS0 cs
0.212 0.373 0.569 scn
-0.005 Tc
0 Tw
4.78 0 Td
(\056\040) Tj
0 Tc
-31.86 -1.15 Td
(\040) Tj
0 g
0.0005 Tc
0.0002 Tw
T*
[ (Frey\054\040Bruno\040S\056\054\040and\040W) 9 (e) -1 (rner\040W) 9 (\056) 1 (\040Pomm) 8 (erehne\056\0401993\056\040) ] TJ
0 Tc
-0.0012 Tw
21.05 0 Td
(\223On\040the\040Fairness\040of\040Pr) Tj
0.0012 Tc
-0.0062 Tw
8.945 0 Td
[ (icing\055\055An\040Em) 9 (pirical\040) ] TJ
0.0004 Tc
-0.0004 Tw
-29.995 -1.15 Td
[ (Survey\040am) 8 (ong\040the\040General\040Population\056\224\040) ] TJ
/TT1 1 Tf
0.0001 Tc
-0.0001 Tw
16.22 0 Td
(Journal\040of\040Economic\040Behavior\040and\040Organization\040) Tj
/TT0 1 Tf
0.0005 Tc
0 Tw
19.89 0 Td
(20\0503\051\072\040) Tj
0.0002 Tc
-36.11 -1.15 Td
(295\055307\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 -1.145 TD
(\040) Tj
0 g
0.0003 Tc
-0.001 Tw
0 -1.15 TD
[ (Gingrich\054\040N) 8 (e) -1 (wt\056\0402009\056\040\040\223Trust\040the\040Governm) 8 (e) -1 (nt\056\224\040\040) ] TJ
/TT1 1 Tf
0 Tc
0 Tw
19.94 0 Td
[ (Human\040Ev) -6 (ents) ] TJ
/TT0 1 Tf
-0.0005 Tc
0.0005 Tw
5.865 0 Td
(\056\040August\04012\056\040) Tj
0.0005 Tc
0 Tw
-25.805 -1.15 Td
[ (http\072\057\057hum) 8 (anevents\056com) 8 (\0572009\05708\05712\057trust\055the\055governm) 8 (ent\057\040) ] TJ
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
T*
(\040) Tj
0 g
0.0003 Tc
0.0004 Tw
T*
[ (Goldm) 8 (a) -1 (n\054\040Dana\040P\056\054\040Anupam) 8 (\040B\056\040Jena\054\040Darius\040N\056\040) ] TJ
-0.0001 Tc
-0.0015 Tw
(Lakdawalla\054\040Jennifer\040L\056\040Ma) Tj
0.0002 Tc
-0.0002 Tw
30.245 0 Td
(lin\054\040Jesse\040D\056\040Malkin\054\040) Tj
0.0001 Tc
-0.0001 Tw
-30.245 -1.15 Td
(and\040Eric\040Sun\056\040\0402010\056\040\040\223The\040Value\040of\040Specialty\040Oncology\040Drugs\056\224\040) Tj
/TT1 1 Tf
0.0008 Tc
-0.0033 Tw
26.19 0 Td
[ (Health\040Servic) 5 (e\040Rese) 5 (arch) ] TJ
/TT0 1 Tf
0.0004 Tc
-0.0004 Tw
9.885 0 Td
(\04045\0501\051\072\040) Tj
-36.075 -1.15 Td
(115\05532\056\040\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
T*
(\040) Tj
0 g
0.0004 Tc
-0.0004 Tw
T*
[ (Goldm) 8 (a) -1 (n\054\040Dana\040P\056\054\040Geoff) 3 (r) -2 (ey\040F\056\040Joyce\054\040Grant\040La) ] TJ
0.0007 Tc
0 Tw
19.165 0 Td
[ (wless\054\040W) 10 (illiam) 9 (\040H\056\040Crown\054\040and\040Vince) 5 (n) 1 (t\040W) 10 (illey\056\040\040) ] TJ
0.0001 Tc
-0.0017 Tw
-19.165 -1.15 Td
(2006\040\223Benefit\040Design\040and\040) Tj
0 Tc
-0.0025 Tw
10.66 0 Td
(Specialty\040Drug\040Use\056\224\040) Tj
/TT1 1 Tf
0.0006 Tc
-0.0006 Tw
8.775 0 Td
[ (Health\040Affa) 6 (irs) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
5.695 0 Td
(\04025\0505\051\072\0401319\05531\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
-25.13 -1.15 Td
(\040) Tj
0 g
0.0002 Tc
-0.0002 Tw
T*
(Griffith\054\040Victoria\056\0402004\056\040) Tj
0.0005 Tc
-0.0005 Tw
9.83 0 Td
[ (\223Pricing\040W) 9 (e) -6 (ighs\040on\040Cancer\040Treatm) 8 (ents\056\224\040\040) ] TJ
/TT1 1 Tf
0.0002 Tc
-0.0002 Tw
16.915 0 Td
(Financial\040Times\054\040) Tj
/TT0 1 Tf
-0.0003 Tc
0.0003 Tw
7.03 0 Td
(June\04003\056\040\040) Tj
0.0003 Tc
0 Tw
-33.775 -1.15 Td
[ (http\072\057\057www\056ft\056com) 8 (\057intl\057cm) 8 (s\057s\0570\0578a7697f6\055) ] TJ
0.0002 Tc
[ (b4fa\05511d8\05581c6\055000e2511c801\056htm) 8 (l) -2 (\043axzz38sOrHssv) ] TJ
/CS0 cs
0.969 0.588 0.275 scn
0 Tc
(\040\040\040) Tj
0 g
T*
(\040) Tj
0.0001 Tc
-0.0001 Tw
T*
(Hall\054\040Stephen\040S\056\0402013\056\040\223The\040Cost\040of\040Living\056\224\040) Tj
/TT1 1 Tf
-0.0003 Tc
0.0003 Tw
18.28 0 Td
(New\040York\040Magazine) Tj
/TT0 1 Tf
0.0001 Tc
-0.0001 Tw
8.11 0 Td
(\056\040October\04020\056\040) Tj
0.0007 Tc
0 Tw
-26.39 -1.15 Td
[ (http\072\057\057nym) 9 (ag\056com) 9 (\057news\057feat) ] TJ
-0.0002 Tc
(ures\057cancer\055drugs\0552013\05510\057\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
T*
(\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0.9 0.9 0.9 RG
n
72 708 462 8 re
S
0.9 0.9 0.9 RG
n
72 695 463 8 re
S
0.9 0.9 0.9 RG
n
72 681 147 8 re
S
0.9 0.9 0.9 RG
n
72 667 3 8 re
S
0.9 0.9 0.9 RG
n
72 653 463 8 re
S
0.9 0.9 0.9 RG
n
72 639 435 8 re
S
0.9 0.9 0.9 RG
n
72 626 141 8 re
S
0.9 0.9 0.9 RG
n
72 612 3 8 re
S
0.9 0.9 0.9 RG
n
72 598 452 8 re
S
0.9 0.9 0.9 RG
n
72 584 3 8 re
S
0.9 0.9 0.9 RG
n
72 570 463 8 re
S
0.9 0.9 0.9 RG
n
72 557 478 8 re
S
0.9 0.9 0.9 RG
n
72 543 3 8 re
S
0.9 0.9 0.9 RG
n
72 529 423 8 re
S
0.9 0.9 0.9 RG
n
72 515 426 8 re
S
0.9 0.9 0.9 RG
n
72 501 355 8 re
S
0.9 0.9 0.9 RG
n
72 488 3 8 re
S
0.9 0.9 0.9 RG
n
72 474 423 8 re
S
0.9 0.9 0.9 RG
n
72 460 436 8 re
S
0.9 0.9 0.9 RG
n
72 446 3 8 re
S
0.9 0.9 0.9 RG
n
72 432 401 8 re
S
0.9 0.9 0.9 RG
n
72 419 388 8 re
S
0.9 0.9 0.9 RG
n
72 405 3 8 re
S
0.9 0.9 0.9 RG
n
72 391 459 8 re
S
0.9 0.9 0.9 RG
n
72 377 465 8 re
S
0.9 0.9 0.9 RG
n
72 363 46 8 re
S
0.9 0.9 0.9 RG
n
72 350 3 8 re
S
0.9 0.9 0.9 RG
n
72 336 371 8 re
S
0.9 0.9 0.9 RG
n
72 322 285 8 re
S
0.9 0.9 0.9 RG
n
72 308 3 8 re
S
0.9 0.9 0.9 RG
n
72 295 464 8 re
S
0.9 0.9 0.9 RG
n
72 281 467 8 re
S
0.9 0.9 0.9 RG
n
72 267 43 8 re
S
0.9 0.9 0.9 RG
n
72 253 3 8 re
S
0.9 0.9 0.9 RG
n
72 239 460 8 re
S
0.9 0.9 0.9 RG
n
72 226 382 8 re
S
0.9 0.9 0.9 RG
n
72 212 3 8 re
S
0.9 0.9 0.9 RG
n
72 198 451 8 re
S
0.9 0.9 0.9 RG
n
72 184 467 8 re
S
0.9 0.9 0.9 RG
n
72 170 3 8 re
S
0.9 0.9 0.9 RG
n
72 157 382 8 re
S
0.9 0.9 0.9 RG
n
72 143 270 8 re
S
0.9 0.9 0.9 RG
n
72 129 3 8 re
S
Q

endstream
endobj
126 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
127 0 obj
<<
/Length 9451
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (27) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0001 Tc
-0.0001 Tw
12 0 0 12 72 708.96 Tm
[ (Hirth\054\040Richa) 4 (r) -2 (d\040A\054\040Micha) 4 (e) -1 (l\040E\056\040Cherne) 4 (w\054\040Edwa) ] TJ
0.0003 Tc
0.0004 Tw
18.27 0 Td
[ (rd\040Miller\054\040A\056\040M) 5 (a) -1 (rk\040Fendrick) 5 (\040and\040W) 9 (illia) 4 (m\040G\056\040) ] TJ
0.0005 Tc
-0.0005 Tw
-18.27 -1.15 Td
[ (Weissert\056\04020) 6 (00\056\040\223) -6 (W) 9 (illing) 6 (n) 1 (ess\040to\040Pay\040for\040a\040Quality\055Adju) ] TJ
-0.0012 Tw
22.195 0 Td
[ (sted\040Lif) 9 (e) -1 (\040Year\072\040In\040Search\040of\040a\040Standard\056\224\040) ] TJ
/TT1 1 Tf
0.0003 Tc
-0.0028 Tw
-22.195 -1.15 Td
(Medical\040Decision\040Making) Tj
/TT0 1 Tf
-0.0003 Tw
10.385 0 Td
(\04020\0503\051\072\040332\05542\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-10.385 -1.15 Td
(\040) Tj
0 g
0.0001 Tc
-0.0001 Tw
0 -1.15 TD
(Howard\054\040David\040H\056\0402014\056\040\223Drug\040Companies\222\040Patien) Tj
0.0005 Tc
-0.0005 Tw
20.47 0 Td
[ (t\055Assistance\040Program) 8 (s\040\226\040Helping\040Patients\040or\040) ] TJ
0.0016 Tc
0 Tw
-20.47 -1.15 Td
[ (Prof) 5 (its) 6 (\077\224\040) ] TJ
/TT1 1 Tf
-0.0003 Tc
0.0003 Tw
(New\040England\040Journal\040of\040Medicine) Tj
/TT0 1 Tf
0 Tc
0 Tw
17.585 0 Td
(\056\040371\0502\051\072\04097\0559) Tj
/CS0 cs
0.212 0.373 0.569 scn
-0.005 Tc
5.525 0 Td
(\056\040) Tj
0 Tc
-23.11 -1.15 Td
(\040) Tj
0 g
T*
[ (Howard\054\040David\040H\054\040John\040Kauh\054\040and\040Jose) -2 (ph\040Lipscom) 8 (b\056\0402010\056\040\223The\040Value\040of\040New\040) ] TJ
0.0004 Tc
-0.0004 Tw
T*
[ (Che) -6 (m) 8 (otherapeutic\040Agents\040for\040Meta) ] TJ
0 Tc
-0.0016 Tw
14.135 0 Td
(static\040Colorectal\040Cancer\056\224\040\040) Tj
/TT1 1 Tf
0.0007 Tc
-0.0023 Tw
10.8 0 Td
[ (Archives\040o) 6 (f) -1 (\040Interna) 6 (l) -1 (\040Medicine) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
(\040) Tj
-24.935 -1.15 Td
(170\0506\051\072\040537\05542\056\040\040) Tj
T*
(\040) Tj
0.0004 Tc
-0.0004 Tw
T*
[ (Howard\054\040David\040H\056\054\040Carolyn\040Kenline\054) 5 (\040Hilla) 4 (rd\040M\056) ] TJ
-0.0012 Tw
19.25 0 Td
[ (\040Lazarus\054\040Ch) 5 (arles\040F\056\040Le) 4 (Maistre\054\040Ric) 4 (hard\040T\056\040) ] TJ
0 Tc
0 Tw
-19.25 -1.15 Td
(Maziarz\054\040Philip\040L\056\040McCarthy\040Jr\056\054\040Susan\040K\056\040Pa) Tj
0.0001 Tc
-0.0001 Tw
(rsons\054\040David\040Szwajcer\054\040Ja) Tj
0 Tc
-0.0016 Tw
28.475 0 Td
(mes\040Douglas\040Rizzo\040and\040) Tj
0.0001 Tc
0.0007 Tw
-28.475 -1.15 Td
[ (Navneet\040S\056\040Majhail\056\0402011\056\040\223Abandonm) 8 (ent\040of\040Hi) ] TJ
0 Tc
0 Tw
19.19 0 Td
[ (gh\040Dose\040Chemotherapy\057He) -6 (m) 8 (a) -1 (topoietic\040Cell\040) ] TJ
0.0007 Tc
-0.0023 Tw
-19.19 -1.15 Td
[ (Transplan) 6 (t) -1 (s\040for\040Breast\040Cancer\056\224\040) ] TJ
/TT1 1 Tf
-0.0001 Tc
-0.0024 Tw
12.92 0 Td
(Health\040Services\040Research) Tj
/TT0 1 Tf
-0.0004 Tc
0.0004 Tw
10.27 0 Td
(\04046\0506\051\072\0401762\05577\056\040) Tj
0 Tc
0 Tw
-23.19 -1.15 Td
(\040) Tj
0 -1.155 TD
(Howard\054\040David\040H\056\054\040Nicole\040A\056\040Molinari\054\040and\040) Tj
0.0002 Tc
-0.0002 Tw
17.72 0 Td
[ (Kenneth\040E\056\040Thorpe\056\0402004\056\040National\040Estim) 8 (ates\040of\040) ] TJ
0.0001 Tc
-0.0001 Tw
-17.72 -1.32 Td
(Medical\040Costs\040Incurred\040by\040Non\055Elderly\040Cancer\040Patients\056\040) Tj
/TT1 1 Tf
-0.0006 Tc
0 Tw
22.885 0 Td
(Cancer) Tj
/TT0 1 Tf
-0.0001 Tc
0.0001 Tw
(\040100\0505\051\072\040883\226891\056\040) Tj
0.0002 Tc
-0.0014 Tw
-22.885 -2.15 Td
[ (Hutchison\054\040Courtney\056\0402) 5 (010\056\040\223Provenge\040Cancer) ] TJ
0.0003 Tc
-0.0009 Tw
18.635 0 Td
(\040Vaccine\072\040Can\040You\040Put\040a\040Price\040on\040Delaying\040) Tj
0.0008 Tc
-0.0008 Tw
-18.635 -1.15 Td
[ (Death) 6 (\077) -5 (\224\040\040) ] TJ
/TT1 1 Tf
-0.0019 Tc
0.0019 Tw
3.78 0 Td
(ABC\040News) Tj
/TT0 1 Tf
0.0003 Tc
-0.0003 Tw
4.295 0 Td
[ (\056\040July\04029\056\040\040http\072\057\057abcnews\056go\056com) 8 (\057H) ] TJ
0 Tw
14.22 0 Td
(ealth\057ProstateCancerNews\057provenge\055) Tj
0.0001 Tc
-22.295 -1.15 Td
[ (cancer\055vaccine\055m) 8 (onths\055life\055worth\055100k\057story\077id\07511269159) ] TJ
/CS0 cs
0.969 0.588 0.275 scn
0 Tc
24 0 Td
(\040\040) Tj
0.212 0.373 0.569 scn
-24 -1.15 Td
(\040) Tj
0 g
-0.0012 Tw
0 -1.15 TD
(IMS\040Institute\040for\040Healthcare\040Info) Tj
0.0003 Tc
-0.0028 Tw
13.215 0 Td
(rmatics\056\0402014\056\040\223Innovation\040in\040Cancer) Tj
0.0006 Tc
-0.0018 Tw
14.83 0 Td
[ (\040C) 8 (a) -1 (re\040and\040Im) 8 (pl) -7 (ications\040for\040) ] TJ
0.0001 Tc
-0.0001 Tw
-28.045 -1.15 Td
[ (Health\040System) 8 (s\072\040Global\040Oncol) ] TJ
0.0004 Tc
-0.0016 Tw
12.19 0 Td
(ogy\040Trend\040Report\224\040Available\040at\072\040) Tj
0.0005 Tc
0 Tw
-12.19 -1.15 Td
[ (http\072\057\057www\056im) 8 (shealth\056com) 8 (\057portal\057site\057im) 8 (shealth\057m) 8 (enuite) -6 (m) 8 (\056) 1 (7) -4 (62a961826aad98f53c753c71ad8c22) ] TJ
-0.0005 Tc
T*
[ (a\057\077) -7 (vgnextoid\075f8d4df7a) -7 (5e) ] TJ
0.0001 Tc
10.285 0 Td
(8b5410VgnVCM10000076192ca2RCRD\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
-10.285 -1.15 Td
(\040) Tj
0 g
-0.0001 Tc
0.0001 Tw
T*
(InsideHealthPolicy\056\0402014\056\040MedPAC) Tj
0.0003 Tc
-0.0003 Tw
14.44 0 Td
[ (\040Explores\040Fixes\040To\040Part\040B\040Drug\040Paym) 8 (ent\040Policy\054\040Calls\040) ] TJ
0.0008 Tc
-0.0008 Tw
-14.44 -1.15 Td
[ (Current\040System) 9 (\040\221Perverse\040Incen) 6 (tive) 5 (\222) ] TJ
0.0004 Tc
-0.0004 Tw
[ (\056) 5 (\040http\072\057\057www\056pipcpatients\056) 5 (org\057pip) 5 (c\055) ] TJ
0 Tc
0 Tw
T*
[ (adm) 8 (i) -2 (n\057pdf\057cde114\137MedPAC\04520Explores\04520Fix) ] TJ
0.0003 Tc
20.105 0 Td
[ (es\04520To\04520Part\04520B) 7 (\04520Drug\04520Paym) 8 (e) -1 (n) ] TJ
0 Tc
-20.105 -1.15 Td
(t\04520Policy\056pdf\040) Tj
T*
(\040) Tj
0.0008 Tw
T*
[ (Jacobson\054\040Mireille\054\040A\056\040Jam) 8 (e) -1 (s\040O\222Malley\054\040Craig\040C\056) ] TJ
0.0006 Tc
-0.0014 Tw
19.58 0 Td
[ (\040Earle\054\040Ju) 6 (lian) 6 (a) -1 (\040Pakes\054\040Peter\040Gaccion) 6 (e\054) 6 (\040and\040) ] TJ
0.0005 Tc
-0.0005 Tw
-19.58 -1.15 Td
[ (Joseph\040P\056Newhouse\056\0402006\056\040\223Does\040Reim) 8 (burse) -6 (m) 8 (e) -1 (nt) ] TJ
0.0004 Tc
-0.0016 Tw
20.085 0 Td
[ (\040Influence\040Che) -6 (m) 8 (otherapy\040Treatm) 8 (e) -1 (nt\040for\040) ] TJ
0.0006 Tc
-0.0006 Tw
-20.085 -1.15 Td
[ (Cancer\040Patients) 5 (\077\224\040) ] TJ
/TT1 1 Tf
7.39 0 Td
[ (Health) 6 (\040Affairs) ] TJ
/TT0 1 Tf
-0.0005 Tc
0.0005 Tw
5.695 0 Td
(\04025\0502\051\072\040437\05543\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-13.085 -1.15 Td
(\040) Tj
0 g
T*
[ (Jacobson\054\040Mireille\054\040Craig\040C\056\040Earle\054\040Mary\040) -2 (Price\054\040and\040Joseph\040P\056\040Newhouse\056\0402010\056\040\223How\040) ] TJ
0.0007 Tc
-0.0007 Tw
T*
[ (Medicare\047) 6 (s\040paym) 9 (ent\040cuts\040for\040cancer\040chem) 9 (othera) ] TJ
0.0004 Tc
-0.0012 Tw
19.09 0 Td
[ (py\040drugs\040changed\040patterns\040of\040treatm) 8 (ent\056\224\040\040) ] TJ
/TT1 1 Tf
0.0006 Tc
0 Tw
16.775 0 Td
(Health\040) Tj
0.0011 Tc
-35.865 -1.15 Td
(Affairs) Tj
/TT0 1 Tf
-0.0005 Tc
0.0005 Tw
2.73 0 Td
(\04029\0507\051\072\0401391\0559\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-2.73 -1.15 Td
(\040) Tj
0 g
-0.0001 Tc
0.0001 Tw
T*
[ (Kahne) -6 (m) 8 (a) -1 (n\054\040Daniel\054\040Jack\040L\056\040Knetsch\054\040and\040Richard\040) ] TJ
0.0001 Tc
-0.0001 Tw
20.02 0 Td
(H\056\040Thaler\054\0401986\056\040\223Fairness\040as\040a\040Constraint\040on\040) Tj
0.0008 Tc
-0.0028 Tw
-20.02 -1.15 Td
[ (Prof) 4 (it\040Seeking\072\040Entitlem) 9 (ents\040in\040the\040Market\056) 6 (\224\040) ] TJ
/TT1 1 Tf
-0.0001 Tc
0.0001 Tw
17.915 0 Td
[ (A) 6 (m) 2 (erican\040Economic\040Review) ] TJ
/TT0 1 Tf
0.0003 Tc
-0.0003 Tw
(\04076\0504\051\072\040728\05541\056\040) Tj
0 Tc
0 Tw
-17.915 -1.15 Td
(\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0.9 0.9 0.9 RG
n
72 708 435 8 re
S
0.9 0.9 0.9 RG
n
72 695 465 8 re
S
0.9 0.9 0.9 RG
n
72 681 199 8 re
S
0.9 0.9 0.9 RG
n
72 667 3 8 re
S
0.9 0.9 0.9 RG
n
72 653 460 8 re
S
0.9 0.9 0.9 RG
n
72 639 283 8 re
S
0.9 0.9 0.9 RG
n
72 626 3 8 re
S
0.9 0.9 0.9 RG
n
72 612 387 8 re
S
0.9 0.9 0.9 RG
n
72 598 445 8 re
S
0.9 0.9 0.9 RG
n
72 584 81 8 re
S
0.9 0.9 0.9 RG
n
72 570 3 8 re
S
0.9 0.9 0.9 RG
n
72 557 440 8 re
S
0.9 0.9 0.9 RG
n
72 543 458 8 re
S
0.9 0.9 0.9 RG
n
72 529 443 8 re
S
0.9 0.9 0.9 RG
n
72 515 359 8 re
S
0.9 0.9 0.9 RG
n
72 501 3 8 re
S
0.9 0.9 0.9 RG
n
72 488 447 8 re
S
0.9 0.9 0.9 RG
n
72 472 398 8 re
S
0.9 0.9 0.9 RG
n
72 446 435 8 re
S
0.9 0.9 0.9 RG
n
72 432 446 8 re
S
0.9 0.9 0.9 RG
n
72 418 294 8 re
S
0.9 0.9 0.9 RG
n
72 405 3 8 re
S
0.9 0.9 0.9 RG
n
72 391 465 8 re
S
0.9 0.9 0.9 RG
n
71 377 305 8 re
S
0.9 0.9 0.9 RG
n
71 363 463 8 re
S
0.9 0.9 0.9 RG
n
71 349 329 8 re
S
0.9 0.9 0.9 RG
n
71 336 3 8 re
S
0.9 0.9 0.9 RG
n
71 322 438 8 re
S
0.9 0.9 0.9 RG
n
71 308 344 8 re
S
0.9 0.9 0.9 RG
n
71 294 466 8 re
S
0.9 0.9 0.9 RG
n
72 280 78 8 re
S
0.9 0.9 0.9 RG
n
72 267 3 8 re
S
0.9 0.9 0.9 RG
n
72 253 439 8 re
S
0.9 0.9 0.9 RG
n
72 239 435 8 re
S
0.9 0.9 0.9 RG
n
71 225 233 8 re
S
0.9 0.9 0.9 RG
n
71 211 3 8 re
S
0.9 0.9 0.9 RG
n
71 198 416 8 re
S
0.9 0.9 0.9 RG
n
71 184 467 8 re
S
0.9 0.9 0.9 RG
n
71 170 108 8 re
S
0.9 0.9 0.9 RG
n
71 156 3 8 re
S
0.9 0.9 0.9 RG
n
71 142 461 8 re
S
0.9 0.9 0.9 RG
n
71 129 426 8 re
S
0.9 0.9 0.9 RG
n
71 115 3 8 re
S
Q

endstream
endobj
128 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
129 0 obj
<<
/Length 9558
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (28) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
0.0003 Tc
-0.0003 Tw
12 0 0 12 72 708.96 Tm
[ (Kaiser\040Fam) 8 (ily\040Foundation\040and\040Health\040) ] TJ
-0.0003 Tc
-0.0009 Tw
15.36 0 Td
(Research\040\046\040Educational\040Trust\056\0402013\056\040) Tj
/TT1 1 Tf
0.0004 Tc
-0.0004 Tw
15.075 0 Td
(Employer\040Health\040) Tj
0.0002 Tc
-0.0002 Tw
-30.435 -1.15 Td
(Benefits\056\0402013\040Annual\040Survey) Tj
/TT0 1 Tf
0.0003 Tc
-0.0003 Tw
11.835 0 Td
[ (\056\040W) 9 (a) -1 (shington\054\040D\056C\056\072\040Kaiser\040Fam) 8 (ily\040Founda) -6 (tion\040and\040Health\040) ] TJ
0.001 Tc
-0.006 Tw
-11.835 -1.15 Td
[ (Research\040\046\040Educationa) 5 (l\040Trust\056) ] TJ
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
12.325 0 Td
(\040) Tj
0 g
-12.325 -1.15 Td
(\040) Tj
0.0005 Tc
-0.0013 Tw
0 -1.15 TD
[ (Kalyanaram) 8 (\054\040Gurum) 8 (u) 1 (rthy\054\040and\040John\040D\056C\056\040Little\056\0401994\056\040) ] TJ
0.0002 Tc
-0.0002 Tw
(\223An\040Empirical\040Analysis\040of\040Latitude\040of\040) Tj
0.0006 Tc
-0.0016 Tw
T*
[ (Price\040Accep) 6 (tance\040in\040Consum) 8 (er\040Package\040Goods\056\224\040) ] TJ
/TT1 1 Tf
0.0005 Tc
-0.0005 Tw
19.745 0 Td
[ (Journal\040of\040C) 8 (onsumer\040Research) ] TJ
/TT0 1 Tf
-0.0003 Tc
0.0003 Tw
12.475 0 Td
(\04021\0503\051\072\040408\05518\056\040) Tj
0 Tc
0 Tw
-32.22 -1.15 Td
(\040) Tj
-0.0003 Tc
0.0003 Tw
T*
(Lakdawalla\054\040Darius\040N\054\040John\040A\056\040) Tj
0 Tc
0 Tw
12.66 0 Td
(Romley\054\040Yuri\040Sanchez\054\040J\056\040Ro) Tj
0.0002 Tc
-0.0012 Tw
11.64 0 Td
(ss\040Maclean\054\040John\040R\056\040Penrod\054\040and\040) Tj
0 Tc
-0.0008 Tw
-24.3 -1.15 Td
[ (Tom) 8 (a) -1 (s\040Philipson\056\0402012\056\040\223How\040Canc) -6 (er\040Patients\040Va) ] TJ
0.0006 Tc
-0.0014 Tw
20.055 0 Td
[ (lue\040Hope\040and\040the\040Im) 8 (plications\040for\040Cost\055) ] TJ
0.0005 Tc
-0.0005 Tw
-20.055 -1.15 Td
[ (Effectivenes) 5 (s\040Assessm) 8 (ents\040of\040High\055Cost\040Cancer\040T) 6 (h) 1 (erapies\056\224\040) ] TJ
/TT1 1 Tf
24.47 0 Td
[ (H) 8 (e) -1 (alth\040Affair) 5 (s) 5 (\040) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
(31\0504\051\072\040676\05582\056\040\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
-24.47 -1.15 Td
(\040) Tj
0 g
0.0003 Tc
0.0003 Tw
T*
[ (Landsem) 8 (\054\040Hope\056\0402013\056\040\223Rationing\040H) 8 (ealth\040Care\040in\040Oregon\056\224\040\040) ] TJ
/TT1 1 Tf
0.0002 Tc
-0.0027 Tw
(Wall\040Street\040Journal) Tj
/TT0 1 Tf
0.0003 Tc
-0.0003 Tw
32.085 0 Td
(\054\040August\0408\056\040\040) Tj
0.0001 Tc
0 Tw
-32.085 -1.15 Td
[ (http\072\057\057online\056wsj\056com) 8 (\057) -2 (news\057articles\057S) 6 (B) 2 (10001424127887324522504579000560184822956) ] TJ
/CS0 cs
1 0 0 scn
0 Tc
(\040\040) Tj
0.212 0.373 0.569 scn
T*
(\040) Tj
0 g
0.0004 Tc
-0.0012 Tw
T*
[ (Kantarjian\054\040Hagop\040M\054\040Tito\040Fojo\054\040M) 5 (i) 3 (chael\040M) 5 (a) ] TJ
-0.0011 Tw
18.135 0 Td
[ (thisen\054\040and\040Leo) 5 (nard\040A\056\040Zwelling\056\0402013\056\040\223Cancer\040) ] TJ
-0.0003 Tw
-18.135 -1.15 Td
[ (Drugs\040in\040the\040United\040States\072\040Justum) 8 (\040Pretium) 8 (\055\055The\040Just\040Price\056\224\040) ] TJ
/TT1 1 Tf
24.605 0 Td
[ (Journal\040of\040C) 7 (linical\040Oncology) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
11.75 0 Td
(\040) Tj
0.0003 Tc
-0.0003 Tw
-36.355 -1.15 Td
(31\05028\051\072\0403600\0554\056\040\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
T*
(\040) Tj
0 g
-0.0004 Tc
0.0004 Tw
T*
[ (Lichtenberg\054\040Frank\056\0402009\056\040\223The\040Effec) -7 (t) -3 (\040of\040New\040Ca) ] TJ
0.0004 Tc
-0.0012 Tw
19.94 0 Td
(ncer\040Drug\040Approvals\040on\040the\040Life\040Expectancy\040) Tj
-0.0003 Tw
-19.94 -1.15 Td
[ (of\040Am) 8 (erican\040Cancer\040Patients\054\0401978\0552004\056\224\040) ] TJ
/TT1 1 Tf
0.0002 Tc
-0.0012 Tw
17.3 0 Td
(Economics\040of\040Innovation\040and\040New\040Technology\040) Tj
/TT0 1 Tf
0.0005 Tc
0 Tw
18.945 0 Td
(18\0505\051\072\040) Tj
0.0003 Tc
-36.245 -1.15 Td
(407\05528\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
T*
(\040) Tj
0 g
-0.0002 Tc
0.0002 Tw
T*
(Lichtenberg\054\040Frank\040R\056\040\0402009\056\040\040\223Inter) Tj
0 Tc
-0.0016 Tw
14.415 0 Td
(national\040Differences\040in\040Cancer\040) Tj
-0.0001 Tc
-0.0011 Tw
(Survival\040Rates\072\040The\040Role\040of\040) Tj
0.0003 Tc
-0.0003 Tw
-14.415 -1.15 Td
(New\040Drug\040Launches\056\224\040) Tj
/TT1 1 Tf
0.0002 Tc
-0.0018 Tw
9.22 0 Td
[ (International\040Journal\040of\040H) 7 (e) -1 (a) ] TJ
0 Tc
0 Tw
11.58 0 Td
(lthcare\040Technology\040and\040Management) Tj
/TT0 1 Tf
0.0004 Tc
-0.0004 Tw
(\04010\0503\051\072\040) Tj
0 Tw
-20.8 -1.15 Td
(138\05555) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
(\056\040) Tj
T*
(\040) Tj
0 g
0.0004 Tc
0.0002 Tw
0 -1.145 TD
[ (Lu\054\040Z\056\040John\040and\040W) 9 (illiam) 8 (\040S\056\040Com) 8 (a) -1 (nor) -7 (\056\0401998\056\040\223Str) ] TJ
0.0002 Tc
-0.0002 Tw
[ (ategic\040P) 6 (r) -2 (icing) 5 (\040of\040New\040Pha) -6 (r) -2 (m) 8 (aceuticals) 4 (\056\040) ] TJ
/TT1 1 Tf
0.0005 Tc
0 Tw
35.52 0 Td
(Review\040) Tj
0.0002 Tc
-0.0002 Tw
-35.52 -1.15 Td
(of\040Economics\040and\040Statistics\040) Tj
/TT0 1 Tf
0 Tc
0 Tw
11.28 0 Td
(80\0501\051\072\040108\05518\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
-11.28 -1.15 Td
(\040) Tj
0 g
0.0002 Tc
-0.0002 Tw
0 -1.15 TD
[ (Lucarelli\054\040Claudio\054\040and\040S) 6 (ean\040Nichols) 4 (on\054\0402009\054\040\223A\040) ] TJ
0.0005 Tc
-0.0017 Tw
[ (Quality\055A) 8 (djusted\040Price\040Index\040for\040Colorectal\040) ] TJ
-0.0005 Tw
T*
[ (Cancer\040Dru) 6 (g) 1 (s\056\224\040) ] TJ
/TT1 1 Tf
0.0002 Tc
-0.0014 Tw
(National\040Bureau\040of\040Economic\040Research) Tj
/TT0 1 Tf
-0.0001 Tc
0.0001 Tw
(\040working\040paper\04015174) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
31.215 0 Td
(\056\040\040) Tj
-31.215 -1.15 Td
(\040) Tj
0 g
0.0002 Tc
-0.0002 Tw
T*
[ (Malin\054\040Jennifer\040L\054\040Jane\040C\056\040W) 9 (eeks\054\040Arnold\040L\040Po) -1 (tosky\054\040Mark\040C) 7 (\056\040Hornbrook\054\040and\040Nancy\040L\040Keating\056\040) ] TJ
0.0001 Tc
-0.0001 Tw
T*
(2013\056\040\040\223Medical\040Oncologists\222\040Perceptions\040of) Tj
0 Tc
-0.001 Tw
17.83 0 Td
(\040Financial\040Incentives\040in\040Cancer\040Care\056\224\040) Tj
/TT1 1 Tf
0.0001 Tc
-0.0001 Tw
15.52 0 Td
(Journal\040of\040) Tj
0.0005 Tc
-0.0005 Tw
-33.35 -1.15 Td
[ (Clinica) 6 (l) -2 (\040Oncology) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
(\04031\0505\051\072\040530\0555) Tj
/CS0 cs
0.212 0.373 0.569 scn
-0.005 Tw
12.64 0 Td
(\056\040\040) Tj
0 Tw
-12.64 -1.15 Td
(\040) Tj
0 g
0.0003 Tc
-0.0003 Tw
T*
[ (Marcus\054\040Amy\040D\056\0402004\056\040\223Price\040Becom) 8 (e) -1 (s\040Factor\040in\040Cancer\040Treatm) 8 (e) -1 (nt\056\224\040) ] TJ
/TT1 1 Tf
-0.0001 Tc
-0.0024 Tw
28.105 0 Td
(Wall\040Street\040Journal) Tj
/TT0 1 Tf
0 Tc
0 Tw
7.83 0 Td
(\040) Tj
0.0002 Tc
-0.0002 Tw
-35.935 -1.15 Td
[ (Septem) 8 (ber\0407\056\040http\072\057\057online\056ws) ] TJ
0 Tw
[ (j\056com) 8 (\057) -2 (news\057articles\057SB109450779986210547\040) ] TJ
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
T*
(\040) Tj
0 g
0.0001 Tc
-0.0001 Tw
T*
(Mas\054\040Alexandre\056\0402006\056\040\223Pay\054\040Reference\040) Tj
0.0003 Tc
-0.0015 Tw
16.135 0 Td
[ (Points\054\040and\040Police\040Perform) 8 (a) -1 (nce\056\224\040\040) ] TJ
/TT1 1 Tf
-0.0004 Tw
13.74 0 Td
(Quarterly\040Journal\040of\040) Tj
0 Tw
-29.875 -1.15 Td
(Economics\040) Tj
/TT0 1 Tf
0 Tc
4.64 0 Td
(121\0503\051\072\040783\055821\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
-4.64 -1.15 Td
(\040) Tj
0 g
0.0001 Tc
-0.0001 Tw
T*
(Maxwell\054\040Sarah\056\0402002\056\040\223Rule\055Based\040) Tj
0.0004 Tc
-0.0004 Tw
14.69 0 Td
[ (Price\040Fairness\040and\040Its\040Effect\040on\040W) 9 (illingness\040to\040Pu) 5 (rchase\056) 5 (\224) -1 (\040) ] TJ
/TT1 1 Tf
-14.69 -1.15 Td
[ (Journal\040of\040E) 6 (c) -1 (onomic\040Psychology\040) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
13.5 0 Td
(23\0502\051\072\040191\055212\056\040\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
-13.5 -1.15 Td
(\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0.9 0.9 0.9 RG
n
72 708 450 8 re
S
0.9 0.9 0.9 RG
n
72 695 425 8 re
S
0.9 0.9 0.9 RG
n
72 681 150 8 re
S
0.9 0.9 0.9 RG
n
72 667 3 8 re
S
0.9 0.9 0.9 RG
n
72 653 451 8 re
S
0.9 0.9 0.9 RG
n
72 639 461 8 re
S
0.9 0.9 0.9 RG
n
72 626 3 8 re
S
0.9 0.9 0.9 RG
n
72 612 451 8 re
S
0.9 0.9 0.9 RG
n
72 598 431 8 re
S
0.9 0.9 0.9 RG
n
71 584 440 8 re
S
0.9 0.9 0.9 RG
n
72 570 3 8 re
S
0.9 0.9 0.9 RG
n
72 557 444 8 re
S
0.9 0.9 0.9 RG
n
72 543 438 8 re
S
0.9 0.9 0.9 RG
n
72 529 3 8 re
S
0.9 0.9 0.9 RG
n
72 515 451 8 re
S
0.9 0.9 0.9 RG
n
72 501 439 8 re
S
0.9 0.9 0.9 RG
n
72 488 81 8 re
S
0.9 0.9 0.9 RG
n
72 474 3 8 re
S
0.9 0.9 0.9 RG
n
72 460 458 8 re
S
0.9 0.9 0.9 RG
n
72 446 466 8 re
S
0.9 0.9 0.9 RG
n
72 432 40 8 re
S
0.9 0.9 0.9 RG
n
72 419 3 8 re
S
0.9 0.9 0.9 RG
n
72 405 459 8 re
S
0.9 0.9 0.9 RG
n
72 391 464 8 re
S
0.9 0.9 0.9 RG
n
72 377 40 8 re
S
0.9 0.9 0.9 RG
n
72 363 3 8 re
S
0.9 0.9 0.9 RG
n
72 350 464 8 re
S
0.9 0.9 0.9 RG
n
72 336 207 8 re
S
0.9 0.9 0.9 RG
n
72 322 3 8 re
S
0.9 0.9 0.9 RG
n
72 308 457 8 re
S
0.9 0.9 0.9 RG
n
72 295 383 8 re
S
0.9 0.9 0.9 RG
n
72 281 3 8 re
S
0.9 0.9 0.9 RG
n
72 267 469 8 re
S
0.9 0.9 0.9 RG
n
72 253 453 8 re
S
0.9 0.9 0.9 RG
n
72 239 160 8 re
S
0.9 0.9 0.9 RG
n
72 226 3 8 re
S
0.9 0.9 0.9 RG
n
72 212 434 8 re
S
0.9 0.9 0.9 RG
n
72 198 363 8 re
S
0.9 0.9 0.9 RG
n
72 184 3 8 re
S
0.9 0.9 0.9 RG
n
72 170 461 8 re
S
0.9 0.9 0.9 RG
n
72 157 139 8 re
S
0.9 0.9 0.9 RG
n
72 143 3 8 re
S
0.9 0.9 0.9 RG
n
72 129 457 8 re
S
0.9 0.9 0.9 RG
n
72 115 243 8 re
S
0.9 0.9 0.9 RG
n
72 101 3 8 re
S
Q

endstream
endobj
130 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
131 0 obj
<<
/Length 9522
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (29) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
12 0 0 12 72 708.96 Tm
(National\040Comprehensive\040Cancer\040Network\056\0402010\056\040) Tj
0.0003 Tc
-0.0003 Tw
19.8 0 Td
(Guidelines\040for\040Breast\040Cancer\040Updated\073\040) Tj
0.0001 Tc
-0.0001 Tw
-19.8 -1.15 Td
[ (Bevacizum) 8 (a) -1 (b\040Recomme) -6 (ndation\040Affirm) 8 (ed\056\040) ] TJ
0 Tw
0 -1.15 TD
(http\072\057\057www\056nccn\056org\057about\057new) Tj
-0.0003 Tc
0.0003 Tw
12.72 0 Td
(s\057newsinfo\056asp\077NewsID\040\075\040259) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
12.25 0 Td
(\056\040) Tj
0 g
-24.97 -1.15 Td
(\040) Tj
0.0004 Tc
-0.0004 Tw
T*
[ (National\040Cancer\040Institute\056\0402014\056\040Cancer\040Drug\040Inf) 8 (orm) 8 (ation\056\040) ] TJ
0.0001 Tc
0 Tw
T*
(http\072\057\057www\056cancer\056gov\057cancert) Tj
0 Tc
12.33 0 Td
(opics\057druginfo\057alphalist) Tj
/CS0 cs
0.212 0.373 0.569 scn
-0.005 Tc
(\040\040) Tj
0 Tc
-12.33 -1.15 Td
(\040) Tj
0 g
0.0008 Tc
-0.0008 Tw
T*
[ (Neum) 9 (ann\054\040Peter\040J\056\0402005\056\040) ] TJ
/TT1 1 Tf
0.0007 Tc
-0.0015 Tw
10.085 0 Td
[ (Using\040Cost\055) 4 (E) 2 (ffec) 5 (tiv) 5 (enes) 5 (s\040Analysis\040to) 6 (\040Improve\040Health\040Care) ] TJ
/TT0 1 Tf
-0.0003 Tc
0.0003 Tw
23.5 0 Td
(\056\040Oxford\054\040) Tj
-0.0001 Tc
0.0001 Tw
-33.585 -1.15 Td
[ (United\040Kingdom) 8 (\073) -2 (\040Oxfor) -7 (d\040University\040Press\056\040) ] TJ
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
T*
(\040) Tj
0 g
0.0003 Tc
-0.0013 Tw
T*
(Newhouse\054\040Joseph\040P\056\0401992\056\040Medical\040Care) Tj
-0.0001 Tc
-0.0009 Tw
16.665 0 Td
[ (\040Costs\072\040How\040Much\040Welfare\040Loss\077) -6 (\040) ] TJ
/TT1 1 Tf
0.0002 Tc
-0.0002 Tw
13.83 0 Td
(Journal\040of\040Economic\040) Tj
0.0006 Tc
0 Tw
-30.495 -1.15 Td
(Perspectives) Tj
/TT0 1 Tf
0 Tc
5.055 0 Td
(\0406\0503\051\072\0403\05521\056\040) Tj
-5.055 -1.15 Td
(\040) Tj
0.0002 Tc
-0.0012 Tw
T*
(Niraula\054\040Saroj\054\040Bostjan\040Seruga\054\040Alberto\040Ocan) Tj
-0.0007 Tc
-0.0005 Tw
18.11 0 Td
[ (a\054\040Tiffany\040Sha) -7 (o) -1 (\040Robyn\040Go) ] TJ
0.0003 Tc
-0.0019 Tw
10.58 0 Td
(ldstein\054\040Ian\040F\056\040Tannock\054\040) Tj
-0.0003 Tw
-28.69 -1.15 Td
[ (and\040Eitan\040A) 8 (m) 8 (ir\056\0402012\056\040\223The\040Price\040We\040Pay\040for\040Pr) ] TJ
-0.0001 Tc
0.0001 Tw
19.41 0 Td
[ (ogress\072\040A\040Meta\055Analysis\040of\040Har) -7 (m) 8 (s\040of\040Newly\040) ] TJ
0.0001 Tc
-0.0001 Tw
-19.41 -1.15 Td
(Approved\040Anticancer\040Drugs\056\224\040) Tj
/TT1 1 Tf
12.275 0 Td
(Journal\040of\040Clinical\040Oncology\040) Tj
/TT0 1 Tf
0.0003 Tc
-0.0003 Tw
11.995 0 Td
(30\05024\051\072\0403012\0559\056\040\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-24.27 -1.15 Td
(\040) Tj
0 g
0.0004 Tc
-0.0004 Tw
T*
[ (PhRMA\040\050Pharm) 8 (aceutical\040Research\040an) 5 (d\040Manuf) ] TJ
-0.0014 Tw
18.605 0 Td
[ (actu) 5 (r) -2 (ers\040of\040Am) 8 (er) -7 (ica\051\056\0402014\056\040Medicines\040in\040) ] TJ
0 Tc
0 Tw
-18.605 -1.15 Td
[ (Developm) 8 (en) -5 (t\056\0402014\056\040http\072\057\057www\056phr) -7 (ma\056or) ] TJ
0.0003 Tc
16.835 0 Td
[ (g\057innovation\057m) 8 (e) -1 (ds\055in\055developm) 8 (ent) ] TJ
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
(\040) Tj
-16.835 -1.15 Td
(\040) Tj
0 g
0.0002 Tc
-0.0002 Tw
T*
[ (Piron\054\040Robert\054\040and\040Luis\040F) 6 (e) -1 (rnandez\056\040\0401995\056\040\223A) ] TJ
0.0001 Tc
-0.0001 Tw
18.19 0 Td
(re\040Fairness\040Constraints\040on\040Profit\055Seeking\040) Tj
0.0007 Tc
0 Tw
-18.19 -1.15 Td
[ (Im) 9 (portant\077) -5 (\224\040) ] TJ
/TT1 1 Tf
0.0003 Tc
-0.0003 Tw
5.08 0 Td
[ (Journal\040of\040E) 6 (c) -1 (onomic\040Psychology) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
13.25 0 Td
(\04016\0501\051\072\04073\05596\056\040) Tj
-18.33 -1.15 Td
(\040) Tj
0.0004 Tc
-0.0014 Tw
T*
(Raborn\040Martin\040L\056\054\040Elise\040M\056\040Pelle) Tj
-0.0008 Tw
13.165 0 Td
[ (tier\054\040Daniel\040B\056\040Sm) 8 (ith\054\040and\040Carolina\040M\056\040R) 7 (e) -1 (yes\056\0402012\056\040\223Patient\040) ] TJ
-0.0004 Tw
-13.165 -1.15 Td
[ (Out\055of\055Pocket\040Paym) 8 (ents\040for\040Oral\040Oncolytics\072\040Re) ] TJ
0.0004 Tw
19.53 0 Td
[ (sults\040from) 8 (\040a\0402009\040US\040Claim) 8 (s\040Data\040Analysis\056\224\040) ] TJ
/TT1 1 Tf
0.0001 Tc
-0.0001 Tw
-19.53 -1.15 Td
(American\040Journal\040of\040Managed\040Care\040) Tj
/TT0 1 Tf
-0.0002 Tc
0.0002 Tw
14.805 0 Td
(18\0505\040No\056\0402\051\072\040SP57\05564\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-14.805 -1.145 Td
(\040) Tj
0 g
0.0006 Tc
-0.0006 Tw
T*
[ (Reekie\054\040W) 9 (\056) 1 (\040Duncan\056\0401978\056\040\223Price\040an) 6 (d\040Quality\040C) 8 (o) -4 (m) 8 (p) ] TJ
-0.0015 Tw
20.96 0 Td
[ (etition\040in\040the\040United) 6 (\040States\040Drug) 6 (\040Industry\056) 6 (\224\040) ] TJ
/TT1 1 Tf
-0.0001 Tc
-0.0011 Tw
-20.96 -1.15 Td
(The\040Journal\040of\040Industrial\040Economics\040) Tj
/TT0 1 Tf
0 Tc
0 Tw
14.97 0 Td
(26\0503\051\072\040223\05537\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
-14.97 -1.15 Td
(\040) Tj
0 g
0.0002 Tc
-0.0009 Tw
T*
[ (Rom) 8 (l) -2 (ey\054\040John\040A\054\040Yuri\040Sanchez\054\040John\040R\056\040Penr) ] TJ
-0.0002 Tw
18.08 0 Td
[ (od\054\040and\040Dana\040P\056\040Goldm) 8 (a) -1 (n\056\0402012\056\040\223Survey\040Results\040) ] TJ
0.0007 Tc
-0.001 Tw
-18.08 -1.15 Td
[ (Show\040That\040Adults\040are\040W) 10 (illing\040to\040Pay\040Higher\040In) 6 (surance\040Pr) 4 (e) 5 (m) 9 (iums\040f) 4 (o) 1 (r\040Generous\040Cov) 6 (erage\040of) 4 (\040) ] TJ
0 Tc
0 Tw
T*
(Specialty\040Drugs\056\224\040) Tj
/TT1 1 Tf
0.0009 Tc
-0.0009 Tw
[ (Health) 6 (\040Affairs\040) ] TJ
/TT0 1 Tf
-0.0001 Tc
-0.0024 Tw
13.31 0 Td
(31\0504\051\072\040683\05590\056\040\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-13.31 -1.15 Td
(\040) Tj
0 g
0.0003 Tc
-0.0015 Tw
T*
(Schrag\054\040Deborah\056\0402004\056\040\223The\040Pri) Tj
0.0005 Tc
-0.0021 Tw
[ (ce\040Tag\040on\040Progress\055\055Chem) 8 (o) -4 (therapy\040for\040Colorectal\040C) 8 (a) -1 (ncer\056\224\040) ] TJ
/TT1 1 Tf
-0.0037 Tc
0 Tw
37.19 0 Td
(New\040) Tj
0.0001 Tc
-0.0001 Tw
-37.19 -1.15 Td
(England\040Journal\040of\040Medicine) Tj
/TT0 1 Tf
0.0004 Tc
-0.0029 Tw
11.75 0 Td
(\040351\0504\051\072\040317\0559\056) Tj
/CS0 cs
1 0 0 scn
0 Tc
0 Tw
6.025 0 Td
(\040) Tj
0.212 0.373 0.569 scn
-17.775 -1.15 Td
(\040) Tj
0 g
0.0002 Tc
-0.0002 Tw
T*
[ (Seabury\054\040Seth\040A\056\054\040Dana\040P\056\040Goldm) 8 (a) -1 (n\054\040J\056\040) ] TJ
0.0001 Tc
-0.0001 Tw
15.805 0 Td
[ (Ross\040Maclean\054\040John\040R) 7 (\056\040Penrod\054\040and\040Darius\040N\056\040) ] TJ
0.0002 Tc
-0.0012 Tw
-15.805 -1.15 Td
[ (Lakdawalla\056\0402012\056\040\223Patients\040Value\040Metastatic\040C) 7 (a) -1 (n) ] TJ
0 Tc
0 Tw
20.19 0 Td
(cer\040Therapy\040More\040Highly\040Than\040is\040Typically\040) Tj
0.0002 Tc
-0.0002 Tw
-20.19 -1.15 Td
[ (Shown\040Through\040Traditional\040Estim) 8 (a) -1 (tes\056\224\040) ] TJ
/TT1 1 Tf
0.001 Tc
-0.001 Tw
16.245 0 Td
[ (Health\040A) 7 (ffair) 5 (s) ] TJ
/TT0 1 Tf
0.0004 Tc
-0.002 Tw
5.695 0 Td
(\04031\0504\051\072\040691\0559\056\040\040) Tj
0 Tc
0 Tw
-21.94 -1.15 Td
(\040) Tj
0.0001 Tc
-0.0001 Tw
T*
(Silber\054\040Judy\056\0402005\056\040Onyx\040Gets\040OK\040for\040Kidney\040Cancer\040Drug\056\040) Tj
/TT1 1 Tf
24.275 0 Td
(Contra\040Costa\040Times) Tj
/TT0 1 Tf
0.001 Tc
-0.001 Tw
8.06 0 Td
[ (\040Decem) 9 (ber\04021\056\040) ] TJ
0 Tc
0 Tw
-32.335 -1.15 Td
(\040) Tj
-0.0001 Tc
0.0001 Tw
T*
(Snider\054\040Julia\040Thornton\054\040John\040A\056\040Romley\054\040John\054\040W) Tj
0.0001 Tc
-0.0001 Tw
19.83 0 Td
[ (illiam) 8 (\040B\056\040Vogt\054\040and\040Tomas\040J\056\040Philipson\056\0402012\056\040) ] TJ
-19.83 -1.15 Td
(\223The\040Option\040Value\040of\040Innovation\056\224\040\040) Tj
/TT1 1 Tf
14.525 0 Td
[ (Forum\040for\040Health\040Econo) 5 (mics\040\046\040Policy) ] TJ
/TT0 1 Tf
0 Tc
0 Tw
(\04015\0502\051\072\0401558\0559544\056\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0.9 0.9 0.9 RG
n
72 708 427 8 re
S
0.9 0.9 0.9 RG
n
72 695 207 8 re
S
0.9 0.9 0.9 RG
n
72 681 305 8 re
S
0.9 0.9 0.9 RG
n
72 667 3 8 re
S
0.9 0.9 0.9 RG
n
72 653 285 8 re
S
0.9 0.9 0.9 RG
n
72 639 267 8 re
S
0.9 0.9 0.9 RG
n
72 626 3 8 re
S
0.9 0.9 0.9 RG
n
72 612 450 8 re
S
0.9 0.9 0.9 RG
n
72 598 210 8 re
S
0.9 0.9 0.9 RG
n
72 584 3 8 re
S
0.9 0.9 0.9 RG
n
72 570 469 8 re
S
0.9 0.9 0.9 RG
n
72 557 117 8 re
S
0.9 0.9 0.9 RG
n
72 543 3 8 re
S
0.9 0.9 0.9 RG
n
72 529 461 8 re
S
0.9 0.9 0.9 RG
n
72 515 450 8 re
S
0.9 0.9 0.9 RG
n
72 501 372 8 re
S
0.9 0.9 0.9 RG
n
72 488 3 8 re
S
0.9 0.9 0.9 RG
n
72 474 424 8 re
S
0.9 0.9 0.9 RG
n
72 460 374 8 re
S
0.9 0.9 0.9 RG
n
72 446 3 8 re
S
0.9 0.9 0.9 RG
n
72 432 419 8 re
S
0.9 0.9 0.9 RG
n
72 419 288 8 re
S
0.9 0.9 0.9 RG
n
72 405 3 8 re
S
0.9 0.9 0.9 RG
n
72 391 451 8 re
S
0.9 0.9 0.9 RG
n
72 377 455 8 re
S
0.9 0.9 0.9 RG
n
72 363 286 8 re
S
0.9 0.9 0.9 RG
n
72 350 3 8 re
S
0.9 0.9 0.9 RG
n
72 336 461 8 re
S
0.9 0.9 0.9 RG
n
72 322 251 8 re
S
0.9 0.9 0.9 RG
n
72 308 3 8 re
S
0.9 0.9 0.9 RG
n
72 295 457 8 re
S
0.9 0.9 0.9 RG
n
72 281 447 8 re
S
0.9 0.9 0.9 RG
n
72 267 234 8 re
S
0.9 0.9 0.9 RG
n
72 253 3 8 re
S
0.9 0.9 0.9 RG
n
72 239 470 8 re
S
0.9 0.9 0.9 RG
n
72 226 216 8 re
S
0.9 0.9 0.9 RG
n
72 212 3 8 re
S
0.9 0.9 0.9 RG
n
72 198 412 8 re
S
0.9 0.9 0.9 RG
n
72 184 456 8 re
S
0.9 0.9 0.9 RG
n
72 170 335 8 re
S
0.9 0.9 0.9 RG
n
72 157 3 8 re
S
0.9 0.9 0.9 RG
n
72 143 461 8 re
S
0.9 0.9 0.9 RG
n
72 129 3 8 re
S
0.9 0.9 0.9 RG
n
72 115 460 8 re
S
0.9 0.9 0.9 RG
n
72 101 454 8 re
S
Q

endstream
endobj
132 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
133 0 obj
<<
/Length 8638
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (30) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
12 0 0 12 72 708.96 Tm
(\040) Tj
0.0002 Tc
-0.0002 Tw
0 -1.15 TD
[ (Sun\054\040Eric\054\040Anupam) 8 (\040B\056\040Jena\054\040Darius\040L) 6 (a) -1 (kdawalla\054\040Ca) ] TJ
0.0004 Tc
0.0004 Tw
20.55 0 Td
[ (rolina\040Reyes\054\040Tom) 8 (a) -1 (s\040J\056\040Philipson\054) 5 (\040and\040Dana\040) ] TJ
0.0002 Tc
-0.0012 Tw
-20.55 -1.15 Td
[ (Goldm) 8 (a) -1 (n\056\0402010\056\040\223The\040Contributions\040of\040I) -7 (m) 8 (proved\040) ] TJ
0.0004 Tc
-0.0014 Tw
19.94 0 Td
(Therapy\040and\040Early\040Detection\040to\040Cancer\040) Tj
-0.0001 Tc
0.0001 Tw
-19.94 -1.15 Td
(Survival\040Gains\054\0401988\0552000\056\224\040) Tj
/TT1 1 Tf
0.0005 Tc
-0.0015 Tw
11.745 0 Td
[ (Forum\040for\040Health\040E) 6 (c) -1 (onomics\040\046\040Policy) ] TJ
/TT0 1 Tf
-0.0005 Tc
0.0005 Tw
15.585 0 Td
(\04013\0502\051\072\0401\05520\056\040) Tj
0 Tc
0 Tw
-27.33 -1.15 Td
(\040) Tj
0.0003 Tc
-0.0003 Tw
T*
[ (Suslow\054\040Valerie\040Y\056\040\040199) 5 (6\056\040\223Measuring\040Quality\040) ] TJ
0.0006 Tc
-0.0018 Tw
18.83 0 Td
[ (Change\040in\040Pharm) 8 (aceutical\040Mark) 6 (ets) 5 (\072) -2 (\040Hedonic\040) ] TJ
0.0001 Tc
-0.0001 Tw
-18.83 -1.15 Td
(Price\040Indexes\040for\040Anti\055Ulcer\040Drugs\056\224\040Chap\056\0404\040in\040) Tj
/TT1 1 Tf
0.0008 Tc
-0.0033 Tw
19.44 0 Td
[ (Competitiv) 5 (e\040Strateg) 6 (i) -1 (es\040in) 6 (\040the\040Pharmaceutical\040) ] TJ
0 Tw
-19.44 -1.15 Td
(Industry) Tj
/TT0 1 Tf
0.0004 Tc
-0.0004 Tw
3.34 0 Td
[ (\054\040edited\040by\040R\056\040Helm) 8 (s\056\040W) 9 (a) -1 (shington\054\040D\056) ] TJ
0.0012 Tc
-0.0028 Tw
15.02 0 Td
[ (C\056\072\040Am) 9 (erican\040Enterprise\040Ins) 5 (titu) 6 (te\056) 6 (\040) ] TJ
0 Tc
0 Tw
-18.36 -1.15 Td
(\040) Tj
0.0002 Tc
-0.0022 Tw
T*
(Szabo\054\040Liz\056\0402004\040\223Price\040of\040Cancer\040) Tj
0 Tc
-0.0025 Tw
13.94 0 Td
(Drugs\040Called\040\221Mind\055Boggling\222\224\040) Tj
/TT1 1 Tf
-0.0006 Tc
0.0006 Tw
13.135 0 Td
(USA\040Today) Tj
/TT0 1 Tf
-0.0002 Tc
-0.0023 Tw
4.58 0 Td
(\056\040July\04021\056\040) Tj
0.0003 Tc
0 Tw
-31.655 -1.15 Td
[ (http\072\057\057usatoday30\056usatoday\056com) 8 (\057news\057) ] TJ
0.0001 Tc
15.335 0 Td
(health\0572004\05507\05521\055cancer\055usat\137x\056htm) Tj
/CS0 cs
0.969 0.588 0.275 scn
0.005 Tc
15.07 0 Td
(\040\040) Tj
0.212 0.373 0.569 scn
0 Tc
-30.405 -1.15 Td
(\040) Tj
0 g
T*
(Thaler\040Richard\056\0401985\054\040\223Mental\040Acc) Tj
0.0009 Tc
-0.0025 Tw
14.16 0 Td
[ (ounting\040and\040Consum) 9 (er\040Choice\054\224\040) ] TJ
/TT1 1 Tf
0.0011 Tc
-0.0011 Tw
13.14 0 Td
[ (Mar) 5 (keting\040S) 6 (cien) 6 (ce) ] TJ
/TT0 1 Tf
0.0005 Tc
-0.0005 Tw
(\0404\0503\051\072\040) Tj
0.0002 Tc
0 Tw
-27.3 -1.15 Td
(199\055214\056\040) Tj
0 Tc
T*
(\040) Tj
0.0003 Tc
-0.0009 Tw
T*
[ (Trusheim) 8 (\054\040Mark\040R\056\054\040and\040Ernst\040R\056\040Berndt\056\0402012\056\040\223The) ] TJ
0.0002 Tc
-0.0002 Tw
21.105 0 Td
[ (\040Segm) 8 (e) -6 (ntation\040of\040Therapeutic\040P) 6 (opulations\040in\040) ] TJ
0 Tw
-21.105 -1.15 Td
(Oncology\056\224\040) Tj
/TT1 1 Tf
0.0003 Tc
-0.0015 Tw
(Health\040Management\054\040Policy\040and\040Innovation) Tj
/TT0 1 Tf
-0.0004 Tc
0.0004 Tw
22.475 0 Td
(\0401\0501\051\072\04019\05534\056\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-22.475 -1.15 Td
(\040) Tj
0 g
0.0002 Tc
-0.0002 Tw
T*
(US\040Food\040and\040Drug\040Administrati) Tj
0.0003 Tc
-0.0017 Tw
12.895 0 Td
[ (on\056\0402014a\056\040Table\040of\040Phar) -7 (m) 8 (acogenom) 8 (ic\040Bi) -7 (om) 8 (arkers\040in\040Drug\040) ] TJ
0.0006 Tc
-0.0006 Tw
-12.895 -1.15 Td
[ (Labeling\056\040A) 8 (ugust\04018\056\040) ] TJ
0.0002 Tc
0 Tw
T*
(http\072\057\057www\056fda\056gov\057drugs\057scien) Tj
0 Tc
12.67 0 Td
(ceresearch\057researchareas) Tj
0.0001 Tc
9.88 0 Td
[ (\057pharm) 8 (acogenetics\057ucm) 8 (083378\056htm\040) ] TJ
0 Tc
-22.55 -1.15 Td
(\040) Tj
0.0002 Tc
-0.0002 Tw
T*
[ (US\040Food\040and\040Drug\040Administration\056\0402) 5 (014\056\040Fast) -2 (\040Track\054\040Breakth) 5 (rough\040Therapy\054\040Accelerated\040) ] TJ
T*
[ (Approval\040and\040Priority\040R) 7 (e) -1 (view\056\040September\04018\054\0402014\056\040) ] TJ
0 Tw
T*
(http\072\057\057www\056fda\056gov\057ForPatients\057) Tj
-0.0003 Tc
12.95 0 Td
(Approvals\057Fast\057default\056htm\040) Tj
0 Tc
-12.95 -1.15 Td
(\040) Tj
0.0003 Tc
-0.0015 Tw
0 -1.145 TD
(US\040General\040Accounting\040Office\056\0402011\056\040) Tj
/TT1 1 Tf
0.0002 Tc
-0.0002 Tw
15.415 0 Td
(Manufacturer\040Discounts\040in\040) Tj
0.0001 Tc
-0.0001 Tw
11.085 0 Td
(the\040340B\040Program\040Offer\040) Tj
-26.5 -1.15 Td
(Benefits\054\040but\040Federal\040Ove) Tj
0 Tc
0 Tw
10.275 0 Td
(rsight\040Needs\040Improvement) Tj
/TT0 1 Tf
0.0001 Tc
-0.0001 Tw
10.555 0 Td
[ (\056\040W) 9 (a) -1 (shington\054\040D\056C\056\040) ] TJ
0 Tc
0 Tw
-20.83 -1.15 Td
(\040) Tj
0 -1.15 TD
(Weeks\054\040Jane\040C\054\040Paul\040J\056\040Catalano\054\040Angel\040Cr) Tj
0.0005 Tc
-0.0005 Tw
17.08 0 Td
[ (onin\054\040Matthew\040D\056\040Finkelm) 8 (an\054\040Jennifer\040W) 9 (\056) 1 (\040Mack\054\040) ] TJ
-0.003 Tw
-17.08 -1.15 Td
(Nancy\040L\056\040Keating\054\040and\040Deborah) Tj
0.0001 Tc
-0.0001 Tw
12.775 0 Td
[ (\040Schrag\056\0402012\040\223Patients\222\040Expectations\040A) 7 (bout\040Effects\040of\040) ] TJ
0.0002 Tc
-0.0002 Tw
-12.775 -1.15 Td
[ (Che) -6 (m) 8 (otherapy\040for\040advanced\040Cancer\056\224\040) ] TJ
/TT1 1 Tf
0.0001 Tc
-0.0001 Tw
15.355 0 Td
(New\040England\040Journal\040of\040Medicine) Tj
/TT0 1 Tf
0 Tc
0 Tw
(\040367\05017\051\072\0401616\05525\056\040\040) Tj
/CS0 cs
0.212 0.373 0.569 scn
-15.355 -1.15 Td
(\040) Tj
0 g
0.0004 Tc
-0.001 Tw
T*
[ (W) 9 (ittes\054\040Robert\040E\056\0402004\056\040\223Cancer\040W) 9 (e) -6 (apons\054\040Out\040of\040Reach\056\224\040) ] TJ
/TT1 1 Tf
0.0008 Tc
-0.0008 Tw
23.715 0 Td
[ (Washington\040P) 7 (o) 1 (st\040) ] TJ
/TT0 1 Tf
0.0002 Tc
-0.0002 Tw
(June\04015\056\040) Tj
0.0001 Tc
0 Tw
-23.715 -1.15 Td
[ (http\072\057\057www\056washingtonpost\056com) 8 (\057) ] TJ
-0.0001 Tw
13.33 0 Td
[ (wp\055dyn\057articles\057A42035\0552004Jun14\056htm) 8 (l) -2 (\040\040) ] TJ
/CS0 cs
0.212 0.373 0.569 scn
0 Tc
0 Tw
-13.33 -1.15 Td
(\040) Tj
0 g
T*
(Woodward\054\040Rebecca\040M\054\040Martin\040L\056\040Brown\054\040Susan\040T\056\040) Tj
0.0004 Tc
-0.0029 Tw
21.02 0 Td
(Stewart\054\040Kathleen\040A\056) Tj
-0.0028 Tw
8.39 0 Td
(\040Cronin\054\040and\040David\040M\056\040) Tj
0 Tc
0 Tw
-29.41 -1.15 Td
(Cutler\056\0402007\056\040\040\223The\040Value\040of\040Medi) Tj
0.0001 Tc
-0.0001 Tw
13.83 0 Td
(cal\040Interventions\040for\040Lung\040Cancer\040) Tj
0.0002 Tc
-0.0014 Tw
13.8 0 Td
[ (in\040the\040Elderly\072\040R) 7 (e) -1 (sults\040from) 8 (\040) ] TJ
-0.0001 Tc
0 Tw
-27.63 -1.15 Td
(SEER\055CMHSF\056\224\040) Tj
/TT1 1 Tf
0.0003 Tc
7.11 0 Td
(Cancer) Tj
/TT0 1 Tf
-0.0003 Tw
2.945 0 Td
(\040110\05011\051\072\0402511\0558\056\040) Tj
0 Tc
0 Tw
-10.055 -1.15 Td
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0.9 0.9 0.9 RG
n
72 708 3 8 re
S
0.9 0.9 0.9 RG
n
72 695 459 8 re
S
0.9 0.9 0.9 RG
n
72 681 430 8 re
S
0.9 0.9 0.9 RG
n
72 667 390 8 re
S
0.9 0.9 0.9 RG
n
72 653 3 8 re
S
0.9 0.9 0.9 RG
n
72 639 443 8 re
S
0.9 0.9 0.9 RG
n
72 626 455 8 re
S
0.9 0.9 0.9 RG
n
72 612 385 8 re
S
0.9 0.9 0.9 RG
n
72 598 3 8 re
S
0.9 0.9 0.9 RG
n
72 584 426 8 re
S
0.9 0.9 0.9 RG
n
72 570 370 8 re
S
0.9 0.9 0.9 RG
n
72 557 3 8 re
S
0.9 0.9 0.9 RG
n
72 543 446 8 re
S
0.9 0.9 0.9 RG
n
72 529 46 8 re
S
0.9 0.9 0.9 RG
n
72 515 3 8 re
S
0.9 0.9 0.9 RG
n
72 501 470 8 re
S
0.9 0.9 0.9 RG
n
72 488 332 8 re
S
0.9 0.9 0.9 RG
n
72 474 3 8 re
S
0.9 0.9 0.9 RG
n
72 460 442 8 re
S
0.9 0.9 0.9 RG
n
72 446 104 8 re
S
0.9 0.9 0.9 RG
n
72 432 444 8 re
S
0.9 0.9 0.9 RG
n
72 419 3 8 re
S
0.9 0.9 0.9 RG
n
72 405 435 8 re
S
0.9 0.9 0.9 RG
n
72 391 253 8 re
S
0.9 0.9 0.9 RG
n
72 377 290 8 re
S
0.9 0.9 0.9 RG
n
72 363 3 8 re
S
0.9 0.9 0.9 RG
n
72 350 439 8 re
S
0.9 0.9 0.9 RG
n
72 336 345 8 re
S
0.9 0.9 0.9 RG
n
72 322 3 8 re
S
0.9 0.9 0.9 RG
n
72 308 441 8 re
S
0.9 0.9 0.9 RG
n
72 295 421 8 re
S
0.9 0.9 0.9 RG
n
72 281 445 8 re
S
0.9 0.9 0.9 RG
n
72 267 3 8 re
S
0.9 0.9 0.9 RG
n
72 253 412 8 re
S
0.9 0.9 0.9 RG
n
72 239 363 8 re
S
0.9 0.9 0.9 RG
n
72 226 3 8 re
S
0.9 0.9 0.9 RG
n
72 212 464 8 re
S
0.9 0.9 0.9 RG
n
72 198 467 8 re
S
0.9 0.9 0.9 RG
n
72 184 207 8 re
S
0.9 0.9 0.9 RG
n
72 170 3 8 re
S
0.9 0.9 0.9 RG
n
72 157 3 8 re
S
0.9 0.9 0.9 RG
n
72 143 3 8 re
S
0.9 0.9 0.9 RG
n
72 129 3 8 re
S
0.9 0.9 0.9 RG
n
72 115 3 8 re
S
0.9 0.9 0.9 RG
n
72 101 3 8 re
S
Q

endstream
endobj
134 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
135 0 obj
<<
/Length 13011
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (31) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
12 0 0 12 72 708.96 Tm
(\040) Tj
0 -1.15 TD
(\040) Tj
38.585 -28.215 Td
(\040) Tj
-19.085 -0.92 Td
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
ET
1 g
80.76 359.34 451.86 329.52 re
f
1 G
0.548 w
1 j
1 J
81.06 688.32 451.32 -328.44 re
B*
140.16 653.76 370.56 -223.14 re
B*
q
1 0 0 1 209.7 518.88 cm
0 g
0 G
1.095 w
0 0 m
0 1.38 -1.08 2.46 -2.34 2.46 c
-3.6 2.46 -4.68 1.38 -4.68 0 c
-4.68 -1.38 -3.6 -2.46 -2.34 -2.46 c
-1.08 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 291.78 571.38 cm
0 g
0 G
1.095 w
0 0 m
0 1.26 -1.08 2.34 -2.46 2.34 c
-3.84 2.34 -4.92 1.26 -4.92 0 c
-4.92 -1.26 -3.84 -2.34 -2.46 -2.34 c
-1.08 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 322.44 535.5 cm
0 g
0 G
1.095 w
0 0 m
0 1.26 -1.02 2.28 -2.34 2.28 c
-3.6 2.28 -4.62 1.26 -4.62 0 c
-4.62 -1.32 -3.6 -2.34 -2.34 -2.34 c
-1.02 -2.34 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 249.12 450.78 cm
0 g
0 G
1.095 w
0 0 m
0 1.26 -1.14 2.34 -2.46 2.34 c
-3.84 2.34 -4.92 1.26 -4.92 0 c
-4.92 -1.32 -3.84 -2.34 -2.46 -2.34 c
-1.14 -2.34 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 217.38 497.76 cm
0 g
0 G
1.095 w
0 0 m
0 1.38 -1.08 2.46 -2.34 2.46 c
-3.66 2.46 -4.68 1.38 -4.68 0 c
-4.68 -1.32 -3.66 -2.46 -2.34 -2.46 c
-1.08 -2.46 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 267.42 576.06 cm
0 g
0 G
1.095 w
0 0 m
0 1.26 -1.08 2.34 -2.46 2.34 c
-3.78 2.34 -4.92 1.26 -4.92 0 c
-4.92 -1.32 -3.78 -2.34 -2.46 -2.34 c
-1.08 -2.34 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 187.26 544.38 cm
0 g
0 G
1.095 w
0 0 m
0 1.38 -1.14 2.46 -2.46 2.46 c
-3.84 2.46 -4.92 1.38 -4.92 0 c
-4.92 -1.38 -3.84 -2.46 -2.46 -2.46 c
-1.14 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 276.48 592.5 cm
0 g
0 G
1.095 w
0 0 m
0 1.26 -1.14 2.34 -2.46 2.34 c
-3.84 2.34 -4.92 1.26 -4.92 0 c
-4.92 -1.32 -3.84 -2.34 -2.46 -2.34 c
-1.14 -2.34 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 287.94 562.2 cm
0 g
0 G
1.095 w
0 0 m
0 1.38 -1.02 2.46 -2.28 2.46 c
-3.6 2.46 -4.62 1.38 -4.62 0 c
-4.62 -1.38 -3.6 -2.46 -2.28 -2.46 c
-1.02 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 286.32 566.88 cm
0 g
0 G
1.095 w
0 0 m
0 1.32 -1.08 2.46 -2.46 2.46 c
-3.84 2.46 -4.92 1.32 -4.92 0 c
-4.92 -1.38 -3.84 -2.46 -2.46 -2.46 c
-1.08 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 236.22 538.92 cm
0 g
0 G
1.095 w
0 0 m
0 1.32 -1.02 2.46 -2.34 2.46 c
-3.6 2.46 -4.62 1.32 -4.62 0 c
-4.62 -1.38 -3.6 -2.46 -2.34 -2.46 c
-1.02 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 307.68 581.64 cm
0 g
0 G
1.095 w
0 0 m
0 1.38 -1.08 2.52 -2.34 2.52 c
-3.6 2.52 -4.68 1.38 -4.68 0 c
-4.68 -1.32 -3.6 -2.46 -2.34 -2.46 c
-1.08 -2.46 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 289.86 560.82 cm
0 g
0 G
1.095 w
0 0 m
0 1.38 -1.02 2.46 -2.34 2.46 c
-3.6 2.46 -4.62 1.38 -4.62 0 c
-4.62 -1.38 -3.6 -2.46 -2.28 -2.46 c
-1.02 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 217.38 516.42 cm
0 g
0 G
1.095 w
0 0 m
0 1.38 -1.08 2.46 -2.34 2.46 c
-3.66 2.46 -4.68 1.38 -4.68 0 c
-4.68 -1.38 -3.66 -2.46 -2.34 -2.46 c
-1.08 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 229.38 585.24 cm
0 g
0 G
1.095 w
0 0 m
0 1.32 -1.08 2.46 -2.46 2.46 c
-3.84 2.46 -4.92 1.32 -4.92 0 c
-4.92 -1.38 -3.84 -2.46 -2.46 -2.46 c
-1.08 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 251.58 492.42 cm
0 g
0 G
1.095 w
0 0 m
0 1.32 -1.08 2.34 -2.34 2.34 c
-3.66 2.34 -4.68 1.32 -4.68 0 c
-4.68 -1.26 -3.66 -2.34 -2.34 -2.34 c
-1.08 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 274.02 560.58 cm
0 g
0 G
1.095 w
0 0 m
0 1.32 -1.08 2.46 -2.34 2.46 c
-3.6 2.46 -4.68 1.32 -4.68 0 c
-4.68 -1.38 -3.6 -2.52 -2.34 -2.52 c
-1.08 -2.52 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 245.82 543.3 cm
0 g
0 G
1.095 w
0 0 m
0 1.32 -1.02 2.46 -2.34 2.46 c
-3.6 2.46 -4.68 1.32 -4.68 0 c
-4.68 -1.38 -3.6 -2.46 -2.34 -2.46 c
-1.02 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 193.02 515.76 cm
0 g
0 G
1.095 w
0 0 m
0 1.26 -1.14 2.28 -2.52 2.28 c
-3.84 2.28 -4.98 1.26 -4.98 0 c
-4.98 -1.32 -3.84 -2.34 -2.46 -2.34 c
-1.14 -2.34 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 243.9 524.4 cm
0 g
0 G
1.095 w
0 0 m
0 1.32 -1.08 2.46 -2.46 2.46 c
-3.84 2.46 -4.92 1.32 -4.92 0 c
-4.92 -1.38 -3.84 -2.52 -2.46 -2.52 c
-1.08 -2.52 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 230.22 446.64 cm
0 g
0 G
1.095 w
0 0 m
0 1.32 -1.08 2.34 -2.46 2.34 c
-3.84 2.34 -4.92 1.32 -4.92 0 c
-4.92 -1.26 -3.84 -2.34 -2.46 -2.34 c
-1.08 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 149.76 571.68 cm
0 g
0 G
1.095 w
0 0 m
0 1.26 -1.14 2.28 -2.46 2.28 c
-3.84 2.28 -4.92 1.26 -4.92 0 c
-4.92 -1.32 -3.84 -2.34 -2.46 -2.34 c
-1.14 -2.34 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 242.82 550.8 cm
0 g
0 G
1.095 w
0 0 m
0 1.32 -1.08 2.34 -2.34 2.34 c
-3.6 2.34 -4.68 1.32 -4.68 0 c
-4.68 -1.26 -3.6 -2.28 -2.34 -2.28 c
-1.08 -2.28 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 242.82 524.94 cm
0 g
0 G
1.095 w
0 0 m
0 1.32 -1.08 2.46 -2.34 2.46 c
-3.6 2.46 -4.68 1.32 -4.68 0 c
-4.68 -1.38 -3.6 -2.46 -2.34 -2.46 c
-1.08 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 232.68 563.82 cm
0 g
0 G
1.095 w
0 0 m
0 1.38 -1.02 2.52 -2.34 2.52 c
-3.6 2.52 -4.68 1.38 -4.68 0 c
-4.68 -1.32 -3.6 -2.46 -2.34 -2.46 c
-1.02 -2.46 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 189.42 562.74 cm
0 g
0 G
1.095 w
0 0 m
0 1.38 -1.02 2.46 -2.34 2.46 c
-3.6 2.46 -4.62 1.38 -4.62 0 c
-4.62 -1.38 -3.6 -2.46 -2.28 -2.46 c
-1.02 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 267.42 540.84 cm
0 g
0 G
1.095 w
0 0 m
0 1.32 -1.08 2.46 -2.46 2.46 c
-3.78 2.46 -4.92 1.32 -4.92 0 c
-4.92 -1.38 -3.78 -2.46 -2.46 -2.46 c
-1.08 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 154.38 548.22 cm
0.5 g
0 G
1.095 w
0 0 m
-2.7 -4.92 l
3.06 -4.92 l
h
B*
Q
q
1 0 0 1 361.32 631.8 cm
0.5 g
0 G
1.095 w
0 0 m
-3 -4.92 l
3 -4.92 l
h
B*
Q
q
1 0 0 1 241.44 553.68 cm
0.5 g
0 G
1.095 w
0 0 m
-2.76 -4.92 l
3 -4.92 l
h
B*
Q
q
1 0 0 1 164.28 445.98 cm
0.5 g
0 G
1.095 w
0 0 m
-2.76 -5.22 l
3 -5.22 l
h
B*
Q
q
1 0 0 1 278.1 575.1 cm
0.5 g
0 G
1.095 w
0 0 m
-3 -4.92 l
2.76 -4.92 l
h
B*
Q
q
1 0 0 1 196.02 546.84 cm
0.5 g
0 G
1.095 w
0 0 m
-2.76 -4.92 l
3 -4.92 l
h
B*
Q
q
1 0 0 1 367.08 562.74 cm
0.5 g
0 G
1.095 w
0 0 m
-2.76 -5.22 l
3 -5.22 l
h
B*
Q
q
1 0 0 1 323.82 578.64 cm
0.5 g
0 G
1.095 w
0 0 m
-3 -4.92 l
3 -4.92 l
h
B*
Q
q
1 0 0 1 309.84 583.56 cm
0.5 g
0 G
1.095 w
0 0 m
-3 -4.92 l
2.76 -4.92 l
h
B*
Q
q
1 0 0 1 240.6 532.02 cm
0.5 g
0 G
1.095 w
0 0 m
-3 -4.92 l
2.76 -4.92 l
h
B*
Q
q
1 0 0 1 366.48 569.04 cm
0.5 g
0 G
1.095 w
0 0 m
-3 -4.92 l
2.76 -4.92 l
h
B*
Q
q
1 0 0 1 257.58 559.44 cm
0.5 g
0 G
1.095 w
0 0 m
-3 -4.92 l
3 -4.92 l
h
B*
Q
q
1 0 0 1 292.86 567.42 cm
0.5 g
0 G
1.095 w
0 0 m
-3 -4.92 l
2.76 -4.92 l
h
B*
Q
q
1 0 0 1 213 540.84 cm
0.5 g
0 G
1.095 w
0 0 m
-3.06 -4.98 l
2.7 -4.98 l
h
B*
Q
q
1 0 0 1 230.46 566.04 cm
0.5 g
0 G
1.095 w
0 0 m
-2.7 -4.92 l
3.06 -4.92 l
h
B*
Q
q
1 0 0 1 267.18 566.58 cm
0.5 g
0 G
1.095 w
0 0 m
-2.76 -5.22 l
3 -5.22 l
h
B*
Q
q
1 0 0 1 249.36 560.82 cm
0.5 g
0 G
1.095 w
0 0 m
-2.7 -4.92 l
3 -4.92 l
h
B*
Q
q
1 0 0 1 287.7 584.94 cm
0.5 g
0 G
1.095 w
0 0 m
-3 -5.22 l
2.7 -5.22 l
h
B*
Q
q
1 0 0 1 267.18 441.06 cm
0.5 g
0 G
1.095 w
0 0 m
-2.76 -4.98 l
3 -4.98 l
h
B*
Q
q
1 0 0 1 210.78 539.7 cm
0.5 g
0 G
1.095 w
0 0 m
-3 -5.16 l
2.76 -5.16 l
h
B*
Q
0 G
1.095 w
452.16 638.16 -4.92 -4.98 re
447.24 638.16 m
h
B*
342.72 538.38 -4.92 -4.98 re
337.8 538.38 m
h
B*
306.3 587.4 -4.92 -4.92 re
301.38 587.4 m
h
B*
263.88 562.5 -4.92 -4.98 re
258.96 562.5 m
h
B*
262.5 456.66 -4.92 -4.92 re
257.58 456.66 m
h
B*
284.7 580.02 -4.92 -4.92 re
279.78 580.02 m
h
B*
252.66 539.7 -4.92 -4.92 re
247.74 539.7 m
h
B*
244.44 520.26 -4.92 -4.92 re
239.52 520.26 m
h
B*
462.54 641.7 -4.92 -4.92 re
457.62 641.7 m
h
B*
470.52 648.84 -4.92 -4.92 re
465.6 648.84 m
h
B*
315.3 589.32 -4.92 -4.92 re
310.38 589.32 m
h
B*
q
1 0 0 1 140.16 430.32 cm
0.548 w
0 0 m
0 223.44 l
S
Q
q
1 0 0 1 140.16 480.54 cm
0.548 w
0 0 m
-4.62 0 l
S
Q
BT
0 g
/TT0 1 Tf
9.0323 0 0 9.0462 128.7 477.06 Tm
(4) Tj
ET
q
1 0 0 1 140.16 511.2 cm
0.548 w
0 0 m
-4.62 0 l
S
Q
BT
/TT0 1 Tf
-0.0151 Tc
9.0323 0 0 9.0462 114.78 507.72 Tm
(10) Tj
ET
q
1 0 0 1 140.16 565.5 cm
0.548 w
0 0 m
-4.62 0 l
S
Q
BT
/TT0 1 Tf
9.0323 0 0 9.0462 124.08 561.72 Tm
(50) Tj
ET
q
1 0 0 1 140.16 588.78 cm
0.548 w
0 0 m
-4.62 0 l
S
Q
BT
/TT0 1 Tf
9.0323 0 0 9.0462 110.1 585.0601 Tm
[ (10) -27 (0) ] TJ
ET
q
1 0 0 1 140.16 612.12 cm
0.548 w
0 0 m
-4.62 0 l
S
Q
BT
/TT0 1 Tf
9.0323 0 0 9.0462 119.4 608.34 Tm
[ (20) -33 (0) ] TJ
ET
q
1 0 0 1 140.16 625.5 cm
0.548 w
0 0 m
-4.62 0 l
S
Q
BT
/TT0 1 Tf
9.0323 0 0 9.0462 110.1 622.08 Tm
[ (30) -27 (0) ] TJ
ET
q
1 0 0 1 140.16 642.78 cm
0.548 w
0 0 m
-4.62 0 l
S
Q
BT
/TT0 1 Tf
9.0323 0 0 9.0462 119.4 639.0601 Tm
[ (50) -33 (0) ] TJ
0.0008 Tc
-0.0107 Tw
0 11.4956 -11.5132 0 103.56 445.38 Tm
[ (P) -17 (ri) 18 (c) -9 (e) 17 (\040) -21 (on\040l) -8 (og\040) 5 (s) -17 (c) 17 (a) -9 (l) 18 (e) -9 (\040\050\0441\054) -10 (000s) 9 (\040) -21 (of\0402013\040) -21 (U) 8 (S) -12 (D\051) ] TJ
ET
q
1 0 0 1 140.16 430.32 cm
0.548 w
0 0 m
370.86 0 l
S
Q
q
1 0 0 1 171.66 430.32 cm
0.548 w
0 0 m
0 -4.38 l
S
Q
BT
/TT0 1 Tf
-0.0042 Tc
0 Tw
11.4956 0 0 11.5132 164.58 413.16 Tm
[ (0\056) 6 (1) ] TJ
ET
q
1 0 0 1 230.46 430.32 cm
0.548 w
0 0 m
0 -4.38 l
S
Q
BT
/TT0 1 Tf
0.0011 Tc
11.4956 0 0 11.5132 223.38 413.16 Tm
[ (0\056) 11 (2) ] TJ
ET
q
1 0 0 1 308.22 430.32 cm
0.548 w
0 0 m
0 -4.38 l
S
Q
BT
/TT0 1 Tf
11.4956 0 0 11.5132 301.14 413.16 Tm
[ (0\056) 16 (5) ] TJ
ET
q
1 0 0 1 367.08 430.32 cm
0.548 w
0 0 m
0 -4.38 l
S
Q
BT
/TT0 1 Tf
11.4956 0 0 11.5132 359.94 413.16 Tm
[ (1\056) 11 (0) ] TJ
ET
q
1 0 0 1 425.88 430.32 cm
0.548 w
0 0 m
0 -4.38 l
S
Q
BT
/TT0 1 Tf
11.4956 0 0 11.5132 418.8 413.16 Tm
[ (2\056) 11 (0) ] TJ
ET
q
1 0 0 1 460.38 430.32 cm
0.548 w
0 0 m
0 -4.38 l
S
Q
BT
/TT0 1 Tf
11.4956 0 0 11.5132 453.3 413.16 Tm
[ (3\056) 16 (0) ] TJ
ET
q
1 0 0 1 503.88 430.32 cm
0.548 w
0 0 m
0 -4.38 l
S
Q
BT
/TT0 1 Tf
11.4956 0 0 11.5132 496.7999 413.16 Tm
[ (5\056) 11 (0) ] TJ
-0.025 Tc
0.036 Tw
-22.355 -1.24 Td
[ (L) -9 (i) -8 (f) -52 (e) -9 (\040ye) -9 (a) -35 (r) -26 (s) -17 (\040ga) -35 (i) -8 (n) -26 (e) -30 (d) -5 (\040o) -26 (n) -21 (\040) 21 (l) -34 (o) -26 (g\040s) -17 (c) -35 (a) -9 (l) -29 (e) -14 (\040\050) -26 (ye) -9 (a) -9 (r) -26 (s) -38 (\051) ] TJ
ET
1 g
1 G
0.548 w
369.24 485.7 137.94 -51.24 re
B*
BT
0 g
/TT0 1 Tf
-0.0145 Tc
0.0369 Tw
9.0323 0 0 9.0462 385.98 472.68 Tm
[ (Sou) -26 (r) -20 (c) 11 (e) -29 (\040) 33 (of) -20 (\040s) -17 (u) 1 (r) -14 (v) 1 (i) -9 (v) 1 (a) -22 (l) 18 (\040ben) -26 (e) 4 (f) -14 (i) -9 (t) -16 (\072) ] TJ
-0.0035 Tc
0.0259 Tw
0 -1.214 TD
[ (Tria) 15 (l\054\040o) 12 (v) 12 (e) 15 (ra) -11 (l) 29 (l) 2 (\040) 33 (s) -6 (u) -22 (rv) 12 (iv) 12 (a) 15 (l) ] TJ
-0.0151 Tc
0.0375 Tw
0 -1.181 TD
[ (T) -9 (r) -14 (i) -10 (a) 4 (l) -10 (\054) -11 (\040pr) -14 (ogr) -14 (e) -23 (s) -24 (s) -18 (i) -10 (on\055) -14 (f) -14 (r) -21 (e) 10 (e) 4 (\040s) -24 (ur) -14 (vi) -10 (va) -23 (l) ] TJ
-0.0055 Tc
-0.0054 Tw
0 -1.187 TD
[ (M) 7 (o) 10 (d) -24 (e) 20 (ll) 27 (in) -24 (g) 10 (\040s) -8 (tu) -24 (d) 10 (y) ] TJ
ET
q
1 0 0 1 381 465.54 cm
0 G
1.095 w
0 0 m
0 1.32 -1.08 2.34 -2.46 2.34 c
-3.84 2.34 -4.92 1.32 -4.92 0.06 c
-4.92 -1.26 -3.84 -2.28 -2.46 -2.28 c
-1.08 -2.28 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 378.54 458.04 cm
0.5 g
0 G
1.095 w
0 0 m
-3 -4.92 l
2.76 -4.92 l
h
B*
Q
1 g
0 G
1.095 w
381 446.22 -4.92 -4.92 re
376.08 446.22 m
h
B*
BT
0 g
/TT0 1 Tf
9.0323 0 0 9.0462 142.14 381.66 Tm
[ (S) 6 (o) 10 (u) -17 (r) -5 (c) 13 (e) -20 (\072\040A) -14 (u) 10 (th) -17 (o) 10 (r) -5 (s) ] TJ
0.0016 Tc
0.0105 Tw
12.5904 0 0 12.6096 228.9 665.1 Tm
[ (F) 15 (i) -2 (gur) 11 (e) -12 (\040) 24 (1\072\040P) 15 (r) -13 (ic) 7 (e) -7 (\040) 19 (v) 25 (e) -12 (r) 11 (sus\040li) -6 (f) 11 (e) -12 (\040) 24 (ye) 12 (a) 12 (r) -13 (s\040) 19 (ga) 12 (ine) -12 (d) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0.9 0.9 0.9 RG
n
72 708 3 8 re
S
0.9 0.9 0.9 RG
n
72 695 3 8 re
S
0.9 0.9 0.9 RG
n
535 356 3 8 re
S
0.9 0.9 0.9 RG
n
306 345 3 8 re
S
0.9 0.9 0.9 RG
n
306 331 3 8 re
S
0.9 0.9 0.9 RG
n
306 317 3 8 re
S
0.9 0.9 0.9 RG
n
306 304 3 8 re
S
0.9 0.9 0.9 RG
n
306 290 3 8 re
S
0.9 0.9 0.9 RG
n
306 276 3 8 re
S
0.9 0.9 0.9 RG
n
306 262 3 8 re
S
0.9 0.9 0.9 RG
n
306 248 3 8 re
S
0.9 0.9 0.9 RG
n
306 235 3 8 re
S
0.9 0.9 0.9 RG
n
306 221 3 8 re
S
0.9 0.9 0.9 RG
n
306 207 3 8 re
S
0.9 0.9 0.9 RG
n
306 193 3 8 re
S
0.9 0.9 0.9 RG
n
306 179 3 8 re
S
0.9 0.9 0.9 RG
n
306 166 3 8 re
S
0.9 0.9 0.9 RG
n
306 152 3 8 re
S
0.9 0.9 0.9 RG
n
306 138 3 8 re
S
0.9 0.9 0.9 RG
n
306 124 3 8 re
S
0.9 0.9 0.9 RG
n
306 110 3 8 re
S
0.9 0.9 0.9 RG
n
306 97 3 8 re
S
0.9 0.9 0.9 RG
n
128 477 5 8 re
S
0.9 0.9 0.9 RG
n
114 507 9 8 re
S
0.9 0.9 0.9 RG
n
124 561 9 8 re
S
0.9 0.9 0.9 RG
n
110 585 13 8 re
S
0.9 0.9 0.9 RG
n
119 608 13 8 re
S
0.9 0.9 0.9 RG
n
110 622 13 8 re
S
0.9 0.9 0.9 RG
n
119 639 13 8 re
S
0.9 0.9 0.9 RG
n
164 413 346 8 re
S
0.9 0.9 0.9 RG
n
239 398 170 8 re
S
0.9 0.9 0.9 RG
n
385 472 95 8 re
S
0.9 0.9 0.9 RG
n
385 461 77 8 re
S
0.9 0.9 0.9 RG
n
385 451 111 8 re
S
0.9 0.9 0.9 RG
n
385 440 59 8 re
S
0.9 0.9 0.9 RG
n
142 381 58 8 re
S
0.9 0.9 0.9 RG
n
228 665 196 8 re
S
Q

endstream
endobj
136 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
137 0 obj
<<
/Length 16011
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (32) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
12 0 0 12 306 708.96 Tm
(\040) Tj
0 -1.15 TD
(\040) Tj
T*
(\040) Tj
19.36 -28.615 Td
(\040) Tj
-19.36 -0.925 Td
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
0 -1.145 TD
(\040) Tj
0 -1.15 TD
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
ET
1 g
77.52 341.04 457.98 333.96 re
f
1 G
0.555 w
1 j
1 J
77.82 674.46 457.44 -332.88 re
B*
128.28 639.42 385.02 -191.7 re
B*
q
1 0 0 1 153.54 490.68 cm
0 g
0 G
1.11 w
0 0 m
0 1.26 -1.14 2.34 -2.52 2.34 c
-3.9 2.34 -4.98 1.26 -4.98 0 c
-4.98 -1.32 -3.9 -2.4 -2.52 -2.4 c
-1.14 -2.4 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 480.3 520.08 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.02 2.4 -2.34 2.4 c
-3.66 2.4 -4.68 1.32 -4.68 0 c
-4.68 -1.26 -3.66 -2.34 -2.34 -2.34 c
-1.02 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 290.58 470.64 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.14 2.4 -2.52 2.4 c
-3.9 2.4 -4.98 1.32 -4.98 0 c
-4.98 -1.32 -3.9 -2.34 -2.52 -2.34 c
-1.14 -2.34 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 138.3 457.86 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.14 2.34 -2.52 2.34 c
-3.9 2.34 -4.98 1.32 -4.98 0 c
-4.98 -1.32 -3.9 -2.34 -2.52 -2.34 c
-1.14 -2.34 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 268.08 472.62 cm
0 g
0 G
1.11 w
0 0 m
0 1.26 -1.08 2.34 -2.46 2.34 c
-3.84 2.34 -4.98 1.26 -4.98 0 c
-4.98 -1.32 -3.84 -2.4 -2.46 -2.4 c
-1.08 -2.4 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 495.84 555.12 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.08 2.34 -2.46 2.34 c
-3.84 2.34 -4.98 1.32 -4.98 0 c
-4.98 -1.32 -3.84 -2.4 -2.46 -2.4 c
-1.08 -2.4 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 482.28 555.36 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.14 2.4 -2.52 2.4 c
-3.9 2.4 -5.04 1.32 -5.04 0 c
-5.04 -1.26 -3.9 -2.34 -2.52 -2.34 c
-1.14 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 450.9 601.26 cm
0 g
0 G
1.11 w
0 0 m
0 1.26 -1.02 2.34 -2.34 2.34 c
-3.66 2.34 -4.68 1.26 -4.68 0 c
-4.68 -1.32 -3.66 -2.4 -2.34 -2.4 c
-1.02 -2.4 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 490.86 506.64 cm
0 g
0 G
1.11 w
0 0 m
0 1.38 -1.14 2.46 -2.52 2.46 c
-3.9 2.46 -4.98 1.38 -4.98 0 c
-4.98 -1.38 -3.9 -2.52 -2.52 -2.52 c
-1.14 -2.52 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 432.3 515.94 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.02 2.34 -2.34 2.34 c
-3.66 2.34 -4.68 1.32 -4.68 0 c
-4.68 -1.32 -3.66 -2.34 -2.34 -2.34 c
-1.02 -2.34 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 444.54 502.44 cm
0 g
0 G
1.11 w
0 0 m
0 1.38 -1.14 2.52 -2.52 2.52 c
-3.9 2.52 -4.98 1.38 -4.98 0 c
-4.98 -1.38 -3.9 -2.46 -2.52 -2.46 c
-1.14 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 490.86 528 cm
0 g
0 G
1.11 w
0 0 m
0 1.38 -1.14 2.52 -2.52 2.52 c
-3.9 2.52 -4.98 1.38 -4.98 0 c
-4.98 -1.38 -3.9 -2.46 -2.52 -2.46 c
-1.14 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 305.82 503.58 cm
0 g
0 G
1.11 w
0 0 m
0 1.38 -1.08 2.52 -2.46 2.52 c
-3.84 2.52 -4.98 1.38 -4.98 0 c
-4.98 -1.38 -3.84 -2.52 -2.46 -2.52 c
-1.08 -2.52 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 321.12 485.52 cm
0 g
0 G
1.11 w
0 0 m
0 1.38 -1.08 2.52 -2.4 2.52 c
-3.66 2.52 -4.74 1.38 -4.74 0 c
-4.74 -1.38 -3.66 -2.52 -2.4 -2.52 c
-1.08 -2.52 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 146.34 630 cm
0 g
0 G
1.11 w
0 0 m
0 1.38 -1.08 2.46 -2.34 2.46 c
-3.66 2.46 -4.74 1.38 -4.74 0 c
-4.74 -1.38 -3.66 -2.52 -2.34 -2.52 c
-1.08 -2.52 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 186 464.7 cm
0 g
0 G
1.11 w
0 0 m
0 1.38 -1.14 2.46 -2.52 2.46 c
-3.9 2.46 -4.98 1.38 -4.98 0 c
-4.98 -1.38 -3.9 -2.52 -2.52 -2.52 c
-1.14 -2.52 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 453.12 513.42 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.08 2.4 -2.46 2.4 c
-3.84 2.4 -4.98 1.32 -4.98 0 c
-4.98 -1.26 -3.84 -2.34 -2.46 -2.34 c
-1.08 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 316.08 503.28 cm
0 g
0 G
1.11 w
0 0 m
0 1.38 -1.08 2.52 -2.46 2.52 c
-3.84 2.52 -4.98 1.38 -4.98 0 c
-4.98 -1.38 -3.84 -2.46 -2.46 -2.46 c
-1.08 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 146.34 494.82 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.08 2.34 -2.34 2.34 c
-3.66 2.34 -4.74 1.32 -4.74 0 c
-4.74 -1.32 -3.66 -2.34 -2.34 -2.34 c
-1.08 -2.34 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 290.58 483.3 cm
0 g
0 G
1.11 w
0 0 m
0 1.38 -1.14 2.52 -2.52 2.52 c
-3.9 2.52 -4.98 1.38 -4.98 0 c
-4.98 -1.38 -3.9 -2.52 -2.52 -2.52 c
-1.14 -2.52 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 170.46 458.16 cm
0 g
0 G
1.11 w
0 0 m
0 1.26 -1.02 2.34 -2.34 2.34 c
-3.66 2.34 -4.74 1.26 -4.74 0 c
-4.74 -1.32 -3.66 -2.4 -2.34 -2.4 c
-1.02 -2.4 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 468.42 630 cm
0 g
0 G
1.11 w
0 0 m
0 1.38 -1.14 2.46 -2.52 2.46 c
-3.9 2.46 -5.04 1.38 -5.04 0 c
-5.04 -1.38 -3.9 -2.52 -2.52 -2.52 c
-1.14 -2.52 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 148.56 517.86 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.14 2.4 -2.52 2.4 c
-3.9 2.4 -4.98 1.32 -4.98 0 c
-4.98 -1.26 -3.9 -2.34 -2.52 -2.34 c
-1.14 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 146.34 484.14 cm
0 g
0 G
1.11 w
0 0 m
0 1.38 -1.08 2.46 -2.34 2.46 c
-3.66 2.46 -4.74 1.38 -4.74 0 c
-4.74 -1.38 -3.66 -2.52 -2.34 -2.52 c
-1.08 -2.52 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 435.66 559.26 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.08 2.4 -2.34 2.4 c
-3.66 2.4 -4.74 1.32 -4.74 0 c
-4.74 -1.26 -3.66 -2.34 -2.34 -2.34 c
-1.08 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 480.3 623.76 cm
0 g
0 G
1.11 w
0 0 m
0 1.26 -1.02 2.34 -2.34 2.34 c
-3.66 2.34 -4.68 1.26 -4.68 0 c
-4.68 -1.32 -3.66 -2.4 -2.34 -2.4 c
-1.02 -2.4 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 372.66 490.08 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.08 2.4 -2.46 2.4 c
-3.84 2.4 -4.98 1.32 -4.98 0 c
-4.98 -1.26 -3.84 -2.34 -2.46 -2.34 c
-1.08 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 356.58 603.9 cm
0.5 g
0 G
1.11 w
0 0 m
-3.06 -5.28 l
2.82 -5.28 l
h
B*
Q
q
1 0 0 1 450.66 611.94 cm
0.5 g
0 G
1.11 w
0 0 m
-3.06 -5.04 l
2.76 -5.04 l
h
B*
Q
q
1 0 0 1 341.04 519.66 cm
0.5 g
0 G
1.11 w
0 0 m
-3 -4.98 l
3.06 -4.98 l
h
B*
Q
q
1 0 0 1 262.56 464.4 cm
0.5 g
0 G
1.11 w
0 0 m
-3.06 -4.98 l
2.76 -4.98 l
h
B*
Q
q
1 0 0 1 496.68 533.88 cm
0.5 g
0 G
1.11 w
0 0 m
-2.76 -5.04 l
3.06 -5.04 l
h
B*
Q
q
1 0 0 1 378.78 544.14 cm
0.5 g
0 G
1.11 w
0 0 m
-3.06 -5.28 l
2.76 -5.28 l
h
B*
Q
q
1 0 0 1 387.12 476.64 cm
0.5 g
0 G
1.11 w
0 0 m
-2.76 -5.28 l
3.06 -5.28 l
h
B*
Q
q
1 0 0 1 483.12 507.18 cm
0.5 g
0 G
1.11 w
0 0 m
-2.82 -4.98 l
3 -4.98 l
h
B*
Q
q
1 0 0 1 474.48 525.24 cm
0.5 g
0 G
1.11 w
0 0 m
-2.76 -5.28 l
3.06 -5.28 l
h
B*
Q
q
1 0 0 1 192.12 490.8 cm
0.5 g
0 G
1.11 w
0 0 m
-2.82 -4.98 l
3.06 -4.98 l
h
B*
Q
q
1 0 0 1 503.64 480.54 cm
0.5 g
0 G
1.11 w
0 0 m
-2.82 -5.04 l
3.06 -5.04 l
h
B*
Q
q
1 0 0 1 493.38 518.58 cm
0.5 g
0 G
1.11 w
0 0 m
-3.06 -5.28 l
3 -5.28 l
h
B*
Q
q
1 0 0 1 419.82 508.86 cm
0.5 g
0 G
1.11 w
0 0 m
-3 -4.98 l
2.82 -4.98 l
h
B*
Q
q
1 0 0 1 366.6 516.9 cm
0.5 g
0 G
1.11 w
0 0 m
-2.76 -4.98 l
3.06 -4.98 l
h
B*
Q
q
1 0 0 1 493.38 559.14 cm
0.5 g
0 G
1.11 w
0 0 m
-3.06 -4.98 l
3 -4.98 l
h
B*
Q
q
1 0 0 1 457.32 524.4 cm
0.5 g
0 G
1.11 w
0 0 m
-2.82 -4.98 l
3 -4.98 l
h
B*
Q
q
1 0 0 1 407.64 527.16 cm
0.5 g
0 G
1.11 w
0 0 m
-2.76 -4.98 l
3.06 -4.98 l
h
B*
Q
q
1 0 0 1 457.32 548.58 cm
0.5 g
0 G
1.11 w
0 0 m
-2.82 -4.98 l
3 -4.98 l
h
B*
Q
q
1 0 0 1 214.32 459.66 cm
0.5 g
0 G
1.11 w
0 0 m
-2.82 -4.98 l
3 -4.98 l
h
B*
Q
q
1 0 0 1 272.52 516.36 cm
0.5 g
0 G
1.11 w
0 0 m
-2.76 -4.98 l
3.06 -4.98 l
h
B*
Q
0 G
1.11 w
353.82 524.7 -4.98 -5.04 re
348.84 524.7 m
h
B*
177.66 469.98 -4.98 -5.04 re
172.68 469.98 m
h
B*
422.34 539.4 -4.98 -4.98 re
417.36 539.4 m
h
B*
340.26 522.18 -5.04 -4.98 re
335.22 522.18 m
h
B*
292.26 460.2 -4.98 -4.98 re
287.28 460.2 m
h
B*
249.54 543 -4.98 -4.98 re
244.56 543 m
h
B*
305.82 494.94 -4.98 -4.98 re
300.84 494.94 m
h
B*
213.48 480.54 -5.04 -5.04 re
208.44 480.54 m
h
B*
249.54 523.02 -4.98 -4.98 re
244.56 523.02 m
h
B*
381.3 531.9 -4.98 -4.98 re
376.32 531.9 m
h
B*
345.24 535.8 -4.98 -4.98 re
340.26 535.8 m
h
B*
q
1 0 0 1 356.58 522.18 cm
0.555 w
0 0 m
-205.56 -37.2 l
121.5 21.96 l
-68.52 -12.48 l
-220.8 -40.02 l
94.08 16.98 l
-90.96 -16.38 l
136.8 24.72 l
123.18 22.26 l
-15.54 -2.76 l
-94.02 -17.22 l
140.1 25.56 l
22.2 3.9 l
-5.28 -1.08 l
92.1 16.68 l
131.76 23.88 l
30.54 5.58 l
73.56 13.32 l
85.44 15.54 l
126.54 23.04 l
117.9 21.42 l
131.76 23.88 l
-164.46 -30 l
147.06 26.7 l
-53.22 -9.72 l
-37.68 -6.96 l
-181.38 -33.06 l
136.8 24.72 l
63.24 11.4 l
63.24 11.4 l
-18.84 -3.3 l
-212.46 -38.64 l
10.02 1.98 l
-66.84 -12.24 l
136.8 24.72 l
-173.1 -31.38 l
100.74 18.36 l
-109.56 -19.98 l
-53.22 -9.72 l
94.08 16.98 l
-42.96 -7.8 l
-212.46 -38.64 l
-145.62 -26.4 l
-68.52 -12.48 l
-109.56 -19.98 l
51.06 9.18 l
22.2 3.9 l
-188.34 -34.14 l
-13.86 -2.52 l
100.74 18.36 l
109.32 19.74 l
-210.54 -38.34 l
-142.26 -25.86 l
-84.06 -15.3 l
-212.46 -38.64 l
76.86 13.92 l
121.5 21.96 l
13.62 2.52 l
S
Q
BT
0 g
/C2_1 1 Tf
11.6517 0 0 11.669 468.72 626.28 Tm
<006e> Tj
/TT0 1 Tf
-0.0005 Tc
0.592 0.113 Td
(802) Tj
ET
q
1 0 0 1 128.28 447.42 cm
0.555 w
0 0 m
0 192 l
S
Q
q
1 0 0 1 128.28 454.98 cm
0.555 w
0 0 m
-4.44 0 l
S
Q
BT
/TT0 1 Tf
0 Tc
9.1549 0 0 9.1685 116.7 451.2 Tm
(0) Tj
ET
q
1 0 0 1 128.28 476.64 cm
0.555 w
0 0 m
-4.44 0 l
S
Q
BT
/TT0 1 Tf
-0.015 Tc
9.1549 0 0 9.1685 111.96 473.16 Tm
(50) Tj
ET
q
1 0 0 1 128.28 498.6 cm
0.555 w
0 0 m
-4.44 0 l
S
Q
BT
/TT0 1 Tf
9.1549 0 0 9.1685 107.22 495.12 Tm
[ (10) -33 (0) ] TJ
ET
q
1 0 0 1 128.28 520.5 cm
0.555 w
0 0 m
-4.44 0 l
S
Q
BT
/TT0 1 Tf
9.1549 0 0 9.1685 107.22 516.78 Tm
[ (15) -33 (0) ] TJ
ET
q
1 0 0 1 128.28 542.46 cm
0.555 w
0 0 m
-4.44 0 l
S
Q
BT
/TT0 1 Tf
9.1549 0 0 9.1685 107.22 538.7401 Tm
[ (20) -33 (0) ] TJ
ET
q
1 0 0 1 128.28 564.12 cm
0.555 w
0 0 m
-4.44 0 l
S
Q
BT
/TT0 1 Tf
9.1549 0 0 9.1685 107.22 560.7 Tm
[ (25) -33 (0) ] TJ
ET
q
1 0 0 1 128.28 586.08 cm
0.555 w
0 0 m
-4.44 0 l
S
Q
BT
/TT0 1 Tf
9.1549 0 0 9.1685 107.22 582.6 Tm
[ (30) -33 (0) ] TJ
ET
q
1 0 0 1 128.28 608.04 cm
0.555 w
0 0 m
-4.44 0 l
S
Q
BT
/TT0 1 Tf
9.1549 0 0 9.1685 107.22 604.32 Tm
[ (35) -33 (0) ] TJ
ET
q
1 0 0 1 128.28 630 cm
0.555 w
0 0 m
-4.44 0 l
S
Q
BT
/TT0 1 Tf
9.1549 0 0 9.1685 107.22 626.22 Tm
[ (40) -33 (0) ] TJ
0.0002 Tc
0.0124 Tw
0 11.6517 -11.669 0 100.62 427.68 Tm
[ (P) -15 (r) -1 (i) 15 (c) -9 (e) 17 (\040p) -4 (e) 17 (r\040l) 15 (i) -5 (fe) 17 (\040y) -4 (e) 17 (a) -9 (r) -1 (\040) 26 (ga) -9 (i) 15 (n) 1 (e) -9 (d) -4 (\040) 26 (\050\0441\054) -12 (0) -4 (00s) 8 (\040of\040) 26 (2) -4 (013\040U) 7 (S) -15 (D) 7 (\051) ] TJ
ET
q
1 0 0 1 128.28 447.42 cm
0.555 w
0 0 m
385.32 0 l
S
Q
q
1 0 0 1 138.84 447.42 cm
0.555 w
0 0 m
0 -4.44 l
S
Q
BT
/TT0 1 Tf
-0.0005 Tc
0 Tw
11.6517 0 0 11.669 127.2 430.02 Tm
[ (19) -5 (96) ] TJ
ET
q
1 0 0 1 179.88 447.42 cm
0.555 w
0 0 m
0 -4.44 l
S
Q
BT
/TT0 1 Tf
11.6517 0 0 11.669 168.3 430.02 Tm
(1998) Tj
ET
q
1 0 0 1 220.98 447.42 cm
0.555 w
0 0 m
0 -4.44 l
S
Q
BT
/TT0 1 Tf
11.6517 0 0 11.669 209.34 430.02 Tm
(2000) Tj
ET
q
1 0 0 1 262.02 447.42 cm
0.555 w
0 0 m
0 -4.44 l
S
Q
BT
/TT0 1 Tf
11.6517 0 0 11.669 250.38 430.02 Tm
(2002) Tj
ET
q
1 0 0 1 303.06 447.42 cm
0.555 w
0 0 m
0 -4.44 l
S
Q
BT
/TT0 1 Tf
11.6517 0 0 11.669 291.42 430.02 Tm
[ (20) -5 (04) ] TJ
ET
q
1 0 0 1 344.1 447.42 cm
0.555 w
0 0 m
0 -4.44 l
S
Q
BT
/TT0 1 Tf
11.6517 0 0 11.669 332.52 430.02 Tm
(2006) Tj
ET
q
1 0 0 1 385.2 447.42 cm
0.555 w
0 0 m
0 -4.44 l
S
Q
BT
/TT0 1 Tf
11.6517 0 0 11.669 373.56 430.02 Tm
(2008) Tj
ET
q
1 0 0 1 426.24 447.42 cm
0.555 w
0 0 m
0 -4.44 l
S
Q
BT
/TT0 1 Tf
11.6517 0 0 11.669 414.6 430.02 Tm
(2010) Tj
ET
q
1 0 0 1 467.28 447.42 cm
0.555 w
0 0 m
0 -4.44 l
S
Q
BT
/TT0 1 Tf
11.6517 0 0 11.669 455.64 430.02 Tm
[ (20) -5 (12) ] TJ
ET
q
1 0 0 1 508.32 447.42 cm
0.555 w
0 0 m
0 -4.44 l
S
Q
BT
/TT0 1 Tf
11.6517 0 0 11.669 496.7399 430.02 Tm
(2014) Tj
-0.0001 Tc
-0.0079 Tw
-17.905 -1.522 Td
[ (A) 6 (ppro) -5 (va) 16 (l) -5 (\040dat) 15 (e) ] TJ
ET
1 g
1 G
0.555 w
132.48 635.52 139.5 -52.2 re
B*
q
1 0 0 1 144.12 615.12 cm
0 g
0 G
1.11 w
0 0 m
0 1.32 -1.14 2.34 -2.52 2.34 c
-3.9 2.34 -4.98 1.32 -4.98 0 c
-4.98 -1.32 -3.9 -2.34 -2.52 -2.34 c
-1.14 -2.34 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 141.6 607.2 cm
0.5 g
0 G
1.11 w
0 0 m
-2.76 -4.98 l
3.06 -4.98 l
h
B*
Q
0 G
1.11 w
144.12 595.56 -4.98 -5.04 re
139.14 595.56 m
h
B*
BT
0 g
/TT0 1 Tf
-0.0154 Tc
0.0079 Tw
9.1549 0 0 9.1685 149.4 622.08 Tm
[ (Sou) -33 (r) -17 (ce) -24 (\040of) -17 (\040) -26 (s) -19 (ur) -17 (vi) -13 (va) -24 (l) 20 (\040) -33 (be) 9 (n) -33 (e) 2 (f) -17 (i) -6 (t) -13 (\072) ] TJ
-0.0085 Tc
0.0338 Tw
0 -1.185 TD
[ (T) -7 (r) -10 (ia) 9 (l\054\040o) 7 (v) 7 (e) 9 (r) -10 (a) -17 (l) 27 (l) -6 (\040) 33 (s) -13 (u) -20 (r) -10 (v) 7 (i) -6 (v) 7 (a) 16 (l) ] TJ
-0.0158 Tc
0.0411 Tw
0 -1.178 TD
[ (T) -14 (r) -17 (i) -7 (a) 2 (l) -7 (\054) -8 (\040pr) -17 (ogr) -17 (e) -24 (s) -20 (s) -20 (i) -13 (on\055) -17 (f) -17 (r) -10 (ee\040) 7 (s) -26 (u) -1 (r) -10 (v) -1 (i) -13 (v) -1 (a) -24 (l) ] TJ
0.0178 Tc
-0.0253 Tw
0 -1.185 TD
[ (M) 29 (o) 33 (de) 36 (l) 27 (l) 53 (i) 20 (n) 7 (g) 33 (\040s) 14 (t) 20 (ud) 33 (y) ] TJ
-0.0155 Tc
0.008 Tw
-2.091 -21.609 Td
[ (T) -14 (he) -24 (\040b) -33 (e) 9 (s) -20 (t) -13 (\040) -33 (f) -10 (i) -13 (t) -13 (\040l) -6 (i) -13 (ne) -24 (\040i) -13 (s) -20 (\072) -13 (\040) -26 (Pr) -17 (i) -13 (c) 2 (e) -24 (\040p) -33 (e) 9 (r) -17 (\040) -33 (l) 20 (i) -6 (f) -17 (e) -24 (\040yea) -30 (r) -10 (\040ga) -30 (i) -6 (ned) -33 (\040\075) -22 (\040\044) -33 (54) -33 (\054) -8 (1) -27 (00) -33 (\040\053) -28 (\040\044) -27 (8\054) -41 (500) -27 (\040x) -33 (\040A) -21 (pp) -27 (r) -17 (oval) -13 (\040) 7 (yea) -30 (r) -10 (\056) ] TJ
-0.0152 Tc
0.0077 Tw
0 -1.001 TD
[ (A) 6 (p) -26 (pr) -16 (ova) -24 (l) 20 (\040) -33 (Y) -20 (e) 3 (a) -24 (r) -16 (\040\075) -28 (\0400) -26 (\040f) -16 (or) -16 (\0401) -26 (99) -33 (5\054) -40 (\0401) -26 (\040f) -16 (or) -16 (\040) -26 (19) -33 (96) -33 (\054) -8 (\040) -26 (et) -13 (c) 9 (\056) -40 (\040For) -16 (\040) -26 (pu) -33 (r) -16 (pos) -19 (e) -24 (s) -19 (\040of) -16 (\040) -33 (di) -6 (s) -26 (pl) -6 (a) 3 (y\054) -8 (\040) -26 (w) 6 (e) -24 (\040r) -16 (e) -24 (\055) 10 (c) -24 (ode) -24 (d\040) -33 (o) 33 (n) -33 (e) 9 (\040) -33 (val) -6 (ue) ] TJ
0.0105 Tc
-0.018 Tw
0 -1.027 TD
[ (f) 9 (r) 9 (o) 26 (m\040\044) -7 (8) 26 (02) 26 (\054) -15 (0) 26 (00) 26 (\040) -33 (t) 13 (o) 26 (\040\0444) 26 (0) 26 (0) -7 (\054) 18 (0) -1 (0) 26 (0) -7 (\056) ] TJ
-0.0021 Tc
-0.0054 Tw
0 -1.001 TD
[ (S) 10 (o) 13 (u) -20 (r) -3 (c) 16 (e) -10 (\072\040Au) 13 (th) -20 (o) 13 (r) -3 (s) ] TJ
-0.0082 Tw
12.7615 0 0 12.7805 180.18 650.88 Tm
[ (F) 9 (i) -6 (gur) 7 (e) -14 (\0402\072) -6 (\040) -23 (P) 9 (r) -17 (i) -6 (c) 9 (e) -14 (\040per) -17 (\040l) -6 (i) -6 (f) -17 (e) 9 (\040) -23 (y) 18 (e) -14 (a) 9 (r) -17 (\040gai) -6 (ned\040) -19 (v) 18 (e) -14 (rsus\040) -23 (a) 9 (p) -5 (pr) 7 (ova) 9 (l) -11 (\040) -19 (dat) -6 (e) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0.9 0.9 0.9 RG
n
306 708 3 8 re
S
0.9 0.9 0.9 RG
n
306 695 3 8 re
S
0.9 0.9 0.9 RG
n
306 681 3 8 re
S
0.9 0.9 0.9 RG
n
538 337 3 8 re
S
0.9 0.9 0.9 RG
n
305 326 3 8 re
S
0.9 0.9 0.9 RG
n
305 313 3 8 re
S
0.9 0.9 0.9 RG
n
305 299 3 8 re
S
0.9 0.9 0.9 RG
n
305 285 3 8 re
S
0.9 0.9 0.9 RG
n
305 271 3 8 re
S
0.9 0.9 0.9 RG
n
305 257 3 8 re
S
0.9 0.9 0.9 RG
n
305 244 3 8 re
S
0.9 0.9 0.9 RG
n
305 230 3 8 re
S
0.9 0.9 0.9 RG
n
305 216 3 8 re
S
0.9 0.9 0.9 RG
n
305 202 3 8 re
S
0.9 0.9 0.9 RG
n
305 188 3 8 re
S
0.9 0.9 0.9 RG
n
305 175 3 8 re
S
0.9 0.9 0.9 RG
n
305 161 3 8 re
S
0.9 0.9 0.9 RG
n
305 147 3 8 re
S
0.9 0.9 0.9 RG
n
305 133 3 8 re
S
0.9 0.9 0.9 RG
n
305 119 3 8 re
S
0.9 0.9 0.9 RG
n
305 106 3 8 re
S
0.9 0.9 0.9 RG
n
305 92 3 8 re
S
0.9 0.9 0.9 RG
n
468 626 24 8 re
S
0.9 0.9 0.9 RG
n
116 451 5 8 re
S
0.9 0.9 0.9 RG
n
111 473 9 8 re
S
0.9 0.9 0.9 RG
n
107 495 14 8 re
S
0.9 0.9 0.9 RG
n
107 516 14 8 re
S
0.9 0.9 0.9 RG
n
107 538 14 8 re
S
0.9 0.9 0.9 RG
n
107 560 14 8 re
S
0.9 0.9 0.9 RG
n
107 582 14 8 re
S
0.9 0.9 0.9 RG
n
107 604 14 8 re
S
0.9 0.9 0.9 RG
n
107 626 14 8 re
S
0.9 0.9 0.9 RG
n
127 430 392 8 re
S
0.9 0.9 0.9 RG
n
288 412 66 8 re
S
0.9 0.9 0.9 RG
n
149 622 96 8 re
S
0.9 0.9 0.9 RG
n
149 611 78 8 re
S
0.9 0.9 0.9 RG
n
149 600 113 8 re
S
0.9 0.9 0.9 RG
n
149 589 60 8 re
S
0.9 0.9 0.9 RG
n
130 391 300 8 re
S
0.9 0.9 0.9 RG
n
130 382 336 8 re
S
0.9 0.9 0.9 RG
n
130 372 103 8 re
S
0.9 0.9 0.9 RG
n
130 363 59 8 re
S
0.9 0.9 0.9 RG
n
180 650 286 8 re
S
Q

endstream
endobj
138 0 obj
<<
/BaseFont /PBEHFB+SymbolMT
/DescendantFonts [ 139 0 R ]
/Encoding /Identity-H
/Subtype /Type0
/ToUnicode 143 0 R
/Type /Font
>>
endobj
139 0 obj
<<
/BaseFont /PBEHFB+SymbolMT
/CIDSystemInfo <<
/Ordering (Identity)
/Registry (Adobe)
/Supplement 0
>>
/CIDToGIDMap /Identity
/DW 1000
/FontDescriptor 140 0 R
/Subtype /CIDFontType2
/Type /Font
/W [ 110 [ 603 ] ]
>>
endobj
140 0 obj
<<
/Ascent 1005
/CIDSet 141 0 R
/CapHeight 0
/Descent -219
/Flags 4
/FontBBox [ 0 -220 1113 1005 ]
/FontFamily (Symbol)
/FontFile2 142 0 R
/FontName /PBEHFB+SymbolMT
/FontStretch /Normal
/FontWeight 400
/ItalicAngle 0
/StemV 0
/Type /FontDescriptor
>>
endobj
141 0 obj
<<
/Filter /FlateDecode
/Length 17
>>
stream
hj`@L&@ . 
endstream
endobj
142 0 obj
<<
/Filter /FlateDecode
/Length1 6036
/Length 3794
>>
stream
h8ktTE_UIH:!<d΃B^N !$yhw: .f
 
 nQ8Μ]ϰqWqV%M{+_} hf,/ŧKP*rwvD QhlY2?ӜĂ 	ր韏
索  !#?u]j!j77&uu͝4Eh|j@uwvnt.?<?@3$"(Sl!cLb(Jd2|iX\zmD|lVǴj).tIH0>qE\|V dC5ɁZ2?Ca4TTdN8EBqe%`:`23<,QQ؀R$!1414~	P9lAxOw$Qx>"0]5No^0Jhc=@5s#b<obq֯ÛQrGXȗz8!s챕ljEsmU<7頂[a=8 <Jΐt"NOr\3V~XCϟa_cd)!ed!#gPŲ8<˶8dd;FkIQ8XxJz[w<Wgc='HJTeAB6e&țrC"Ih4DOӋ1bd_[{ BڄM.A&\FD5lO<8|h54JFcvk|&p>~hƝӉzvpF7773|7,db%yd&>2
\nl')s6D,Gp˩>@VOA:DJLHfVX=0bP,
BP8$(%΋3._?4^
˒ң\RF!8ͳOz%&m!(% z3F~O d%-jx[\OY-iza?>0*a=O5<$azw6(l!"adlzZ~LX+V;.`J|C<?٪G19//ًhx8*zLɢdOH
`8~V[fS?>e'3<{f9ܢ<{noWv_iIqQ{=k挂\[N23kw[MMKMI49qRB%.vbLtEDQNʫ^],CWWQT5FW:Ҏ߰Z,E-Ҽ\թɊn84_1&-dDdVPɭU'^թWu9/UUr!d4R3DS!
DJON=Est5KNGI_kAl	TatR0jVCC}-4iMUn<<F:)?5'TSm*gQKwjxpU޾*VUb4.Y/9ĻF'hZk/Mju=ցT>:վficj(zNՔܐ%~ظ3N"03)ӜSwUĭ
y(>!!7ኴ*}b.aԾwv/%Dʰ|dl6lzN"r%)XfviiQak`VvhDF߾=ʫИ6 G^k֌{5/M̱֕8K$gkNCջ5n0">hi\5fw.ddnꦰ4%D-'jo:kD_Eԋmqb&,dRWÊq:<!.Io
oJh:
`7tL9s"ab M`
L&`ʔ20YL>yP||咹w>3ϗx{FDE%	 B,|P<E]گུ0P^p!AEhD ,B؊/vo)7ŷ Q\w#N>TdIi@821l1jA<_$eUa#d
B! 	sB1*U$8Iբe`|* {n<zupBY5,CP؉3l=ys nC~>ֳseJ8J/p<C{0|i-%Z3kDf pCYGWl64፣-Ro8X1<p)`>\my@Z՘|s
"DX|D!Djt<M(1kmr10lB2:mGF*YKG1hHKPCBy"I3$x엘</=-(HOLF4Aj̬,Og,%Y{KgD(@FeNXG˜'$N"9<![`_V9r0_`.'*	EUb(EQ$EPJbxn?Qp$	LByO:
(Q('1uW>Wߨ$
|VA*B+,u\KkWC{P^|#5]i1EI%U9FzOU*M :!?!si=J4ȥAS<MwǦyY0yȉ-^՜5Yި!ȅ%oOjnj|˷pug;p˝!4ä#K~y~^cFtu'ht7HtSbM~8wgND઼rU
Q%?\bM{<QYPUmF@34Y6d{#xqJwI	A$dO E.LX..(]l.yåfΘoϰ[[[vΐB<a+*ZSZzOU!qiʀ|D
NFEEC}Fƹ`%9'xBåa'o"3jXMUK|;;	L̤$Y%$qo/_x|ÜMdU_h5?ݗV08FiZBarax4BGh
P.BHGz:>@=6;PVvljXvU]Fj][KkF.1;T[\PUaYѾYh 4~?b"4@I/XRHއ6BEI;#0H8R;:wl4  vcPNX U?{`4nMm7Ȯ`K(X !uU< ;k=W2M1?_j	ǯ/cLD` M\
endstream
endobj
143 0 obj
<<
/Filter /FlateDecode
/Length 219
>>
stream
hTPj0[nJ(w2=VRC#g+$'=ޓ95"3{bޑeႃ#(Jĭ[u 2E=Ti8E^A~Ev4$NH;#Ru{!o:AޘhrM[6ȚJgdw֥7?ž^NHy33'髑l޿|j9U Ƚk
endstream
endobj
144 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
145 0 obj
<<
/Length 18957
>>
stream
q
BT
/GS0 gs
/TT0 1 Tf
0.0027 Tc
10.98 0 0 10.98 300.48 75.8401 Tm
[ (33) 5 (\040) ] TJ
/C2_0 1 Tf
0 Tc
-20.809 -2.262 Td
<0003> Tj
/TT0 1 Tf
12 0 0 12 306 708.96 Tm
(\040) Tj
0 -1.15 TD
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
18.935 -27.99 Td
(\040) Tj
-18.935 -0.92 Td
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
T*
(\040) Tj
11.75 Tc
-19.5 -1.15 Td
(\040\040) Tj
ET
1 g
82.56 321.18 447.54 326.28 re
f
1 G
0.542 w
1 j
1 J
82.8 646.92 447 -325.2 re
B*
94.2 635.52 414.18 -296.16 re
B*
105.6 612.72 402.78 -242.4 re
B*
105.6 612.72 402.78 -242.4 re
B*
129.96 595.62 106.02 -83.88 re
B*
264.18 595.62 106.26 -83.88 re
B*
398.64 595.62 106.26 -83.88 re
B*
129.96 474.54 106.02 -83.88 re
B*
264.18 474.54 106.26 -83.88 re
B*
q
1 0 0 1 138.12 519.9 cm
0 g
0 G
0.814 w
0 0 m
0 1.32 -1.08 2.4 -2.46 2.4 c
-3.78 2.4 -4.86 1.32 -4.86 0 c
-4.86 -1.38 -3.78 -2.46 -2.46 -2.46 c
-1.08 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 171.18 531.96 cm
0 g
0 G
0.814 w
0 0 m
0 1.26 -1.08 2.34 -2.46 2.34 c
-3.78 2.34 -4.86 1.26 -4.86 0 c
-4.86 -1.26 -3.78 -2.28 -2.4 -2.28 c
-1.08 -2.28 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 216.18 556.92 cm
0 g
0 G
0.814 w
0 0 m
0 1.32 -1.08 2.34 -2.46 2.34 c
-3.78 2.34 -4.86 1.32 -4.86 0 c
-4.86 -1.26 -3.78 -2.28 -2.46 -2.28 c
-1.08 -2.28 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 227.82 578.1 cm
0 g
0 G
0.814 w
0 0 m
0 1.26 -1.02 2.34 -2.28 2.34 c
-3.54 2.34 -4.56 1.26 -4.56 0 c
-4.56 -1.26 -3.54 -2.28 -2.28 -2.28 c
-1.02 -2.28 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 150.06 525.6 cm
0 g
0 G
0.814 w
0 0 m
0 1.32 -1.02 2.4 -2.34 2.4 c
-3.6 2.4 -4.62 1.32 -4.62 0 c
-4.62 -1.38 -3.6 -2.46 -2.34 -2.46 c
-1.02 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 146.28 519.9 cm
0 g
0 G
0.814 w
0 0 m
0 1.32 -1.14 2.4 -2.46 2.4 c
-3.84 2.4 -4.92 1.32 -4.92 0 c
-4.92 -1.38 -3.84 -2.46 -2.46 -2.46 c
-1.14 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 140.04 541.62 cm
0 g
0 G
0.814 w
0 0 m
0 1.32 -1.08 2.4 -2.34 2.4 c
-3.6 2.4 -4.62 1.32 -4.62 0 c
-4.62 -1.38 -3.6 -2.46 -2.34 -2.46 c
-1.08 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 197.76 592.08 cm
0.5 g
0 G
0.814 w
0 0 m
-3 -5.16 l
2.7 -5.16 l
h
B*
Q
q
1 0 0 1 222.18 576.36 cm
0.5 g
0 G
0.814 w
0 0 m
-3 -5.16 l
2.94 -5.16 l
h
B*
Q
q
1 0 0 1 150.06 547.86 cm
0.5 g
0 G
0.814 w
0 0 m
-3 -5.16 l
2.94 -5.16 l
h
B*
Q
q
1 0 0 1 194.52 569.28 cm
0.5 g
0 G
0.814 w
0 0 m
-2.7 -4.86 l
2.94 -4.86 l
h
B*
Q
q
1 0 0 1 155.76 522.06 cm
0.5 g
0 G
0.814 w
0 0 m
-3 -5.16 l
2.94 -5.16 l
h
B*
Q
q
1 0 0 1 360.12 550.68 cm
0 g
0 G
0.814 w
0 0 m
0 1.26 -1.08 2.34 -2.46 2.34 c
-3.78 2.34 -4.86 1.26 -4.86 0 c
-4.86 -1.26 -3.78 -2.28 -2.46 -2.28 c
-1.08 -2.28 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 314.88 523.14 cm
0 g
0 G
0.814 w
0 0 m
0 1.32 -1.14 2.46 -2.46 2.46 c
-3.84 2.46 -4.92 1.32 -4.92 0 c
-4.92 -1.32 -3.84 -2.46 -2.46 -2.46 c
-1.14 -2.46 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 273.9 530.88 cm
0 g
0 G
0.814 w
0 0 m
0 1.26 -1.02 2.28 -2.28 2.28 c
-3.54 2.28 -4.56 1.26 -4.56 0 c
-4.56 -1.26 -3.54 -2.34 -2.28 -2.34 c
-1.02 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 359.58 586.68 cm
0 g
0 G
0.814 w
0 0 m
0 1.32 -1.02 2.46 -2.28 2.46 c
-3.6 2.46 -4.62 1.32 -4.62 0 c
-4.62 -1.38 -3.6 -2.46 -2.28 -2.46 c
-1.02 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 325.98 577.68 cm
0.5 g
0 G
0.814 w
0 0 m
-2.7 -4.86 l
3 -4.86 l
h
B*
Q
q
1 0 0 1 304.56 531.54 cm
0.5 g
0 G
0.814 w
0 0 m
-3 -5.16 l
2.7 -5.16 l
h
B*
Q
0 G
0.814 w
314.88 519.6 -4.92 -4.86 re
309.96 519.6 m
h
B*
q
1 0 0 1 491.04 590.04 cm
0 g
0 0 m
0 1.32 -1.08 2.34 -2.4 2.34 c
-3.78 2.34 -4.86 1.32 -4.86 0 c
-4.86 -1.26 -3.78 -2.28 -2.4 -2.28 c
-1.08 -2.28 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 466.14 517.32 cm
0 g
0 0 m
0 1.26 -1.08 2.28 -2.34 2.28 c
-3.6 2.28 -4.62 1.26 -4.62 0 c
-4.62 -1.26 -3.6 -2.34 -2.34 -2.34 c
-1.08 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 456.36 534.54 cm
0.5 g
0 0 m
-2.7 -5.16 l
3 -5.16 l
h
B*
Q
q
1 0 0 1 476.7 528.84 cm
0.5 g
0 0 m
-2.7 -5.16 l
2.94 -5.16 l
h
B*
Q
q
1 0 0 1 473.7 538.32 cm
0.5 g
0 0 m
-3 -5.16 l
3 -5.16 l
h
B*
Q
459.36 542.16 -4.92 -4.92 re
454.44 542.16 m
h
B*
q
1 0 0 1 227.82 438.96 cm
0 g
0 0 m
0 1.38 -1.02 2.46 -2.28 2.46 c
-3.54 2.46 -4.56 1.38 -4.56 0 c
-4.56 -1.32 -3.54 -2.4 -2.28 -2.4 c
-1.02 -2.4 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 176.04 419.4 cm
0 g
0 0 m
0 1.38 -1.02 2.46 -2.28 2.46 c
-3.54 2.46 -4.56 1.38 -4.56 0.06 c
-4.56 -1.32 -3.54 -2.4 -2.28 -2.4 c
-1.02 -2.4 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 167.4 404.52 cm
0.5 g
0 0 m
-3 -5.16 l
3 -5.16 l
h
B*
Q
q
1 0 0 1 199.68 414.54 cm
0.5 g
0 0 m
-3 -5.16 l
2.94 -5.16 l
h
B*
Q
q
1 0 0 1 229.5 417.78 cm
0.5 g
0 0 m
-2.76 -4.86 l
2.94 -4.86 l
h
B*
Q
192.9 454.2 -4.92 -4.92 re
187.98 454.2 m
h
B*
147.36 408.84 -4.92 -4.86 re
142.44 408.84 m
h
B*
210.48 466.68 -4.86 -4.92 re
205.62 466.68 m
h
B*
189.36 452.28 -4.86 -4.86 re
184.5 452.28 m
h
B*
176.88 400.68 -4.86 -4.86 re
172.02 400.68 m
h
B*
165.78 469.68 -4.92 -4.92 re
160.86 469.68 m
h
B*
165.78 453.12 -4.92 -4.92 re
160.86 453.12 m
h
B*
199.92 460.44 -4.86 -4.92 re
195.06 460.44 m
h
B*
q
1 0 0 1 275.28 410.88 cm
0 g
0 0 m
0 1.26 -1.02 2.28 -2.28 2.28 c
-3.6 2.28 -4.62 1.26 -4.62 0 c
-4.62 -1.26 -3.6 -2.28 -2.28 -2.28 c
-1.02 -2.28 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 359.58 422.94 cm
0 g
0 0 m
0 1.38 -1.02 2.46 -2.28 2.46 c
-3.6 2.46 -4.62 1.38 -4.62 0 c
-4.62 -1.32 -3.6 -2.4 -2.28 -2.4 c
-1.02 -2.4 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 310.8 402.6 cm
0 g
0 0 m
0 1.32 -1.08 2.46 -2.46 2.46 c
-3.78 2.46 -4.86 1.32 -4.86 0 c
-4.86 -1.32 -3.78 -2.46 -2.46 -2.46 c
-1.08 -2.46 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 363.36 437.64 cm
0 g
0 0 m
0 1.32 -1.02 2.4 -2.28 2.4 c
-3.54 2.4 -4.56 1.32 -4.56 0 c
-4.56 -1.38 -3.54 -2.46 -2.28 -2.46 c
-1.02 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 352.26 456.6 cm
0 g
0 0 m
0 1.38 -1.08 2.46 -2.46 2.46 c
-3.78 2.46 -4.86 1.38 -4.86 0 c
-4.86 -1.32 -3.78 -2.4 -2.46 -2.4 c
-1.08 -2.4 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 347.4 421.32 cm
0 g
0 0 m
0 1.38 -1.08 2.46 -2.46 2.46 c
-3.78 2.46 -4.92 1.38 -4.92 0 c
-4.92 -1.32 -3.78 -2.46 -2.46 -2.46 c
-1.08 -2.46 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 318.9 408.72 cm
0 g
0 0 m
0 1.26 -1.08 2.28 -2.4 2.28 c
-3.78 2.28 -4.86 1.26 -4.86 0 c
-4.86 -1.26 -3.78 -2.34 -2.4 -2.34 c
-1.08 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 273.9 468.72 cm
0 g
0 0 m
0 1.26 -1.08 2.28 -2.4 2.28 c
-3.78 2.28 -4.86 1.26 -4.86 0 c
-4.86 -1.26 -3.78 -2.34 -2.4 -2.34 c
-1.08 -2.34 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 352.8 420.24 cm
0 g
0 0 m
0 1.38 -1.08 2.46 -2.46 2.46 c
-3.78 2.46 -4.86 1.38 -4.86 0 c
-4.86 -1.32 -3.78 -2.46 -2.46 -2.46 c
-1.08 -2.46 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 317.28 416.16 cm
0 g
0 0 m
0 1.38 -1.02 2.46 -2.28 2.46 c
-3.54 2.46 -4.62 1.38 -4.62 0 c
-4.62 -1.32 -3.54 -2.46 -2.28 -2.46 c
-1.02 -2.46 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 273.9 412.5 cm
0 g
0 0 m
0 1.26 -1.08 2.34 -2.4 2.34 c
-3.78 2.34 -4.86 1.26 -4.86 0 c
-4.86 -1.26 -3.78 -2.28 -2.4 -2.28 c
-1.08 -2.28 0 -1.26 0 0 c
h
B*
Q
q
1 0 0 1 348.18 439.26 cm
0 g
0 0 m
0 1.32 -1.08 2.46 -2.4 2.46 c
-3.78 2.46 -4.86 1.32 -4.86 0 c
-4.86 -1.38 -3.78 -2.46 -2.4 -2.46 c
-1.08 -2.46 0 -1.38 0 0 c
h
B*
Q
q
1 0 0 1 350.34 463.14 cm
0.5 g
0 0 m
-2.94 -4.86 l
2.76 -4.86 l
h
B*
Q
q
1 0 0 1 362.28 430.86 cm
0.5 g
0 0 m
-2.94 -5.16 l
2.7 -5.16 l
h
B*
Q
q
1 0 0 1 358.8 419.7 cm
0.5 g
0 0 m
-3 -5.16 l
2.7 -5.16 l
h
B*
Q
q
1 0 0 1 361.2 424.32 cm
0.5 g
0 0 m
-2.7 -4.86 l
3 -4.86 l
h
B*
Q
q
1 0 0 1 361.2 441.18 cm
0.5 g
0 0 m
-2.7 -4.92 l
3 -4.92 l
h
B*
Q
q
1 0 0 1 352.02 426.78 cm
0.5 g
0 0 m
-3 -4.92 l
2.94 -4.92 l
h
B*
Q
q
1 0 0 1 352.02 436.8 cm
0.5 g
0 0 m
-3 -4.86 l
2.94 -4.86 l
h
B*
Q
291 408 -4.86 -4.86 re
286.14 408 m
h
B*
q
1 0 0 1 129.96 511.44 cm
0.542 w
0 0 m
0 84.18 l
S
Q
q
1 0 0 1 129.96 517.44 cm
0.542 w
0 0 m
-3.78 0 l
S
Q
BT
0 g
/TT0 1 Tf
0 Tc
7.3195 0 0 7.3301 120.78 514.6801 Tm
(0) Tj
ET
q
1 0 0 1 129.96 535.38 cm
0.542 w
0 0 m
-3.78 0 l
S
Q
BT
/TT0 1 Tf
-0.0164 Tc
7.3195 0 0 7.3301 117 532.5601 Tm
(50) Tj
ET
q
1 0 0 1 129.96 553.56 cm
0.542 w
0 0 m
-3.78 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 113.22 550.8 Tm
[ (10) -33 (0) ] TJ
ET
q
1 0 0 1 129.96 571.74 cm
0.542 w
0 0 m
-3.78 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 113.22 568.98 Tm
[ (15) -33 (0) ] TJ
ET
q
1 0 0 1 129.96 589.92 cm
0.542 w
0 0 m
-3.78 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 113.22 587.16 Tm
[ (20) -33 (0) ] TJ
ET
q
1 0 0 1 264.18 511.44 cm
0.542 w
0 0 m
0 84.18 l
S
Q
q
1 0 0 1 264.18 520.68 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 247.38 517.92 Tm
[ (10) -33 (0) ] TJ
ET
q
1 0 0 1 264.18 543.78 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 247.38 541.02 Tm
[ (20) -33 (0) ] TJ
ET
q
1 0 0 1 264.18 566.82 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 247.38 564.0601 Tm
[ (30) -33 (0) ] TJ
ET
q
1 0 0 1 264.18 589.92 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 247.38 587.16 Tm
[ (40) -33 (0) ] TJ
ET
q
1 0 0 1 398.64 511.44 cm
0.542 w
0 0 m
0 84.18 l
S
Q
q
1 0 0 1 398.64 521.76 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 381.84 519 Tm
[ (10) -33 (0) ] TJ
ET
q
1 0 0 1 398.64 544.56 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 381.84 541.8 Tm
[ (20) -33 (0) ] TJ
ET
q
1 0 0 1 398.64 567.42 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 381.84 564.6 Tm
[ (30) -33 (0) ] TJ
ET
q
1 0 0 1 398.64 589.92 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 381.84 587.16 Tm
[ (40) -33 (0) ] TJ
ET
q
1 0 0 1 129.96 390.36 cm
0.542 w
0 0 m
0 84.18 l
S
Q
q
1 0 0 1 129.96 396.06 cm
0.542 w
0 0 m
-3.78 0 l
S
Q
BT
/TT0 1 Tf
0 Tc
7.3195 0 0 7.3301 120.78 393.3 Tm
(0) Tj
ET
q
1 0 0 1 129.96 414.3 cm
0.542 w
0 0 m
-3.78 0 l
S
Q
BT
/TT0 1 Tf
-0.0164 Tc
7.3195 0 0 7.3301 117 411.48 Tm
(50) Tj
ET
q
1 0 0 1 129.96 432.48 cm
0.542 w
0 0 m
-3.78 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 113.22 429.72 Tm
[ (10) -33 (0) ] TJ
ET
q
1 0 0 1 129.96 450.36 cm
0.542 w
0 0 m
-3.78 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 113.22 447.9 Tm
[ (15) -33 (0) ] TJ
ET
q
1 0 0 1 129.96 468.6 cm
0.542 w
0 0 m
-3.78 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 113.22 465.78 Tm
[ (20) -33 (0) ] TJ
ET
q
1 0 0 1 264.18 390.36 cm
0.542 w
0 0 m
0 84.18 l
S
Q
q
1 0 0 1 264.18 396.06 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
0 Tc
7.3195 0 0 7.3301 255 393.3 Tm
(0) Tj
ET
q
1 0 0 1 264.18 414.3 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
-0.0164 Tc
7.3195 0 0 7.3301 247.38 411.48 Tm
[ (10) -33 (0) ] TJ
ET
q
1 0 0 1 264.18 432.48 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 247.38 429.72 Tm
[ (20) -33 (0) ] TJ
ET
q
1 0 0 1 264.18 450.36 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 247.38 447.9 Tm
[ (30) -33 (0) ] TJ
ET
q
1 0 0 1 264.18 468.6 cm
0.542 w
0 0 m
-3.54 0 l
S
Q
BT
/TT0 1 Tf
7.3195 0 0 7.3301 247.38 465.78 Tm
[ (40) -33 (0) ] TJ
ET
q
1 0 0 1 129.96 511.44 cm
0.542 w
0 0 m
106.02 0 l
S
Q
q
1 0 0 1 136.5 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
-0.0171 Tc
8.9461 0 0 8.959 127.32 498 Tm
[ (19) -33 (96) ] TJ
ET
q
1 0 0 1 157.38 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
8.9461 0 0 8.959 148.2 498 Tm
[ (20) -33 (00) ] TJ
ET
q
1 0 0 1 178.26 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
8.9461 0 0 8.959 169.08 498 Tm
[ (20) -33 (04) ] TJ
ET
q
1 0 0 1 199.38 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
8.9461 0 0 8.959 190.2 498 Tm
[ (20) -33 (08) ] TJ
ET
q
1 0 0 1 220.26 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
8.9461 0 0 8.959 211.08 498 Tm
[ (20) -33 (12) ] TJ
ET
q
1 0 0 1 264.18 511.44 cm
0.542 w
0 0 m
106.26 0 l
S
Q
q
1 0 0 1 270.12 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
8.9461 0 0 8.959 260.94 498 Tm
[ (19) -33 (96) ] TJ
ET
q
1 0 0 1 291.3 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
-0.0104 Tc
8.9461 0 0 8.959 282.06 498 Tm
[ (20) -27 (0) 7 (0) ] TJ
ET
q
1 0 0 1 312.42 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
-0.0171 Tc
8.9461 0 0 8.959 303.24 498 Tm
[ (20) -33 (04) ] TJ
ET
q
1 0 0 1 333.54 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
-0.0104 Tc
8.9461 0 0 8.959 324.36 498 Tm
[ (20) -20 (08) ] TJ
ET
q
1 0 0 1 354.72 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
-0.0171 Tc
8.9461 0 0 8.959 345.54 498 Tm
[ (20) -33 (12) ] TJ
ET
q
1 0 0 1 398.64 511.44 cm
0.542 w
0 0 m
106.26 0 l
S
Q
q
1 0 0 1 404.34 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
-0.0104 Tc
8.9461 0 0 8.959 395.1 498 Tm
[ (19) -20 (96) ] TJ
ET
q
1 0 0 1 425.46 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
-0.0171 Tc
8.9461 0 0 8.959 416.28 498 Tm
[ (20) -33 (00) ] TJ
ET
q
1 0 0 1 446.58 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
-0.0104 Tc
8.9461 0 0 8.959 437.4 498 Tm
[ (20) -20 (04) ] TJ
ET
q
1 0 0 1 467.76 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
-0.0171 Tc
8.9461 0 0 8.959 458.58 498 Tm
[ (20) -33 (08) ] TJ
ET
q
1 0 0 1 488.88 511.44 cm
0.542 w
0 0 m
0 -3.48 l
S
Q
BT
/TT0 1 Tf
8.9461 0 0 8.959 479.7 498 Tm
[ (20) -33 (12) ] TJ
ET
q
1 0 0 1 129.96 390.36 cm
0.542 w
0 0 m
106.02 0 l
S
Q
q
1 0 0 1 135.66 390.36 cm
0.542 w
0 0 m
0 -3.78 l
S
Q
BT
/TT0 1 Tf
-0.0104 Tc
8.9461 0 0 8.959 126.48 376.92 Tm
[ (19) -20 (96) ] TJ
ET
q
1 0 0 1 156.84 390.36 cm
0.542 w
0 0 m
0 -3.78 l
S
Q
BT
/TT0 1 Tf
-0.0171 Tc
8.9461 0 0 8.959 147.66 376.92 Tm
[ (20) -33 (00) ] TJ
ET
q
1 0 0 1 177.96 390.36 cm
0.542 w
0 0 m
0 -3.78 l
S
Q
BT
/TT0 1 Tf
8.9461 0 0 8.959 168.78 376.92 Tm
[ (20) -33 (04) ] TJ
ET
q
1 0 0 1 199.14 390.36 cm
0.542 w
0 0 m
0 -3.78 l
S
Q
BT
/TT0 1 Tf
-0.0104 Tc
8.9461 0 0 8.959 189.9 376.92 Tm
[ (20) -20 (08) ] TJ
ET
q
1 0 0 1 220.26 390.36 cm
0.542 w
0 0 m
0 -3.78 l
S
Q
BT
/TT0 1 Tf
-0.0171 Tc
8.9461 0 0 8.959 211.08 376.92 Tm
[ (20) -33 (12) ] TJ
ET
q
1 0 0 1 264.18 390.36 cm
0.542 w
0 0 m
106.26 0 l
S
Q
q
1 0 0 1 270.12 390.36 cm
0.542 w
0 0 m
0 -3.78 l
S
Q
BT
/TT0 1 Tf
8.9461 0 0 8.959 260.94 376.92 Tm
[ (19) -33 (96) ] TJ
ET
q
1 0 0 1 291.3 390.36 cm
0.542 w
0 0 m
0 -3.78 l
S
Q
BT
/TT0 1 Tf
-0.0104 Tc
8.9461 0 0 8.959 282.06 376.92 Tm
[ (20) -27 (0) 7 (0) ] TJ
ET
q
1 0 0 1 312.42 390.36 cm
0.542 w
0 0 m
0 -3.78 l
S
Q
BT
/TT0 1 Tf
-0.0171 Tc
8.9461 0 0 8.959 303.24 376.92 Tm
[ (20) -33 (04) ] TJ
ET
q
1 0 0 1 333.54 390.36 cm
0.542 w
0 0 m
0 -3.78 l
S
Q
BT
/TT0 1 Tf
-0.0104 Tc
8.9461 0 0 8.959 324.36 376.92 Tm
[ (20) -20 (08) ] TJ
ET
q
1 0 0 1 354.72 390.36 cm
0.542 w
0 0 m
0 -3.78 l
S
Q
BT
/TT0 1 Tf
-0.0171 Tc
8.9461 0 0 8.959 345.54 376.92 Tm
[ (20) -33 (12) ] TJ
ET
1 g
1 G
0.542 w
129.96 608.94 106.02 -13.02 re
B*
BT
0 g
/TT0 1 Tf
-0.015 Tc
10.0306 0 0 10.0451 170.4 599.52 Tm
[ (Br) -29 (e) -8 (a) -2 (s) -33 (t) ] TJ
ET
1 g
264.18 608.94 106.26 -13.02 re
B*
BT
0 g
/TT0 1 Tf
0.0182 Tc
10.0306 0 0 10.0451 297.24 599.52 Tm
[ (C) 33 (o) 34 (lo) 34 (r) 28 (e) 25 (ct) 27 (al) ] TJ
ET
1 g
398.64 608.94 106.26 -13.02 re
B*
BT
0 g
/TT0 1 Tf
-0.0223 Tc
10.0306 0 0 10.0451 437.7 599.52 Tm
[ (Ki) -44 (d) -7 (n) -37 (e) -9 (y) ] TJ
ET
1 g
129.96 487.56 106.02 -13.02 re
B*
BT
0 g
/TT0 1 Tf
-0.015 Tc
10.0306 0 0 10.0451 170.94 478.14 Tm
[ (Bl) -30 (o) -5 (o) 1 (d) ] TJ
ET
1 g
264.18 487.56 106.26 -13.02 re
B*
BT
0 g
/TT0 1 Tf
-0.0223 Tc
10.0306 0 0 10.0451 305.94 478.14 Tm
[ (Ot) -44 (h) -13 (e) -9 (r) ] TJ
ET
1 g
386.4 414.84 110.1 -41.58 re
B*
BT
0 g
/TT0 1 Tf
-0.0167 Tc
0.0208 Tw
7.3195 0 0 7.3301 400.56 404.46 Tm
[ (S) 23 (o) -33 (ur) -20 (c) -15 (e) -15 (\040) -8 (o) -33 (f) -20 (\040su) -41 (r) -12 (viv) 8 (a) -24 (l) -34 (\040be) -15 (n) -41 (e) -15 (f) -12 (it\072) ] TJ
0.0004 Tc
0.0119 Tw
0 -1.187 TD
[ (T) 21 (r) -3 (i) -17 (a) 2 (l) 16 (\054) -4 (\040o) -16 (v) 17 (eral) 16 (l) -17 (\040) 8 (s) 13 (u) -16 (rv) 25 (i) 16 (v) 17 (al) ] TJ
0.0172 Tc
-0.0049 Tw
0 -1.22 TD
[ (T) 38 (r) 14 (ia) 18 (l) 33 (\054) 13 (\040pr) 14 (o) 34 (g) 42 (r) 14 (e) 18 (ss) 38 (io) 34 (n\055) 14 (f) 14 (r) 22 (e) 18 (e) 10 (\040) 8 (s) 38 (u) -7 (r) 55 (v) 34 (iv) 42 (a) 10 (l) ] TJ
-0.0149 Tc
0.019 Tw
0 -1.228 TD
[ (M) -11 (o) 2 (d) -31 (e) -14 (ll) -32 (in) -31 (g\040st) -32 (u) 10 (d) -39 (y) ] TJ
ET
q
1 0 0 1 395.88 398.52 cm
0 G
0.814 w
0 0 m
0 1.38 -1.02 2.46 -2.28 2.46 c
-3.54 2.46 -4.56 1.38 -4.56 0 c
-4.56 -1.32 -3.54 -2.46 -2.28 -2.46 c
-1.02 -2.46 0 -1.32 0 0 c
h
B*
Q
q
1 0 0 1 393.72 393.12 cm
0.5 g
0 G
0.814 w
0 0 m
-2.7 -5.16 l
3 -5.16 l
h
B*
Q
1 g
0 G
0.814 w
396.18 383.04 -4.86 -4.86 re
391.32 383.04 m
h
B*
BT
0 g
/TT0 1 Tf
0.0004 Tc
0.0131 Tw
0 11.386 -11.4023 0 102.9 378.12 Tm
[ (P) -18 (r) 1 (i) 15 (c) -9 (e) 17 (\040pe) 12 (r\040l) 20 (i) -12 (fe) 12 (\040) 5 (ye) 12 (a) -9 (r) 1 (\040) 26 (ga) -9 (i) 15 (ne) -9 (d\040) 26 (\050\0441\054) -13 (000s) 10 (\040of\040) 26 (2013) -5 (\040) 5 (U) 6 (S) -18 (D) 11 (\051) ] TJ
-0.0133 Tw
11.386 0 0 11.4023 274.74 354.9 Tm
[ (A) 6 (pprova) 17 (l) -6 (\040da) -9 (t) 15 (e) ] TJ
-0.0128 Tc
0.0042 Tw
8.9461 0 0 8.959 107.52 343.38 Tm
[ (Sou) -22 (r) -15 (c) 9 (e) -25 (\072) -10 (\040A) -15 (u) -2 (th) -29 (or) -15 (s) ] TJ
0.0005 Tc
0.0102 Tw
12.4704 0 0 12.4885 135.72 623.94 Tm
[ (F) 13 (i) -5 (gur) 6 (e) -13 (\040) 20 (3\072\040P) 18 (r) -18 (i) -5 (c) 11 (e) -13 (\040) 25 (pe) 7 (r) -13 (\040) 20 (li) -5 (f) -13 (e) 7 (\040y) 24 (e) -13 (a) 7 (r) -13 (\040) 20 (ga) 11 (i) -5 (ne) 11 (d\040v) 24 (e) -13 (r) 6 (sus\040a) 11 (ppr) 6 (ova) 11 (l) -5 (\040da) 11 (t) -5 (e) -13 (\040) 25 (by\040) 20 (i) -5 (ndic) 7 (a) -8 (t) -5 (i) -5 (on) ] TJ
ET
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
0.9 0.9 0.9 RG
n
306 708 3 8 re
S
0.9 0.9 0.9 RG
n
306 695 3 8 re
S
0.9 0.9 0.9 RG
n
306 681 3 8 re
S
0.9 0.9 0.9 RG
n
306 667 3 8 re
S
0.9 0.9 0.9 RG
n
306 653 3 8 re
S
0.9 0.9 0.9 RG
n
533 317 3 8 re
S
0.9 0.9 0.9 RG
n
306 306 3 8 re
S
0.9 0.9 0.9 RG
n
306 293 3 8 re
S
0.9 0.9 0.9 RG
n
306 279 3 8 re
S
0.9 0.9 0.9 RG
n
306 265 3 8 re
S
0.9 0.9 0.9 RG
n
306 251 3 8 re
S
0.9 0.9 0.9 RG
n
306 237 3 8 re
S
0.9 0.9 0.9 RG
n
306 224 3 8 re
S
0.9 0.9 0.9 RG
n
306 210 3 8 re
S
0.9 0.9 0.9 RG
n
306 196 3 8 re
S
0.9 0.9 0.9 RG
n
306 182 3 8 re
S
0.9 0.9 0.9 RG
n
306 168 3 8 re
S
0.9 0.9 0.9 RG
n
72 155 288 8 re
S
0.9 0.9 0.9 RG
n
120 514 4 8 re
S
0.9 0.9 0.9 RG
n
117 532 7 8 re
S
0.9 0.9 0.9 RG
n
113 550 11 8 re
S
0.9 0.9 0.9 RG
n
113 568 11 8 re
S
0.9 0.9 0.9 RG
n
113 587 11 8 re
S
0.9 0.9 0.9 RG
n
247 517 11 8 re
S
0.9 0.9 0.9 RG
n
247 541 11 8 re
S
0.9 0.9 0.9 RG
n
247 564 11 8 re
S
0.9 0.9 0.9 RG
n
247 587 11 8 re
S
0.9 0.9 0.9 RG
n
381 519 11 8 re
S
0.9 0.9 0.9 RG
n
381 541 11 8 re
S
0.9 0.9 0.9 RG
n
381 564 11 8 re
S
0.9 0.9 0.9 RG
n
381 587 11 8 re
S
0.9 0.9 0.9 RG
n
120 393 4 8 re
S
0.9 0.9 0.9 RG
n
117 411 7 8 re
S
0.9 0.9 0.9 RG
n
113 429 11 8 re
S
0.9 0.9 0.9 RG
n
113 447 11 8 re
S
0.9 0.9 0.9 RG
n
113 465 11 8 re
S
0.9 0.9 0.9 RG
n
255 393 4 8 re
S
0.9 0.9 0.9 RG
n
247 411 11 8 re
S
0.9 0.9 0.9 RG
n
247 429 11 8 re
S
0.9 0.9 0.9 RG
n
247 447 11 8 re
S
0.9 0.9 0.9 RG
n
247 465 11 8 re
S
0.9 0.9 0.9 RG
n
127 498 370 8 re
S
0.9 0.9 0.9 RG
n
126 376 237 8 re
S
0.9 0.9 0.9 RG
n
170 599 296 8 re
S
0.9 0.9 0.9 RG
n
170 478 157 8 re
S
0.9 0.9 0.9 RG
n
400 404 77 8 re
S
0.9 0.9 0.9 RG
n
400 395 63 8 re
S
0.9 0.9 0.9 RG
n
400 386 91 8 re
S
0.9 0.9 0.9 RG
n
400 377 48 8 re
S
0.9 0.9 0.9 RG
n
274 354 64 8 re
S
0.9 0.9 0.9 RG
n
107 343 58 8 re
S
0.9 0.9 0.9 RG
n
135 623 348 8 re
S
Q

endstream
endobj
146 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
xref
0 147
0000000000 65535 f 
0000000009 00000 n 
0000000287 00000 n 
0000000327 00000 n 
0000000578 00000 n 
0000000829 00000 n 
0000001132 00000 n 
0000001423 00000 n 
0000001714 00000 n 
0000002005 00000 n 
0000002284 00000 n 
0000002576 00000 n 
0000002868 00000 n 
0000003160 00000 n 
0000003440 00000 n 
0000003732 00000 n 
0000004024 00000 n 
0000004316 00000 n 
0000004596 00000 n 
0000004888 00000 n 
0000005193 00000 n 
0000005501 00000 n 
0000005795 00000 n 
0000006089 00000 n 
0000006371 00000 n 
0000006677 00000 n 
0000006971 00000 n 
0000007308 00000 n 
0000007633 00000 n 
0000007958 00000 n 
0000008283 00000 n 
0000008608 00000 n 
0000008933 00000 n 
0000009258 00000 n 
0000009540 00000 n 
0000009836 00000 n 
0000010118 00000 n 
0000010168 00000 n 
0000018311 00000 n 
0000018457 00000 n 
0000018484 00000 n 
0000031772 00000 n 
0000031847 00000 n 
0000032152 00000 n 
0000032235 00000 n 
0000074482 00000 n 
0000075095 00000 n 
0000075241 00000 n 
0000075268 00000 n 
0000075568 00000 n 
0000075676 00000 n 
0000084708 00000 n 
0000087876 00000 n 
0000087984 00000 n 
0000096181 00000 n 
0000096266 00000 n 
0000096410 00000 n 
0000096639 00000 n 
0000096924 00000 n 
0000097012 00000 n 
0000110343 00000 n 
0000110631 00000 n 
0000111233 00000 n 
0000111504 00000 n 
0000111925 00000 n 
0000112202 00000 n 
0000112679 00000 n 
0000112963 00000 n 
0000113071 00000 n 
0000121838 00000 n 
0000121946 00000 n 
0000129337 00000 n 
0000129445 00000 n 
0000137622 00000 n 
0000137730 00000 n 
0000145942 00000 n 
0000146050 00000 n 
0000154396 00000 n 
0000154564 00000 n 
0000154809 00000 n 
0000154917 00000 n 
0000164052 00000 n 
0000164224 00000 n 
0000164495 00000 n 
0000178182 00000 n 
0000178290 00000 n 
0000186226 00000 n 
0000186334 00000 n 
0000196197 00000 n 
0000196305 00000 n 
0000204557 00000 n 
0000204665 00000 n 
0000212993 00000 n 
0000213101 00000 n 
0000221595 00000 n 
0000221703 00000 n 
0000230143 00000 n 
0000230251 00000 n 
0000238471 00000 n 
0000238579 00000 n 
0000245500 00000 n 
0000245609 00000 n 
0000253815 00000 n 
0000253972 00000 n 
0000254216 00000 n 
0000254529 00000 n 
0000254620 00000 n 
0000265953 00000 n 
0000266244 00000 n 
0000266353 00000 n 
0000275335 00000 n 
0000275444 00000 n 
0000284004 00000 n 
0000284113 00000 n 
0000292076 00000 n 
0000292185 00000 n 
0000300657 00000 n 
0000300766 00000 n 
0000308363 00000 n 
0000308472 00000 n 
0000317087 00000 n 
0000317196 00000 n 
0000317235 00000 n 
0000319934 00000 n 
0000329013 00000 n 
0000329122 00000 n 
0000338559 00000 n 
0000338668 00000 n 
0000348173 00000 n 
0000348282 00000 n 
0000357894 00000 n 
0000358003 00000 n 
0000367579 00000 n 
0000367688 00000 n 
0000376380 00000 n 
0000376489 00000 n 
0000389555 00000 n 
0000389664 00000 n 
0000405730 00000 n 
0000405878 00000 n 
0000406112 00000 n 
0000406381 00000 n 
0000406471 00000 n 
0000410354 00000 n 
0000410647 00000 n 
0000410756 00000 n 
0000429768 00000 n 
trailer
<<
/Size 147
/Root 36 0 R
/Info 2 0 R
>>
startxref
429877
%%EOF
